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ABSTRACT 
The halichondrins are a series of polyether macrolides displaying potent in vitro and 
in vivo antitumour activities and, as such, represent important leads as anticancer 
drugs. These compounds had previously been isolated from a number of unrelated 
marine sponges, such as Lissodendoryx sp., a high yielding deep-water sponge 
located off the Kaikoura coast of New Zealand. 
Structure-activity relationships in the halichondrin senes have now been 
investigated. Hemi-synthetic modifications of selected naturally-occurring 
halichondrins have produced over fourteen new analogues. The biological activities 
of twelve of these analogues have been assessed in an in-house P388 in vitro assay 
and in the National Cancer Institute's (USA) in vitro sixty cell-line human tumour 
panel. An analysis of these data has shown that the lactone ring (Cl-C30), the 
olefinic functionalities (Cl9 and C26), the natural C38 stereochemistry and the 
tricyclo ring system (C-E rings) are essential structural features of the halichondrins. 
The characterisation of the hemi-synthetic derivatives has been facilitated by the full 
NMR spectroscopic assignments of halichondrin B and homohalichondrin B. 
The future progress of the halichondrins as anticancer drugs will have been assisted 
by the development of an understanding of the general chemistry of the 
halichondrins. 
2 
CHAPTER! 
Introduction 
Chapter 1- Introduction 3 
1.1 Marine Natural Products 
1.1.1 Introduction- Natural Products as Potential Drug Sources 
For thousands of years mankind has sought to conquer and control diseases arising in 
humans, domesticated animals and food crops. Nature, in particular terrestrial flora 
and fauna, has traditionally provided the source for the treatment of many such 
diseases. However, the use of crude preparations from plants and animals can have 
several disadvantages including seasonal and geographical variations in the 
quantities of the active constituent(s). Other drawbacks include the possible co-
occurrence of undesirable components with detrimental side effects and the loss of 
biological activity in the preparation or storage of the crude material. It is therefore 
desirable to isolate the individual natural products giving rise to the observed 
biological activity. 
Williams et azl define a natural product as an organic compound that has "no explicit 
role in the internal economy of the organism that produces it". These authors argue 
that the existence of natural products in an organism serves to increase its survival 
fitness and hence gain a competitive edge in its environment. They further suggest 
that all natural products have evolved under the pressure of natural selection to 
interact with specific receptors of the competitor. 
Biologically active natural products associated with an organism may be synthesised 
de novo by the organism itself or they may be sequestered from a dietary source. It 
is also possible that a symbiotic organism in close association synthesises the 
bioactive natural product. 
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Bioactive natural products can be seen as having a protective role in the organism: 
protection from predation, protection from competition for space, light and nutrients, 
and protection from infection by micro-organisms. This is supported by the 
observation that many organisms will only produce natural products while under 
some kind of stress.2 Williams et all note that natural products are common in 
organisms lacking an immune system and are sparse in those possessing an immune 
system. This implies that natural products play an important role in the chemical 
defences of organisms lacking immune systems such as plants, fungi, micro-
organisms and invertebrate animals. Indeed, the very survival of such organisms 
may, in part, be a function of the chemical "warfare" available to it. Natural 
compounds isolated from species which are lacking an immune system are therefore 
a rich source of biologically active compounds. 
Screening of extracts for a particular biological activity, for example antiviral 
activity, from plant, animal, microbial or fungal sources with a disease-specific 
biological assay provides an invaluable guide for the separation and isolation of 
bioactive natural products. In this way important leads in drug discovery and 
development can be revealed for the potential treatment of specific diseases. 
1.1.1.1 Cancer 
"Cancer" describes more than two hundred different diseases, each characterised by 
unrestrained cell growth. 3 Cancer is caused, in most instances, by mutation or 
abnormal activation of cellular genes that control cell growth and mitosis. Only a 
minute fraction of cells that mutate actually lead to cancer. This is because most of 
the mutated cells have a decreased survival capacity, due to the mutation, and only a 
few mutated cells actually lose the feedback mechanism that prevents excessive cell 
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growth. The immune system also serves to destroy most mutated cells before they 
can develop into a cancer. 4 
A cancer cell has many characteristics that distinguish it from a normal cell and 
gives rise to its invasive nature. A cancer cell does not respect usual cellular growth 
limits, resulting in unrestrained growth. The cells are less adhesive to each other and 
can therefore move through tissues and be freely circulated by the bloodstream 
resulting in numerous new growths. Some cancers produce angiogenic factors ie 
causing the growth of new blood vessels, to supply the nutrients to the cells that are 
required for cancer growth. As cancer cells undergo indefinite proliferation they 
have an increasingly high nutrient demand resulting in the gradual nutritive death of 
normal cells and ultimately death for the patient. 4 
Cancer cells are continuously dividing, though this process is inefficient. Normal 
cells divide more rapidly than cancer cells but fewer are in a state of active division 
at any one moment. Therefore drugs which can specifically target the continuously 
dividing cancer cells will be relatively selective as anticancer compounds. A "good" 
anticancer drug will be able to differentiate between the normal, healthy cells and 
cancerous cells (ie the drug should be "selective") and it should also be able to 
destroy the cancer cells (ie the drug should be cytotoxic). It is important to note that 
cytotoxicity alone is not sufficient for antitumour activity in a therapeutic sense, 
since the compound must also be selectively toxic. However, cytotoxicity is 
consistent with most observations of antitumour activity. "Cytotoxicity" is therefore 
described as an in vitro observation of biological activity and "antitumour activity" is 
described as an in vivo activity. 
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1.1.1.2 Marine Natural Products 
The seas and oceans of the world cover a vast area of the earth and contain a huge 
diversity of relatively unexplored flora and fauna. It has been estimated that four-
fifths of the Earth's animal life live in or on the water.S Coupled with the growing 
accessibility of the marine environment, such as by SCUBA diving, marine 
organisms now represent a valuable resource for the discovery of novel bioactive 
natural products with pharmaceutical potential. 
Data from the National Cancer Institute (NCI) in the USA, compiled by Dr. Peter 
Murphy of the Australian Institute of Marine Sciences (AIMS) in 1992,6 further 
illustrates the utility of screening marine natural products as potential drug sources. 
Figure 1.1.1 displays the number of anticancer leads from various sources in the 
NCI in vitro preclinical antitumour drug screen. It can be seen that although, relative 
to terrestrial sources, a low number compounds of marine origin have been screened, 
there are a high proportion of anticancer leads originating from marine animal 
sources. 
Absolute number screened in italics 
Terrestrial Animals 
Terrestrial Plants 
6540 
Marine Animals 
Marine Plants 
Mica organisms 
0 2 
Percentage 
Figure 1.1.1 Anticancer Leads with Significant Selective Cytotoxic Activity in the 
NCI Preclinical Antitumour Drug Discovery Screen. 6 
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Australian results from AIMS6 indicate that more specifically, the manne 
invertebrate phylum Porifera (sponges) provides a rich source of cytotoxic marine 
natural products, with over 11% of specimens in this phylum displaying significant 
cytotoxicity (viz ICso <4 Jlg/mL). 
1.1.1.3 Sponges7 
Sponges are classed in a subkingdom of their own called Parazoa as they appear to 
have travelled a unique evolutionary route relative to other animals. 8 They are 
classed in the phylum Porifera (meaning "pore bearing"). In the adult stage they are 
sessile and largely plant-like in appearance. There are about five thousand species of 
sponges divided into four classes based on their skeletal structure. 8 Their habitat 
generally consists of attachment to the ocean floors of shallow coastal areas although 
some sponges are located at great depths. A few sponges are found in fresh water. 
Sponges are essentially an aggregation of cells, with no specialised organs or tissues, 
although there is some degree of coordination between different cell types, and 
cellular recognition within the aggregation. Sponges are filter-feeders, drawing in 
water through oscules (pores) dotting the external surface of the sponge body into 
one or more internal chambers by the combined effect of the current across the 
osculum (the cavity at the top of the chamber) and flagella lining the cavity 
protruding from numerous collar cells (choanocytes). 8 The choanocytes trap and 
absorb passing nutrients. As sponges lack an immune system and are filter-feeders, 
it is probable that the presence of bioactive compounds provides a defence against 
potentially harmful filtered bacteria. 
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1.1.2 The Marine Chemistry Group 
The Marine Chemistry Group at the University of Canterbury was formed in 1975 
with the main objective being to isolate and identify the structures of new classes of 
biologically active compounds derived from marine sources. 
A wide range of extracts are screened in the Marine Chemistry Group's in-house in 
vitro antimicrobial, antiviral (Appendix I) and antitumour assays. Those samples 
producing extracts with a pertinent biological response are re-extracted on a larger 
scale in a bioassay-directed chromatographic separation of the active constituents. 
Once isolated, the active components are identified. The P388 antitumour assay is 
discussed in detail (Section 1.1.2.1) and examples of bioassay-directed "hits" (ie the 
isolation of biologically active compounds) are described in Section 1.1.2.2 which 
serves to highlight the success of the Marine Chemistry Group's approach. 
1.1.2.1 The P388 Antitumour Assay 
The in vitro "antitumour" assay uses the P388 cell line (murine leukemia cells) and it 
is up to a hundred times more sensitive to cytotoxicity effects than the antiviral BSC-
1 cell line. The P388 assay is therefore a cytotoxicity-based assay against a specific 
leukemia cell type. The ICso result obtained from this assay represents the 
concentration of the test compound at which the number of viable cells is reduced by 
fifty per cent relative to the control. 
A two-fold dilution series of the sample of interest is incubated with P388 cells and 
MTT, a yellow tetrazolium salt, in small plastic wells. After seventy-two hours of 
incubation the concentration of the sample required to reduce the number of viable 
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cells by fifty per cent relative to a control (P388 cells, MTT, media and solvent) is 
calculated. The mitochondria of viable leukemia cells reduce the yellow dye MTT to 
a purple formazan derivative. 9 By measuring the light absorbance at 540 nm in each 
well, a direct quantification of formazan formation and therefore the number of 
viable cells is able to be determined. The absorbance is expressed as a percentage 
cell viability relative to the control, and is plotted against the logarithm of the sample 
concentration in the well to generate a sample concentration vs cell viability curve. 
The antilogarithm of the concentration producing a fifty per cent reduction in the 
number of viable cells gives the ICso result, which is usually expressed in units of 
ng/rnL. 
The P388 cell line represents a rapidly dividing cell type, thus its efficacy in finding 
products with activity in the predominantly occurring slow growing solid tumours of 
humans such as lung, colon, breast, skin and kidney cancers is strictly limited.l0 
However, it is important to consider that a P388-active compound may still display a 
selective activity against these types of tumour. 
1.1.2.2 Bioassay-Directed Isolations 
The antiviral and antitumour compounds mycalamide A (1.1.1) and mycalamide B 
(1.1.2) were isolated in an antiviral-directed extraction of a New Zealand species of 
Mycale found in the Otago Harbour.11,12 
R = H mycalamide A (1.1.1) 
R = CH3 mycalamide B (1.1.2) 
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The mycalamides later proved to be too cytotoxic to be effective as antiviral agents 
but at present they represent important anticancer leads. 
A bioassay-directed analysis of bulk New Zealand Latrunculia sp. sponge extracts 
led to the isolation of the structurally related iminoquinones, discorhabdins A, B and 
C as the major cytotoxic components.12 Discorhabdins A, B and C (1.1.3) displayed 
strong antiviral activity in vitro; high activity in the in vitro P388 assay and selected 
antimicrobial activity.13 Discorhabdin C, like the mycalamides, currently represents 
an important anticancer lead. 
0 
discorhabdin C ( 1.1.3) 
Br 
Bioassay-directed separation of the active constituents from a small sample of a 
deep-water Kaikoura sponge (Lissodendoryx sp.) yielded several novel members of 
the halichondrin series of antitumour compounds. The isolation of halichondrins at 
high levels compared to other sponges allowed the bioassay-directed, bulk extraction 
and separation of relatively "large" quantities of halichondrins.l4 Some of this 
material provided the basis for the investigations described in this thesis (Section 
1.4). The halichondrins are discussed in greater detail in Section 1.2. 
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1.1.3 Anticancer Drug Development- the NCI 
Since 1955, the National Cancer Institute (NCI) of the National Institutes of Health 
in the USA has operated a major program to coordinate anticancer drug development 
at a national and international level. Screening of synthetic and naturally occurring 
compounds has been undertaken at the NCI to ascertain the antitumour and other 
biological properties of these compounds. In fact, mass screening of synthetic or 
naturally occurring products as well as complex extracts of natural products has 
proved to be the most effective means of discovering new chemotypes with 
antitumour or other biological properties.l5 The discovery of novel active 
compounds has, in some cases, lead directly to candidates for new drug development 
or these compounds have served as the starting point for analogue synthesis directed 
at producing analogues with more potent and/or selective biological activities. 
From 1975 to 1985, the primary screen used by the NCI was the in vivo P388 mouse 
leukemia assay. An increasing emphasis on solid tumour models and disease-
specific screening saw, in 1985, the introduction of an in vitro disease-oriented panel 
of (predominantly) human tumour cell lines as the primary screen and the phasing 
out of the in vivo P388 murine leukemia screen used previously. Figure 1.1.1 
displays the NCI screening and drug development strategy operational in 1990. 
Decisions and actions regarding the pathway of potential anticancer drugs in this 
strategy are controlled by the Decision Network Committee (DNC) of the NCI. 
Compounds that prove sensitive in the in vitro primary screen are selected for 
secondary in vivo xenograft testing with selected, sensitive human tumour cell lines. 
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! 
Disease-oriented, in vitro 
primary screen employing 
multiple human tumour 
cell lines 
In vivo xenograft testing 
with selected sensitive 
human tumour cell 
lines 
Formulation/toxicology/ 
bulk drug production 
t 
INDA approval 
Clinical trials 
Figure 1.1.1 Schematic Representation of NCI Preclinical Screening and Drug 
Development Operational in 1990.15 
12 
Stages "lA" and "IB" of the DNC strategy involve, among other actions, the in vitro 
testing of selected compounds in the primary screening system. Approximately two 
hundred compounds that possess suitable bioactivities pass this point each year. At 
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the IIA stage in preclinical development, isolation and/or synthesis of the drug is 
optimised and the studies on the feasibility and cost of scale-up are carried out. The 
qualitative and quantitative analytical methods for the drug are set up, and tests of 
oral bioavailability are conducted. In vivo activity is tested for in appropriate 
models. The DNC allows approximately ten compounds per year past this point. 
Stage liB involves bulk drug production and purity monitoring, while route and 
schedule dependency studies are undertaken in vivo. At this stage pharmacokinetic 
studies are carried out and toxicological evaluations in rodents and dogs are also 
undertaken. At stage III level, INDA (Investigational New Drug Application) 
approval is sought, then clinical trials may commence. 
Currently (as of May 311994), the primary in vitro screen comprises sixty human 
tumour cell lines in nine histological subpanels viz leukemias, non-small cell lung 
cancers, colon cancers, CNS cancers, melanomas, ovarian cancers, renal cancers, 
prostate cancers and breast cancers. 
Each compound is tested in quadruplicate at each of three different concentration 
ranges (1Q-7, lQ-8, lQ-9 Mas the upper limits with five log10 dilutions) against the 
sixty tumour cell lines in the panei.15 Three different target responses may be 
chosen to quantitate the data: by the Glso, LCso or TGI response. The Glso 
represents the drug concentration producing an apparent fifty per cent decrease in the 
number of tumour cells relative to an appropriate non-drug control at the end of the 
drug incubation. 15 The LCso is defined as the concentration of drug producing an 
apparent fifty percent reduction in the number of tumour cells in reference to an 
appropriate non-drug control at the start of the incubation. The TGI is the 
concentration at which the number of tumour cells remaining at the end of the 
incubation is the same as at the beginning of the incubation. 
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A mean-graph format can be constructed to display the data. This graph displays 
horizontal bars for individual cell line for any of the desired target responses (for 
example, the negative logwTGI results) relative to the averaged response (negative 
logwTGI) over all cell lines. The mean graph therefore provides a characteristic 
"fingerprint" for a given compound, depicting individual cell lines that are 
proportionally more sensitive than average (bars to the right of the average response) 
or less sensitive than the average (bars to the left of the average response). Mean 
graphs from the testing of halichondrin Bin the NCI primary screen are displayed in 
Appendix II (at 1 x lQ-8 M, average of quadruplicate). 
Compounds may be classified as having non-specific cytotoxicity ( eg a general cell 
poison) by showing no cell line or panel-specific differential cytototoxicity. Other 
compounds may show differential cytotoxicity for specific cell lines or panels in the 
screen; these compounds are of most interest as they may represent a new class of 
disease-specific compounds and/or a new mechanism of action. The observation of 
such selective cytotoxicity "implicitly suggests the presence of a cell-specific 
receptor that differentiates one tumour from another11 .16 These compounds will 
serve as important tools for probing tumour-specific anticancer agents and could be 
useful in the treatment of specific cancer types.16 
The distinctive mean-graph "fingerprint" can also give an indication of the 
mechanism of action of a particular class of compounds. Boyd9 states that: 
a medicinal chemist might wish to prepare new derivatives of a 
known prototype drug that might have improved physiochemical 
properties, or lower toxicity or otherwise potentially improved 
features, yet that retained the desired highly characteristic cellular 
response "fingerprint" produced by the prototype. 
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1.2 The Halichondrins 
1.2.1 Background 
A novel series of structurally related polyether macrolides with remarkable 
antitumour activities were first reported in 1985 by Uemura et azl7 followed up by a 
related paper in 1986 by Hirata and Uemura.18 These compounds were named the 
halichondrins after the sponge they were extracted from, Halichondria okadai 
Kadota, located off the Pacific coast of Japan. Eight halichondrins were isolated and 
identified: halichondrins B (1.2.1) and C; norhalichondrins B (1.2.2), A and C; and 
homohalichondrins B (1.2.2), A and C. The unique members of the halichondrin 
series (eg norhalichondrin or homohalichondrin) differ in structure beyond the C45 
position. The families A (1.2.4), B (1.2.5) and C (1.2.6) designate the degree of 
oxygenation at the C12 and Cl3 positions. 
CHs 
~ H 1:1 CHs ~ 1:1 0 
H 
HO zj:j L HyO::, ,,,,,,'' O H ~ : H 
'',,, CH3 
54 
HO 
H 34 H 
halichondrin B (1.2.1) 
:27 
t:l: Q G : 22(''' 2s''CH3 
ltllfJ 
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H 43 
~3 
~ H 
HO,,czw L ,,, M N : 
51 47 : 
A
,,,,'' 0 : 
H = 
HO 0 
CHs 
norhalichondrin B ( 1.2.2) 
H 
55 
HO 
OH H 
A family ( 1.2.4) 
H 
H 
CHs 
~ H H H 
H 34 H 
B family (1.2.5) 
16 
0 
0 
C family (1.2.6) 
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The halichondrin series of compounds are characterised by a large 22-membered 
lactone ring (C1-C30), two exocyclic olefinic groups at C19 and C26, an unusual 
tricyclo ring system (the C to E rings) and numerous furanose and pyranose ring 
systems such as the A to L rings common to all halichondrins isolated thus far. 
In terms of cytotoxicity and antitumour activity, Uemura et al reported halichondrin 
B (1.2.1) as the most cytotoxic of the halichondrins they isolated. The in vitro 
cytotoxicity results for the compounds tested against the B-16 melanoma cell line are 
given in Table 1.2.1.18 
Table 1.2.1 ICso values against B-16 melanoma cells (ng/mL) 
Halichondrin series 
norhalichondrin 
halichondrin 
homohalichondrin 
Halichondrin family 
A family B family 
5.2 
0.26 
NRa 
0.09 
0.10 
a Data not reported (NR) but result less than for halichondrin B. 
C family 
NRa 
0.35 
From the cytotoxicity results shown in Table 1.2.1, it can be seen that halichondrin 
B and homohalichondrin B present higher activities relative to the other 
halichondrins. 
The antitumour activities of halichondrin B (1.2.1) and homohalichondrin B (1.2.3) 
were also investigated by in vivo testing on mice with B-16 melanoma, P388 
leukemia and L-1210 leukemia tumours. A three hundred per cent increase in the 
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life expectancy of the P388 leukemia afflicted mice was reported relative to the 
control group (no halichondrin administered) for halichondrin B.18 Similar results 
were observed for the other two cell lines and for homohalichondrin B.18 
In 1993, Pettit et al reported the isolation and characterisation of two new 
halichondrin compounds, halistatin 1 (1.2.7)19 and halistatin 2 (1.2.8).20 Halistatin 1 
is essentially 1 Oa-hydroxy substituted halichondrin B and halistatin 2 is 1 Oa-
hydroxy substituted homohalichondrin B. Halistatin 1 was initially isolated from the 
East Indian Ocean sponge Phakellia carteri, a sponge located in the coastal areas of 
the Republic of Cormoros. Halichondrin B (1.2.1) and homohalichondrin B (1.2.3) 
were also isolated from this sponge. This sponge yielded <0.1 rng of these 
halichondrins per kg (wet sponge). Halistatin 2 was isolated from Axinella cf. 
carteri (Dendy), also a Cormoros sponge, along with halistatin 1, halichondrin B and 
homohalichondrin B. Axinella cf. carteri yielded ca 0.1 mg of these halichondrins 
per kg wet sponge. 
CH3 
- H 
HO, -~ ~ HYO':,,,,,,'' 0 H ~ : H 
'',,, CH3 
54 HO 
halistatin 1 (1.2.7) 
37 
0 
H 34 H 
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9H3 
H 
1-:1 H 
0 
55 M 
HO H 
OH H H CH3 
halistatin 2 ( 1.2.8) 
The cytotoxicities of halistatin 1 and halistatin 2 were tested in the NCI's human 
tumour, disease-oriented in vitro primary screen. The overall Glso results were 
reported at 7.1 x 10-10 M and 6.8 x 10-10 M respectively.20 Halichondrin B (1.2.1) 
was reported by Pettit to be more active with a Glso of 2.3 x 10-10 M. 
1.2.2 Halichondrins- Marine Chemistry Group Involvement 
In 1987, halichondrin-type compounds were first identified by Dr. Robin Lake from 
two unrelated sponges. One of these sponges was identified as one or more new 
species of the genus Lissodendoryx Topsent (class Demospongiae, subclass 
Ceractinomorphia, order Poecilosclerida, family Myxillidae).21 This bright yellow 
sponge (Figure 1.2.1) was collected by dredging deep waters (ca lOOm) off the 
Kaikoura coast. 
Dr. Lake also detected halichondrins in a cytotoxic extract from another sponge, 
Raspailia agminata (order Axinellida, family Raspailiidae), a black, shallow water 
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sponge from the Leigh area of the North Island.22 The halichondrins were present at 
low levels (<0.5 mg total halichondrins/kg wet sponge) relative to the high yielding 
Lissodendoryx sp. sponge (ca 1.6 mg/kg). 
Figure 1.2.1 Lissodendoryx sp. 
From a small sample of Lissodendoryx sp. sponge a new halichondrin-type 
compound was identified, by Dr. Lake, as one of the major cytotoxic components, 
although at that stage a full characterisation was not achieved. 22 It was observed that 
this compound transformed cleanly to another compound in CD30D. Two other 
major cytotoxic compounds were identified as a mixture of halichondrin B (1.2.1) 
and homohalichondrin B (1.2.3). 
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A later extraction of Lissodendoryx sp. by Dr. Marc Litaudon reisolated 4.5 mg of 
the new halichondrin, which was then able to be structurally characterised by MS 
and NMR spectroscopy. This novel halichondrin was given the name 
isohomohalichondrin B (1.2.9) 14 as it is isobaric with homohalichondrin B (1.2.3). It 
has an obvious similarity to the structure of norhalichondrin B (1.2.2), except at C53 
there is an aliphatic ketone rather than a carboxylate and a -CH2CH20H terminus 
attached to C53. 
0 
HO ~H 0 43 L ,,, 
,, N M : 
51 47 : 
,,,, 
,, 0 H ~ H ~28 
HO O 
CH 3 
isohomohalichondrin B ( 1.2.9) 
A bulk extraction of ca 100 kg of Lissodendoryx sp. sponge produced 52.8 mg 
halichondrin B, 53.5 mg of homohalichondrin B, 65.8 mg of isohomohalichondrin B 
and several novel, minor, halichondrin compounds.23 Five of these minor 
compounds have been isolated and their structures established: 3 mg of Me-
isohomohalichondrin B-a (1.2.10), 7 mg of neohomohalichondrin B (1.2.11), 0.7 mg 
of Me-isohomohalichondrin B-b (1.2.12), 0.9 mg of isonorhalichondrin B (1.2.13) 
and 0.7 mg of the previously identified norhalichondrin B (1.2.2).23 
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qH3 
H 
H H 
HO 
H3CO 
H H 
Me-isohomohalichondrin B-a (1.2.10) 
OH 0 
52 
OH 
neohomohalichondrin B (1.2.11) 
HO,,,,,~H  43 L 
N ~ 0 
' 51 47 = ~0 0 H ~' 
CH 30 
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isonorhalichondrin B (1.2.13) 
Me-isohomohalichondrin B-a (1.2.10) was observed to transform to 
isohomohalichondrin B (1.2.9) in an NMR tube, presumably via acetal hydrolysis. 
The reverse reaction, although much slower, was realised on a sample of 
isohomohalichondrin Bin CD30D.23 It is still unclear as to which compound is the 
natural component and which is a product of the extraction and purification 
procedure. A small amount of the C53 ketal diastereoisomer of Me-
isohomohalichondrin B-a was also isolated, and this material was also observed to 
transform rapidly to isohomohalichondrin B (1.2.9). 
Me-isohomohalichondrin B-b (1.2.12) is the C55 methoxyl derivative of 
isohomohalichondrin B. Neohomohalichondrin B (1.2.11) has a structure similar to 
halichondrin B (1.2.1) except for an additional methylene group inserted between the 
two secondary alcohol groups in the terminal moiety. Finally, isonorhalichondrin B 
(1.2.13) displays a unique terminal M and N ring fusion. 
The cytotoxicities of the halichondrins isolated in the bulk Lissodendoryx sp. 
extraction were tested in our in-house in vitro P388 murine leukemia assay and in the 
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NCI's in vitro antitumour primary screening system (the Glso data).23 These results 
are summarised in Table 1.2.2. It is apparent that isohomohalichondrin B (1.2.9) 
and Me-isohomohalichondrin B-a (1.2.10) possess cytotoxicities in the order of 
halichondrin B (1.2.1) and homohalichondrin B (1.2.3). Neohomohalichondrin B 
(1.2.11) and Me-isohomohalichondrin B-b (1.2.12) appear to be very slightly less 
active in the NCI screen. The P388 cell line appears to be relatively insensitive to 
Me-isohomohalichondrin B-b. Both isonorhalichondrin B (1.2.13) and 
norhalichondrin B (1.2.2) appear to be less cytotoxic relative to the other 
halichondrins in the NCI screen, although the P388 assay appears to be more 
sensitive to isonorhalichondrin B than the cytotoxicity result from the NCI Glso 
result tends to suggest. A further analysis of these results in terms of their 
relationship to structure is found in Chapter 9. 
Table 1.2.2 In Vitro Cytotoxicities of Halichondrins From Lissodendoryx sp. 
Compound 
halichondrin B (1.2.1) 
norhalichondrin B (1.2.2) 
homohalichondrin B (1.2.3) 
isohomohalichondrin B (1.2.9) 
Me-isohomohalichondrin B-a (1.2.10) 
neohomohalichondrin B (1.2.11) 
Me-isohomohalichondrin B-b (1.2.12) 
isonorhalichondrin B (1.2.13) 
P388 ICso 
(ng/mL) 
0.78 
0.22 
0.18 
0.1 
0.8 
10.0 
0.4 
Giso 
(xlQ-10 M) 
1.38 
29.50 
3.16 
1.15 
1.23 
3.39 
2.00 
12.30 
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Halichondrin B (1.2.1) was later chosen for in vivo evaluation against selected 
tumours. Halichondrin B was found to be active in vivo against selected sensitive 
melanoma, colon, ovarian, lung and breast cancer cell line xenograft implantations in 
athymic nude mice. 
Currently, halichondrin B (1.2.1) has NCI Decision Network Committee "IIA 
status", awaiting further supplies for preclinical development and the implementation 
of an effective, sensitive method of analysis for halichondrin B in body fluids. 
1.2.3 Halichondrin Mechanism of Action 
An analysis of the halichondrin B (1.2.1, Appendix II) and homohalichondrin B 
(1.2.3) mean-graph "fingerprints" by the COMPARE pattern recognition algorithm 
showed that their profiles were most highly correlated to the structurally unrelated, 
tubulin-binding standards vincristine and taxol. 24 
Tubulin is a globular protein that normally undergoes polymerisation to form 
microtubules which, in tum, play an important role in moving chromosomes together 
and apart during the process of mitosis (cellular replication). Most antimitotic agents 
are known to interfere with the in vitro polymerisation of tubulin via specific 
interaction. One notable exception is the anticancer compound taxol, a complex 
terpene, that acts to stabilise microtubules, thus acting as a depolymerisation 
inhibitor of tubulin. 
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The alkaloid colchicine binds specifically and reversibly with tubulin, resulting in 
the blocking of mitosis at metaphase by arresting the formation of the mitotic 
spindle. The Vinca rosea alkaloids vincristine and vinblastine inhibit mitosis in 
metaphase by tubulin binding, but at a site distinct from the colchicine binding site. 25 
The "vinca site" represents the region of tubulin where the vinca alkaloids and their 
competitive inhibitors (eg maytansine) bind. The peptide antimitotics dolastatin 10 
and phomopsin A are non-competitive inhibitors of the vinca alkaloid binding to 
tubulin. Classically, this is interpreted as binding in a region, physically near to, but 
distinct from the vinca site and this site is termed the "vinca domain". 
Investigations by Bai et a[24 noted the accumulation of cells arrested in mitosis at 
cytotoxic concentrations of either halichondrin B (1.2.1) or homohalichondrin B 
(1.2.3) for L1210 murine leukemia cells in vitro. These compounds were found to 
inhibit the polymerisation of purified tubulin and microtubule assembly dependent 
on microtubule associated proteins. Halichondrin B was found to be a relatively 
weak inhibitor of tubulin polymerisation, despite its potent cytotoxicity. Bai et az24 
speculated that this was a reflection of either the highly efficient uptake of the drug 
or its intracellular metabolism to more potent compounds. Halichondrin B did not 
interfere with colchicine binding to tubulin, but was found to be a non-competitive 
inhibitor of the vinca alkaloid vinblastine. This suggested that halichondrin B was 
binding in the vinca domain of tubulin. Vinca domain drugs inhibit tubulin-
dependent GTP hydrolysis and also inhibit GTP/GDP exchange at the exchangeable 
nucleotide site of tubulin. Halichondrin B was found to inhibit net GTP hydrolysis 
and nucleotide exchange on tubulin. These observations verified the earlier 
COMPARE differential cytotoxicity analysis that the mode of action for 
halichondrin B and homohalichondrin B was as antimitotic agents. 
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1.3 Halichondrin Supply 
As indicated in Section 1.1.3, the bulk supply of a potential anticancer drug is an 
essential requirement for entry into the clinical trial stage. There are several options 
for obtaining large amounts (gram quantities) of a material such as the halichondrins: 
collection, aquaculture, microbial or tissue culture, genome transfer or the total 
synthesis of the compound. These options are briefly discussed. 
1.3.1 Collection 
Bulk extraction of sponges producing the halichondrins has provided the major 
source of the halichondrins isolated to date. Lissodendoryx sp. provides a rich source 
of halichondrins relative to the other spongesl4 (refer Sections 1.2.1 and 1.2.2). 
Initial investigations established that the only known source of Lissodendoryx sp. 
was in deep water off the Kaikoura peninsula. Before large quantities of sponge can 
be collected, it is essential to gauge the size of the existing sponge field, the impact 
of collection on the environment and the regrowth of the sponge in the harvested 
area. A major survey of the sponge field has been undertaken to establish the 
population size and density of sponge and the efficiency and impact of trawling on 
the sponge field. 26 
A video on board a Remote Operated Vehicle (ROV) was used to establish the 
preferred habitat and population density over a 5.3 km2 area of the sea bed. It was 
found that Lissodendoryx sp. was the dominant sponge in this area with an average 
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density of 5.4 ± 2.7 gfm2 with only 43% of the habitat being available to it.26 
Controlled trawls within the sponge field were backed up by the use of the ROV. 
Trawling was estimated to be 73% efficient26 at harvesting the Lissodendoryx 
sponge. Re-examination of the trawled areas after 12 months will establish the 
regrowth pattern in the trawled areas. 
1.3.2 Aquaculture 
The aquaculture of explanted Lissodendoryx sp. into a more accessible environment 
may provide the quantities necessary for bulk halichondrin extraction. However, it is 
possible that the explanted sponge may not survive or produce halichondrins in a 
new environment. Alterations in salinity, pressure, temperature, sunlight, oxygen 
levels, available nutrients, associated microorganisms, competition and other forms 
of stress may all contribute to decrease the chances of survival of the sponge or limit 
the production of halichondrins. 
Initial explants of Lissodendoryx sp. were taken from deep water off Kaikoura to a 
more accessible shallow water site in Wellington Harbour by Dr. Chris Battershill of 
the New Zealand Oceanographic Institute. These sponge samples were found to 
double in size over the four months at the new site and it was also observed that 
small samples had broken off the main explants and had recruited neighbouring 
sites. 26 It appears that the sponge can survive and is rapidly growing under these 
conditions. Investigations on samples of the Wellington Harbour sponges indicate 
that high levels of cytotoxicity are still produced in the sponge. Efforts are currently 
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focused on identifying the cytotoxic components to determine the quantities and 
relative proportions of halichondrins being produced in the explanted sponge. 
1.3.3 Microbial or Tissue Culture 
Given that halichondrins have been found in several unrelated species of sponge, it 
would evidently appear more likely that the halichondrins are produced by a 
symbiotic, microbial source rather than de novo by the sponge cells. Therefore the 
isolation and culture of the microorganisms responsible for producing the 
halichondrins could provide au efficient method for bulk halichondrin production. 
Alternatively, the location of the sponge cell type producing the halichondrins and its 
subsequent culture could efficiently provide the quantities of halichondrin required. 
Some preliminary investigations to determine the location of the halichondrins 
within the sponge were carried out by Dr. Mary Garson while in the Marine 
Chemistry Group. Sponge cell dissociation aud separation into different cell types 
by a Ficoll gradient27 was carried out as well as membrane fractionation, and a 
combined Ficoll gradient-membrane fractionation experiment. These experiments 
were followed up with P388 bioassays and electron microscopy. The results of these 
experiments suggested that the activity associated with Lissodendoryx sp. was 
associated with the sponge cells themselves rather than a symbiont source. 28 There 
appeared to be little in the way of bacterial cells associated with the sponge, from 
electron micrographs of tissue preparations and the fractions from the dissociation 
experiments. 29 The results furthermore suggested that the activity was membrane-
associated. Antibiotic experiments on Lissodendoryx sp. to kill any sponge-
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associated extracellular and intracellular bacterial cells may help to confirm that the 
sponge cells are producing the halichondrins de novo. 
1.3.4 Genome Transfer 
The transfer of the genome from a halichondrin producing cell to a vector amenable 
to fermentation is becoming increasingly viable, particularly for compounds of 
polyketide biosynthetic origins. 26 
1.3.5 Synthesis 
The total synthesis of the halichondrins provides another option in supplying a large 
amount of halichondrin material. This is by no means a trivial task. Kishi and co-
workers first reported the total synthesis of halichondrin B (1.2.1) and 
norhalichondrin B (1.2.2) in 1992.29 Although the starting points for the synthesis 
relied upon inexpensive compounds of known absolute stereochemistry, the 
synthesis encompassed over a hundred reaction steps. A review of the Kishi 
synthesis (Appendix III) was undertaken in order to examine some of the chemistry 
that might be pertinent to this project, and it gives the overall synthetic strategy in 
the total synthesis of halichondrin B. For the bulk total synthesis of halichondrins to 
be cost competitive relative to the bulk extraction methods, a great deal of synthetic 
refinement will be required. 
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1.4 Project Aims 
The objectives of this project fell into four main areas: 
i) A prime objective of this project was to develop an understanding of the 
relationship between structure and the expression of biological activity in the 
halichondrin series of antitumour compounds. 
The chemical modification of selected members of the halichondrin family would 
give some insight into the essential structural and conformational features for the 
expression of biological activity. Evidence from the pharmaceutical industry has 
shown that the most effective drug may not be the natural compound, but rather an 
analogue of it. Therefore, it was also possible that the analogues produced may have 
improved biological properties relative to the naturally-occurring compounds, and 
thus provide additional leads as potential antitumour drugs. 
ii) The structural assignment of the derivatives produced during the course of this 
project relied upon the full assignment of the NMR spectral data of the parent 
compounds, to be used for reference purposes. The initial objective to be 
accomplished, prior to the production of halichondrin analogues, was therefore 
the full spectroscopic assignment of selected naturally-occurring halichondrins. 
iii) Another objective of this work was to gain an understanding of the important 
solution conformation(s) of the halichondrins and selected derivatives. 
It is likely that the conformation(s) of the halichondrins is an important factor in the 
expression of antitumour activity. It was envisaged that computer modelling would 
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provide essential information as to the important solution conformation(s). This data 
could then be related to the NMR data collected for verification. 
iv) The final objective of this project was the development of the general 
chemistry of the halichondrins. Along with a knowledge of the relative 
reactivities of the various functional groups in the molecule gained in the 
structure/activity studies this would allow for the future design of specific 
derivatives, such as orally bioavailable derivatives. 
For example, an important consideration in the development and evaluation of any 
potential pharmaceutical is a study of pharmacokinetics which is defined by Albert 
as uthe study of the kinetics of drug absorption, distribution, metabolism, and 
excretion u. 30 The detection and/ or quantification of small quantities of halichondrins 
for in vivo phannacokinetic studies in drug development trials requires specific 
"labelling" of the molecule and therefore a knowledge of the chemistry of the 
halichondrins. Potentially, this could involve hapten binding for enzyme linked 
immunoassay (ELISA), fluorescent labelling or isotopic labelling. 
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2.1 Introduction 
One of the goals of this research was to produce semi-synthetic derivatives of the 
naturally-occurring halichondrins. To facilitate the NMR spectroscopic 
characterisation of these derivatives it was initially necessary to fully assign the 
NMR spectra of selected, naturally-occurring halichondrins. This information was 
then used as a reference for future chemical modifications, allowing the NMR 
spectra to be assigned in terms of differences relative to the parent compound. 
Initially, the 75 MHz Be and 300 MHz lH NMR spectra of halichondrin B (1.2.1) 
were completely assigned in CDCl3/ 0.1% pyridine-ds. Later, a full assignment of 
homohalichondrin B (1.2.3) was also achieved. Hirata and Uemura had previously 
achieved only a partial assignment of the 13C and I H NMR spectra of halichondrin B 
and homohalichondrin Bin CD30D.l8 Dr. Marc Litaudon, in the Marine Chemistry 
Group, subsequently attained a partial assignment of the 1 H NMR spectrum of 
halichondrin B in CD30D from material isolated from Lissodendoryx sp. Pettit et al 
have since published NMR data (also in CD30D) on the related halichondrins 
halistatin 1 (1.2. 7) and halistatin 2 (1.2.8) (lOa-hydroxyhalichondrin B and lOa-
hyroxyhomohalichondrin B respectively).l9,20 Their assignments are also 
incomplete. 
The absolute stereochemistry of the halichondrins was determined by Uemura et al 
from the X-ray crystal structure of the p-bromophenacyl ester of norhalichondrin 
A.17 The relative stereochemistry of halichondrin B was examined to ensure that it 
was consistent with that proposed by Uemura et al. It was also important to consider 
whether the conformation of the X-ray crystal structure accurately represented the 
major solution conformations of the basic halichondrin, B series, subunit. 
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The relative stereochemistry of halichondrin B (1.2.1) was determined at certain 
points in the molecule using selective lD and 2D NMR spectroscopic techniques. 
Some insight was also gained, from these experiments, as to the overall folding 
conformation of halichondrin B in solution. Coupling constants were collected for 
halichondrin B and related to the X-ray crystal structure of norhalichondrin A. It 
was necessary to model the solution conformations of the Cl to C14 subunit as there 
was a discrepancy between the experimental and X-ray crystal structure-derived 
coupling constants for Hll-H12. The terminal moiety of halichondrin B (C44-C54) 
was also modelled to determine possible solution conformations of this area in the 
molecule to give coupling constants and dihedral angles that were related to the 
experimental NMR data collected. 
The solution conformations of the terminal bicyclic nng system of 
isohomohalichondrin B (1.2.9) were investigated by selected NMR experiments and 
computer modelling. The optical rotation of isohomohalichondrin B was measured 
to aid in the evaluation of the absolute stereochemistry. 
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of 
The lH NMR spectrum of halichondrin B (1.2.1) shows considerable overlap in the 
methylene and methine regions (Figure 2.2.1). There are however some distinct and 
isolated signals such as the olefinic protons 19=CH2 and 26=CH2; the methine 
protons Hll, H32 and H7; the methylene protons H18' and H2', and the methyl 
protons Me-25 and Me-42. Similarly, the 13C NMR spectrum of halichondrin B 
(1.2.1) is also very complex (Figure 2.2.2). To fully assign the lH and 13C NMR 
spectra of halichondrin B it was therefore necessary to perform a range of selective 
lD and 2D NMR experiments which allowed individual signals to be isolated and 
thus assigned. 
The NMR experiments used to carry out these assignments are illustrated with 
specific examples. Figures 2.2.3 and 2.2.4 display the important correlations from 
these experiments which enabled the full assignment of the 1 H and 13C NMR spectra 
of halichondrin B (1.2.1) to be achieved. Table 2.2.1 and Table 2.2.2 list the 
chemical shifts of the protons and carbons ofhalichondrin B respectively. All NMR 
experiments were performed for ca. 10 mg of halichondrin B in CDCl3/ 0.1% 
pyridine-ds. Hirata and Uemura have stated that the decomposition of halichondrins 
occurs in acidic solutioniS and Cooper et al claim a specific mode of decomposition 
for the tricyclo ring system (C, D and E rings) under acidic conditions in a related 
synthetic Cl-C21 B series fragment.31 To eliminate the risk of acid-catalysed 
decomposition, pyridine-ds was added to all CDCl3 solutions. 
CH3-42 
CH3-25 
Hll 
26=CH2 
l9=CH2 H7 H32 H2' 
H18' 
I 
5 . 0 4 . 5 4 . 0 3. 5 3 . 0 2 . 5 2 . 0 1. 5 1. 0 ppm 
Figure 2.2.1 1 H NMR Spectrum of Halichondrin B 
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Table 2.2.1 lH NMR Data for Halichondrin B (1.2.1) 
Proton a Literature CDCl3 Proton a Literature CDCl3 
3 ppm18,b lippmc 8ppm18,b lippmc 
H2 2.44 2.35 H28 1.94 
H2' 2.57 2.60 H28' 2.02 
H3 3.88 3.86 H29 4.25 4.21 
H4 1.35 H30 4.63 4.63 
H4' 1.74 H31 2.04 
HS 1.40 CH3-31 1.07 0.99 
HS' 2.08 H32 3.22 3.18 
H6 4.33 4.34 H33 3.87 3.80 
H7 2.98 2.94 H34 1.79 
HS 4.31 4.33 H34' 2.13 
H9 4.13 4.04 H35 4.12 4.10 
H10 4.18 4.20 H36 4.10 4.10 
Hll 4.60 4.60 H37 1.92 
H12 4.71 4.68 H37' 2.37 
H13 1.98 1.94 H39 2.24 
H13' 2.09 2.15 H39' 2.24 
H15 1.62 H40 4.05 4.00 
H15' 2.18 H41 3.69 3.63 
H16 1.42 H42 2.23 
H16' 2.16 CH3-42 0.94 0.94 
H17 4.08 4.10 H43 1.29 
H18 2.32 2.26 H43' 1.52 
H18' 2.80 2.80 H45 1.42 
19=CH 5.02 4.92 H45' 1.50 
19' =CH 5.07 4.98 H46 2.35 
H20 4.46 4.37 CH3-46 1.01 0.99 
H21 1.40 H47 3.56 3.61 
H21' 1.88 H48 4.10 4.05 
H22 1.60 H49 1.83 1.90 
H22' 1.60 H49' 2.27 2.32 
H23 3.71 3.53 HSO 4.00 4.08 
H24 1.04 H51 3.78 3.80 
H24' 1.70 H52 1.61 1.62 
H25 2.20 H52' 1.75 1.79 
CH3-2S 1.10 1.07 H53 3.87 4.02 
26=CH 4.82 4.77 H54 3.46 3.54 
26'=CH 4.88 4.81 H54' 3.53 3.61 
H27 3.62 3.54 
a The symbol' represents the less shielded proton of a geminal pair. 
b Literature data recorded in CD30D at 360 MHz. 
c Data recorded at 23°C in CDCl3 at 300 MHz with chemical shifts in ppm 
and referenced to C HC13, BH 7.25 ppm. 
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Table 2.2.2 13C NMR Data for Halichondrin B (1.2.1) 
Carbon Literature CDCI3 Carbon Literature CDCI3 
oppml8,a Oppmb oppml8,a oppmb 
C1 171.8 171.2 C28 36.9 
C2 41.2 40.4 C29 73.8 71.2 
C3 74.9 73.7 C30 77.3 76.9 
C4 30.7 C-CH3-31 37.5 36.6 
C5 30.0 C-CH3-31 15.9 15.1 
C6 69.6 68.2 C32 78.0 77.2 
C7 79.1 77.4 C33 65.5 66.3 
C8 75.8 74.3 C34 29.1 
C9 73.3 73.8 C35 77.3 75.0 
C10 78.0 76.5 C36 78.0 76.2 
Cll 83.8 82.1 C37 45.6 43.5 
C12 82.5 81.1 C38 114.8 112.5 
C13 49.4 48.3 C39 45.0 42.7 
C14 111.3 110.1 C40 73.0 71.7 
ClS 34.4 C41 80.8 79.0 
C16 28.2 C-CH3-42 27.1 25.6 
C17 76.3 75.4 C-CH3-42 18.2 17.5 
C18 39.7 38.7 C43 36.5 
19,C=CHz 153.2 151.8 C44 98.4 97.4 
19C=CHz 105.8 104.5 C45 36.9 
C20 76.1 75.5 C-CH3-46 27.1 25.7 
C21 28.2 C-CH3-46 18.3 17.8 
C22 32.0 C47 81.3 80.2 
C23 75.3 74.9 C48 75.1 71.7 
C24 43.4 C49 35.9 
C-CH3-2S 37.5 35.9 cso 81.3 79.0 
C-CH3-2S 18.4 18.0 C51 73.1 73.0 
26C=CHz 153.2 151.6 C52 37.2 
26C=CHz 104.8 104.2 C53 71.6 70.1 
C27 75.1 73.5 C54 67.1 66.9 
a Literature data recorded in CD30D at 75.4 MHz. 
b Data recorded at 23"C in CDCl3 at 75 MHz with chemical shifts in ppm and 
referenced to CDCl3, oc 77.0 ppm. 
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2.2.1 The COSY Experiment 
The initial assignment of protons in the lH NMR spectrum of halichondrin B (1.2.1) 
began with the double quantum filtered COSY (COrrelation SpectroscopY) 
experiment (Figure 2.2.5). From this experiment, correlations between adjacent 
(geminal and vicinal) protons can be observed. The strength of the observed 
correlation is a function of the coupling constant between the protons; the larger the 
coupling constant, the stronger the correlation. An example of how the COSY 
spectrum was used in the assignment of the 1 H NMR spectrum of halichondrin B 
will be illustrated by focusing on the Cl-C14 spin system. 
The isolated protons H2', H7 and Hll in the lH NMR spectrum of halichondrin B 
(1.2.1) provided the lead-in to the Cl-C14 spin system. The correlations discussed 
are indicated in Figure 2.2.5. A strong correlation was observed between H2' (DH 
2.60 ppm) and its geminal partner H2 (oH 2.34 ppm). Both of these protons were 
correlated to only one methine proton, H3, at OH 3.86 ppm. From H3, the only 
correlation to protons on C4 was to H4 ( OH 1.35 ppm), with H4' being assigned by a 
geminal correlation to OH 1.74 ppm. Correlations to the methylene protons on CS 
from H4/H4' were not able to be isolated as they were obscured by other correlations 
in this area of the COSY spectrum. From H7 (DH 2.94 ppm), it was possible to see 
only one correlation to an adjacent methine proton at OH 4.34 ppm. From this 
correlation, there were observed correlations to methylene protons (HS', OH 2.08 ppm 
and HS, OH 1.40 ppm) and a methine proton (H9, OH 4.04 ppm). This indicated that 
the chemical shifts of H6 and H8 were very similar and therefore appearing as one 
correlation to H7. From the H9 proton a clear correlation to HlO at OH 4.20 ppm was 
observed and also a strong correlation was apparent from HlO to the isolated Hll 
proton at OH 4.60 ppm. The Hll proton also showed one other correlation to H12 at 
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OH 4.68 ppm, and this proton was correlated, in turn, to one of the Cl3 methylene 
protons, H13 at OH 1.94 ppm. Finally, the Hl3' proton (at OH 2.15 ppm) was located 
by the appearance of a strong geminal correlation to H13. 
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Figure 2.2.5 COSY Spectrum of Halichondrin B 
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2.2.2 The TOCSY Experiment 
The TOCSY experiment (TOtal Correlation SpectroscopY) reveals the connectivity 
of protons through a spin system. The 2D-TOCSY spectrum of halichondrin B 
(1.2.1) is shown in Figure 2.2.6. Again, the example of the Cl-Cl4 spin system will 
be used to illustrate the utility of this experiment and its application to the 
assignment of the lH NMR spectrum ofhalichondrin B. 
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Figure 2.2.6 2D-TOCSY Spectrum of Halichondrin B 
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A cross-section through the Hll proton in the 2D-TOCSY spectrum is displayed as a 
lD trace in Figure 2.2. 7. From this cross-section, through-bond correlations were 
seen from Hll to H12, Hl3 and H13' in one direction and to HlO, H9, H8 and H7 
(weak) in the other direction. The appearance of a TOCSY signal is dependent on 
the magnitude of the coupling constant for the transmission of magnetisation through 
the spin system and also on the length of the spin-lock (the mixing time) in the pulse 
sequence of the experiment. For this experiment, a mixing time of 100 ms was used. 
A small coupling constant between H7 and H8 explains the observation of a weak 
signal for the H7 proton and is amplified by the losses in the transfer of 
magnetisation through the spin system as the proton concerned was further removed 
from the irradiated proton. 
H8 
Hll H9 
H12 l 
I ! 
HIO I ~~~~L m an·~~ i1LH13 
I \,1 I I I "' ~u~~......,,........._...__ 
s:o 4. 0 2. 0 l.S l. 0 ppm 
Figure 2.2.7 Cross-Section Through Hll From 2D-TOCSY Spectrum 
A cross-section through H7 (Figure 2.2.8) from the 2D-TOCSY spectrum showed 
correlations to H8, H9, HlO and Hll in one direction and to H6, HS', HS and H4, 
H4', H3, H2' and H2 in the other direction. Similar cross-sections can be obtained 
through H2' (at OH 2.60 ppm) showing correlations through to H6. 
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Figure 2.2.8 Cross-Section Through H7 From 2D-TOCSY Spectrum 
A "time-economic" alternative to acquiring a 2D-TOCSY spectrum is to perform a 
lD-TOCSY experiment. The lD experiment is performed by selectively irradiating 
isolated signals in the 1 H NMR spectrum. The pulse sequence of the lD-TOCSY 
experiment differs from that of the 2D-TOCSY experiment in that it initially has a 
selective go· irradiation pulse rather than a non-selective go· pulse (Figure 2.2.9). 
The lD-TOCSY experiment can be used to probe specific spin systems providing 
they have a sufficiently isolated (in terms of chemical shift) proton. 
lD-TOCSY Pulse Sequence 
spin-lock 
fixed mixing time 
time 
2D-TOCSY Pulse Sequence 
spin-lock 
--~-~-variable mixing time 
time 
Figure 2.2.9 Pulse Sequences for lD and 2D-TOCSY Experiments 
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The lD-TOCSY experiment from selective irradiation of the Hll proton in the lH 
NMR spectrum of halichondrin B (Figure 2.2.10, bottom spectrum) gave the 
spectrum shown in Figure 2.2.10 (top spectrum). Essentially, the lD-TOCSY 
experiment gives the same information as can be obtained from a cross-section 
through the 2D-TOCSY experiment (Figure 2.2.10, middle spectrum). 
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Figure 2.2.1 0 lD-TOCSY vs 2D-TOCSY Spectra for Hll 
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The advantages of performing a 1D-TOCSY over the 2D analogue are the enhanced 
resolution obtained, and the reduction in the time required to obtain a given signal to 
noise ratio. Another advantage, related to the time saving, is that the duration of the 
spin lock (the mixing time) in the pulse sequence (Figure 2.2.9) can be varied, for a 
given irradiated proton, to give a range of 1D spectra on a reasonable time scale. 
This enables connectivity, relative to the irradiated proton, to be established. 
An example of varied mixing times for the 1D-TOCSY experiment is shown in 
Figure 2.2.11 for irradiation of the Hll proton. For a 10 ms mixing time, 
correlations were seen to H12 and HlO. As the mixing time was increased to 25 ms, 
contributions from H9 were clearly observed; and at 50 ms, H13' and H13 and H8 
were seen. Finally, with a 120 ms mixing time, contributions were observed from 
the H7 proton. 
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Figure 2.2.11 Varied Mixing Times for 1D-TOCSY Spectra Through H11 
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As the mixing time is increased, the time for the transmission of magnetisation 
through the spin system is also increased. There is however, a trade-off between the 
sensitivity of the signal and the duration of the mixing time. This effect can be seen 
in Figure 2.2.11 above. As the spectra are plotted on the same vertical scale, it is 
apparent that the sensitivity of the spectrum acquired with a mixing time of 120 ms is 
much reduced relative to the spectrum obtained using a 10 ms mixing time. Two 
main reasons for this observation are that the magnetisation becomes spread over an 
increased number of signals as the mixing time is increased, and there is also a 
greater chance for relaxation losses occurring during this increased mixing time. 
2.2.3 The HMQC Experiment 
The HMQC experiment (Heteronuclear Multiple Quantum Coherence) shows 13C-
1 H single bond correlations. As a 1 H detected experiment, it is much more sensitive 
relative to the 13C detected HETCOR experiment which gives the same information. 
The HMQC experiment (and the HMBC experiment, Section 2.2.4) is particularly 
useful when there is no 13C NMR spectrum available, for example if there is not 
enough material to acquire a good spectrum. The HMQC (and HMBC) experiment 
can therefore be used to effectively obtain and indirectly assign the 13C NMR 
spectrum. The HMQC and HMBC experiments were therefore crucial in the Be 
NMR spectroscopic assignment of halichondrin derivatives produced in small 
quantities during the structure-activity investigations. 
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The HMQC spectrum of halichondrin B (Figure 2.2.12) was especially useful in the 
assignment of methylene protons that were obscured or unclear in the COSY 
spectrum. The spectrum was acquired with a narrowed 13C NMR spectral window 
(8c 10 to 8c 90 ppm), and therefore the olefinic 13C-1H correlations appeared as 
foldbacks into this window. All correlations discussed are indicated on the HMQC 
spectrum. 
C32 
H15 
oo 
@IJ @ 
~ 00 o 0 e ~ e 
~0 
• ~<&~., ~ """ ~ • ~ ,..:. • .. ., ~ o ~ e• <> o ~ <::)c oc:o o ~ 
e 
80 70 60 50 40 30 20 
Fl (ppm) 
Figure 2.2.12 HMQC Spectrum of Halichondrin B 
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It was possible in many cases to determine where geminal partners of methylene 
protons were situated, either as chemical-shift equivalent protons appearing as one 
correlation to one carbon or as a pair of correlations into one carbon in the case of 
chemical-shift distinct protons. For example, only one COSY and TOCSY 
correlation was observed between H40 ( DH 4.00 ppm) and H39 ( DH 2.24 ppm). The 
HMQC spectrum of halichondrin B showed one intense correlation from a proton at 
DH 2.24 ppm to a carbon at oc 42.7 ppm, implying the H39 protons were chemically-
shift equivalent. The C15 carbon resonance was able to be assigned from the 
chemical shifts of the attached methylene protons. 
Assignment of the carbons with attached methine protons was relatively straight 
forward as in many cases the 1 H NMR chemical shift of the proton was relatively 
isolated or the 13C NMR chemical shift could be estimated. The H32 proton, for 
example, was relatively isolated in the 1 H NMR spectrum of halichondrin B at OH 
3.18 ppm, so a single correlation in the HMQC spectrum from H32 at OH 3.18 ppm 
into a carbon at oc 77.2 ppm allowed C32 to be assigned. 
2.2.4 The HMBC Experiment 
The HMBC experiment (H eteronuclear MultiBond Coherence), like the HMQC 
experiment, is also a reverse ( 1 H) detected experiment. The HMBC experiment 
shows correlations to carbons from protons on carbons two to three (and sometimes 
four) bonds removed. The HMBC spectrum of halichondrin B (Figure 2.2.13) was 
useful in the assignment of the 13C NMR chemical shifts of carbons without attached 
protons such as the spiro carbon centres: Cl4, C38 and C44 and the carbon of the 
H43 
H45' 
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lactone, Cl. For example, correlations were observed from a foldback carbon at 8c 
31.6 ppm in the spectrum, corresponding to a real carbon at 8c 97.4 ppm, to the 
previously identified H45 (8H 1.42 ppm), H45' (8H 1.50 ppm), H43 (8H 1.29 ppm) 
and H43' (8H 1.52 ppm). This identified the carbon signal as belonging to C44. 
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Figure 2.2.13 HMBC Spectrum of Halichondrin B 
In conjunction with the closely related HMQC experiment, assignments of 1 H NMR 
chemical shifts of some unidentified methylene protons were also made. A real 
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carbon at 8c 34.4 ppm showed a weak HMBC correlation to a proton at OH 1.94 
ppm. This proton was identified as H13 as it was the only proton of this approximate 
chemical shift within three bonds of a methylene carbon. In the HMQC spectrum of 
halichondrin B, the carbon at 8c 34.4 ppm was correlated to a methylene pair of 
protons at OH 1.62 ppm and OH 2.18 ppm (indicated in Figure 2.2.12). The carbon at 
8c 34.4 ppm was therefore identified as C15 and the methylene protons on this 
carbon as H15 (8H 1.62 ppm) and H15' (8H 2.18 ppm). Unfortunately no HMBC 
correlations were observed from the C14 carbon to the H15/H15' protons. 
The assignments of the C17, C35 and C36 13C NMR chemical shifts from the 
HMQC experiment were ambiguous as they were correlated to protons at OH 4.10 
ppm attached to carbons with very similar 13C NMR chemical shifts. The HMBC 
spectrum showed that the carbon at 8c 75.0 ppm (appearing as a foldback to 8c 9.2 
ppm) was correlated to protons at OH 2.35 ppm (H37'), OH 2.13 ppm (H34'), OH 1.79 
ppm (H34), OH 3.80 ppm (H33), OH 3.18 ppm (H32, weak) and to OH 4.10 ppm (H35 
or H36). Given that relatively strong correlations were observed to H33 it was more 
likely that the carbon at 8c 75.0 ppm was C35 as this represented a three bond 
HMBC correlation. There remained two unassigned 13C NMR signals at 8c 75.4 
ppm and 8c 76.2 ppm. A cross-section through H32 (OH 3.18 ppm) in the HMBC 
spectrum showed correlations to the previously identified carbons C33 (8c 66.3 ppm, 
appearing as a foldback to 8c 0.4 ppm), C34 (8c 29.1, weak), C-CH3-31(8c 36.6 
ppm) and C-CH3-31 (8c 15.1 ppm). Another correlation was observed to a carbon at 
8c 76.9 ppm (appearing as a foldback to 8c 10.4 ppm) which had previously been 
assigned as C30, and a strong correlation slightly upfield appearing at 8c 11.1 ppm 
in the spectrum was unidentified. This carbon signal at 8c 76.2 ppm (folded back to 
8c 11.1 ppm in the HMBC spectrum) was assigned as C36. The remaining 13C 
NMR signal at 8c 7 5.4 ppm was therefore assigned as C 17. 
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2.3 Conformation and Stereochemistry Studies 
on Halichondrin B 
2.3.1 Solution Conformation and Relative Stereochemistry 
From NMR Experiments 
Assignment of the relative stereochemistry of some centres in halichondrin B (1.2.1) 
was achieved by consideration of vicinal coupling constants and the observation of 
correlations in the NOESY spectrum of halichondrin B. In particular, it allowed the 
relative stereochemistry of some of the methylene protons to be inferred. This 
information also gave some insight into the average solution conformation of 
halichondrin Bin CDCl3. This data was subsequently related to the X-ray crystal 
structure of the Uemura et al norhalichondrin A derivative. 
2.3.1.1 The NOESY Experiment 
The NOESY (Nuclear Overhauser and Exchange SpectroscopY) experiment shows 
correlations between protons situated close in space and is a direct result of the 
nuclear Overhauser effect. The NOESY spectrum of halichondrin B (1.2.1) is shown 
in Figure 2.3.1. The important correlations that were observed are indicated in 
Figure 2.3.2, showing the inferred stereochemistry at specified points in the 
molecule. All correlations discussed below are indicated on the NOESY spectrum, 
Figure 2.3.1. 
The methylene protons that were assigned a relative stereochemistry solely from the 
NOESY spectrum are indicated in Figure 2.3.2 as those displaying a specified 
orientation. For example, the H4 and H4' methylene protons were able to be 
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assigned a relative stereochemistry as NOESY correlations were observed between 
H6 (DH 4.34 ppm) and H4 (DH 1.35 ppm). This indicated a cis 1,3-diaxial 
relationship for H4 relative to H6. Additionally, a NOESY correlation from H3 at 
DH 3.86 ppm to H4' at DH 1.74 ppm implied a trans stereochemistry for the H4' 
proton relative to H6. 
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Figure 2.3.1 NOESY Spectrum of Halichondrin B 
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The NOESY spectrum of halichondrin B also showed three interesting correlations 
that gave an indication of the overall folding conformation of the molecule in CDCh 
solution. NOESY correlations were observed between the following protons: H2' 
(OH 2.60 ppm) and H20 (OH 4.37 ppm), H2' and 19=CH (OH 4.92 ppm), and between 
H29 (OH 4.21 ppm) and 19=CH. These correlations indicated that the F ring of 
halichondrin B (Cl7-C20) was orientated with 19=CH directed "into" the lactone 
ring and in close proximity to H2' and H29 which must also be inward facing. A 
model was constructed of the Cl-C33 region of halichondrin B indicating that this 
was a feasible conformation providing that the G ring (C23-C27) was orientated with 
26=CH2 and CH3-25 pointing "outwards" with respect to the lactone ring. 
Inspection of the Uemura et al X-ray crystal structure of the norhalichondrin A 
derivative, which was imported from the Cambridge Crystallographic Database, 
indicated that the average folding conformation in solution postulated for 
halichondrin B from the NOESY spectrum was also the conformation existing in the 
crystal structure. This X -ray crystal structure is shown in Appendix V. Interatomic 
distances were collected from the X-ray crystal structure for the three NOESY 
correlations discussed above. These distances are given in Table 2.3.1. The 
experimentally observed NOESY correlations were therefore acceptable in terms of 
interatomic distance, as these values were within the distance that a NOB interaction 
may be observed: 
Table 2.3.1 X-ray Crystal Structure Distances Between Protons 
NOESY Interatomic 
interaction distance (A) 
19=CH - H29 2.8 
19=CH - H2' 2.6 
H20- H2' 2.9 
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2.3.1.2 Coupling Constants 
Coupling constants were collected for halichondrin B (1.2.1) from the 1 H NMR 
spectrum and lD and 2D-TOCSY experiments. These data are listed in Table 2.3.2 
(H2-H21) and Table 2.3.3 (H22-H54). The vicinal coupling constants (3fHH) were 
converted to possible dihedral angles via a computer application of the Karplus 
equation.33 Also listed in Tables 2.3.2 and 2.3.3 are the norhalichondrin A 
derivative X-ray crystal structure derived vicinal coupling constants. These values 
were obtained using the Karplus relationship in the program MacroModel V 4.0 
which calculates 3JHH from the observed vicinal (H-C-C-H) dihedral angles. 
The Karplus equation relates the vicinal coupling constant (3 lHH) to the dihedral 
angle between two vicinal protons. This is a function of the identity and orientation 
of the attached alpha and beta substituents. The computer program generates a plot 
of the vicinal coupling constant as a function of the dihedral angle between the two 
protons and thus allows possible orientations of the vicinal protons to be obtained 
from experimental coupling constants. 
The dihedral angles that were obtained from the NMR data were related to the X -ray 
crystal structure of the p-bromophenacy 1 ester of norhalichondrin A 17 where 
applicable ie H2-H43. This was carried out to compare the average solution 
conformation to the conformation of the crystal structure, and allowed the relative 
stereochemistry of some vicinal protons to be inferred. The calculated dihedral 
angles generally correlated well with the X-ray crystal structure conformation, 
although there was the suggestion of some minor twisting in the ring systems in the 
C29 to C44 region relative to the X-ray crystal structure, as demonstrated by the 
construction of Dreiding molecular models. 
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Table 2.3.2 Coupling Constants for H2-H21 of Halichondrin B 
Proton Mult. lHH X-ray Proton Mult. lHH X-ray 
(Hz) a 3JHHb (Hz) a 3JHHb 
H2 dd 3.3, 16.2 1.1 c H13 dd 4.7, 13.3 5.9 
H2' dd 8.4, 16.2 10.6C Hl3' d 13.3 1.3 
H3 dd 8.4, 12.6 1.1, 2.8, H15 rn 6.7, 13.5d 
10.6, 11.7 
H4 rn 4.2, 11.7, H15' rn 4.8, 13.6d 
13.6 
H4' rn 2.5, 2.8, H16 rn 1.5, 4.8, 
3.8 13.5d 
HS rn 3.8, 11.4, H16' rn 0.7, 11.4, 
13.6 13.6d 
HS' rn 2.5, 2.8, H17 rn 1.1, 1.5, 
3.8 7.6, 11.4 
H6 ddd 4.2,9.5,9.5 4.3, 9.2, H18 d 16.2 1.1C 
11.4 
H7 dd 2.1, 9.5 3.4, 9.4 H18' dd 7.6,16.2 7.6C 
HS dd 2.1, 4.1 3.4, 4.2 19=CH d 1.4 
H9 dd 4.1, 6.6 4.2, 5.8 19' =CH d 1.4 
HlO dd 4.7, 6.6 4.6, 5.8 H20 dd 1.4,10.9 1.4, 11.3 
Hll dd 4.7,4.7 4.6, 7.0 H21 rn 1.4, 1.5, 
13.7d 
H12 d 4.7,4.7 1.3, 5.9, H21' rn 1.4, 5.9, 
7.0 11.3d 
a Experimental data recorded in CDCl3 at 300 MHz. b Units in Hz 
c Assignment of stereochemistry by comparison to experimental 3 JHH and NOESY data. 
d X-ray crystal structure assignment of 3 JHH to specific chemical shifts of methylene protons 
are interchangeable. 
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Table 2.3.3 Coupling Constants for H22-H54 of Halichondrin B 
Proton Mult. lHH X-ray Proton Mult. lHH X-ray 
(Hz) a 3JHHb (Hz) a 3JHHb 
H22 m 1.4, 1.7, H39 6.0d 
13.7d 
H22' m 1.7, 2.3,d H39' 1.4d 
11.5,11.6 
H23 m 1.7, 2.3, H40 dd 2.2, 4.4 1.4, 2.6, 
11.5, 11.6 5.2 
H24 11.6, 12.4 H41 dd 2.2,2.2 2.6, 3.0 
H24' 2.3, 3.2 H42 m 3.0, 3.5, 
7.0, 12.3 
H25 m 3.2, 7.0, CH3-42 d 7.1 7.0 
12.4 
CH3-2S d 7.0 7.0 H43 dd 4.3, 13.0 3.8C 
26=CH s H43' dd 13.0, 13.0 12.3C 
26'=CH d 1.5 H45 dd 12.6, 12.6 
H27 d 12.5 1.4,11.2 H45' dd 4.2, 12.6 
H28 m 1.4, 11.2d H46 m 
H28' m 1.3, 11.2d CH3-46 d 6.9 
H29 m 1.3, 2.5, H47 
10.7 
H30 dd 6.5, 9.3 2.5, 9.7 H48 
H31 m 7.0, 9.7, H49 
10.7 
CH3-31 d 6.9 7.0 H49' 
H32 dd 5.9, 8.0 7.5, 10.7 HSO 
H33 ddd 5.9, 5.9, 4.7, 7.5, H51 
11.0 11.3 
H34 ddd 11.0, 11.0, 10.9,11.3C H52 dd 4.3,13.7 
11.0 
H34' ddd 5.9, 5.9, 4.7, 5.4C H52' 
11.0 
H35 m 5.4, 7.1, H53 
10.9 
H36 dd 1.4,11.2 7.1, 8.0, H54 dd 6.6,11.3 
8.8 
H37 8.0d H54' dd 2.7,11.3 
H37' 8.8d 
a Experimental data recorded in CDCl3 at 300 MHz. b Units in Hz. 
c Assignment of stereochemistry by comparison to experimental 3 lHH and NOESY data. 
d X-ray crystal structure assignments of 3 lHH to specific chemical shifts of methylene protons 
are interchangeable. 
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There was a major anomaly with the experimental Hll-H12 coupling constant 
relative to the X -ray crystal structure coupling constant calculated from the dihedral 
angle using the Karplus equation in MacroModel. The "A series" halichondrins are 
characterised by a hydroxyl groups at C12 and C13. The X-ray crystal structure was 
therefore modified to a "B series" halichondrin ie norhalichondrin B which has 
hydrogens at C12 and Cl3, to gather the Hll-Hl2, H12-Hl3' and coupling 
constants. The experimentally observed 3JHHOf 4.7 Hz for Hll-H12 compared well 
to the value of 4.5 Hz quoted by Uemura et al in CD30D.18 However, the coupling 
constant of 7.0 Hz calculated from the dihedral angle in the modified X-ray crystal 
structure suggested several possibilities. 
There could be a weakness in the model used to calculate the coupling constant in 
this situation, or the presence of unaccounted for coupling mechanisms. There is a 
lack of data in the 5.5-7.0 Hz range34 which may lead to incorrect data extrapolations 
for this region. Another problem with the Karplus model is the absence of 
norbornene type structures and derivatives from the data set;34 the C8-C14 tricycle 
system could perhaps be loosely considered such a derivative. 
Bonds which are in close proximity to the coupled nuclei, as in the cage structure of 
C8-Cl4 may provide important, alternative coupling mechanisms for the 
transmission of the coupling.35 This may result in a reduced value for the observed 
Hll-Hl2 coupling constant relative to the Karplus derived value which does not take 
this into account. 
Another possible explanation for this anomaly could be that the geometry of the C 1 
C 14 subunit observed in the X -ray crystal structure, and in particular the 
conformation around the constrained tricycle ring system, may be different due to 
the presence of the hydroxyl groups at position C12 and Cl3. A conformational 
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search of the C2-C15 subunit was undertaken on the B series halichondrin to assess 
whether this would alter the conformational distribution and therefore the observed 
coupling constant for the H11-H12 protons. This modelling is described in Section 
2.3.2. 
The X -ray crystal structure coupling constant data from the norhalichondrin A 
crystal could only be compared for the C1-C44 region as the structure of 
halichondrin B differs beyond C44. The C44-C54 subunit was therefore 
conformationally searched in MacroModel to gain some insight into possible 
solution conformations of this area in the molecule. This work also enabled 
Boltzmann-weighted vicinal coupling constants to be extracted for the H45-H54 
subunit conformers. These were then compared to the experimental vicinal coupling 
constants in this region. These modelling investigations are also described in Section 
2.3.2. 
Some methylene protons were assigned a relative stereochemistry by comparing 
experimental coupling constants to the X -ray crystal structure derived values and 
interpreting relevant NOESY observations. In some cases this allowed an evaluation 
of the predominant conformation of specific rings in the molecule. These methylene 
protons are depicted in Figure 2.3.3 as protons in bold type and are denoted with a 'c' 
in Tables 2.3.2 and 2.3.3. For example, the "I" ring of halichondrin B was 
determined as being in a boat conformation from the H34/H34' coupling constants 
and NOESY data. The H34 and H34' protons were assigned a relative 
stereochemistry based on the experimental vicinal coupling constants to H33 and 
H35. There was a NOESY correlation observed between H32 and H36. This 
implied a cis, diaxial relationship for these two protons. The "I" ring could either be 
in a chair or in a boat (or twist- boat) conformation. A chair conformation would 
imply relatively small vicinal coupling constants for H33-H34, H33-H34', H35-H34 
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and H35-H34' as the dihedral angles for all four pairs would be± ca 60". However, a 
true boat conformation would result in one large coupling constant (dihedral angle of 
ca 180"), and one smaller coupling constant (dihedral angle ca 50-60") for the cis 
proton. The vicinal coupling constants actually observed between H34 and H33, and 
H34 and H35 were 11.0 Hz for both couplings. The vicinal couplings between H34' 
and H33, and H34' and H35 were both observed at 5.9 Hz. These observations best 
describe a true boat conformation for the "I" ring. The H34' proton must therefore 
have been cis with respect to H33 and H35 with two small coupling constants to H33 
and H35. The large coupling constants observed to H33 and H35 from H34 implied 
an axial position and therefore the opposite relative stereochemistry to H34'. In the 
X-ray crystal structure of the norhalichondrin A derivative the "I" ring is in a true 
boat conformation, and the coupling constants for H34 and H34' were close to those 
observed experimentally (see Table 2.3.3). 
The "L" ring of halichondrin B was determined as being in a chair conformation. It 
was assumed that the methyl group CH3-42 was in an equatorial position. A boat 
conformation would result in a small dihedral angle (ca 0") between H40 and H41 
giving rise to a large coupling constant. The fact that the observed coupling constant 
was 2.2 Hz implied a chair conformation for the "L" ring. The H43 and H43' 
coupling constants to the axial H42 proton would give rise to one small coupling 
constant to the cis equatorial proton and one large coupling constant to the trans, 
axial proton. Experimentally, the large coupling constant was observed between 
H43' and H42 (3JHH 13.0 Hz) and the small coupling constant between H43 and H42 
(31HH 4.3 Hz). The H43 proton was therefore assigned as cis with respect to H42, 
and H43' was assigned as the axial proton. The X-ray crystal structure of the "L" 
ring was also in a chair conformation and the coupling constants for H41 to H40 and 
H43 and H43' compared well (refer Table 2.3.3) with the experimental results. 
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The H18 and H18' protons were assigned a relative stereochemistry based on similar 
coupling constant arguments. 
Assignment of the relative stereochemistry of the H2 and H2' protons was a little 
more ambiguous and this assignment remains tentative. The NOESY spectrum of 
halichondrin B showed correlations from H2' to H20 and H2' to CH=19. The H2' 
proton had a vicinal coupling constant of 8.4 Hz to H3. This implied that the 
dihedral angle between H2' and H3 was either around o· or 180". From the NOESY 
spectrum we knew that H2' pointed inwards towards H20 and was therefore ca 180" 
(ie anti) with respect to H3. The vicinal coupling constant for the H2 proton to H3 
was observed at 3.3 Hz. This meant that the H2 dihedral angle was either +90" 
(clockwise rotation) or -90" (anti-clockwise rotation) relative to H3. There was not 
sufficient experimental data to conclude which orientation the H2 and therefore the 
H2' protons had. However, by examining the X-ray crystal structure conformation 
the proton that was within NOB interaction distance to H20 and CH=19 was anti 
with respect to H3, as predicted, so this was assigned as the H2' proton. The other 
proton on C2 had a dihedral angle of -90" to H3 and was 4. 7 A from H20 and 3. 7 A 
from CH=19. This proton was therefore assigned as H2. The X-ray crystal structure 
coupling constants for H2' and H2 compared relatively well to the experimental 
values (refer Table 2.3.2 ). 
Overall, the average solution conformation of the C1-C44 portion of halichondrin B 
(1.2.1) in CDCh appeared to be remarkably consistent with that of the X-ray crystal 
structure of the norhalichondrin A derivative, both in terms of the overall folding 
conformation of the molecule and also in terms of the conformation of the individual 
A to Lrings. 
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2.3.2 Computer Modelling of Halichondrin B 
The computer modelling described in this thesis involved using the program 
MacroModel V4.0 with the associated auxiliary computational chemistry program 
BatchMin. BatchMin carries out all of the energetic tasks associated with a 
conformational search and structure minimisations while MacroModel can be used to 
monitor the progress and results of BatchMin tasks so that numerical and structural 
information can be viewed and analysed. BatchMin jobs can be initiated 
independently of MacroModel by submitting jobs as command files (a "COM" file) 
in non-interactive batch mode. This significantly speeds up the processing time. 
The molecular mechanics force field that was used in MacroModel/BatchMin for 
carrying out energy calculations from a specific molecular geometry was the MM2* 
force field. 36,37 This force field was tested on each structure submitted for energy 
calculations to ensure there were no low quality parameters present which would 
produce unreliable results. 
The NMR experiments for the spectroscopic studies of the halichondrins were 
carried out in chloroform. The solvent medium can play an important role in 
determining the conformations and relative energies for a particular structure. 
Therefore all energetic tasks were carried out using the implicit solvent model 
"GB/SA" with chloroform parameters. 38 The implicit model treats the solvent as a 
continuum with the loss of specific solvent-solute interactions that are part of an 
explicit solvent model. 
Conformational searching was carried out using the Monte Carlo method in 
MacroModel/BatchMin. 39,40 This method modifies an input structure by randomly 
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changing specified torsion angles. Torsional angles to be varied must be specified 
along with ring closure atoms if a ring is present. This allows the ring to be broken, 
the torsional angles to be varied, and the ring to be reformed at the specified ring 
closure atoms. The stereochemistry at chiral centres must also be specified to avoid 
inversion of stereochemistry during conformational searches. 
The Monte Carlo searches performed were "usage-directed" structure selections. 
This means that the least used structures were used as starting geometries for Monte 
Carlo steps. This ensured that conformational space was efficiently searched. 
Energy minimisations were carried out using the PR (Polak-Ribiere) conjugate 
gradient (PRCG) minimisation algorithm. 41 This enables a rapid convergence to a 
low energy gradient and is the best general minimisation method. 42 For Monte 
Carlo searches, energy minimisations are carried out for every Monte Carlo step. 
2.3.2.1 The C2-C15 Subunit 
A conformational search was carried out on the C2-Cl5 fragment of the "B" 
halichondrin series. Initially, the C2-C15 subunit was excised from the X-ray crystal 
structure and modified to give a CH3 group at C3 and Cl4. This structure was then 
used as one starting conformation for a Monte Carlo conformational search in 
MacroModel. Two other searches were initiated from slightly different starting 
geometries. 
The resulting output was identical for all three searches and resulted in only two 
unique, minimised conformations. The global minimum was lower in energy by 
30.4 kJ/mol relative to the other conformer. This meant that for a Boltzmann-
weighted distribution at 23 · C there would be greater than 99.99% of the structures in 
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the lower energy conformation at any one time. Therefore the "average" solution 
geometry would essentially be represented by the lower energy conformation only. 
The two conformers are displayed in Figure 2.3.4 along with their MM2* energies. 
The lower energy conformer (CONFORMER ONE, MM2* Energy -195.6 kJ/mol) 
has the A and B rings in the more stable chair/chair conformation. The higher 
energy conformer exists in a chair (B ring)/twist-boat (A ring) conformation. 
CONFORMATION ONE 
MM2* Energy= -195.6 kJ/mol 
~A ring (chair conformation) 
CONFORMATION TWO 
MM2* Energy= -165.2 kJ/mol 
~A ring (twist-boat conformation) 
Figure 2.3.4 C2-C 15 Conformational Search Output 
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Vicinal coupling constants were collected in MacroModel for the lower energy 
conformer. These values are given in Table 2.3.4 relative to the X-ray crystal 
structure coupling constants and the experimental data for the H6-H13 protons. 
Table 2.3.4 Modelling-Derived Coupling Constants for H6-Hl3 
Coupled CONFORMER ONE X-ray Experimental 
protons 3JHH(Hz) 3JHH(Hz) 3JHH (Hz) 
H6-H7 9.3 9.2 9.5 
H7-H8 2.5 3.4 2.1 
H8-H9 3.3 4.2 4.1 
H9-H10 6.0 5.8 6.6 
H10-H11 4.6 4.6 4.7 
H11-H12 6.4 7.0 4.7 
H12-H13 5.5 5.9 4.7 
H12-H13' 1.2 1.3 
From Table 2.3.4, it can be seen that the computer modelling-derived vicinal 
coupling constants of the C6-C13 area correlated well with the experimental results, 
except for H11-H12 which had a coupling constant of 6.4 Hz relative to the 
experimental value of 4.7 Hz. There were only relatively minor changes in terms of 
dihedral angles and therefore conformation from the X -ray crystal structure 
conformation to CONFORMER ONE. It is interesting to note that the adjacent H10-
H11 and H12-Hl3 coupling constants compared well between CONFORMER ONE 
and the experimentally observed coupling constants. This suggested that the 
dihedral angles for H10-Hll and H12-H13 were similar between CONFORMER 
ONE and the experimental solution conformation. By implication, the H11-H12 
dihedral angles were also similar between CONFORMER ONE and the solution 
conformation. This indicated that there was a problem with the Karplus derivation 
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of coupling constants from dihedral angles for this type of system rather than any 
significant conformational difference between the X-ray crystal structure and the 
experimental solution conformation. Possible problems with the Karplus model 
were highlighted in Section 2.3.1.2. 
2.3.2.2 The C44-C54 Subunit- The Terminal Moiety 
The Monte Carlo method of conformational searching is able to find all populated 
minima for up to 10-12 rotatable torsional angles.37 It was decided to divide the 
C44-C54 subunit into two searches to reduce the number of rotatable torsional angles 
and thus increase the efficiency of the search. For this reason, only the M and N 
rings of halichondrin B were conformationally searched using MacroModel before 
the C51-C54 "tail" portion was added. A further conformational search on the 
lowest energy conformer(s) for the C44-C54 subunit was then undertaken. 
The M ring and N rings of halichondrin B were generated in the computer program 
Chem3D Plus, with the M ring in a chair conformation, and a primary hydroxyl 
group at C51 and a methyl and a hydroxyl group on C44. This structure was 
searched with four different starting geometries. The same set of low energy 
conformers was produced in each search (Figure 2.3.5). A Boltzmann-weighted 
distribution was calculated at 23·c for the conformers produced. The lowest energy 
conformer (CONFORMATION ONE) and the next lowest conformer 
(CONFORMATION TWO) totalled 97.2% of the populated conformations. A 
closer examination of these two conformers indicated that the only difference 
between them was the orientation of the C51 hydroxyl group. The conformation of 
the M and N rings were the only concern at this stage as the tail portion was to be 
added for the next conformational search. 
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The C52-C54 "tail" was added to both conformers and they were both used as 
starting points for a Monte Carlo conformational search of the C51-C54 region. 
CONFORMATION ONE (49.7%) 
MM2* Energy= -125.4 kJ/mol 
CONFORMATION TWO (47.4%) 
MM2* Energy= -125.3 kJ/mol 
Figure 2.3.5 Conformational Search Output C44-C51 
Five searches were initiated from different starting orientations of the C51-C54 tail 
for the C44-C54 subunit. The global minimum and low energy conformers were 
identical for all searches. Each conformer was tested to ensure that it was in fact a 
true minima using a BatchMin minima test command on each conformer in the 
output structure file generated from the conformational search. The Boltzmann-
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weighted distribution of the each conformer was calculated at 23.C; there were six 
conformers contributing greater then 5% to this distribution. These conformations 
contributed to ca 94% of the total population of conformers and they are depicted in 
Figure 2.3.6 with their MM2* energies and Boltzmann-weighted populations. 
CONFORMATION ONE (29.7%) 
MM2* Energy= -173.0 kJ/mol 
CONFORMATION THREE (18.9%) 
MM2* Energy= -171.8 kJ/mol 
CONFORMATION FIVE (8.5%) 
MM2* Energy= -169.8 kJ/mol 
CONFORMATION TWO (19.2%) 
MM2* Energy = -171.9 kJ/mol 
CONFORMATION FOUR (12.5%) 
MM2* Energy= -170.8 kJ/mol 
CONFORMATION SIX (5.7%) 
MM2* Energy= -168.9 kJ/mol 
Figure 2.3.6 Conformational Search Output C43-C54 
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Coupling constants were collected from MacroModel for each conformer for each 
dihedral angle (H-C-C-H). A Boltzmann-weighted coupling constant was calculated 
over all conformers for each dihedral angle. These results are given in Table 2.3.5. 
Also included in Table 2.3.5 are the range of coupling constants generated from the 
conformational search for each dihedral angle. 
Table 2.3.5 Modelling-Derived Coupling Constants for H45-H54 
Coupled 
protons 
H45-H46 
H45'-H46 
H46-H47 
H47-H48 
H48-H49 
H48-H49' 
H49-H50 
H49'-H50 
H50-H51 
H51-H52 
H51-H52' 
H52-H53 
H52,-H53 
H53-H54 
H53-H54' 
Boltzmann 
-weighted 
3JHH(Hz) 
12.2 
3.9 
2.3 
1.9 
1.3 
5.8 
9.6 
4.2 
4.7 
2.3 
11.2 
1.1 
10.6 
7.0 
3.3 
Experimental Range of 3 lHH 
3 lHH (Hz) from modelling 
12.5 12.2-12.2 
3.7 3.8-4.0 
3.0 2.2-2.3 
2.5 1.9-2.0 
1.2-1.4 
5.4-6.2 
9.5 9.5-9.6 
4.8 3.7-4.9 
5.4 0.3-9.6 
4.3 1.0-9.1 
9.3 1.3-11.3 
1.0-10.5 
10.5 1.1-11.7 
6.6 0.5-10.7 
2.7 2.0-4.4 
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Further to the coupling constant data collected from the 1 H NMR spectrum, and lD 
and 2D-TOCSY experiments, additional coupling constant data were collected from 
the active couplings in the phase sensitive COSY experiment. "Active" couplings in 
a COSY correlation arise due to a direct coupling between the protons giving rise to 
the cross-correlation and can be identified as those where the phase of the peak in the 
correlation changes phase. 43 These data are displayed in Table 2.3.5 for comparison 
with the modelling results. 
There were a large range of modelling-derived coupling constants for each specified 
dihedral angle between the different conformers in the H51-H54 region. For 
example, the H50-H51 coupling constant has a range from 0.3 Hz to 9.3 Hz for the 
first fifteen low energy conformers. Given this, the Boltzmann-weighted coupling 
constant of 4.7 Hz compared well with the experimentally observed value of 5.4 Hz. 
Generally, there was a good correlation between the modelling derived coupling 
constants and the experimental values. 
However, it is important to note that the MM2* energies calculated represent 
enthalpies at OOK, so it was important to calculate the effect of entropy on the overall 
distribution of conformers. It is possible that "more ordered" conformations with 
low enthalpies relative to the global minimum may have a higher Gibb's Free Energy 
and therefore a decreased relative importance. For example, the relative populations 
can change in a system with a high degree of intra-molecular hydrogen bonding 
(such as in the solvent chloroform) which would have an associated entropic cost.44 
The conformations stored from the C44-C54 conformational search were used as the 
input file in a BatchMin command file to calculate the entropies from a rigid rotor, 
harmonic oscillator analysis (the "RRHO" command). The entropy values at 296oK 
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that were produced for each conformer were used as a correction to the enthalpy 
values from the conformational search. The relative order of the conformational 
search output conformers with a greater than 5% Boltzmann weighted population did 
not change. There were only minor changes in the relative populations of these 
conformations. 
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2.4 NMR Spectroscopic Assignment 
Homohalichondrin B 
77 
of 
The complete assignment of the 1 H and Be NMR spectra of homohalichondrin B 
(1.2.3) has been achieved. This enabled the characterisation of homohalichondrin B 
derivatives to be made in terms of differences relative to the homohalichondrin B 
NMR spectra. Hirata and Uemura 18 have previously assigned the 1 H NMR 
spectrum homohalichondrin B in eD30D but their assignments were incomplete and 
there were no Be NMR data given. 
The 300 MHz 1 H NMR spectrum of homohalichondrin B (Figure 2.4.1) in CDel3/ 
0.1% pyridine-ds showed some key differences to the halichondrin B lH NMR 
spectrum (Figure 2.2.1). The most obvious difference was seen in the H47 proton 
signal which appeared as an isolated narrow doublet at OH 3.06 ppm in the lH NMR 
spectrum of homohalichondrin B but was obscured in the halichondrin B spectrum at 
OH 3.61 ppm. Other apparent differences in the lH NMR spectrum of 
homohalichondrin B were a clearly visible doublet signal at OH 3.69 ppm (HSS/HSS') 
and a change in the relative position of the four methyl doublet resonances relative to 
halichondrin B. 
A range of lD and 2D NMR experiments were run on 9.1 mg of homohalichondrin 
B (1.2.3) in CDel3/0.l% pyridine-ds and all protons (non-exchangeable) and 
carbons were assigned. The 7 5 MHz 13C NMR spectrum of homohalichondrin B is 
displayed in Figure 2.4.2. 
The important HMQe and HMBe correlations in the NMR spectroscopic 
assignment of homohalichondrin B are depicted in Figure 2.4.3 and the 2D-TOCSY 
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(100 ms mixing time), Phase Sensitive COSY (PS COSY) and NOESY correlations 
are displayed in Figure 2.4.4. The 1 H NMR and 13C NMR chemical shifts for 
homohalichondrin B are given in Table 2.4.1 and Table 2.4.2 respectively. 
As expected, the 13C and 1H NMR chemical shifts for the Cl-C43 subunit were very 
similar to those of halichondrin B (1.2.1). Hirata and Uemura 18 did not publish 13C 
NMR data for homohalichondrin B so the literature reference data for comparison, 
which is displayed in Table 2.4.2, are for those of homohalichondrin A (essentially 
the C12 and C13 hydroxyl substituted homohalichondrin B). 
The 13c and 1 H NMR assignment for the C44-C55 subunit of homohalichondrin B is 
discussed in more detail. 
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Table 2.4.1 1 H NMR Data for Homohalichondrin B (1.2.3) 
Protona Literature CDCl3 Proton a Literature CDCl3 
8 ppm18,b Sppmc 8 ppml8,b 8ppmc 
H2 2.44 2.34 H28 1.94 
H2' 2.56 2.58 H28' 2.02 
H3 3.88 3.88 H29 4.25 4.20 
H4 1.34 H30 4.63 4.65 
H4' 1.72 H31 2.04 
H5 1.38 CH3-31 1.05 0.99 
HS' 2.08 H32 3.22 3.17 
H6 4.33 4.34 H33 3.87 3.78 
H7 2.98 2.94 H34 1.80 
HS 4.30 4.32 H34' 2.14 
H9 4.10 4.04 H35 4.10 4.10 
HlO 4.18 4.20 H36 4.10 4.10 
H1l 4.60 4.58 H37 1.90 
Hl2 4.70 4.68 H37' 2.35 
Hl3 2.00 1.94 H39 2.21 
Hl3' 2.08 2.16 H39' 2.21 
Hl5 1.60 H40 3.95 3.92 
Hl5' 2.16 H4l 3.66 3.60 
Hl6 1.40 H42 2.32 
H16' 2.16 CH3-42 0.94 0.93 
Hl7 4.10 4.10 H43 1.29 
Hl8 2.32 2.26 H43' 1.45 
Hl8' 2.80 2.79 H45 1.42 
19=CH 5.02 4.91 H45' 1.42 
19' =CH 5.06 4.98 H46 2.18 
H20 4.45 4.38 CH3-46 0.93 0.90 
H21 1.44 H47 3.12 3.06 
H21' 1.88 H48 3.58 3.53 
H22 1.60 H49 1.90 1.79 
H22' 1.60 H49' 2.16 2.15 
H23 3.70 3.52 HSO 3.90 3.90 
H24 1.05 H51 4.02 4.04 
H24' 1.70 H52 2.00 2.02 
H25 2.20 H52' 2.00 2.02 
CH3-2S 1.08 1.06 H53 4.23 4.25 
26=CH 4.82 4.75 H54 3.50 3.57 
26'=CH 4.87 4.80 H55 3.58 3.69 
H27 3.61 3.54 H55' 3.59 3.69 
a The symbol ' represents the less shielded proton of a geminal pair. 
b Literature data recorded in CD30D at 360 MHz. 
c Data recorded at 23°C in CDCl3 at 300 MHz with chemical shifts in ppm 
and referenced to CHCl3, OH 7.25 ppm. 
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Table 2.4.2 13C NMR Data for Homohalichondrin B (1.2.3) 
Carbon Literature CDCl3 Carbon Literature CDCl3 
0 ppml8,a oppmb 0 ppm18,a oppmb 
Cl 171.8 171.2 C29 73.8 71.2 
C2 41.1 40.4 C30 77.3 76.6 
C3 75.1 73.6 C-CH3-Jl 37.4 36.8 
C4 30.7 C-CH3-Jl 15.8 15.0 
cs 30.0 C32 77.9 77.5 
C6 69.6 68.2 C33 65.6 66.5 
C7 79.0 77.7 C34 29.4 
cs 75.9 74.3 C35 77.6 75.3 
C9 73.8 73.8 C36 78.0 76.3 
ClO 85.5 76.5 C37 45.6 43.4 
Cll 75.5 82.1 C38 114.8 112.4 
C12 113.3 81.1 C39 44.9 42.5 
C13 82.3 48.3 C40 72.3 70.8 
C14 111.3 110.1 C41 81.0 79.4 
C15 34.4 C-CH3-42 27.1 25.8 
C16 28.1 C-CH3-42 18.2 17.7 
C17 76.3 75.4 C43 36.5 
C18 39.8 38.7 C44 98.1 96.6 
19C=CH2 153.0 151.8 C45 36.8 
19C=CH2 105.8 104.5 C-CH3-46 30.1 28.9 
C20 75.9 75.0 C-CH3-46 17.6 17.1 
C21 29.0 C47 74.5 72.8 
C22 32.0 C48 65.2 63.6 
C23 75.2 74.8 C49 31.4 
C24 43.4 cso 75.4 74.7 
C-CH3-2S 37.2 35.9 C51 78.4 76.3 
C-CH3-2S 18.4 18.0 C52 37.2 
26C=CHz 153.2 151.5 C53 79.8 79.8 
26C=CHz 104.8 104.2 C54 75.0 72.0 
C27 75.0 73.5 css 65.1 65.6 
C28 36.9 
a Literature data for homohalichondrin A recorded in CD30D at 75.4 MHz. 
b Data recorded at 23°C in CDCl3 at 75 MHz with chemical shifts in ppm and 
referenced to CDCl3, oc 77.0 ppm. 
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The remaining unassigned methyl doublet in the 1 H NMR spectrum after the 
assignment of the Cl-C44 subunit was CH3-46. The HMQC spectrum showed a 
correlation for this doublet at OH 0.90 ppm to a carbon at oc 17.1 ppm (CH3-46). 
The CH3-46 protons showed a COSY correlation to a proton at OH 2.18 ppm (H46). 
The H46 proton gave an HMQC correlation to the C-CH3-46 carbon at oc 28.9 ppm. 
A 2D-TOCSY correlation from the CH3-46 protons to OH 1.42 ppm and an HMBC 
correlation from the previously assigned C44 also to OH 1.42 ppm allowed the H45 
and H45' protons to be assigned. The isolated doublet at OH 3.06 ppm in the lH 
NMR spectTum of homohalichondrin B gave a COSY correlation to the proton at OH 
2.18 ppm (H46). This doublet resonance was attributed to the H47 proton. An 
HMQC correlation between the H47 proton and a carbon at oc 72.8 ppm assigned 
the directly attached carbon, C47. A COSY correlation was observed from the H47 
resonance to another methine proton resonating at OH 3.53 ppm which was assigned 
as H48. An HMQC correlation from H48 to a directly attached carbon resonance at 
oc 63.6 ppm assigned C48. The C45 carbon was assigned from an HMBC 
correlation from H47 to a previously unidentified carbon at oc 36.8 ppm. A COSY 
correlation from H48 to a methylene proton at OH 2.15 ppm allowed H49' to be 
assigned. The geminal partner to H49' (ie H49) was able to be assigned from an 
HMQC correlation to the C49 carbon at oc 31.4 ppm and a NOESY correlation from 
H47. 
A COSY correlation was observed between two methine protons at OH 3.90 ppm and 
OH 4.04 ppm. The proton at OH 4.04 ppm showed a COSY correlation to OH 2.02 
ppm. H51 was therefore assigned a chemical shift of OH 4.04 ppm, H50 at OH 3.90 
ppm. Carbon C50 was assigned a chemical shift of oc 74.7 ppm from the correlation 
to H50 in the HMQC spectrum, and C51 at oc 76.3 ppm from an HMQC correlation 
to H51. 
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Two COSY correlations were observed from a central proton at OH 3.57 ppm to OH 
4.25 ppm and to one in the other direction at OH 3.69 ppm. The central proton was 
therefore assigned as H54. The intensity of the OH 3.69 ppm HMQC correlation to a 
carbon at oc 65.6 pp~ suggested that there were two protons contributing to the 
signal, and the proton and carbon chemical shifts were consistent with those 
expected for a terminal methylene group such as H55/H55' and C55. The H53 
proton was therefore assigned a chemical shift of OH 4.25 ppm and the C53 carbon a 
chemical shift of oc 79.8 ppm from an observed HMQC correlation. Finally, the 
C52 carbon was assigned a chemical shift from the observance of HMQC 
correlations to H52 and H52'. 
The relative stereochemistry at C50, C51, C53 and C54 in homohalichondrin B 
(1.2.3) was not settled by Hirata and Uemura.l8 From the NOESY spectrum of 
homohalichondrin Bit was possible to assign a relative stereochemistry to the C51 
centre and the relative orientation of the C49 methylene protons and also a likely 
solution conformation for the terminal M and N rings. NOESY correlations were 
observed from H47 to H49, from H47 to H51 and from H48 to H50. Based on the 
relative stereochemistry at the C47 and C48 centres as determined by Hirata and 
Uemura, H50, H51 and H49 must be on the same face of theN ring as H47. For 
NOESY correlations to be observed from H47 to H49 and H51 implied a chair/ chair 
conformation for the M and N rings. However, nothing could be said about the 
relative stereochemistry at the C53, C54 or C55 centres. 
The overall folding conformation of the lactone ring appeared to be the same as that 
of halichondrin B (described in Section 2.3.1), with NOESY correlations observed 
across the ring from H2' to H20, H2' to 19=CH, and also from 19=CH to H29. 
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2.5 
2.5.1 
Conformational and Stereochemical Studies 
on Isohomohalichondrin B 
Introduction 
Isohomohalichondrin B (1.2.9) was first isolated by Dr. Rob Lake and identified by 
Dr. Marc Litaudon in the Marine Chemistry Group from a Lissodendoryx sp. 
extraction.I4 The solution conformation(s) of the terminal M and N rings had not 
been fully investigated. 
It is important to note that the norhalichondrin A structure has identical M and N 
pyranose rings to those of isohomohalichondrin B. The X-ray crystal structure 
conformation of the M and N rings of the p-bromophenacyl ester of norhalichondrin 
A obtained by Uemura et az17 is a chair and a twist-boat ring system respectively. 
This is shown in Figure 2.5.1 from Uemura et az17 with the terminal p-
bromophenacyl ester group removed for simplicity. 
Figure 2.5.1 X-ray Crystal Structure Conformation ofNorhalichondrin A 
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The average solution conformation of the terminal M and N rmgs of 
isohomohalichondrin B (1.2.9) was determined by selective NOB NMR experiments 
and vicinal coupling constants obtained from the 1 H NMR spectrum and a 2D-
TOCSY experiment. The conformation suggested from these experiments was then 
modelled using the computer program MacroModel. The resulting vicinal coupling 
constants and interatomic distances between protons were compared to the 
experimentally obtained coupling constants and NOB observations respectively to 
look for possible anomalies. 
The absolute stereochemistry of isohomohalichondrin B (1.2.9) was also assigned, 
based on the defined stereochemistry of the X-ray crystal structure of the 
norhalichondrin A derivative17 and the measured optical rotation of 
isohomohalichondrin B relative to norhalichondrin A and the other known 
halichondrins. 
2.5.2 Isohomohalichondrin B NMR Experiments 
A 2D-TOCSY experiment (100 ms mixing time) and selected difference NOB 
experiments were recorded for ca 2.5 mg of pure isohomohalichondrin B (1.2.9). 
The coupling constants in the terminal region of isohomohalichondrin B were 
extracted from the isolated signals in the lH NMR spectrum (viz CH3-46, H47, H48, 
H52', H52, H54/H54' and H55/H55') and from cross-sections through these protons 
in the 2D-TOCSY spectrum. The coupling constants (and multiplicity data) 
extracted are given in Table 2.5.1. The NOB irradiation of the CH3-46, H48 and 
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H4 7 protons in separate experiments gave some crucial correlations. These 
correlations are also given in Table 2.5.1. 
Strong H47 to H48 and H48 to H47 NOE correlations confirmed a cis fusion of the 
M and N rings as in all other halichondrins isolated to date. Key NOE enhancements 
from irradiation of H47 to H51 (1.4%) and to H49 (0.4%) also implied a cis 
relationship for these three protons. This implied an axial orientation for H47, H49 
and H51 in the N ring and also assigned H49 as the axial proton and H49' as the 
equatorial proton, and therefore indicated a chair conformation existed for the N 
ring. 
Table 2.5.1 lH NMR Data for Isohomohalichondrin B H45-H55 
Proton Multiplicitya OH (ppm)14 lHH(Hz) NOE to(%) 
H45 1.49 
H45' dd 1.52 12.7, 12.7 
H46 m 2.18 
CHJ-46 d 0.90 6.9 H45/H45'(1.0% ), 
H47(2.0%), H46(0.6%) 
H47 d 3.23 2.3 CH3-46(0.6%), H51(1.4%), 
H46(0.6%), H48(3.3%), 
H49(0.3%) 
H48 br. s 3.75 H46(zl.8%), H49'(zl.8%), 
H49(0.4%), H47(3.3%) 
H49 d 1.84 13.2 
H49' d 2.13 13.2 
H50 s 3.52 
H51 dd 3.82 5.0, 8.0 
H52 dd 2.62 5.0, 15.7 
H52' dd 2.93 8.0, 15.7 
H54/H54' t 2.73 5.4, 5.4 
H55/H55' t 3.86 5.4, 5.4 
a Abbreviations are as follows: dd =doublet of doublets, m =multiplet, d = doublet, br. =broad, 
s = singlet and t = triplet. 
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Another key point is that HSO appeared as a singlet resonance in the 1 H NMR 
spectrum of isohomohalichondrin B and H51 was coupled only into H52 and H52'. 
This implied that HSO and H51 were at a dihedral angle of around 90· and therefore 
that HSO was in an equatorial position. Similarly, as the H48 resonance was 
observed to be a broad singlet in the 1 H NMR spectrum of isohomohalichondrin B 
and H47 was a doublet with a small coupling constant, the dihedral angle between 
these two protons must be around 90". These observations indicated an average 
chair conformation existed for the N ring as in a boat conformation these dihedral 
angles would be close to o· and would therefore give rise to relatively large coupling 
constants for H47, H48 and H50, H51. 
Dreiding models constructed of the chair/chair conformation fully supported the 
NMR observations discussed above. 
2.5.3 Computer Modelling of Isohomohalichondrin B- M and N 
rings 
Initially the chair/chair conformation of theM and N rings (the C44-C55 subunit) of 
isohomohalichondrin B was constructed using the CSC Chem3D Plus program. This 
structure was then minimised in Macro Model using a MM2 * force field with PRCG 
as the conjugate gradient minimisation algorithm. Chloroform was selected as the 
solvent as this was the solvent used for the NMR experiments. The output structure 
generated was tested to ensure it was indeed a true minimum. This structure, having 
passed the minimum test, was then analysed to give vicinal coupling constants 
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(3 JHH) and interatomic distances between protons situated around the M and N rings 
(ie H45-H51). 
Figure 2.5.2 depicts the minimised chair/chair conformation from the modelling 
output and gives the associated interatomic distances between protons with an 
experimentally observed NOB. Interatomic distances for NOB observations to and 
from CH3-46 were not able to be calculated from the model because of the fixed 
orientation of the three equivalent CH3-46 protons in the minimised conformation. 
o/oNOE 
(internuclear distance in A) 
Figure 2.5.2 NOB Observations and Corresponding Modelling Distances 
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The interatomic distances between protons (taken from the minimised chair/chair 
model) which had an experimentally observed NOB, were within reason for a NOB 
observable distance. This therefore further supported the proposed chair/chair 
conformation of the terminal rings of isohomohalichondrin B. 
The vicinal coupling constants collected from the minimised chair/chair 
conformation were compared to the experimentally obtained results and these data 
are given in Table 2.5.2. 
Table 2.5.2 Comparison of Vicinal Coupling Constants- Experimental vs Modelling 
Coupled 
protons 
H46-H47 
H47-H48 
H48-H49 
H48-H49' 
H49-H50 
H49'-H50 
H50-H51 
Experimental 
3JHH (Hz) 
::;2.3 
::;2.3 
<5.8 
<5.8 
<5.8 
<5.8 
<2.9 
Modelling 
3JHH (Hz) 
2.3 
1.2 
3.0 
3.0 
3.0 
3.1 
1.0 
The experimental coupling constants for H47-H46 and H47-H48 were assigned as 
being ::;2.3 Hz, as H47 appeared as a doublet in the 1 H NMR spectrum of 
isohomohalichondrin B, with a 2.3 Hz coupling to either H46 or H48. This meant 
that one proton had a coupling of 2.3 Hz and the other proton a coupling of less than 
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this, ie less than the linewidth of the peak which gave the appearance of no further 
splitting of the doublet. As the H49 and H49' resonances appeared to show no 
coupling apart from their geminal coupling, the vicinal coupling constant was given 
as the linewidth of these signals from a cross-section through H48 to give a F2 
dimension trace from the 2D-TOCSY spectrum. F2 is the directly detected axis in a 
2D NMR experiment and is therefore of higher resolution than Fl, which is 
indirectly detected. Similarly, the H50-H51 coupling constant was approximated 
from the linewidth of H50 obtained from a cross-section through H48 in the F2 
dimension of the 2D-TOCSY experiment. The experimental observation of small 
coupling constants for protons H47 to H51 appeared to justify the proposed 
chair/chair conformation of the terminal M and N rings of isohomohalichondrin B 
relative to the minimised model conformation of this region. 
2.5.4 Optical Rotation of Isohomohalichondrin B 
The absolute stereochemistry of isohomohalichondrin B (1.2.9) was initially based 
on the stereochemistry of the X-ray crystal structure of a norhalichondrin A 
derivative. I 7 The ORD (Optical Rotatory Dispersion) spectrum of 
isohomohalichondrin B was recorded and the specific rotation ([ a]o) calculated and 
compared to those of known halichondrins to give the assignment of the absolute 
stereochemistry further credibility. Table 2.5.3 gives the specific rotations for 
isohomohalichondrin B and other known halichondrins. All specific rotations were 
measured in methanol. 
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The similarity of both the sign and the magnitude of the specific rotation for 
isohomohalichondrin B relative to the other halichondrins was indicative of the same 
absolute stereochemistry. 
Table 2.5.3 Specific Rotation for Selected Halichondrins 
Compound Concentration 
(mg/mL) 
isohomohalichondrin B -21.6 1.02 
bali chondrin B 18 -58.9 0.94 
norhalichondrin A 18 -47.8 1.13 
halichondrin C 18 -41.6 0.49 
homohalichondrin A 18 -97.1 1.23 
halistatin t19 -58.4 0.57 
halistatin 220 -59.0 0.48 
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3.1 Introduction 
Initial investigations into the relationship between structure and the expression of 
biological activity in the halichondrin series were focused on manipulations of the 
oxidation level of functionalities at the terminal moiety region of selected 
halichondrins. 
Acetylations of isohomohalichondrin B (1.2.9) and homohalichondrin B (1.2.3) were 
aimed at reducing the polarity of the terminal moiety. A monoacetylation of 
isohomohalichondrin B was undertaken to provide the C55 protected hydroxyl 
analogue to allow a selective oxidation of the C50 secondary alcohol to be 
attempted. It was anticipated that the C50 ketone derivative of isohomohalichondrin 
B would provide useful structure-activity information. 
A reduction of the C53 ketone group in the "tail" of isohomohalichondrin B was 
undertaken with the objective of increasing the polarity in this region and, as such, to 
provide further biological activity data. 
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3.2 Acetylations 
3.2.1 Acetylations of lsohomohalichondrin B 
An acetylation was initially attempted on a small quantity of isohomohalichondrin B 
(1.2.9) prior to attempting the monoacetylation of the C55 primary hydroxyl group 
on larger scale. 
Isohomohalichondrin B (1.2.9, 1.4 mg) was reacted overnight at room temperature 
with acetic anhydride dissolved in pyridine.45 Silica TLC (Thin Layer 
Chromatography) of the worked-up material indicated the presence of two spots of 
lower polarity relative to isohomohalichondrin B, the lower spot appearing as the 
major component. 
A 1 H NMR spectrum acquired from the acetylation mixture, performed in 
CDCl3/0.l% pyridine-ds, indicated that the characteristic terminal H55/H55' triplet 
of isohomohalichondrin B at OH 3.86 ppm had moved by OH 0.46 ppm to a less 
shielded position at DH 4.32 ppm. Also apparent from the 1 H NMR spectrum of the 
acetylation mixture was the movement of the of the H54/H54' signal from OH 2.74 
ppm in the 1 H NMR spectrum of isohomohalichondrin B to a less shielded position 
at DH 2.80 ppm. These chemical shifts described for the protons a (H55/H55') and p 
(H54/H54') to the C55 hydroxyl group were characteristic of an acetylation at the 
hydroxyl group.46 The broad singlet resonance of the H50 proton was still visible at 
OH 3.52 ppm in the acetylation mixture, although it was likely that a less shielded 
H50 signal corresponding to diacetylation at both the H50 secondary hydroxyl and 
the C55 hydroxyl group was also present, but obscured by other resonances in the 
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spectrum. The acetate proton resonances were masked in the spectrum by a broad 
water peak at ca DH 2.00 ppm, so it was not possible to determine the relative 
amounts of monoacetylated and diacetylated isohomohalichondrin B present in the 
mixture. However, the relative intensity of the two silica TLC spots indicated that 
the major component was the more polar monoacetate derivative, with the diacetate 
present as a very minor component. 
Low resolution FAB-MS (Fast Atom BombardmentMass Spectrometry) performed 
on the product showed the presence of several parent ions corresponding to the 
monoacetate of isohomohalichondrin B (MH+, MNa+, MNa+ -AcO•) and one parent 
ion corresponding to the diacetate of isohomohalichondrin B (MH+). The MS results 
therefore confirmed that the acetylation attempt had been successful with both the 
monoacetate (3.2.1) and the diacetate being formed in the reaction. 
0 
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isohomohalichondrin B monoacetate (3.2.1) 
A selective monoacetylation47 of the C55 primary hydroxyl group was undertaken 
on a larger quantity (2.3 mg) of isohomohalichondrin B. Isohomohalichondrin B 
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(1.2.9) in pyridine was reacted with acetic anhydride at -s·c for three hours. Silica 
TLC of the product showed the appearance of a single spot at a higher Rr (Retention 
factor) relative to that of isohomohalichondrin B. The Rf was identical with that of 
the monoacetate of the previously described acetylation. A 1 H NMR spectrum of the 
product (Figure 3.2.1), performed in CDCl3/0.l% pyridine-ds, was similar to that 
described previously. Now apparent in the spectrum was the distinctive CH3 singlet 
proton resonance of the acetate protons at OH 2.02 ppm. A COSY experiment was 
also performed on this sample. An analysis of the COSY spectrum indicated that the 
chemical shifts around the A to M rings were identical with those of 
isohomohalichondrin B, 14 and that the changes were focused in the terminal region 
of the molecule. The COSY connectivities for the H45/H45' to H55/H55' region are 
depicted in Figure 3.2.2. 
Figure 3.2.1 1 H NMR Spectrum of Isohomohalichondrin B Monoacetylation 
Product 
THe LIBRARY 
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A strong COSY correlation was observed between two protons at OH 2.88 ppm and 
OH 2.80 ppm, which were assigned as corresponding to the H52' and H52 protons 
respectively. From these two protons, two correlations were observed into a methine 
proton at OH 3.81 ppm (H51). Two correlations from the relatively isolated H48 
proton (at OH 3.74 ppm) to OH 1.82 ppm and OH 2.10 ppm assigned the chemical 
shifts of the H49 and H49' methylene protons respectively. A single correlation from 
H49 to a methine proton at OH 3.52 ppm located the H50 proton resonance. The 
chemical shift of the H50 proton was the same as that of isohomohalichondrin B, 
implying acetylation at this position had not occurred. The one COSY correlation 
remaining unassigned at OH 2.80 ppm/ OH 4.32 ppm was assigned as corresponding to 
the H54/H54' and H55/H55' protons respectively. The 1 H NMR data for protons in 
the H45/H45' to H55/H55' region are cited in Table 3.2.1 relative to the 
corresponding 1H NMR chemical shifts of isohomohalichondrin B (1.2.9).14 The 
observation of an unshifted H50 resonance and the a and ~-shifts of the H55/H55' 
and H54/H54' methylene protons, relative to isohomohalichondrin B, implied that 
the C55 monoacetate of isohomohalichondrin B (3.2.1) had been formed, in support 
of the TLC evidence. 
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Figure 3.2.2 Isohomohalichondrin B Monoacetate- Terminal Region COSY 
Correlations 
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Table 3.2.1 1 H NMR Data for Isohomohalichondrin B Monoacetate (3.2.1)-
Terminal Region 
Proton a Isohomohalichondrin B b 
8ppmc 
H45 1.49 
H45' 1.52 
H46 2.18 
CH3-46 0.90 
H47 3.23 
H48 3.75 
H49 1.84 
H49' 2.13 
H50 3.52 
H51 3.82 
H52 2.62 
H52' 2.93 
H54 2.73 
H54' 2.73 
H55 3.86 
H55' 3.86 
CSS-OCOCH3 
Isohomohalichondrin B 
Monoacetate 8 ppmc 
1.49 
2.14 
0.89 
3.24 
3.74 
1.82 
2.10 
3.52 
3.81 
2.62 
2.88 
2.80 
2.80 
4.32 
4.32 
2.02 
a The symbol' represents the less shielded proton of a geminal pair. 
b Appendix IV. 
c Data recorded at 23 oc in CDCl3 at 300 MHz with chemical shifts in ppm 
and referenced to C HO 3, OH 7.25 ppm. 
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A small amount of isohomohalichondrin B monoacetate (3.2.1) was subsequently 
used as the starting material for an oxidation attempt of the C50 hydroxyl group; this 
reaction is described in Section 3.3. 
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3.2.1 Acetylation of Homohalichondrin B 
There were two primary objectives in undertaking an acetylation of 
homohalichondrin B (1.2.3). The first objective was to protect the terminal C54, 
C55-diol group from periodate cleavage in the osmylation and periodate cleavage 
reactions of homohalichondrin B, which are described in detail in Chapter 4. The 
second objective was to generate additional biological activity data to further the 
understanding of structure-activity relationships. 
The acetylation of homohalichondrin B (1.2.3) was initially attempted on a small 
scale, followed by a larger scale acetylation. The reaction of a small quantity of 
homohalichondrin B with acetic anhydride in pyridine was monitored by silica TLC 
at room temperature. After forty-five minutes reaction TLC indicated a small 
amount of homohalichondrin B, and two less polar spots indicating the formation of 
both the monoacetate and the diacetate product (3.2.2). After five hours reaction, 
TLC of the reaction mixture indicated the absence of starting material and the 
presence of only the least polar of the initially observed spots, indicating complete 
conversion of homohalichondrin B to the diacetate product. A 1 H NMR spectrum of 
the product, acquired in CDCl3/0.l% pyridine-ds, showed a new quintet at OH 5.13 
ppm, and two acetate CH3 singlet resonances at OH 2.04 ppm and OH 2.10 ppm, 
indicating formation of homohalichondrin B diacetate (3.2.2) was successful. The 
quintet at OH 5.13 ppm was assigned as the H54 methine resonance. Also apparent 
from the spectrum was the disappearance of the characteristic H55/H55' doublet at 
OH 3.69 ppm. An assignment of the lH and 13C NMR resonances in the terminal 
region of the diacetate was achieved in the assignment of the homohalichondrin B 
diacetate diketone derivative (4.3.3); the NMR data and NMR correlations for 4.3.3 
are given in Tables 4.3.5 (lH NMR data) and 4.3.6 (13C NMR data) and in Figure 
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4.3.7 (NMR correlations). The lH NMR chemical shifts of 4.3.3 in the terminal 
region correlated well with the isolated signals of the terminal region in the 1 H NMR 
spectrum of 3.2.2; namely H54, the two acetate CH3 singlets and the methyl group 
CH3 
~ H H 
H H 43 0 
55 0 
0 H H ~ 
H H =n %~ CH3 9~ ~ g 
I 0 ,,v,,,,
1 
- E 
CH3 22 (' 'CH3 
homohalichondrin B diacetate (3.2.2) '',,,, 
The diacetylation was repeated twice on a larger scale in overnight reactions, to 
provide sufficient material for the osmylation reactions described in Chapter 4, and 
for biological assay. Silica TLC and a lH NMR spectrum of each product (Figure 
3.2.3), performed in CDCl3/0.l% pyridine-ds, were identical with that from the 
small scale reaction. 
5:0 4.5 3.5 2.0 1.5 
Figure 3.2.3 lH NMR Spectrum of Homohalichondrin B Diacetate 
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3.3 Oxidation 
Oxidation of the C50 alcohol of isohomohalichondrin B monoacetate (3.2.1) was 
attempted using the readily prepared reagent pyridinium chlorochromate (PCC)48 as 
the oxidising agent. A successful trial reaction was performed on a small quantity of 
cholesterol before committing 3.2.1 to the reaction conditions of the oxidation. 
A small quantity of isohomohalichondrin B monoacetate (3.2.1) dissolved in 
dichloromethane was added to a suspension of PCC and sodium acetate (added to 
buffer the solution) in dichloromethane. The mixture was stirred vigorously at room 
temperature and the reaction progress was monitored by silica TLC. After sixty 
hours reaction, silica TLC indicated the formation of a new spot at a lower polarity 
relative to the starting material (3.2.1); some starting material was also visible in the 
mixture. 
A 1 H NMR spectrum of the worked-up material in CDCb/0.1% pyridine-ds showed 
very weak proton resonances. However, it was possible to identify that the C55 
acetate was intact, and that there were some minor differences in the spectrum 
relative to the 1 H NMR spectrum of isohomohalichondrin B monoacetate (Figure 
3.2.1). Notably, the methyl region of the spectrum indicated the movement of the 
CH3-42 and CH3-46 doublets to more shielded positions, and some changes in the ca 
OH 3.20 ppm region where the H47 and H32 protons were situated in the lH NMR 
spectrum of isohomohalichondrin B monoacetate. It was not possible to observe 
changes in the region where the H50 resonance occurred at in the 1 H NMR spectrum 
of 3.2.1 (oH 3.52 ppm) as this position was obscured by other solvent related 
resonances. 
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It was difficult to assess if the CSO alcohol oxidation was successful given the small 
scale of the reaction and, as a result of this, the lack of supporting NMR and MS 
data. However, it did appear that some reaction had occurred, although an 
assessment of the product(s) formed and the reaction yield was not possible. 
It was recognised that an assessment of the biological activity of the reaction 
material could give a further indication as to the success of the reaction. This aspect 
is discussed in Section 3.5. 
To enable a full characterisation of the reaction product(s) from this reaction, it was 
decided to repeat the oxidation reaction of the monoacetate of isohomohalichondrin 
B on a larger scale. The oxidation was re-attempted on isohomohalichondrin B 
monoacetate (3.2.1) but the reaction that had been observed initially was not able to 
be reproduced; time and material constraints prohibited any subsequent 
investigations of this reaction. The identity of the initially observed product remains 
unknown. 
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3.4 Sodium Borohydride Reduction 
The ketone located at position C53 in isohomohalichondrin B (1.2.9) was targeted in 
a sodium borohydride reduction reaction. It was recognised that there was the 
possibility of two diastereoisomeric alcohol derivatives being produced at the new 
C53 centre arising from hydride attack on either face of the ketone (3.4.1 and 3.4.2). 
isohomohalichondrin B reduction isomers (3.4.1 and 3.4.2) 
Initially a trial reaction on a small quantity of cholestan-3-one was undertaken to 
establish reaction conditions and work-up procedures. Having successfully achieved 
this, the reaction conditions were applied to a small amount of isohomohalichondrin 
B. 
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Sodium borohydride was added to isohomohalichondrin B (1.2.9) dissolved in 
isopropyl alcohol. The resulting suspension was stirred vigorously at room 
temperature, monitoring progress of the reaction by silica TLC. After fifteen 
minutes reaction, silica TLC of the reaction mixture indicated the presence of two 
new spots of increased polarity relative to an isohomohalichondrin B reference TLC 
spot; the less polar of the two spots being more intense, indicating that it was the 
major product. Also apparent from the TLC plate was the complete disappearance of 
isohomohalichondrin B from the reaction mixture, indicating that the reaction was 
complete. The reaction was quenched after thirty minutes and a 1 H NMR spectrum 
was obtained from the product (in CDCb/0.1% pyridine-ds), and is displayed in 
Figure 3.4.1. Comparison of this spectrum with that of isohomohalichondrin B 
indicated several major changes. The methyl region indicated the movement of the 
CH3-46 doublet resonance from ()H 0.90 ppm to a less shielded position overlying 
the CH3-42 doublet resonance at ()H 0.94 ppm. The distinctive H55/H55' triplet at 
()H 3.86 ppm was no longer visible, and the resonances corresponding to the H52 (()H 
2.62 ppm), H52' (()H 2.93 ppm) and H54/H54' ( ()H 2.73 ppm) protons had also 
moved to positions that were not immediately obvious. The final major change 
visible from this spectrum was the movement of the chemical shift of the 
characteristic H47 proton resonance to a less shielded position. This resonance 
appeared as a narrow doublet at () H 3.23 ppm in the 1 H NMR spectrum of 
isohomohalichondrin B, but was split into two separate and isolated narrow doublets 
at ()H 3.32 ppm and ()H 3.26 ppm in the spectrum of the reaction products. The sum 
of the integrals over both resonances was equivalent to the integral over a single 
unshifted olefinic proton resonance, indicating that these two resonances represented 
the two separate diastereoisomers produced in the reaction. The ratio of the integrals 
of the two H47 resonances was approximately 3:2 in favour of the less shielded 
resonance. 
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Figure 3.4.1 1 H NMR Spectrum of Isohomohalichondrin B Reduction Products 
The reaction was repeated on a slightly larger quantity of isohomohalichondrin B 
(1.2.9) to obtain sufficient material for separation of the two diastereoisomers. Silica 
TLC of the product was identical with that observed in the previous reaction. The 
products from the two separate reactions were combined prior to preparative HPLC 
(High Performance Liquid Chromatography) separation. Separation of the two 
diastereoisomers was accomplished using a preparative Cl8 HPLC column, the 
chromatogram indicating that the less polar product was the major product. 1 H 
NMR spectra of the two products, performed in CDCl3/0.l% pyridine-ds, indicated 
that the separation was successful as evidenced by the clean separation of the two 
H47 proton resonances. The chemical shift of the H47 proton for the major, less 
polar product (3.4.1) was OH 3.32 ppm. The corresponding H47 resonance in the lH 
NMR spectrum of the minor, more polar product (3.4.2) was observed at OH 3.26 
ppm. Other differences in the 1 H NMR spectra of the two products were apparent in 
the methyl region, with the less polar of the two products showing the CH3-46 and 
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CH3-42 doublet resonances as two very close, but separate doublet signals. For the 
more polar product they appeared at exactly the same chemical shift resulting in the 
appearance of a single doublet with twice the intensity of the adjacent CH3-31 and 
CH3-25 methyl resonances. 
A relatively low recovery off the C18 column meant there was insufficient material 
to progress with the NMR spectral assignment of the two products. A further, large 
scale, sodium borohydride reduction was therefore repeated on isohomohalichondrin 
B (1.2.9), the products separated as previously and the products were combined with 
those from the first HPLC separation. 
3.4.1 Reduction Isomer 3.4.1 
The lH NMR spectrum of the major, less polar component, reduction isomer 3.4.1, 
performed in CDCl3/0.l% pyridine-ds, is shown in Figure 3.4.2. The lH NMR 
spectrum indicated that there was more than 90% reduction isomer 3.4.1 present in 
the sample with respect to reduction isomer 3.4.2, by integral. A 13C NMR spectrum 
was acquired on this sample as there was sufficient material to obtain an adequate 
signal to noise ratio. Additionally, a range of selective 1D and 2D NMR 
experiments were performed on reduction isomer 3.4.1, namely COSY, 2D-TOCSY 
(20 ms, 60 ms and 100 ms mixing times), NOB, HMQC and selective 1D-TOCSY 
experiments. 
Analysis of the NMR experiments focused interest on changes in the terminal region 
of the molecule. The 1 H and 13C NMR spectral assignments in the region of the A 
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to L rings were identical with those of isohomohalichondrin B (1.2.9).14 The signals 
remaining in the various NMR spectra after assignment of the 1 H and 13C signals in 
the A-L region were subsequently examined. The assignments in the terminal 
region of reduction isomer 3.4.1 are discussed. The assignments made for reduction 
isomer 3.4.1 are cited in Table 3.4.1 for the 1 H NMR data and in Table 3.4.2 for the 
13c NMR data. The important correlations from the various NMR experiments 
performed are depicted in Figure 3.4.3. 
Table 3.4.1 lH NMR Data for Isohomohalichondrin B Reduction Isomer 3.4.1 
Proton a oppmb Proton a oppmb Proton a oppmb 
H2 2.34 H21 1.38 H39 2.22 
H2' 2.58 H21' H39' 2.22 
H3 3.87 H22 1.62 H40 3.95 
H4 1.37 H22' 1.62 H41 3.64 
H4' 1.74 H23 3.53 H42 2.26 
HS 1.38 H24 1.04 CH3-42 0.94 
HS' 2.08 H24' 1.70 H43 
H6 4.34 H25 2.20 H43' 
H7 2.94 CH3-2S 1.07 H45 1.48 
HS 4.33 26=CH 4.75 H45' 1.53 
H9 4.04 26'=CH 4.80 H46 2.22 
H10 4.18 H27 3.53 CH3·46 0.94 
H11 4.60 H28 1.90 H47 3.32 
H12 4.68 H28' 2.00 H48 3.78 
H13 1.94 H29 4.18 H49 1.82 
H13' 2.15 H30 4.64 H49' 2.14 
H15 H31 2.02 HSO 3.49 
H15' CH3·3l 0.99 H51 3.61 
H16 H32 3.18 H52 1.56 
H16' 2.14 H33 3.80 H52' 2.12 
H17 4.10 H34 1.79 H53 4.16 
H18 2.26 H34' H54 1.72 
H18' 2.79 H35 4.10 H54' 1.72 
19=CH 4.91 H36 4.10 H55 3.83 
19'=CH 4.98 H37 1.92 H55' 3.83 
H20 4.38 H37' 2.36 
a The symbol ' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCI3 at 300 MHz with chemical shifts in ppm and 
referenced to CHCl3, OH 7.25 ppm. 
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Table 3.4.2 Be NMR Data for Isohomohalichondrin B Reduction Isomer 3.4.1 
Carbon oppma Carbon oppma Carbon oppma 
C1 171.2 C21 29.5 C39 42.5 
C2 40.4 C22 31.7 C40 71.1 
C3 73.7 C23 74.9 C41 79.0 
C4 30.7 C24 43.4 C-CH3-42 25.7 
C5 30.0 C-CH3-25 35.9 C-CH3-42 17.6 
C6 68.2 C-CH3-25 18.0 C43 
C7 77.6 26C=CH2 151.6 C44 97.3 
C8 74.3 26C=CH2 104.2 C45 37.2 
C9 73.8 C27 73.4 C-CH3-46 28.4 
ClO 76.5 C28 C-CH3-46 17.3 
C11 82.1 C29 71.2 C47 76.2 
C12 81.1 C30 77.2 C48 66.4 
C13 48.3 C-CH3-31 36.6 C49 34.4 
Cl4 110.1 C-CH3-31 15.0 C50 67.2 
C15 34.4 C32 77.4 C51 81.1 
C16 28.2 C33 66.4 C52 38.3 
C17 C34 29.1 C53 71.8 
C18 38.7 C35 75.1 C54 38.4 
19C=CH2 151.8 C36 C55 61.4 
19C=CH2 104.5 C37 43.2 
C20 75.4 C38 
a Data recorded at 23 °C in CDCl3 at 75 MHz with chemical shifts in ppm and referenced to 
CHCl3, Be 77.0 ppm. Some Be NMR chemical shifts assigned from HMQC spec mat 
300MHz. 
Figure 3.4.2 1 H NMR Spectrum of Reduction Isomer 3.4.1 
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The 13C NMR spectrum of reduction isomer 3.4.1 indicated the presence of four new 
and isolated signals relative to isohomohalichondrin B: at <5c 81.1 ppm, <5c 71.8 ppm, 
3c 67.2 ppm, and <5c 61.4 ppm. These signals were subsequently assigned as C51, 
C53, C50 and C55 respectively. The methyl group remaining unassigned in the lH 
NMR spectrum at ()H 0.94 ppm was assigned as the CH3-46 methyl resonance. 
These methyl protons showed a COSY correlation to a proton signal at ()H 2.22 ppm 
which was assigned as the H46 resonance. A COSY correlation from H46 ( ()H 2.22 
ppm) to ()H 3.32 ppm confirmed the position of the H47 resonance. A COSY 
correlation from H47 was observed to a proton at ()H 3.78 ppm (H48). Two COSY 
correlations from H48 to methylene protons at ()H 1.82 ppm and ()H 2.14 ppm located 
H49 and H49'. An isolated HMQC correlation was observed for a proton at ()H 3.49 
ppm attached to a carbon resonating at <5c 67.2 ppm. TOCSY correlations from H49, 
H49' and H48 to the ()H 3.49 ppm signal indicated that it was the H50 resonance. 
The H45 (()H 1.48 ppm) and H45' ( ()H 1.53 ppm) protons were located from two 
separate, selective 1D-TOCSY irradiations of the ()H 3.32 ppm resonance (ie H47) 
with mixing times of 100 ms and 150 ms. A COSY correlation was observed 
between the H45 and H45' protons. 
The COSY spectrum indicated the presence of a methine proton at ()H 4.16 ppm 
correlated to two methylene protons, one at ()H 2.12 ppm and the other at ()H 1.72 
ppm. From the HMQC spectrum it was apparent that the isolated correlation at ()H 
1.72 pprn13c 38.4 ppm corresponded to two equivalent methylene protons attached 
to one carbon. This implied that the proton at ()H 4.16 ppm was situated between two 
pairs of methylene protons. The only remaining assignment possible for the proton 
at ()H 4.16 ppm was as the newly formed H53 proton. The methylene proton at ()H 
2.12 ppm also showed a COSY correlation to a methine proton at ()H 3.61 ppm. This 
methine proton was correlated to a carbon at <5c 81.1 ppm in the HMQC spectrum. 
Chapter 3- Alterations to Terminal Groups of Halichondrins 114 
An NOE from irradiation at the H47 resonance to the methine proton at <>a 3.61 ppm 
provided additional evidence that it was the H51 proton, and therefore the methylene 
proton at <>a 2.12 ppm was assigned as the H52' proton, lying between H51 and H53. 
The equivalent methylene protons at Ba 1.72 ppm were assigned as H54 and H54'. 
The methylene partner to H52 was assigned from a COSY correlation from H51 to a 
proton at Ba 1.56 ppm. An isolated signal which remained unassigned in the 13C 
NMR spectrum at Be 61.4 ppm, and appeared in the HMQC spectrum as an isolated 
correlation to a proton at oa 3.83 ppm was assigned as corresponding to the C55 
carbon and H55/H55' protons respectively. Finally, the remaining unassigned 
carbons in the terminal region were able to be assigned from the Be NMR spectrum 
and the HMQC spectrum. All of the correlations described are shown in Figure 
3.4.3. 
As expected there were some significant changes in 1 H and 13c NMR chemical 
shifts around the C53 centre. Two interesting observations are highlighted. Firstly, 
the H53 resonance at oa 4.16 ppm appeared at a relatively deshielded position for a 
methine proton in this environment. Secondly, the H47 proton recorded a chemical 
shift (oa 3.32 ppm) that was less shielded than H47 was in the lH NMR spectrum of 
isohomohalichondrin B (oa 3.23 ppm), although this position was significantly 
removed from the reaction centre at C53. These two observations could, in part, be 
explained by the occurrence of hydrogen bonding from the new C53 hydroxyl proton 
to theN-ring ether oxygen, resulting in deshielding of the H53 and H47 protons and 
a corresponding movement of chemical shifts for these proton resonances to less 
shielded positions in the lH NMR spectrum of the reduction isomer 3.4.1. 
High Resolution FAB-MS performed on reduction isomer 3.4.1 indicated the parent 
ion (MH+), corresponding to a molecular formula of C61Hss019; a gain of two 
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hydrogen atoms relative to isohomohalichondrin B. These data confirmed that 
isohomohalichondrin B had been successfully reduced to 3.4.1. 
3.4.2 Reduction Isomer 3.4.2 
The NMR spectral assignment of the more polar and minor reduction product, 
reduction isomer 3.4.2, was aided by the partial assignment of the 1 H and 13C NMR 
spectra of reduction isomer 3.4.1. The _1 H NMR spectrum of reduction isomer 3.4.2 
is displayed in Figure 3.4.4. There was no reduction isomer 3.4.1 apparent in this 
1 H NMR spectrum (by integral over the distinctive H47 signals), indicating an 
excellent HPLC separation had been achieved for this product. 
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Figure 3.4.4 1 H NMR Spectrum of Reduction Isomer 3.4.2 
A 13C NMR spectrum was not acquired due to the reduced amount of reduction 
isomer 3.4.2 available compared to reduction isomer 3.4.1. However, it was possible 
Chapter 3- Alterations to Terminal Groups of Halichondrins 116 
to achieve a partial assignment of the 13c NMR spectrum indirectly via an HMQC 
experiment. Two additional NMR experiments, which aided in the assignment of the 
1 H NMR spectrum, were performed on reduction isomer 3.4.2: a COSY experiment 
and a selective 1D-TOCSY experiment. The 1 H and Be NMR data for reduction 
isomer 3.4.2 are cited in Tables 3.4.3 and 3.4.4 respectively. 
Table 3.4.3 1 H NMR Data for Isohomohalichondrin B Reduction Isomer 3.4.2 
Proton a oppmb Proton a oppmb Protona oppmb 
H2 2.35 H21 1.38 H39 2.22 
H2' 2.58 H21' H39' 2.22 
H3 3.87 H22 1.60 H40 3.93 
H4 1.36 H22' 1.60 H41 3.63 
H4' 1.74 H23 3.53 H42 2.26 
HS H24 1.04 CH3·42 0.94 
HS' 2.08 H24' 1.70 H43 
H6 4.34 H25 2.20 H43' 
H7 2.94 CH3-2S 1.07 H45 1.48 
HS 4.32 26=CH 4.75 H45' 1.52 
H9 4.04 26'=CH 4.80 H46 2.20 
HlO 4.18 H27 3.53 CH3·46 0.94 
Hll 4.60 H28 1.92 H47 3.26 
H12 4.68 H28' H48 3.76 
H13 1.93 H29 4.20 H49 1.83 
H13' 2.15 H30 4.66 H49' 2.14 
H15 H31 2.01 HSO 3.48 
H15' CH3-31 0.99 H51 3.63 
H16 H32 3.18 H52 1.56 
H16' 2.14 H33 3.81 H52' 2.10 
H17 4.10 H34 1.78 H53 4.16 
H18 2.26 H34' H54 1.74 
H18' 2.80 H35 4.10 H54' 1.74 
19=CH 4.91 H36 4.10 H55 3.86 
19'=CH 4.98 H37 1.92 H55' 3.86 
H20 4.38 H37' 2.35 
a The symbol ' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 oc in CDCl3 at 300 MHz with chemical shifts in ppm and 
referenced to CHC13, OH 7.25 ppm. 
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Table 3.4.4 13c NMR Data for Isohomohalichondrin B Reduction Isomer 3.4.2 
Carbon Oppma Carbon Oppma Carbon Oppma 
Cl C21 C39 42.3 
C2 40.2 C22 31.7 C40 71.0 
C3 73.6 C23 74.8 C41 79.0 
C4 C24 43.4 C-CH3-42 25.4 
C5 C-CH3-2S C-CH342 17.5 
C6 68.2 C-CH3-2S 18.0 C43 
C7 77.6 26C=CH2 C44 
C8 74.3 26C=CH2 104.2 C45 
C9 73.8 C27 73.4 C-CH3-46 
ClO 76.5 C28 C-CH346 17.5 
Cll 82.1 C29 71.1 C47 76.0 
C12 81.1 C30 77.0 C48 66.6 
C13 48.3 C-CH3-31 C49 34.3 
C14 C-CH3-31 15.0 cso 67.4 
C15 C32 77.4 C51 77.0 
C16 C33 66.6 C52 38.5 
C17 C34 C53 69.8 
C18 38.6 C35 C54 
19C=CH2 C36 C55 62.0 
19C=CH2 104.5 C37 43.2 
C20 75.2 C38 
a Data recorded at 23°C in CDCl3 with chemical shifts in ppm, assigned from an HMQC 
spectrum at 300 MHz. 
The 13C and lH NMR spectral data in the region of the A-L rings of reduction 
isomer 3.4.2 were consistent with those of reduction isomer 3.4.1 (Section 3.4.1) and 
isohomohalichondrin B (1.2.9).14 Notable differences in the NMR data between the 
two reduction isomers were apparent, as expected, in the terminal (C44-C55) region. 
Apart from the H47 proton resonance, the lH NMR chemical shifts from H45/H45' 
to H55/H55' were only slightly different to those of reduction isomer 3.4.1. The 
more obvious changes were apparent in terms of the 13C NMR chemical shifts 
between the two diastereoisomers. The C51 13C NMR chemical shift of reduction 
isomer 3.4.2 at oc 77.0 ppm was observed at a more shielded position than the 
reduction isomer 3.4.1 C51 resonance (Be 81.1 ppm). Two other significant changes 
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were the shift of the C53 resonance to a more shielded position and the shift of the 
C55 carbon resonance to a less shielded position relative to reduction isomer 3.4.1. 
High Resolution F AB-MS performed on reduction isomer 3.4.2 gave the parent ion 
(MH+), corresponding to a molecular formula of C61Hss019; isobaric with reduction 
isomer 3.4.1. These data confirmed that reduction isomer 3.4.1 and reduction isomer 
3.4.2 were in fact related as diastereoisomers and that the two diastereoisomers, 
being the reduction products of isohomohalichondrin B (1.2.9), had been 
successfully produced. 
3.4.3 Computer Modelling of Reduction Diastereoisomers 
The relative stereochemistry at the new C53 centre was not able to be ascertained in 
terms of the NMR data collected for either reduction isomer 3.4.1 or reduction 
isomer 3.4.2. It was anticipated that a knowledge of the solution conformation(s) of 
the two possible diastereoisomeric reduction products might provide evidence that 
could lead to their identification as either reduction isomer 3.4.1 or 3.4.2. This 
knowledge could also provide useful information as to the conformational 
requirements for biological activity in the terminal C44-C55 region. The differing 
physical properties of the two isomers such as their polarities by silica TLC and C18 
HPLC, and the observed differences in the NMR data provided evidence that their 
"average" solution conformations could be different. The "average" solution 
conformation describes a single, theoretical conformation, arising from a Boltzmann-
weighted distribution of conformers with differing energies. This "average" 
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conformation is that observed on the NMR time-scale, arising from the presence, in 
solution, of the various populated conformers. 
Computer modelling of the terminal region to determine the solution conformation(s) 
of each diastereoisomer was undertaken. Conformational searching of the terminal 
moiety of the two reduction diastereoisomers was carried out using the Monte Carlo 
search method in the program MacroModel V4.0 with the associated computational 
program BatchMin, using the parameters described previously in Section 2.3.2. 
Initially the C4'3-C51 subunit was excised from the X-ray crystal structure of the 
norhalichondrin A p-bromophenacyl ester,17 in the CSC Chem3D Plus program. 
The C43 methylene group was converted to a methyl group and the L-ring ether 
oxygen was converted to a free hydroxyl group. The C52-C55 "tail" was 
subsequently added as separate R and S chiralities at the C53 stereocentre to generate 
the two reduction product diastereoisomers. The conformational searching of each 
diastereoisomer is described. 
3.4.3.1 Modelling of the C53-R Diastereoisomer 
The R-diastereoisomer generated in Chem3D Plus was used as the starting 
conformation for a Monte Carlo conformational search in MacroModel using the 
chloroform GB/SA solvent model. Two additional searches were initiated from 
different starting geometries. 
The global minimum and low energy conformers were identical for all three 
searches. Each conformer was subsequently tested to ensure that it was in fact a true 
local minima using the BatchMin minima test on the conformers in the output 
structure file. Having successfully passed this test, the Boltzmann-weighted 
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distribution of each conformer was calculated at 23 ·c resulting in three conformers 
contributing greater than 5% to the distribution. These three conformers are 
displayed in Figure 3.4.5 along with their MM2* energies and percentage 
Boltzmann-weighted contributions to the distribution. 
CONFORMATION ONE (64.6%) 
MM2* Energy=- 150.9 kJ/ mol 
CONFORMATION TEREE (6.5%) 
MM2* Energy=- 145.2 kJ/ mol 
CONFORMATION TWO (15.1 %) 
MM2* Energy=- 147.3 kJ/ mol 
Figure 3.4.5 R-Diastereoisomer Conformational Search Output 
As can be seen in Figure 3.4.5, the M and N rings of the low energy conformers 
generated in the conformational search were all chair/chair in conformation, with the 
conformational variations occurring exclusively in the "tair' region of the structure. 
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3.4.3.2 Modelling of the C53-S Diastereoisomer 
The S-diastereoisomer was modelled in the same manner as the R -diastereoisomer 
described above. Monte Carlo conformational searches initiated from two separate 
starting conformations yielded the same set of low energy conformers. Each 
conformer was tested using the BatchMin minima test to ensure that it was in fact a 
true local minima. Having successfully passed this test, the Boltzmann-weighted 
distribution of each conformer in the structure output file was calculated at 23·c, 
resulting in seven conformers contributing greater than 5% to the distribution. 
Figure 3.4.6 depicts these seven conformers with their MM2* energies and 
Boltzmann-weighted contributions. 
As with the R-diastereoisomer, the S-diastereoisomer conformational search output 
displayed identical chair/chair conformations for the terminal M and N rings. The 
"average" solution conformation of the "tail" region of the modelling output was 
calculated from Boltzmann-weighted vicinal coupling constants derived from 
dihedral angles (H-C-C-H) in MacroModel, for both the Rand S-diastereoisomers. 
An attempt was made to collect experimental coupling constants in the "tail" region 
of reduction isomers 3.4.1 and 3.4.2 to relate to the modelling-derived Boltzmann-
weighted "average" solution conformations. In principle, relating the 
experimentally-derived vicinal coupling constants for each diastereoisomer to the 
Boltzmann-weighted data from the modelling results for each diastereoisomer should 
have lead to the identification of the C53-stereochemistry of the reduction isomers. 
However, this was not possible due to the complex nature of the 1 H NMR 
resonances in the H51-H55/H55' regions of both diastereoisomers; all resonances 
appeared as complex or distorted signals. 
Chapter 3- Alterations to Terminal Groups of Halichondrins 122 
CONFORMATION ONE (22.9%) 
MM2* Energy=- 147.1 kJ/ mol 
CONFORMATIONTHREE (9.5%) 
MM2* Energy=- 144.9 kJ/ mol 
CONFORMATIONTWO (15.8%) 
MM2* Energy=- 146.2 kJ/ mol 
CONFORMATIONFIVE (7.7%) 
MM2* Energy=- 144.4 kJ/ mol 
CONFORMATION FOUR (9.0%) 
MM2* Energy=- 144.8 kJ/ mol 
CONFORMATION SIX (5.6%) 
MM2* Energy=- 143.6 kJ/ mol 
CONFORMATION SEVEN (5.2%) 
MM2* Energy= -143.4 kJ/ mol 
Figure 3.4.6 S-Diastereoisomer Conformational Search Output 
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It is interesting to note the proximity of the C53 hydroxyl group to theN-ring ether 
oxygen in all of the R and S-diastereoisomers of Figures 3.4.5 and 3.4.6, except 
CONFORMATION SIX of the S-diastereoisomer conformational search output. 
This suggested that the presence of hydrogen bonding plays an important role in the 
"average" solution conformation of both diastereoisomers in chloroform. This was 
predicted in Section 3.4.1 from an analysis of the NMR data. 
Although the solution conformations of the two diastereoisomers appeared to be 
quite different, it would be purely speculative to draw any conclusions relating the 
other physical differences between reduction isomers 3.4.1 and 3.4.2, such as their 
relative polarities, to the conformations of the modelling output in order to assign a 
stereochemistry at the new C53 stereo centre. 
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3.5 Biological Activity Data 
Table 3.5.11ists the biological activities of the derivatives described in this Chapter. 
Included in this table are the P388 cytotoxicities of the five derivatives produced, the 
relevant parent halichondrins, and the Gisos (over all sixty cell lines) of three 
derivatives described in this Chapter which underwent testing in the NCI's primary 
screening system. The COMPARE correlation coefficients are also listed for the 
NCI tested compounds. 
Table 3.5.1 In Vitro Cytotoxicities of Selected Halichondrins 
Compound 
homohalichondrin B (1.2.3) 
isohomohalichondrin B 
(1.2.9) 
isohomohalichondrin B 
monoacetate (3.2.1) 
homohalichondrin B 
diacetate (3.2.2) 
isohomohalichondrin B 
monoacetate oxidation 
product 
reduction isomer 3.4.1 
reduction isomer 3.4.2 
P388 ICso 
(ng/mL) 
0.22 
0.18 
0.22 
2.3 
70.7 
0.5 
0.6 
NCI Giso COMPARE 
(xi0-10 M) Correlationa 
3.16 0.95 
1.15 0.74 
1.58 0.85 
2.04 0.80 
L78 0.87 
a Conelation coefficients from the Compare pattern-recognition algorithm were 
calculated by computer using the Glso-centred mean graph profiles of differential 
cellular sensitivities to each of the compounds. The Glso-centred mean graph 
profile of halichondrin B (1. 2.1) was used as the "seed" for all of the 
comparisons. 
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The biological activity of the isohomohalichondrin B monoacetate derivative (3.2.1) 
was very similar to the parent halichondrin viz isohomohalichondrin B (1.2.9), in 
both the P388 assay and the NCI primary screen results. While the similar activity 
results for 3.2.1 relative to 1.2.9 could be interpreted as implying hydrolysis of the 
terminal acetate of 3.2.1 was occurring in the assays, the COMPARE correlation 
coefficient suggested that the NCI mean graph profile was more like that of the 
halichondrin B "seed" mean graph profile than was isohomohalichondrin B (1.2.9). 
This tended to suggest that the acetate remained intact, modifying the mean graph 
profile of 3.2.1 relative to isohomohalichondrin B (1.2.9) while retaining a similar 
average cytotoxicity. 
The homohalichondrin B diacetate derivative (3.2.2) displayed a greater than ten-fold 
reduction in P388 activity relative to homohalichondrin B (1.2.3). Therefore it 
appeared that the absence of free hydroxyl groups in the terminal moiety conferred a 
reduction in the observed P388 cytotoxicity. 
As indicated in Section 3.3, it was anticipated that an assessment of the biological 
activity of the oxidation product would provide additional evidence as to the reaction 
or otherwise of isohomohalichondrin monoacetate (3.2.1) under PCC oxidation 
conditions. The cytotoxicity of the isohomohalichondrin B monoacetate oxidation 
product was more than three hundred times less active than the isohomohalichondrin 
B monoacetate derivative (3.2.1) in terms of their respective P388 activities. This 
implied that the monoacetate of isohomohalichondrin B (3.2.1) underwent reaction 
with PCC. However, nothing further could be said about the product formed in 
terms of structural identification ie whether the formation of the C50 ketone was 
successful. 
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Reduction isomer 3.4.1 displayed similar biological activity results to its C53 
diastereoisomer, reduction isomer 3.4.2 in both the P388 assay and in the NCI 
primary screen. This implied that the conformational differences observed from the 
computer modelling conformational searches, conferred by the change in 
stereochemistry at C53, were not of great importance in determining the relative 
biological activities of the two diastereoisomers. The P388 and NCI primary screen 
cytotoxicities of reduction isomer 3.4.1 and reduction isomer 3.4.2 were slightly 
reduced relative to the parent halichondrin, isohomohalichondrin B (1.2.9). The 
COMPARE correlation coefficients however, suggested that the reduction isomers 
were more "halichondrin B-like 11 in terms of their mechanism of action as 
antimitotics than was isohomohalichondrin B. 
In general terms, the biological activity data collected for the derivatives described in 
this Chapter suggested that the presence of at least one free hydroxyl group in the 
terminal moiety was essential for the expression of a high level of cytotoxicity. The 
addition of hydroxyl groups to the terminal moiety, as for the isohomohalichondrin B 
reduction isomers (3.4.1 and 3.4.2) did not appear to alter the observed biological 
activity to any significant degree. 
Further discussion of these biological activities relative to a range of other 
halichondrin derivatives is made in Chapter 9. 
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CHAPTER4 
Modifications to Olefins 
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4.1 Introduction 
The exocyclic double bonds at C 19 and C26 in the halichondrin molecule were 
targeted in an investigation of their relative importance to the expression of 
biological activity. This involved the manipulation of the oxidation level at the C19 
and C26 centres of selected halichondrins. 
The preparation of a diketone derivative at positions C19 and C26 was the initial 
goal. As well as giving important structure-activity data, it was envisaged that this 
analogue would provide a useful starting point for further modifications. 
Two approaches to generating the diketone were attempted: via ozonolysis and 
reductive cleavage of the ozonide formed, and via the di-osmate ester to the diol and 
cleavage to furnish the diketone derivative. It was envisaged that the intermediate 
C19 and C26 diol would also provide important biological activity information. 
Other alterations to the exocyclic olefins included catalytic hydrogenation to produce 
the C19 and C26 methyl substituted derivatives which also provided useful 
bioactivity data. A reduction of the diketone compound at C19 and C26 was also 
attempted with the object of generating a dihydroxy compound at these positions. 
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4.2 Trial Ozonolysis 
Ozonolysis was initially attempted on a model compound, ~-pinene, which has an 
exocyclic olefinic functionality. This was undertaken to ensure reaction conditions 
and handling procedures were suitable to be applied to the halichondrins in terms of 
reaction yield and recovery of material on a small scale. 
A method commonly used to cleave an ozonide to yield a ketone is the reductive zinc 
dust/acetic acid method.49,50 Microscale ozonolysis to furnish the ozonide followed 
by a reductive zinc/aqueous acetic acid work-up to give the desired ketone was 
attempted on ~-pinene. 
An ozone generator capable of producing millimolar quantities of ozone was 
constructed, based on a novel design by Beroza and Bieri.51 Ozonolysis was 
attempted on a small quantity of ~-pinene dissolved in dichloromethane until ozone 
was detected in the outlet gases. This was followed by addition of a reductive 
zinc/aqueous acetic acid suspension to the solution. The resulting mixture was 
stirred vigorously overnight at room temperature and then extracted into ether. 1 H 
NMR spectroscopy of the resulting material indicated that considerable degradation 
had occurred. 
Further investigations of ~-pinene in a zinc/aqueous acetic acid suspension revealed 
that this step was resulting in the acid decomposition observed. It was decided 
therefore that the acidic work-up conditions would be too severe to be applied to the 
halichondrins and alternative methods of generating the diketone via osmylation 
were investigated. 
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4.3 Osmylation Reactionss2 
The generation of a ketone functional group from an olefin via osmylation can be 
accomplished by several distinct methodologies. The ketone may be directly 
accessed in a one-step reaction using a catalytic amount of osmium tetroxide and 
sodium perchlorate53,54 or sodium periodate55 to oxidatively cleave the osmate (VI) 
ester, regenerating osmium tetroxide. While this method has the advantage of using 
reduced amounts of expensive and toxic osmium tetroxide and minimising mass 
transfers, it was realised that a two-step method to yield the halichondrin diketone 
via the vic-diols at Cl9 and C26 would give an additional intermediate product for 
structure-activity evaluation. 
Baran 56 describes a suitable pyridine-catalysed57 osmylation to generate the 
corresponding osmate ester, followed by reductive cleavage in aqueous bisulfite 
solution to yield the desired vic-diol product. It was recognised that the halichondrin 
diketone could then be generated by periodate cleavage of the resulting two vic-dials. 
Initially, a trial osmylation and reductive bisulfite reaction was carried out on ~­
pinene. The periodate cleavage step was carried out on benzoin which was cleaved 
to form benzoic acid and benzaldehyde. Finally, the stability of 
isohomohalichondrin B was tested under the periodate cleavage reaction conditions 
before committing it to the reaction. 
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4.3.1 Initial Studies 
4.3.1.1 Trial Osmylation and Periodate Cleavage 
A trial osmylation on a small quantity of ~-pinene was successfully undertaken. The 
lH NMR spectrum of the reaction product acquired in CDCl3/0.l% pyridine-ds 
indicated the complete loss of the olefinic proton signals and the appearance of a 
new doublet of doublets at OH 3.51 ppm. These protons were assigned as the 
diastereotopic diol methylene protons and it was concluded the reaction had been 
successful. 
A trial periodate cleavage of benzoin to benzoic acid and benzaldehyde was also 
accomplished, a 1 H NMR spectrum of the reaction products showing a new 
resonance at OH 10.2 ppm, characteristic of an unsubstituted aromatic aldehyde 
proton. 58 
The reaction conditions applied to the two trial reactions were then utilised in the 
subsequent reactions of selected halichondrins. 
4.3 .1.2 Stability of Isohomohalichondrin B to Periodate 
It was important to ensure that isohomohalichondrin B (1.2.9) was stable to the 
periodate reaction conditions to avoid the complication of possible side-reactions not 
associated with cleavage of the diol. A small sample of isohomohalichondrin B 
(1.2.9) was placed under the periodate reaction conditions to be applied to the diol of 
isohomohalichondrin B. TLC and lH NMR of the worked-up material indicated no 
reaction had occurred and therefore that isohomohalichondrin B was stable under 
these conditions. 
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4.3.2 Osmylation of Isohomohalichondrin B 
An ether solution of osmium tetroxide was added to isohomohalichondrin B (1.2.9) 
dissolved in pyridine and the solution was stirred at room temperature for four hours. 
Sodium metabisulfite in water/pyridine was then added and the mixture was stirred 
at room temperature for a further twenty minutes. 
Silica TLC of the product after work -up indicated the appearance of a single new 
spot of increased polarity relative to isohomohalichondrin B, and no evidence of 
starting material. 
A 1 H NMR spectrum of the product clearly showed the complete loss of all four 
olefinic proton signals (Figure 4.3.1), indicating the reaction had gone to 
completion. A range of2D NMR experiments (COSY, 2D-TOCSY (100 ms mixing 
time) and HMQC) were also pe1formed on this sample, in CDC!)/ 0.1% pyridine-ds. 
A partial assignment of the 1 H and 13C NMR spectra was accomplished and these 
data are given in Tables 4.3.1 and 4.3.2 respectively, and the important correlations 
from the NMR experiments are depicted in Figure 4.3.2. It proved difficult to assign 
lH NMR chemical shift values to the terminal "hydroxy" methylene protons C19-
CH2-0- and C26-CH2-0- and the methine protons adjacent to these two groups, 
namely H27 and H20. 
The COSY spectrum showed a proton at OH 4.61 ppm strongly correlated to a proton 
resonance at OH 4.35 ppm. The HMQC spectrum showed these two protons to be 
correlated to the same carbon at 8c 88.1 ppm, indicating that they were methylene 
protons. Similarly, a strong COSY correlation was observed between a proton at OH 
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4.56 ppm and another at OH 4.74 ppm which were also associated with a single 
carbon in the HMQC spectrum at oc 81.5 ppm. These lH NMR chemical shifts 
were too deshielded to be assigned as diastereotopic diol protons when related to the 
chemical shift of OH 3.51 ppm observed for the ~-pinene diol methylene protons. 
Fortuitously, the osmate ester of ~-pinene had been synthesised from ~-pinene by 
David Stirling in the Marine Chemistry Group, the 1 H NMR spectrum of which 
showed the diastereotopic osmate ester methylene protons were situated at OH 4.20 
ppm. This corresponded to a shift of OH 0.34 - 0.40 ppm, to a more shielded 
position, relative to the olefinic protons of ~-pinene. This predicted 1 H NMR 
chemical shift to produce the osmate ester derivative is in the order of the chemical 
shifts observed for the new methylene protons of isohomohalichondrin B upon 
osmylation, relative to the olefinic protons. These observations indicated that the 
product formed from the osmylation of isohomohalichondrin B was the di-osmate 
ester ( 4.3.1). It proved difficult to assign lH and Be NMR chemical shifts around 
the two C19 and C26 centres, notably C20/H20 and C27/H27. 
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Table 4.3.1 lH NMR Data for Isohomohalichondrin B Di-osmate Ester ( 4.3.1) 
Proton a oppmb Proton a oppmb Proton a oppmb 
H2 2.42 H21 H39 2.22 
H2' 2.52 H21' H39' 2.22 
H3 3.88 H22 H40 3.90 
H4 1.40 H22' H41 3.58 
H4' 1.71 H23 3.50 H42 2.25 
HS 1.50 H24 1.02 CH3-42 0.92 
H5' 2.23 H24' 1.67 H43 1.29 
H6 4.36 H25 2.05 H43' 1.48 
H7 2.88 CH3-2S 1.13 H45 1.45 
HS 4.34 26-CH-0 4.56C H45' 1.45 
H9 4.00 26'-CH-0 4.74C H46 2.12 
H10 4.16 H27 CH3-46 0.89 
H11 4.57 H28 H47 3.23 
H12 4.64 H28' H48 3.72 
H13 1.88 H29 4.08 H49 1.82 
H13' 2.11 H30 4.71 H49' 2.08 
H15 H31 2.00 HSO 3.48 
H15' CH3-31 0.95 H51 3.81 
H16 H32 3.08 H52 2.60 
H16' H33 3.78 H52' 2.91 
H17 4.05 H34 1.60 H54 2.73 
H18 1.85 H34' 2.10 H54' 2.73 
H18' 2.74 H35 4.04 H55 3.84 
19 -CH-0 4.35C H36 4.04 H55' 3.84 
19' -CH-0 4.61C H37 1.89 
H20 H37' 2.31 
a The symbol' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 oc in CDCl3 at 300 MHz with chemical shifts in ppm and 
referenced to C HC13, DH 7.25 ppm. 
c Assignments of methylene pairs tentative - may be interchanged. 
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Table 4.3.2 13C NMR Data for Isohomohalichondrin B Di-osmate Ester (4.3.1) 
Carbon Oppma Carbon 
C1 C21 
C2 41.0 C22 
C3 C23 
C4 C24 
C5 C-CH3-2S 
C6 68.8 C-CH3-2S 
C7 78.0 26C-CH2-0 
C8 74.5 26C-CH2-0 
C9 74.2 C27 
C10 76.8 C28 
Cll 82.5 C29 
C12 81.5 C30 
Cl3 48.5 C-CH3-31 
C14 C-CH3-31 
CIS C32 
C16 C33 
C17 C34 
C18 35.0 C35 
19C-CH2-0 C36 
19C-CH2-0 88.1b C37 
C20 C38 
oppma 
75.4 
42.0 
15.4 
81.5b 
77.2 
15.0 
78.8 
36.8 
Carbon 
C39 
C40 
C41 
C-CH3-42 
C-CH3-42 
C43 
C44 
C45 
C-CH3-46 
C-CH3-46 
C47 
C48 
C49 
cso 
CSl 
C52 
C53 
C54 
css 
42.8 
71.4 
79.0 
17.5 
36.8 
16.9 
76.1 
66.7 
45.4 
66.6 
76.5 
45.4 
46.2 
58.3 
a 13c NMR spectral data assigned from HMQC experiment, recorded at 23°C in CDCl3 
at 300 MHz with chemical shifts in ppm. 
b Assignments tentative - may be interchanged. 
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One-sixth of this material was retained for bioassay and mass spectrometry analysis. 
The remaining five-sixths was used to produce the diketone. At this stage it was 
anticipated that FAB-MS would confirm the diol as the molecular ion as an analysis 
of the NMR data had not been undertaken. No parent ion corresponding to the diol 
product was detected. It was noted that the product was black in solution, and a 
subsequent analysis of the NMR data aroused the strong suspicion that the osmate 
ester (which is usually black59) had not been cleaved to form the diol at the bisulfite 
step. Repeated FAB-MS some time later was unable to detect the parent ion 
corresponding to the di-osmate ester product, perhaps indicating that decomposition 
of the product had occurred. 
Prior to submitting the isohomohalichondrin B di-osmate ester (4.3.1) for biological 
evaluation, it was passed through a small C18 column to remove any remaining 
osmium tetroxide (which is cytotoxic), to remove the possibility of misinterpretation 
of the biological activity. 
4.3.3 Periodate Cleavage of Isohomohalichondrin B Osmylation 
Product 
The isohomohalichondrin B osmylation product ( 4.3.1) was cleaved to the diketone 
product of isohomohalichondrin B ( 4.3.2) by reaction with sodium periodate in a 
methanol/water60 mix. The reaction was stirred at room temperature in the dark and 
monitored by silica TLC. The reaction was carried out in the dark, to avoid possible 
periodate decomposition. 61 Completion of the reaction, after four days, was 
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indicated by the formation of a single silica TLC spot of lower polarity relative to the 
osmylation product and of a similar polarity to that of isohomohalichondrin B. 
HO ~H 43 L ,,, 
,, N M :: 
51 47 = ,,, 
,\, 0 -
n I H 6H3 H0~0 
isohomohalichondrin B diketone ( 4.3.2) 
A 1 H NMR spectrum of the product (Figure 4.3.3) showed several significant 
changes relative to the spectra of the osmylation product and isohomohalichondrin B 
(1.2.9). The CH3-25 doublet was apparent at on 1.09 ppm, in a more shielded 
position compared to the osmylation product CH3-25 (on 1.13 ppm) and slightly less 
shielded relative to isohomohalichondrin B (on 1.05 ppm). The doublet at on 1.13 
ppm was still visible in the 1 H NMR spectrum of the product, contributing <8% to 
the total material (by integral), indicating the reaction yield was >92%. The region 
from on 4.60 ppm to on 4.70 ppm appeared to contain a reduced number of proton 
resonances when compared to the lH NMR spectrum of the osmylation product and 
this region appeared very similar to the 1 H NMR spectrum of isohomohalichondrin 
B. 
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A range of selective lD and 2D NMR experiments (COSY, 2D-TOCSY (100 ms 
mixing time), NOE, HMQC and HMBC) were acquired from the product (4.3.2). 
An analysis of these data gave a partial assignment of the 1 H and Be NMR spectra 
of the product formed and indicated that ketone functionalities had been formed at 
C19 and C26. The important NMR correlations from these experiments are depicted 
in Figure 4.3.4. The 1 H and Be NMR data are cited in Tables 4.3.3 and 4.3.4 
respectively. 
5. 0 4.5 4.0 3.5 2.5 2.0 1.5 
Figure 4.3.3 1 H NMR Spectrum of Isohomohalichondrin B Diketone ( 4.3.2) 
The HMBC s.pectrum of the product showed the presence of two new Be NMR 
' signals situ'ated at oc 208.9 ppm and oc 216.9 ppm, characteristic positions for 
carbonyl carbon resonances, which were assigned as C26 and Cl9 respectively. The 
C19 carbonyl carbon showed HMBC correlations to H20, Hl8 and Hl8', and the 
C26 carbonyl showed correlations to the H25, CH3-2S and H24' protons. 
Unfortunately, no HMBC correlation was observed from C26 to the H27 proton. 
Apart from this region, the other 1H and 13C NMR chemical shifts were very similar 
to those of isohomohalichondrin B. 
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Table 4.3.3 1 H NMR Data for Isohomohalichondrin B Dik:etone ( 4.3.2) 
Proton a oppmb Proton a oppmb Proton a oppmb 
H2 2.38 H21 H39 2.22 
H2' 2.59 H21' H39' 2.22 
H3 3.87 H22 1.69 H40 3.93 
H4 1.33 H22' H41 3.62 
H4' 1.70 H23 3.76 H42 2.30 
HS 1.38 H24 1.62 CH3-42 0.94 
HS' 2.12 H24' 2.00 H43 1.35 
H6 4.26 H25 2.45 H43' 1.52 
H7 2.95 CH3-2S 1.09 H45 1.49 
HS 4.32 H27 H45' 1.49 
H9 4.05 H28 H46 2.18 
HlO 4.20 H28' CH3-46 0.88 
Hll 4.60 H29 4.05 H47 3.25 
H12 4.70 H30 4.62 H48 3.74 
Hl3 1.96 H31 2.04 H49 1.85 
H13' 2.18 CH3-31 0.96 H49' 2.14 
H15 H32 3.12 HSO 3.53 
HlS' H33 3.71 HSl 3.81 
H16 H34 H52 2.58 
H16' 2.18 H34' H52' 2.94 
H17 4.39 H35 4.07 H54 2.75 
H18 2.15 H36 4.12 H54' 2.75 
H18' 2.74 H37 1.92 HSS 3.85 
H20 3.83 H37' 2.35 HSS' 3.85 
a The symbol 'represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCl3 at 300 MHz with chemical shifts in ppm 
and referenced to CH03, OH 7.25 ppm. 
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Table 4.3.4 13C NMR Data for Isohomohalichondrin B Diketone ( 4.3.2) 
Carbon Bppma Carbon Bppma Carbon Bppma 
Cl 171.2 C21 C39 42.7 
C2 39.5 C22 C40 71.5 
C3 74.9 C23 74.0 C41 79.2 
C4 C24 42.5 ,C-CH3-42 
C5 C-CH3-25 43.0 C-CH3-42 17.8 
C6 68.3 C-CH3-25 14.8 C43 36.9 
C7 78.4 C26 208.9 C44 
C8 75.2 C27 C45 37.2 
C9 C28 C-CH3-46 
ClO 76.5 C29 C-CH3-46 17.3 
Cll 82.5 C30 76.8 C47 76.1 
C12 81.2 C-CH3-31 C48 66.3 
C13 48.2 C-CH3-31 14.7 C49 
C14 110.0 C32 78.2 cso 66.4 
C15 C33 77.2 C51 76.5 
C16 C34 C52 
C17 73.8 C35 C53 211.1 
C18 C36 C54 46.2 
C19 216.9 C37 C55 58.3 
C20 C38 112.5 
a 13c NMR spectral data assigned from HMQC and HMBC experiments, recorded at 
23°C in CDCl3 at 300 MHz with chemical shifts in ppm. 
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The periodate cleavage product (4.3.2) was subjected to HPLC and C18 column 
chromatography to remove any osmium tetroxide (or osmylation product) in the 
reaction mixture before submitting 4.3.2 for biological assay and MS. 
The high resolution FAB-MS spectrum of 4.3.2 gave the parent ion (MK+) 
corresponding to a molecular formula of Cs9Hs2021, a loss of two carbon and four 
hydrogen atoms and the addition of two oxygen atoms, relative to 
isohomohalichondrin B (C61Hs601g). This data confirmed the diketone of 
isohomohalichondrin B ( 4.3.2) was formed in the reaction. 
4.3.4 Osmylation and Periodate Cleavage of Homohalichondrin 
B Diacetate 
The hemi-synthesis of the diketone derivative of homohalichondrin B ( 4.3.3) 
provided the starting point for the production of two further derivatives. It was 
envisaged that the reaction of the diketone with an isotopically labelled ylide in a 
Wittig reaction would provide a labelled homohalichondrin B molecule that could be 
useful in pharmacokinetic studies. This reaction is discussed in Section 8.4. 
The dike tone of homohalichondrin B also provided the starting point for the sodium 
borohydride reduction of the C19 and C26 diketone, the idea being to increase the 
polarity in this region and thus provide useful structure-activity information. This 
reaction is discussed in Section 4.4. 
The C19 and C26 diketone of isohomohalichondrin B (4.3.2) was not able to be used 
for the two further reactions described above, as the C53 ketone would be expected 
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to react under the conditions of both the Wittig and the sodium borohydride 
reactions. Alternatively, the use of homohalichondrin B to produce the diketone 
derivative necessitated protection of the terminal diol, which would be expected to 
cleave under the periodate oxidation conditions. 
Reactivity tables62 report that the diacetate derivative of a diol is stable to osmium 
tetroxide, bisulfite, sodium periodate, sodium borohydride and Wittig reaction 
conditions. Thus it was decided that protection of homohalichondrin B as a diacetate 
derivative would provide suitable protection for the planned reaction sequence. The 
diacetylation of homohalichondrin B was described in Section 3.2.1. The immediate 
objective was therefore to produce the homohalichondrin B diacetate diketone 
derivative ( 4.3.3). 
9Hs 
9Hs H H 
H H 1:1 0 
0 
H 34 
52 
H H CHs 
homohalichondrin B diacetate diketone ( 4.3.3) 
0 
The sodium periodate stability of the diacetate of homohalichondrin B (3.2.2, 
Section 3.2.1) was tested, under the conditions to be performed on the osmylation 
product, prior to committing the material to the initial osmylation. Silica TLC and a 
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1 H NMR spectrum (in CDCl3/ 0.1% pyridine-ds) of the material after work-up 
indicated that homohalichondrin B diacetate was unreactive under the periodate 
reaction conditions. 
Having passed the stability test, an ether solution of osmium tetroxide was added to 
homohalichondrin B diacetate (3.2.2) dissolved in pyridine and stirred at room 
temperature for four and a half hours, followed by addition of sodium metabisulfite 
(Na2S20s) in water/pyridine. This mixture was stirred for twenty minutes at room 
temperature. Silica TLC of the product showed that no starting material remained. 
A lH NMR spectrum obtained from the product (in CDCIJ/ 0.1% pyridine-ds) 
indicated the presence of the two acetate CH3 singlet signals at OH 2.04 ppm and OH 
2.10 ppm and a quintet at OH 5.13 ppm corresponding to the H54 methine proton, 
indicating that the diacetate remained intact (Figure 4.3.5). 
L 0 Pll"' 
Figure 4.3.5 lH NMR Spectrum ofHomohalichondrin B Diacetate Osmylation 
Product 
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Also apparent was the absence of the olefinic resonances from the spectrum. 
However, the Me-25 doublet appeared at OH 1.04 ppm compared to OH 1.13 ppm for 
the Me-25 resonance of the isohomohalichondrin B di-osmate ester (4.3.1). The 1H 
NMR spectrum also showed an apparent reduction in the number of resonances in 
the OH 4.50 ppm to OH 4.80 ppm region relative to the 1 H NMR spectrum of the 
isohomohalichondrin B di-osmate ester (Figure 4.3.1). The resonances in this 
region of the spectrum were assigned as corresponding to the osmate ester methylene 
protons, H30, H11 and H12. These were resonances that would not have been 
expected to significantly alter in the 1 H NMR spectrum of the corresponding 
homohalichondrin B diacetate osmylation product derivative as they were well 
removed from the differing terminal moiety. Along with the difference in the 
chemical shift of the Me-25 protons, it suggested that the product in this case was 
more likely to be the diol at positions C19 and C26, with the new diastereotopic 
methylene protons obscured by other resonances in the ca OH 3.60 ppm to OH 4.00 
ppm region of the spectrum. This material was subsequently committed for the 
periodate cleavage step. 
The osmylation/bisulfite reaction material was dissolved in a methanol/water 
periodate solution, stirred in the dark at room temperature, and the reaction progress 
was monitored by silica TLC. The reaction was worked-up when silica TLC 
indicated the formation of a single, less polar spot relative to homohalichondrin B 
and the starting material, and the complete disappearance of homohalichondrin B 
diacetate osmylation product, after two days reaction. A 1 H NMR spectrum acquired 
from this material (in CDCl3/ 0.1% pyridine-ds, Figure 4.3.6) indicated that the 
diacetate had remained intact during the reaction sequence as predicted. The 
characteristic Me-25 doublet that appeared at a chemical shift of OH 1.09 ppm in the 
1 H NMR spectrum of the diketone of isohomohalichondrin B (Figure 4.3.1) was 
also observed for this product. A range of 2D NMR experiments were performed on 
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this product (viz COSY, 2D-TOCSY (100 ms mixing time), HMQC and HMBC 
experiments) which enabled a partial assignment of the 1 H and l3C NMR spectra to 
be achieved (Tables 4.3.5 and 4.3.6 respectively), and confirmed that the C19 and 
C26 diketone of homohalichondrin B diacetate (4.3.3) had been formed. The 
important correlations from these NMR experiments are summarised in Figure 4.3.7. 
The NMR data were consistent with those of the diketone of isohomohalichondrin B 
( 4.3.2) in the region of the A-L rings. 
Table 4.3.5 I H NMR Data for Homohalichondrin B Diacetate Dike tone ( 4.3.3) 
Proton a oppmb Proton a oppmb Proton a oppmb 
H2 2.38 H21' 1.92 H40 3.92 
HZ' 2.56 H22 1.65 H41 3.58 
H3 3.87 H22' H42 2.32 
H4 1.29 H23 3.74 CH3-42 0.93 
H4' 1.70 H24 1.58 H43 1.30 
H5 1.36 H24' 1.96 H43' 1.48 
H5' 2.12 H25 2.44 H45 1.40 
H6 4.26 CH3-25 1.09 H45' 1.40 
H7 2.95 H27 H46 2.12 
HS 4.30 H28 CH3-46 0.90 
H9 4.05 H28' H47 3.05 
HlO 4.19 H29 4.04 H48 3.51 
Hll 4.60 H30 4.60 H49 1.74 
H12 4.68 H31 2.01 H49' 2.12 
H13 1.94 CH3-31 0.96 H50 3.88 
H13' 2.17 H32 3.09 H51 4.02 
HIS 1.78 H33 3.70 H52 1.73 
H15' 2.22 H34 1.80 H52' 1.98 
H16 H34' 2.10 H53 4.34 
H16' H35 C54-0COCH3 2.10 
H17 4.38 H36 4.09 H54 5.13 
HIS 2.15 H37 1.88 CSS-OCOCH3 2.04 
H18' 2.73 H37' 2.34 H55 4.18 
H20 H39 2.18 H55' 4.30 
H21 1.45 H39' 2.18 
a The symbol ' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCI3 at 300 MHz with chemical shifts in ppm and 
referenced to CHCI3, OH 7.25 ppm. 
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Table 4.3.6 13C NMR Data for Homohalichondrin B Diacetate Diketone ( 4.3.3) 
Carbon oppma Carbon oppma Carbon oppma 
Cl 171.2 C23 73.4 C-CH3-42 17.4 
C2 39.2 C24 41.7 C43 36.7 
C3 74.2 C-CH3-25 C44 
C4 C-CH3-25 14.4 C45 36.5 
C5 C26 208.6 C-CH3-46 
C6 68.1 C27 C-CH3-46 17.0 
C7 77.8 C28 C47 72.7 
C8 74.5 C29 C48 63.4 
C9 C30 76.3 C49 
ClO 76.2 C-CH3-31 C50 74.2 
Cll 82.1 C-CH3-31 14.0 C51 76.2 
C12 80.8 C32 78.2 C52 
Cl3 48.0 C33 66.1 C53 75.9 
C14 110.1 C34 C54 72.2 
C15 33.2 C35 C54-0COCH3 170.7 
C16 C36 C54-0COCH3 20.6 
C17 73.2 C37 42.8 C55 63.6 
C18 42.7 C38 CSS-OCOCH3 170.7 
C19 217.0 C39 42.1 CSS-OCOCH3 20.4 
C20 C40 70.5 
C21 C41 79.2 
C22 C-CH3-42 
a 13c NMR spectral data assigned from HMQC and HMBC experiments, recorded at 23°C 
in CDCl3 at 300 MHz with chemical shifts in ppm. 
Figure 4.3.6 1 H NMR Spectrum of Homohalichondrin B Diacetate Diketone ( 4.3.3) 
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These reactions provided the material for the Wittig reaction described in Section 
8.4. It was necessary to repeat the reactions described above, on a similar scale, to 
yield sufficient material for the sodium borohydride reduction reaction (Section 4.4 ). 
A malfunction of a micropipette during the addition of osmium tetroxide, resulting in 
the delivery of less than a two-fold molar quantity of osmium tetroxide solution to 
homohalichondrin B diacetate, provided interesting evidence of the differential 
reactivity of the C 19 and C26 olefinic groups. A 1 H NMR spectrum of the osmium 
tetroxide/bisulfite work-up material indicated that the CHz=26 olefinic protons (OH 
4.75 ppm and DH 4.80 ppm) had completely disappeared and that the CHz=l9 
olefinic protons at OH 4.91 ppm and OH 4.98 ppm were ca 20-25 % of their original 
size in terms of integral. This indicated that the CHz=26 group had reacted more 
readily under these conditions than the corresponding CHz=l9 group. The Uemura 
et al X -ray crystal structure conformation of norhalichondrin A 17 and the solution 
conformations of halichondrin B and homohalichondrin B indicated by NMR 
spectroscopy (described in Sections 2.3 and 2.4 respectively), which suggested that 
the CHz=l9 group was directed into the lactone ring and was less exposed than the 
CH2=26 group which pointed towards the outside of the lactone, were consistent 
with this observation. This material was then re-reacted with osmium 
tetroxide/bisulfite prior to periodate cleavage, as described previously, to produce the 
diketone derivative of homohalichondrin B diacetate ( 4.3.3). 
Chapter 4~ Modifications to Olefins 151 
4.4 Homohalichondrin B Diacetate Diketone 
Reduction 
Homohalichondrin B diacetate diketone (4.3.3) was dissolved in 20% 
dichloromethane/isopropyl alcohol. A suspension of sodium borohydride in 
isopropyl alcohol was added to 4.3.3 in solution; the resulting suspension was stirred 
at room temperature and the reaction monitored by silica TLC. After eighteen hours 
reaction, silica TLC indicated the formation of two more polar spots relative to both 
homohalichondrin B (1.2.9) and the starting material (4.3.3), and the absence of 
starting material in the reaction mixture. 
A 1 H NMR spectrum of the product acquired in CDCl3/0.l% pyridine-ds indicated 
the material was a mixture of at least two different components. It appeared from 
this spectrum that the C19 ketone had fully reacted, as the distinctive H18' methylene 
proton signal at 3H 2. 73 ppm had moved. Also obvious in this spectrum was the 
unexpected loss of one of the terminal acetate groups, as the H54 quintet was not 
present, and only one of the CH3 proton singlet resonances remained. The methyl 
region of the spectrum also indicated several overlapping resonances, with the 3H 
1.09 ppm CH3-25 doublet of the starting material no longer present. Separation of 
the two components that were visible by TLC was achieved on a small diol column, 
providing sufficient material to perform a lH NMR spectrum of each. 
The 1 H NMR spectrum of the least polar fraction indicated that it was probably still 
a mixture of several components as the methyl region of the spectrum was still 
complex. However, the CH3-25 doublet that appeared at bH 1.09 ppm in the 
spectrum of 4.3.3 had moved to a more shielded position. There was insufficient 
material to make further progress with these products. 
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The 1 H NMR spectrum of the more polar fraction also indicated a mixture of 
components were present, and that only one acetate group remained intact. A methyl 
doublet appeared at a relatively deshielded position in the spectrum at a chemical 
shift of OH 1.14 ppm. Again, there was insufficient material to make further progress 
with these products. 
It appeared that the unexpected cleavage of an acetate group had occurred during the 
reaction, and although it was likely that the products represented the C19 and C26 
alcohol derivatives with four diastereoisomeric product combinations possible, it 
would have been impossible to determine the identity of the products without 
committing more material to the reaction to obtain mass spectrometry data and 
generate good NMR data that would aid in the analysis. 
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4.5 Hydrogenation 
Two methods of hydrogenation were attempted to gain access to the C19 and C26 
methyl derivatives of homohalichondrin B (4.5.1); using palladium on carbon63 as a 
catalyst and by using Adams' catalyst. 64 
H 
55 
HO 
OH H H CH3 
tetrahydro homohalichondrin B ( 4.5.1) 
It was anticipated that 4.5.1 would provide useful biological activity data as to the 
relative importance of the sp2 hybridisation of the C19 and C26 centres. Although it 
is possible to produce four diastereoisomers from this reaction, it was recognised that 
the relative inaccessibility of the hydrogen bound catalyst to one face of the C 19 
olefin could result in only two possible diastereoisomers being produced. 
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4.5.1 Catalyst : Palladium on Carbon 
Homohalichondrin B (1.2.3) dissolved in ethanol was stirred over 0.5% palladium on 
carbon catalyst under hydrogen at a slightly positive atmospheric pressure. After 
stirring the reaction overnight at room temperature there was no apparent reaction by 
1 H NMR spectroscopy, as the spectrum was identical with that of homohalichondrin 
B. The reaction was then attempted using an alternative hydrogenation catalyst-
Adams' catalyst. 
4.5.2 Catalyst : Adams' Catalyst 
A suspension of Adams' catalyst (Pt02) in ethyl acetate was pre-reduced under 
hydrogen for thirty minutes prior to the introduction of homohalichondrin B (1.2.3). 
A 1 H NMR spectrum of the product, after four hours reaction at ambient 
temperature, was acquired in CDCl3/ 0.1% pyridine-ds, and is displayed in Figure 
4.5.1. The spectrum indicated the complete disappearance of the olefinic CH2= 19 
and CH2=26 proton resonances of homohalichondrin B, and the movement of the 
distinctive homohalichondrin B Hl8' multiplet at DH 2.79 ppm. The reaction was 
therefore assumed to have gone to completion, with no homohalichondrin B (1.2.3) 
detectable by 1 H NMR spectroscopy. A range of selective lD and 2D NMR 
experiments were performed on this material, ie COSY, lD and 2D-TOCSY (100 ms 
mixing time), HMQC and NOE experiments. The important connectivities 
established from these experiments are depicted in Figure 4.5.2. The corresponding 
lH and 13C NMR data are summarised in Tables 4.5.1 and 4.5.2 respectively. 
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Table 4.5.1 lH NMR Data for Tetrahydro Homohalichondrin B ( 4.5.1) 
Proton3 3ppmb Proton a 3ppmb Proton a 3ppmb 
H2 2.39 H21 H39 2.18 
H2' 2.52 H21' H39' 2.18 
H3 3.92 H22 1.55 H40 3.92 
H4 1.36 H22' 1.55 H41 3.55 
H4' 1.78 H23 3.28 H42 2.32 
H5 1.35 H24 0.98 CH3-42 0.91 
H5' 2.08 H24' 1.18 H43 1.23 
H6 4.38 H25 H43' 1.44 
H7 2.94 CHJ·25 H45 1.40 
HS 4.30 H26 H45' 1.40 
H9 4.04 CH3-26 H46 2.15 
H10 4.19 H27 CH3-46 0.90 
Hll 4.60 H28 H47 3.06 
H12 4.67 H28' H48 3.53 
H13 1.89 H29 3.97 H49 1.75 
H13' 2.13 H30 4.67 H49' 2.13 
H15 H31 1.98 H50 3.90 
H15' CH3-31 0.96 H51 4.04 
H16 H32 3.12 H52 1.98 
H16' H33 3.68 H52' 1.98 
H17 H34 1.80 H53 4.25 
H18 H34' 2.12 H54 3.55 
H18' H35 4.10 H55 3.66 
H19 H36 4.10 H55' 3.66 
CH3·l9 H37 1.86 
H20 H37' 2.33 
a The symbol ' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCl3 at 300 MHz with chemical shifts in ppm and 
referenced to CH03, OH 7.25 ppm. 
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Table 4.5.2 13C NMR Data for Tetrahydro Homohalichondrin B ( 4.5.1) 
Carbon oppma Carbon 8ppma Carbon oppma 
C1 C21 C38 
C2 40.4 C22 32.5 C39 42.3 
C3 74.6 C23 74.5 C40 70.6 
C4 C24 34.8 C41 79.2 
C5 C-CH3-25 C-CH3-42 
C6 68.0 C-CH3-25 C-CH3-42 17.4 
C7 77.5 C-CH3-26 C43 
C8 73.9 C-CH3-26 C44 
C9 C27 C45 
C10 76.3 C28 C-CH3-46 
Cll 81.9 C29 C-CH3-46 17.3 
C12 80.8 C30 77.0 C47 72.5 
C13 48.0 C-CH3-31 C48 63.7 
C14 C-CH3-31 14.6 C49 31.2 
C15 C32 75.7 C50 73.0 
C16 C33 66.0 C51 76.0 
C17 C34 C52 36.8 
C18 C35 C53 79.5 
C19 C36 C54 71.9 
C20 C37 43.0 C55 65.7 
a 13c NMR spectral data assigned from HMQC experiment, recorded at 23 o in CDCl3 at 
300 MHz with chemical shifts in ppm. 
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Figure 4.5.1 lH NMR Spectrum of Tetrahydro Homohalichondrin B ( 4.5.1) 
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Analysis of the NMR experiments performed on the hydrogenation product(s) 
indicated that the A-E and H-0 rings were intact, and that the lH and 13c NMR data 
were consistent with those of homohalichondrin B (1.2.3) in these regions. It proved 
difficult to assign chemical shifts around the F and G rings. The HMQC spectrum 
showed at least five new C-H correlations in the methyl region, and three 
correlations corresponding to CH3-46, CH3-42 and CH3-31 which appeared at 
similar chemical shifts to those of homohalichondrin B. The observation of at least 
five new correlations in the HMQC spectrum implied that there were 
diastereoisomers present. However, the assignment of the individual 
diastereoisomers was not possible due to the complex nature of the spectra in the 
methyl region. An HMQC correlation at OH 0.69 ppm!Oc 5.2 ppm appeared as an 
isolated doublet in the 1 H NMR spectrum of the homohalichondrin B hydrogenation 
products (Figure 4.5.1). A doublet appearing in this region is characteristic of 
methyl protons coupled to a methine proton on a directly attached carbon, and this 
signal also showed a 2D-TOCSY correlation to another methyl doublet signal at OH 
0.88 ppm. These two methyl groups probably represented an individual 
diastereoisomer of the C25-C26 dimethyl system. It was also possible to assign 
chemical shifts for the H24 and H24' methylene protons, the C24 carbon, the H23 
proton, the C23 carbon and the H22/H22' protons and C22 carbon based on COSY, 
2D-TOCSY and HMQC connectivities. 
High resolution FAB-MS showed the presence of the MNa+ parent ion 
corresponding to a molecular formula of C61H90019, representing a gain of four 
hydrogen atoms relative to homohalichondrin B. This confirmed that the 
hydrogenation of homohalichondrin B had been successful and the tetrahydro 
homohalichondrin B derivatives ( 4.5.1) had been formed. 
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4.6 Biological Activity Data 
The biological activity results for selected derivatives described in this Chapter are 
listed in Table 4.6.1. Included in this table are the P388 cytotoxicities of the 
diketone derivative (4.3.2), the di-osmate ester derivative (4.3.1), the tetrahydro 
reduction product (4.5.1) and the relevant parent halichondrins. Also included in this 
table are the cytotoxicities of these derivatives and the parent halichondrins which 
underwent testing in the NCI's primary screening system (Gisos over all sixty cell 
lines) against selected tumour cell lines. Also included are the COMPARE 
colTelation coefficients for the NCI tested compounds. 
Table 4.6.1 In Vitro Cytotoxicities of Selected Halichondrins 
Compound 
homohalichondrin B (1.2.3) 
isohomohalichondrin B 
(1.2.9) 
isohomobalichondrin B di-
osmate ester (4.3.1) 
isobomobalichondrin B 
diketone ( 4.3.2) 
tetrabydro 
bomobalicbondrin B (4.5.1) 
P388 ICso 
(ng/mL) 
0.22 
0.18 
>1250 
21.9 
12.6 
NCI Giso COMPARE 
(xlQ-10 M) Correlationa 
3.16 0.95 
1.15 0.74 
>1000 <0.71 
95.5 0.82 
362 0.87 
a Correlation coefficient from the Compare pattern-recognition algorithm were 
calculated by computer using the Glso-centred mean graph profiles of differential 
cellular sensitivities to each of the compounds. The Giso-centred mean graph 
profile of halichondrin B was used as the "seed" for all of the comparisons. 
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From the data in Table 4.6.1 it can be seen that there was a significant reduction in 
the cytotoxicity which was observed for all three derivatives in the P3 88 assay 
relative to their parent halichondrins. The isohomohalichondrin B di-osmate ester 
derivative (4.3.1) was inactive in terms of the ICso and the Glso result, relative to 
isohomohalichondrin B. The COMPARE correlation coefficient for the di-osmate 
ester of <0.71 suggested that this derivative had lost the ability to act as a 
polymerisation inhibitor of tubulin. The loss of activity observed for the 
isohomohalichondrin B di-osmate ester (4.3.1) probably reflected the conformational 
changes arising from a change to sp3 hybridisation, and an increase in polarity and 
bulk of the osmate esters at Cl9 and C26. 
It was interesting to see the return of activity upon cleavage of the osmylation 
product to produce the diketone derivative of isohomohalichondrin B (4.3.2). A 
<8% contribution of uncleaved osmylation product to the diketone of 
isohomohalichondrin B (as discussed in Section 4.3.3) would be expected result in a 
<8% decrease in the observed biological activity. This is not considered particularly 
significant in terms of the biological nature of the assays. An eighty-fold reduction 
in biological activity was observed in the NCI primary screen for 
isohomohalichondrin B diketone ( 4.3.2) relative to isohomohalichondrin B ( 1.2.9) in 
terms of the Glso result. This implied that the maintenance of sp2 character was not 
the only requirement for the C19 and C26 centres, but the nature of the substituent 
was also an important contributor to the expression of biological activity. It 
appeared that the relatively polar nature of the ketones, the absence of attached 
hydrogens and/or the conformational consequences of this, lead to the observed 
reduction in activity. 
In considering of the biological activity of the tetrahydro homohalichondrin B 
diastereoisomers ( 4.5.1), it was assumed that the P388 assay result and the NCI Giso 
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result represented an average result for all the diastereoisomers produced. A sixty-
fold reduction in the P388 activity for 4.5.1 relative to homohalichondrin B (1.2.3) 
indicated the relative importance of maintaining the sp2 nature and geometry of the 
C 19 and C26 centres to retain the biological activity of the halichondrins. The Giso 
result was over a hundred fold less active than homohalichondrin B (1.2.3). It 
appeared that the P388 cell line was slightly less sensitive than the averaged NCI cell 
line to this modification. The relatively high COMPARE correlation (0.87) 
suggested that the tetrahydro homohalichondrin B (4.5.1) derivative was still able to 
display a similar antimitotic mean-graph profile to that of halichondrin B (1.2.1) and 
homohalichondrin B (1.2.3). 
In general terms, these results indicated the relative importance of the Cl9 and C26 
olefinic groups in the expression of biological activity. It appeared that it was not 
just the sp2 nature of the C 19 and C26 centres that governed the expression of 
biological activity; it appeared that there was a specific requirement for the attached 
groups to be olefinic. 
The biological activities of these derivatives in relation to other halichondrin 
derivatives are discussed further in Chapter 9. 
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5.1 Introduction 
The twenty-two membered lactone ring (Cl-C30), a characteristic functionality of 
the halichondrins, was targeted in an investigation of its relative importance to the 
expression of biological activity in the halichondrin series. 
Efforts were initially focused on opening the Cl-O-C30 linkage via methanolysis. 
Methanolysis was initially attempted on a small quantity of isohomohalichondrin B 
(1.2.9), before scaling up the reaction. The methanolysis of homohalichondrin B 
(1.2.3) was subsequently undertaken. A reductive cleavage of the lactone was also 
attempted on homohalichondrin B. 
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5.2 Methanolysis 
5.2.1 Methanolysis of Isohomohalichondrin B 
A solution of sodium methoxide in methanol was added to a small quantity of 
isohomohalichondrin B (1.2.9). The reaction was stirred at room temperature, 
monitoring the reaction by silica TLC. After two hours, no reaction was apparent by 
TLC so the sodium methoxide concentration was increased, and the reaction was 
stirred overnight. After this time, silica TLC indicated the appearance of a single 
spot of reduced polarity relative to isohomohalichondrin B, and the disappearance of 
starting material from the reaction mixture. The reaction was worked-up and silica 
TLC of the product showed a single, more polar spot relative to 
isohomohalichondrin B. An account of these observations, in light of the identified 
product, is discussed later. A 1 H NMR spectrum of the product, performed in 
CDCl3/ 0.1% pyridine-ds, indicated no starting material was present and that there 
were several major changes relative to the 1 H NMR spectrum of 
isohomohalichondrin B. Notable changes were apparent in the methyl region of the 
spectrum, with the movement of the methyl doublet at OH 1.00 ppm (CH3-31) to a 
new position at OH 1.13 ppm. At OH 3.33 ppm in the lH NMR spectrum, a new 
singlet signal was apparent (integral corresponding to three protons); a characteristic 
position and appearance of a methoxyl resonance. Also apparent was the movement 
of the H32 resonance (from OH 3.20 ppm) and the H18' resonance (from OH 2.80 
ppm), and the movement of other signals into this region of the spectrum. 
The reaction was repeated on a larger scale, giving a product with a 1 H NMR 
spectrum (Figure 5.2.1, in CDCl3/ 0.1% pyridine-ds) identical to that from the 
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previous reaction. This material was combined with that of the previous reaction and 
a series ofNMR experiments were performed (viz DQ COSY, 2D-TOCSY (100 ms 
mixing time), NOE, NOESY, HMQC and HMBC experiments). A partial 
assignment of the 1 H and 13C NMR spectra was achieved from an analysis of the 
NMR experiments. These assignments are given in Tables 5.2.1 ( lH NMR data) and 
5.2.2 (13C NMR data), and the important correlations from the NMR experiments are 
depicted in Figure 5.2.2. 
Table 5.2.1 lH NMR Data for Lactone-Opened Isohomohalichondrin B (5.2.1) 
Proton a oppmb Proton a oppmb Protona oppmb 
H2 H21 1.67 H39 2.22 
H2' H21' H39' 2.22 
H3 3.84 H22 1.62 H40 3.92 
H4 1.42 H22' 1.62 H41 3.63 
H4' 1.78 H23 3.60 H42 2.27 
H5 1.40 H24 1.07 CH3-42 0.95 
H5' 2.06 H24' 1.77 H43 1.32 
H6 4.27 H25 2.26 H43' 1.52 
H7 2.96 CH3-25 1.06 H45 1.45 
HS· 4.52 26=CH 4.81 H45' 1.45 
H9 4.06 26'=CH 4.90 H46 2.12 
H10 4.18 H27 3.95 CH3·46 0.90 
Hll 4.60 H28 1.96 H47 3.23 
H12 4.66 H28' 2.05 H48 3.73 
H13 1.96 H29 3.66 H49 1.83 
H13' 2.16 H30 3.18 H49' 2.12 
H15 H31 1.84 H50 3.49 
H15' CH3·31 1.13 H51 3.80 
H16 H32 3.36 H52 2.63 
H16' H33 3.84 H52' 2.90 
H17 4.05 H34 1.94 H54 2.74 
Hl8 2.22 H34' 2.05 H54' 2.74 
H18' 2.64 H35 4.14 H55 3.63 
19=CH 4.86 H36 4.06 H55' 3.63 
19'=CH 4.95 H37 1.96 C55-0CH3 3.33 
H20 4.48 H37' 2.40 
a The symbol' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCI3 at 300 MHz with chemical shifts in ppm and 
referenced to CHa3, 8H 7.25 ppm. 
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Table 5.2.2 13C NMR Data for Lactone-Opened Isohomohalichondrin B (5.2.1) 
Carbon Dppma Carbon Dppma Carbon Dppma 
Cl C21 C39 43.6 
C2 C22 C40 71.3 
C3 76.2 C23 77.8 C41 79.0 
C4 C24 42.5 C-CH3-42 25.5 
cs C-CH3-2S 35.9 C-CH3-42 17.0 
C6 68.3 C-CH3-2S 17.5 C43 36.8 
C7 77.3 26C=CH2 C44 97.2 
C8 74.3 26C=CH2 C45 
C9 73.9 C27 75.3 C-CH3·46 
C10 75.4 C28 C-CH3-46 16.5 
Cll 82.2 C29 73.4 C47 76.0 
C12 81.0 C30 72.1 C48 66.3 
C13 46.9 C-CH3-31 39.2 C49 
C14 110.4 C-CH3-31 15.0 cso 66.2 
ClS C32 76.9 est 76.2 
Cl6 C33 66.5 CS2 45.0 
C17 76.8 C34 CS3 207.9 
C18 38.6 C35 75.4 CS4 43.7 
19C=CH2 C36 75.0 css 67.1 
19C=CH2 C37 45.0 CSS-OCH3 58.6 
C20 79.7 C38 112.0 
a Datueco<ded at 23°C in CDC13 witi ohemioal shifts in ppm, assign~ from HMQC and 
HMBC spectra at 300 MHz. i 1 
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Figure 5.2.1 lH NMR Spectrum ofLactone-Openedlsohomohalichondrin B (5.2.1) 
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Analysis of the NMR data indicated that the methoxyl group was not attached at the 
Cl position, but at the terminal C55 position. An isolated HMQC correlation was 
observed for the methoxyl group carbon at <>c 58.6 ppm to the methoxyl protons (8H 
3.33 ppm). An HMBC correlation was observed from this carbon to the H551H55' 
protons at ()H 3.63 ppm. The C55 carbon at Be 67.1 ppm showed an HMBC 
correlation to the H54/H54' protons (BH 2.74 ppm) and to the methoxyl protons at ()H 
3.33 ppm. The observed lH NMR chemical shifts in this region were consistent with 
those observed for Me-isohomohalichondrin B-b (1.2.12), 65 the naturally occurring 
C55 methoxyl derivative of isohomohalichondrin B. Reaction at the terminal 
hydroxyl group was not anticipated under the reaction conditions used. A 
mechanism to account for this most unusual, and unexpected, finding is given in 
Figure 5.2.3. This mechanism involves initial formation of an enolate and 
elimination of the terminal hydroxyl group to give an a.,~-unsaturated compound 
followed by Michael addition of a methoxyl group to regenerate the enolate and 
reformation of the C53 ketone. 
HO 
isohomohalichondrin B 
a-laO 
55 
55 
0 
53 
methanolysis product 
p 
a-ifJ:J 
Figure 5.2.3 Proposed Mechanism for Terminal Methoxy Formation 
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COSY correlations and a key NOESY correlation were used primarily to assign the 
1 H NMR chemical shifts around the H and I rings. A NOESY correlation from the 
unidentified resonance at bH 3.36 ppm to a proton at bH 4.06 ppm (H36) aided in the 
assignment of the chemical shift of the H32 proton. COSY correlations from OH 
3.36 ppm (H32) to OH 3.84 ppm and OH 1.84 ppm located the H33 and H31 proton 
resonances respectively. A COSY correlation was observed from H31 (OH 1.84 
ppm) to the previously assigned CH3-31 doublet resonance at OH 1.13 ppm. The 
COSY spectrum also revealed the location of the H30 resonance; a correlation from 
H31 (bH 1.84 ppm) was observed to a resonance at OH 3.18 ppm. The signal at bH 
3.18 ppm (H30) was correlated to another proton resonating at OH 3.66 ppm, which 
was assigned as the H29 resonance. 
The large change in the lH NMR chemical shift observed for H30, from OH 4.66 
ppm in isohomohalichondrin B to OH 3.18 ppm in the methanolysis product, implied 
that the C1-0-C30 bond had been cleaved to give the alcohol derivative at C30. It 
was not possible to locate the H2 and H2' protons, or the C1 or C2 carbon in the 
NMR spectra of the product, although there were some minor changes observed in 
the lH and 13C NMR chemical shifts observed around the A and Brings, that were 
consistent with lactone cleavage. 
The NOESY and difference NOE NMR spectra showed the NOE correlations as 
negative signals, as opposed to the positive correlations observed in the NOESY and 
NOE spectra of homohalichondrin Band halichondrin B, and the other derivatives 
isolated. It is likely that the opening of the lactone ring resulted in the molecule 
behaving more like a macromolecule in solution, arising from the splaying out of the 
released lactone ring, giving a relatively long correlation time (tc) and resulting in 
the observation of negative NOEs. 
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An infrared (IR) spectrum was performed on the product (5.2.1). TheIR spectrum 
lacked the distinctive u 173 2 em -1 lactone stretch present in the IR spectrum of 
isohomohalichondrin B, and the other halichondrins isolated to date. A new band at 
u 1574 cm·l was also observed, characteristic of a carboxylate stretch band. 66 
High resolution FAB-MS performed on the product (5.2.1) showed the parent ion 
corresponding to a molecular formula of C62H9002o, a gain of one carbon atom, four 
hydrogen atoms and one oxygen atom relative to isohomohalichondrin B (1.2.9). 
This indicated that a CH3 group and a hydroxyl group had been added to 
isohomohalichondrin B in the reaction. 
The observation of carboxylate functionality in the IR spectrum, combined with the 
MS result confirmed that the lactone had been cleaved to produce the C 1 
carboxylate, via hydrolysis of the initially formed Cl methyl ester. This was also 
indicated by the TLC evidence before (a less polar product) and after work-up (the 
formation of a more polar product). The structure of the isohomohalichondrin B 
methanolysis product was therefore given as 5.2.1. The observance of either a 
carboxylate or a carboxylic acid (as for 5.2.1) being a function of pH. 
OH 
H ~28 OGX QD G ~ 0 
\ I - E 
\,,, 111CH 
22 r 3 
lactone-opened isohomohalichondrin B (5.2.1) ,,,,,, 
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5.2.2 Methanolysis of Homohalichondrin B 
To demonstrate that the opening of the lactone ring to give the carboxylate at Cl via 
methanolysis was a general reaction of the halichondrin series, and to avoid the 
complication of terminal moiety involvement in the reaction, methanolysis was 
attempted on homohalichondrin B (1.2.3). 
Homohalichondrin B (1.2.3) was reacted with sodium methoxide in methanol, 
stirring the reaction overnight at room temperature. Silica TLC of the reaction 
mixture indicated the appearance of a less polar component. After reaction work-up, 
TLC performed on the product indicated the presence of a more polar spot relative to 
homohalichondrin B. These TLC observations were consistent with those observed 
in the methanolysis of isohomohalichondrin B (Section 5.2.1). A lH NMR spectmm 
performed on the product indicated that the reaction was incomplete, with 
approximately 50% homohalichondrin B and 50% reaction product in the reaction 
mixture. The mixture was committed for re-reaction with sodium methoxide, stirring 
the reaction overnight at room temperature, and monitoring the reaction by TLC. A 
1 H NMR spectrum (Figure 5.2.4) performed after this time (in CDCb/ 0.1% 
pyridine-d 5) indicated that 90% of the halichondrin had been transformed into 
product with about 10% homohalichondrin B remaining. The CH3-31 doublet 
resonance, present at OH 0.99 ppm in the lH NMR spectrum of homohalichondrin B, 
was absent in the spectmm of the reaction product. Other notable changes in the 1 H 
NMR spectrum of the product, relative to that of homohalichondrin B, was the 
movement of the H30 signal from OH 4.65 ppm and the movement of the H18' (from 
OH 2.79 ppm) and H32 (from DH 3.17 ppm) resonances, and the appearance of a new 
doublet of doublets at DH 3.34 ppm. The methoxyl resonance present in the lH NMR 
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spectrum of lactone opened isohomohalichondrin B (Figure 5.2.1), was absent from 
the spectrum of the homohalichondrin B methanolysis product (Figure 5.2.4 ). 
Figure 5.2.4 1 H NMR Spectrum of Lactone-Opened Homohalichondrin B ( 5.2.2) 
A series of NMR experiments were performed on the product (5.2.2), namely COSY, 
2D-TOCSY (100 ms mixing time), NOB, HMQC and HMBC experiments. An 
analysis of the data generated from these experiments enabled a partial assignment of 
the 1 H and 13C NMR spectra to be achieved. These 1 H and 13C NMR data are cited 
in Tables 5.2.3 and 5.2.4 respectively, and the important NMR correlations from 
these experiments are shown in Figure 5.2.5. 
Relative to the 1 H and 13C NMR data for homohalichondrin B (Tables 2.4.1 and 
2.4.2), the NMR data for the methanolysis product of homohalichondrin B (5.2.2) 
were significantly different in the region of the A-J rings, focusing interest more 
specifically in changes around the A and H rings. Irradiation of the isolated doublet 
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of doublets at OH 3.34 ppm gave negative NOEs for resonances at OH 4.06 ppm 
(H36), bH 1.13 ppm (CH3-31) and ()H 3.86 ppm (H33), indicating that the irradiated 
signal was the H32 resonance. Irradiation of the isolated doublet of doublets at OH 
3.23 ppm gave NOEs to proton resonances at bH 3.34 ppm (H32), bH 3.86 ppm 
(H33), indicating that the signal at ()H 3.23 ppm was the H30 resonance. 
Table 5.2.3 1 H NMR Data for Lactone-Opened Homohalichondrin B (5.2.2) 
Proton a () ppmb Proton a <3ppmb Proton a ()ppmb 
H2 2.35 H21 1.64 H39 2.22 
H2' H21' H39' 2.22 
H3 3.82 H22 H40 3.95 
H4 1.45 H22' H41 3.61 
H4' 1.80 H23 3.60 H42 2.30 
H5 1.40 H24 1.05 CH3·42 0.94 
HS' 2.06 H24' 1.80 H43 1.30 
H6 4.26 H25 2.27 H43' 1.49 
H7 2.94 CH3-2S 1.06 H45 1.45 
HS 4.48 26=CH 4.80 H45' 1.45 
H9 4.06 26'=CH 4.86 H46 2.15 
HlO 4.18 H27 3.95 CH3-46 0.92 
Hll 4.60 H28 H47 3.06 
H12 4.67 H28' 2.02 H48 3.53 
Hl3 1.93 H29 3.70 H49 1.78 
H13' 2.17 H30 3.23 H49' 2.15 
H15 H31 1.85 H50 3.90 
H15' CH3-Jl 1.13 H51 4.03 
Hl6 1.74 H32 3.34 H52 2.00 
H16' 2.00 H33 3.86 H52' 2.00 
H17 4.10 H34 1.92 H53 4.26 
H18 2.25 H34' 2.10 H54 3.55 
H18' 2.62 H35 4.14 H55 3.67 
19=CH 4.86 H36 4.06 H55' 3.67 
19'=CH 4.97 H37 1.95 
H20 4.48 H37' 2.40 
a The symbol' represents the less shielded proton of a geminal pair. 
b Data recorded at 23°C in CDCl3 at 300 MHz with chemical shifts in ppm and 
referenced to CHC13, OH 7.25 ppm. 
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Table 5.2.4 13C NMR Data for Lactone-Opened Homohalichondrin B ( 5.2.2) 
Carbon Sppma Carbon Sppma Carbon Sppma 
Cl C21 C39 43.5 
C2 43.6 C22 C40 70.8 
C3 76.0 C23 77.7 C41 79.2 
C4 C24 42.5 C-CH3-42 25.5 
C5 C-CH3·25 35.5 C-CH3-42 17.0 
C6 68.4 C-CH3-25 18.1 C43 
C7 77.5 26C=CH2 150.8 C44 
C8 74.2 26C=CH2 C45 
C9 C27 C-CH3-46 28.0 
ClO 76.5 C28 36.8 C-CH3-46 18.0 
Cll 82.1 C29 73.6 C47 72.6 
C12 81.0 C30 72.2 C48 63.5 
C13 47.0 C-CH3-31 39.0 C49 
C14 C-CH3·3l 15.4 C50 74.6 
C15 C32 76.6 C51 76.4 
C16 C33 66.3 C52 
C17 C34 C53 79.6 
C18 38.5 C35 C54 72.0 
19C=CH2 C36 75.4 C55 65.3 
19C=CH2 C37 45.0 
C20 79.4 C38 
a Data recorded at 23 oc in CDCl3 with chemical shifts in ppm, assigned from HMQC 
and HMBC spectra at 300 MHz. 
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Figure 5.2.5 Lactone-Opened Homohalichondrin B- Important NMR Correlations 
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The lH and 13C NMR data in the terminal spin system (C45-C55) were very similar 
to those of homohalichondrin B (1.2.3), indicating that the terminal moiety was 
unmodified. 
High resolution FAB-MS performed on the methanolysis product (5.2.2) gave the 
parent ion corresponding to a molecular formula of C61Hss02o. a gain of one 
oxygen and two hydrogen atoms relative to homohalichondrin B (1.2.3). These data 
confirmed that 5.2.2 had been formed in the reaction. 
g;3 
- H H 
H H 
55 
HO 
OH H H CHs 
lactone-opened homohalichondrin B (5.2.2) 
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5.3 Lithium Aluminium Hydride Reduction 
A lithium aluminium hydride reduction of the Cl-C30 lactone of homohalichondrin 
B (1.2.3) was undertaken with the objective being to produce the lactone-cleaved Cl 
and C30 alcohol derivative ( 5.3.1). 
H H 
H H OH 
55 
HO 0 H ~ 
OH =27 08: Q D G : 0 
\\ ,,1 E 
22 (' 'Oi3 
1111
11 
H H 
lactone-reduced homohalichondrin B (5.3.1) 
Homohalichondrin B (1.2.3) was dissolved in dry tetrahydrofuran before the addition 
of fresh lithium aluminium hydride. The resulting suspension was stirred vigorously 
for four hours, at room temperature. Reaction work-up involved quenching the 
reaction with acidified water and extracting the halichondrin material on a small C18 
column, washing the column with water to remove lithium salts and eluting with 
methanol to obtain the halichondrin material. The Cl8 column work-up procedure 
was tested on a small quantity of homohalichondrin B, without lithium aluminium 
hydride added, to ensure the halichondrin material was stable to the work-up 
conditions and that a high recovery was attainable. 
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TLC performed on the reaction mixture showed a single, more polar spot relative to 
a homohalichondrin B reference spot. A lH NMR spectrum of the product, acquired 
in CDCl3/ 0.1% pyridine-d5, is displayed in Figure 5.3.1. Several major changes 
were apparent in this spectrum relative to the 1 H NMR spectrum of 
homohalichondrin B (Figure 2.4.1). In the methyl region of the spectrum, it was 
apparent that the doublet resonance corresponding to the CH3-31 protons had moved 
from OH 0.99 ppm to a new position at OH 1.13 ppm. Also apparent from the 
spectrum was the loss of one proton resonance (by integral) in the OH 4.65 ppm 
region where the H30 and H12 resonances were situated in the 1 H NMR spectrum of ,. 
homohalichondrin B. A new doublet of doublets was observed at OH 3.37 ppm and 
the distinctive H2' resonance (OH 2.58 ppm) was no longer visible. The distinctive 
H18' multiplet at OH 2.79 ppm in homohalichondrin B was visible at OH 2.62 ppm in 
the spectrum of the product and no homohalichondrin B Hl8' signal was apparent at 
OH 2. 79 ppm, indicating that there was no starting material remainin from the 
I ' 
reaction. 
Figure 5.3.1 1 H NMR Spectrum of Homohalichondrin B Lactone Reduction 
Product (5.3.1) 
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A series of NMR experiments were performed on the product : COSY, 2D-TOCSY 
(100 ms mixing time), 1D-TOCSY, NOB and HMQC experiments. A partial 
assignment of the 1 H and 13C NMR spectra was achieved from an analysis of the 
various NMR spectra. The important correlations from these experiments are 
depicted in Figure 5.3.2. The 1 H and 13C NMR data are cited in Tables 5.3.1 and 
5.3.2 respectively. 
Table 5.3.1 lH NMR Data for Lactone-Reduced Homohalichondrin B (5.3.1) 
Proton a Bppmb Proton a oppmb Proton a oppmb 
Hl 3.75 19'=CH 4.95 H37 1.96 
Hl' 3.75 H20 4.38 H37' 2.38 
H2 1.72 H21 1.62 H39 2.22 
H2' 1.72 H21' H39' 2.22 
H3 3.61 H22 H40 3.92 
H4 1.55 H22' H41 3.62 
H4' 1.70 H23 3.54 H42 2.27 
H5 1.36 H24 1.06 CH3-42 0.94 
H5' 2.08 H24' 1.75 H43 1.38 
H6 4.30 H25 2.20 H43' 1.50 
H7 2.88 CH3-2S 1.06 H45 1.42 
HS 4.40 26=CH 4.81 H45' 1.42 
H9 4.04 26'=CH 4.91 H46 2.10 
HlO 4.19 H27 3.92 CH3-46 0.92 
Hll 4.59 H28 2.03 H47 3.07 
H12 4.67 H28' 2.03 H48 3.55 
H13 1.94 H29 3.62 H49 1.78 
H13' 2.15 H30 3.17 H49' 2.15 
H15 H31 1.79 H50 3.90 
H15' CH3-31 1.13 H51 4.03 
H16 H32 3.37 H52 2.00 
H16' H33 3.85 H52' 2.00 
H17 4.05 H34 1.93 H53 4.25 
H18 2.22 H34' 2.03 H54 3.55 
H18' 2.62 H35 4.14 HSS 3.70 
19=CH 4.84 H36 4.04 H55' 3.70 
a The symbol 'represents the less shielded proton of a geminal pair. 
b Data recorded at 23°C in CDCl3 at 300 MHz with chemical shifts in ppm and 
referenced to CH03, BH 7.25 ppm. 
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Table 5.3.2 Be NMR Data for Lactone-Reduced Homohalichondrin B (5.3.1) 
Carbon oppma Carbon oppma Carbon oppma 
Cl 60.6 C21 C39 44.0 
C2 C22 C40 71.2 
C3 73.5 C23 78.1 C41 79.5 
C4 C24 42.5 C-CH3-42 
C5 C-CH3-25 C-CH3-42 17.8 
C6 68.6 C-CH3-2S 18.5 C43 
C7 78.0 26C=CH2 C44 
C8 79.3 26C=CH2 C45 
C9 C27 C-CH3-46 
ClO C28 C-CH3-46 18.0 
Cll 82.3 C29 C47 73.0 
C12 81.1 C30 72.3 C48 63.7 
C13 47.4 C-CH3-31 C49 
C14 C-CH3-31 15.7 C50 
C15 C32 77.0 C51 
C16 C33 C52 
C17 C34 C53 
C18 C35 C54 72.5 
19C=CH2 C36 C55 65.8 
19C=CH2 C37 45.5 
C20 74.6 C38 
a Data recorded at 23 °C in CDCl3 with chemical shifts in ppm, assigned from an 
HMQC spectrum at 300 MHz. 
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Figure 5.3.2 Lactone-Reduced Homohalichondrin B- Important NMR Correlations 
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The lH and 13C NMR assignments for the terminal region of the molecule (C38-
C55) were consistent with those observed for homohalichondrin B. As expected, the 
changes in chemical shifts were centred around the A to J rings, with the most 
notable differences being observed around the regions of the A, H and I rings. 
The assignments of 1 H NMR chemical shifts around the H to J rings were similar to 
those observed for the lactone opened homohalichondrin B (5.2.2). The H30 proton 
resonance was observed at BH 3.17 ppm in the lactone reduction product (5.3.1), a 
shift of BH 1.48 ppm to a more shielded position relative to homohalichondrin B. 
This was consistent with the H30 1 H NMR resonance observed for the lactone-
opened homohalichondrin B product (5.2.2), situated at BH 3.23 ppm, and implied 
that the lactone had been cleaved using lithium aluminium hydride to give the 
secondary C30 alcohol. The 1 H NMR chemical shifts of other protons in this region 
were also consistent with those observed for the lactone-opened homohalichondrin B 
(5.2.2). 
As with the lactone-opened homohalichondrin B (5.2.2), some changes in the 1 H and 
13C NMR chemical shifts were observed around the regions of the C to G rings. 
COSY correlations around the A to E rings assigned the chemical shifts of the 
protons in this region. The H3 resonance was observed at OH 3.61 ppm, shielded by 
BH 0.30 ppm compared to the shift observed for the H3 resonance of 
homohalichondrin B (1.2.3). An isolated HMQC correlation was observed for a 
carbon at Be 60.6 ppm, correlated to protons at BH 3.75 ppm, typicall3C and lH 
NMR chemical shifts for an aliphatic -CH2-0H. As the terminal C55 primary 
alcohol had already been assigned, the BH 3.75 ppm resonance was assigned as 
corresponding to the new, equivalent, H1 and H1' protons and the Be 60.6 ppm 
resonance as the C1 carbon. A COSY correlation was observed from the H1 and H1' 
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protons to protons resonating at OH 1.72 ppm, which were assigned as the resonances 
of the H2 and H2' methylene protons. Additionally, from the OH 3.75 ppm resonance 
(Hl/Hl'), 1D and 2D-TOCSY correlations were observed to the previously assigned 
H3 proton at OH 3.61 ppm, and to the OH 1.72 ppm protons (H2/H2'). 
Interestingly, the NOEs observed for this product were positive, as opposed to the 
negative NOEs observed for both the homohalichondrin B and isohomohalichondrin 
B methanolysis products (5.2.2 and 5.2.1 respectively). This implied a solution 
behaviour more like that observed for the other halichondrins, with a relatively short 
correlation time ( 'tc), resulting in the observation of positive NOEs. It was possible 
that in CDCl3 solution, the Cl hydroxyl group of 5.3.1 was involved in an 
intramolecular hydrogen bond to the C30 alcohol group, resulting in a conformation 
of the Cl-C30 region that was similar to homohalichondrin B (1.2.3) and 
halichondrin B (1.2.1), and thus gave rise to a "halichondrin-like" solution 
behaviour. Conversely, the presence of the ionic Cl carboxylate (or carboxylic acid) 
group in the products 5.2.1 and 5.2.2 was possibly forcing the carboxylate end of the 
lactone ring away from interaction with C30, resulting in splaying out of the 
molecule. 
High resolution FAB-MS performed on the reduction product (5.3.1) established that 
the parent ion corresponding to a molecular formula of C6tH900t9 was present, a 
gain of four hydrogen atoms relative to the molecular formula of homohalichondrin 
B. This confirmed that 5.3.1 was the product formed in the lithium aluminium 
hydride reduction of homohalichondrin B. 
Chapter 5- Lactone Alterations 184 
5.4 Biological Activity Data 
The biological activities of the three derivatives discussed in this Chapter are listed 
in Table 5.4.1. Listed are the cytotoxicities against the P388 cell line of all three 
compounds, with the NCI-derived Glsos (averaged over all sixty cell lines) and 
COMPARE correlations for these three derivatives. The relevant parent 
halichondrins: homohalichondrin B (1.2.3), isohomohalichondrin B (1.2.9) and Me-
isohomohalichondrin B-b (1.2.12) have their cytotoxicities given in terms of their 
ICso and Glso results for comparison. 
All of the derivatives produced showed a significant increase in ICso and Giso 
concentrations relative to their respective parent compounds. In terms of the P388 
ICso results the lactone-opened isohomohalichondrin B (5.2.1) product displayed a 
3500-fold decrease in activity relative to isohomohalichondrin B (1.2.9). The 
naturally occurring C55 methoxyl derivative of isohomohalichondrin B (1.2.12) 
resulted in a greater than fifty-fold decrease in P388 activity relative to 
isohomohalichondrin B. Providing that the reduction in biological activity conferred 
by the presence of a terminal methyl group at C55 was independent of the reduction 
in biological activity conferred by the opening of the lactone ring to give 5.2.1, then 
the biological activity (ie the ICs o) due to the lactone opening of 
isohomohalichondrin B only could be seen as being ca 11 ng/ mL or a greater than 
sixty-fold reduction in cytotoxicity relative to isohomohalichondrin B (1.2.9). The 
homohalichondrin B lactone-opened product (5.2.2), given the 10% contribution by 
homohalichondrin B, presented at least a twenty-four fold reduction in P388 activity 
rdative to homohalichondrin B (1.2.3), although synergistic or antagonistic effects 
due to the presence of homohalichondrin B could not be discounted. A similar 
analysis of the NCI Glso results indicated ca 280-fold decrease in biological activity 
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for the lactone-opened isohomohalichondrin B product (5.2.1) relative to 
isohomohalichondrin B, or a reduction in activity of about 160-fold for opening of 
the lactone ring only, by taking into account the reduction in activity conferred by 
terminal methylation. In comparison, the homohalichondrin B lactone-opened 
product (5.2.2) recorded at least a 260-fold reduction in activity relative to 
homohalichondrin B (1.2.3). Generally, the P388 cytotoxicity results suggested that 
the P388 cell line was less sensitive to the effect of opening the lactone ring than in 
the NCI primary screen which is averaged over sixty different cell lines. 
Table 5.4.1 In Vitro Cytotoxicities of Selected Halichondrins 
Compound 
homohalichondrin B (1.2.3) 
isohomohalichondrin B 
(1.2.9) 
Me-isohomohalichondrin B-
b (1.2.12) 
lactone-opened 
isohomohalichondrin B 
(5.2.1) 
lactone-opened 
homohalichondrin B (5.2.2) 
lactone-reduced 
homohalichondrin B (5.3.1) 
P388 ICso 
(ng/mL) 
0.22 
0.18 
10 
630 
5.4 
56 
NCI Giso COMPARE 
(X10-10 M) Correlationa 
3.16 0.95 
1.15 0.74 
2.00 0.72 
324 <0.71 
851 0.81 
490 0.73 
a Conelation coefficient from the Compare pattern-recognition algorithm were 
calculated by computer using the Glso-centred mean graph profiles of differential 
cellular sensitivities to each of the compounds. The Glso-centred mean graph 
profile of halichondrin B was used as the "seed" for all of the comparisons. 
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In terms of the COMPARE correlation coefficient for the isohomohalichondrin B 
lactone-opened derivative (5.2.1), the reduction in the similarity of its Giso-centred 
profile to either halichondrin B (COMPARE defined as being 1.00) or 
isohomohalichondrin B (1.2.9) probably reflected a reduction in the ability to act as 
antimitotic compound. The lactone-opened homohalichondrin B derivative (5.2.2) 
appeared to display only a slight reduction in the COMPARE coefficient relative to 
homohalichondrin B, even though the cytotoxicity of this compound was 
significantly reduced. 
The lactone-reduced homohalichondrin B product (5.3.1) also showed a significant 
reduction in the P388 cytotoxicity assay of greater than 250-fold relative to the 
parent halichondrin, homohalichondrin B (1.2.3). Similarly, the Giso result indicated 
a greater than 150-fold reduction in activity relative to homohalichondrin B (1.2.3). 
The COMPARE correlation coefficient indicated a significant reduction in the ability 
of 5.3.1 to display the characteristic antimitotic mean-graph profile observed for 
homohalichondrin B (1.2.3). 
In general terms, the lactone ring was observed to play a significant role in the 
expression of cytotoxicity in the halichondrins. 
A further discussion of the biological activities of these analogues in relation to other 
halichondrin analogues is found in Chapter 9. 
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CHAPTER6 
Acid Stability Studies 
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6.1 Introduction 
In order to gain an insight into the general chemistry of the halichondrins, an 
investigation of the acid stability of selected members of the halichondrin series was 
undertaken. It was anticipated that a knowledge of this stability would give useful 
information as to the ability to react other reagents with halichondrins under specific 
acidic reaction conditions without acid decomposition. 
Hirata and Uemura18 reported in 1986 that halichondrins underwent decomposition 
in acidic solution, although the authors did not report conditions or a specific 
mode(s) of decomposition. 
In 1993, Cooper et al reported a specific mode of acid decomposition in a synthetic 
Cl-C21 "B family" halichondrin fragment as part of their synthetic efforts towards 
the total synthesis of halichondrin B (1.2.1). 31 The authors reported the 50% 
conversion of a C14-ketal synthetic fragment to a furan derivative (refer to Appendix 
III) "presumably owing to traces of HCl in the solvent" (CDCl3). They further 
suggested that "this reactivity has biological significance".31 
A series of trial reactions were performed, placing selected halichondrins under 
acidic conditions using a range of acids of varying acid strengths and concentrations, 
with the objective of isolating and identifying specific acid catalysed reaction 
products. 
Once a suitable reaction conditions were developed which enabled the generation of 
a series of acid catalysed reaction products, a method of separating these products 
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was developed and subsequently performed. Structural characterisation of the 
isolated derivatives was then undertaken. 
A study of the interaction and possible equilibration between the various acid 
catalysed reaction products under similar reaction conditions was undertaken, in 
closely monitored time-scale reactions, performed on the individual products. 
In the total synthesis of halichondrin B (1.2.1) and norhalichondrin B (1.2.2) 
reported by Kishi's group,67 the final step in the synthesis was the formation of the 
C38 spiro centre with camphor sulfonic acid in dichloromethane (refer to Appendix 
III). No data on the stereoselectivity of this transformation was given, except to say 
that it was "very high''. It was therefore important to consider the effect of the acidic 
reaction conditions on the stereoselectivity of the closure of the spiro centre and the 
effect of acid on the rest of the halichondrin molecule. A time-scale reaction study 
of the acid catalysed reaction of homohalichondrin B (1.2.3) in camphor sulfonic 
acid solution (in dichloromethane) was therefore undertaken. 
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6.2 Acid Stability Studies 
Kishi and co-workers reported67 the formation of the C14 spiro centre in a Cl-C38 
synthetic fragment using a mild acid, pyridinium p-toluene sulfonate (PPTS), in 
dichloromethane to effect ketalisation in the total synthesis of halichondrin B and 
norhalichondrin B. A more detailed description of this reaction in the context of the 
overall total synthesis can be found in Appendix III. An initial point for studying the 
acid stability of homohalichondrin B (1.2.3) was therefore undertaken using PPfS in 
dichloromethane solution. Subsequently, a stronger acid, p-toluene sulfonic acid 
(PTSA), and finally trifluoroacetic acid (TFA) were investigated in acid stability 
studies of homohalichondrin B (1.2.3). 
6.2.1 PPTS Stability Studies of Homohalichondrin B 
The reaction of a small quantity (0.3 mg) of homohalichondrin B (1.2.3) with PPfS 
in deuterochloroform was monitored by lH NMR spectroscopy. A reference lH 
NMR spectrum of homohalichondrin B in deuterochloroform was obtained, then 
PPfS was added to give a 1:3 ratio of PPfS to homohalichondrin B. The reaction 
was left standing at room temperature and monitored at regular time intervals. After 
forty-five minutes no reaction was observed by lH NMR spectroscopy, so additional 
PPfS was added to give a 1: 1 ratio of PPTS to homohalichondrin B in the NMR 
tube. 
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After seventy-seven hours at a 1:1 ratio and at room temperature, a 1H NMR 
spectrum obtained from the solution indicated the appearance of new signals and the 
reduction in the intensity of other, homohalichondrin B resonances. A new doublet 
of doublets was apparent at OH 3.12 ppm (lying between the H32 and H47 
resonances), and the intensity of the CH3-46 doublet at OH 0.90 ppm was reduced 
relative to the 1H NMR spectrum of homohalichondrin B (Figure 2.4.1). Also 
apparent from the 1H NMR spectrum was the increase in the intensity of the doublet 
resonance situated at OH 0.99 ppm (CH3-31). 
After six days, a 1 H NMR spectrum obtained from the mixture indicated some 
additional changes relative to the spectrum acquired after seventy-seven hours. The 
regions around OH 4.25 ppm, OH 3.52 ppm and OH 3.80 ppm showed an increase in 
complexity and the resonances at OH 3.12 ppm and OH 0.99 ppm continued to 
increase in intensity while the OH 0.90 ppm resonance continued to decrease in 
intensity. 
After ten days, a 1 H NMR spectrum of the reaction mixture showed a number of 
additional resonances appearing in the region of the olefinic 19=CH2 and 26=CH2 
resonances and three resonances centred about OH 6.34 ppm. 
After fifteen days reaction, the 1 H NMR spectrum showed an increase in the number 
of signals in the methyl region of the spectrum, although the intensity of the OH 0.90 
ppm resonance was still decreasing and the resonance at OH 0.99 ppm was still 
increasing in intensity. 
Finally, after twenty-two days reaction, the lH NMR spectrum showed three new 
resonances centred about OH 6.25 ppm, and a continuation of the trends previously 
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described. At this point the reaction was quenched and worked-up as the (almost) 
complete disappearance of the CH3-46 doublet at OH 0.90 ppm indicated that there 
was very little homohalichondrin B (1.2.3) remaining in the NMR tube. 
Furthermore, and that there was a mixture of several components present. A lH 
NMR spectrum of the reaction product was identical with that observed before work-
up. 
Silica TLC performed on the reaction mixture indicated the appearance of a single 
spot, with the same Rf as the starting material, homohalichondrin B (1.2.3). Reverse 
phase analytical HPLC indicated the presence of several apparently major, more 
polar components, relative to homohalichondrin B; some homohalichondrin B; and 
some less polar components. In light of the unusual HPLC behaviour of the acid 
products (discussed in Section 6.2.3), it was likely that some of the products from the 
reaction had not been observed as they were found to be very late eluting with the 
chosen solvent system. A preparative HPLC collection of the peaks observed to be 
eluting off the column was attempted. However, there was insufficient material to 
progress further with. 
In general, this reaction indicated that the halichondrins were stable under the PPTS 
conditions described, as long as reaction times were less than seventy-seven hours. 
This should prove useful information for reactions of halichondrins which need to be 
undertaken in acidic reaction conditions. 
At this stage it was decided to attempt a more rapid generation of the acid products 
using the related, but stronger acid, PTSA. 
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6.2.2 PTSA Stability Studies of Homohalichondrin B 
Two methods of rapidly generating the acid catalysed reaction of homohalichondrin 
B (1.2.3) were attempted. Initially, a two-phase reaction was attempted and later a 
one-phase system was undertaken. 
6.2.2.1 Two-phase PTSA Reaction 
As a gentle way of introducing a stronger acid (relative to PPTS) to 
homohalichondrin B (1.2.3), a two-phase reaction was initially attempted. PTSA in 
aqueous solution was added to small quantity (0.3 mg) of homohalichondrin B 
(1.2.3) dissolved in dichloromethane to give a PTSA : homohalichondrin B ratio of 
1:360. The reaction was stirred vigorously at room temperature and monitored by 
reverse phase HPLC with time. No reaction was apparent by HPLC after forty-seven 
hours so the reaction was worked-up. A 1 H NMR spectrum of this material 
confirmed that no reaction had occurred with only homohalichondrin B (1.2.3) being 
identified in the spectrum. 
This material was committed for re-reaction with PTSA in a two-phase reaction, 
increasing the amount of PTSA present, to give a 1: 1 ratio of PTSA to 
homohalichondrin B (1.2.3). Again, the reaction was monitored by reverse phase 
HPLC. No reaction was apparent by HPLC after forty-eight hours vigorously 
stirring at room temperature, so the reaction was worked-up. lH NMR spectroscopy 
confirmed that no reaction had occurred. At this stage it was decided to try a single 
phase solvent system to generate the acid reaction of homohalichondrin B. 
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6.2.2.2 One-phase PTSA Reaction 
A solution of PTSA in dichloromethane was added to the unreacted 
homohalichondrin B (from the two-phase reactions) in dichloromethane to give a ca 
220:1 ratio of PTSA to homohalichondrin B (1.2.3). The resulting solution was 
stirred at room temperature for forty-eight hours . A 1 H NMR spectrum obtained 
from the product after this time showed the presence of only homohalichondrin B, 
indicating that no reaction had occurred. More severe reaction conditions were then 
attempted with TFA as the acid. 
These reactions indicated that the halichondrins were stable under the PTSA 
conditions described, as long as reaction times were less than forty-eight hours. As 
with the PPTS reaction, this information should prove useful for reactions of 
halichondrins which need to be performed in acidic reaction conditions. 
6.2.3 TFA Reaction Studies of Homohalichondrin B 
A series of reactions aimed at producing acid catalysed reaction products of 
homohalichondrin B for characterisation and biological activity evaluation were 
undertaken. Initially, a time-scale reaction of homohalichondrin B with TF A in 
CD30D was monitored by lH NMR spectroscopy. Subsequently, a series of TFA 
reactions in dichloromethane were developed to allow the generation of a series of 
acid products and the development of an HPLC method capable of separating them 
for structural determination and biological activity assessment. 
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6.2.3.1 TFA Reaction in Methanol 
A lH NMR spectrum of a small quantity (0.3 mg) of homohalichondrin B (1.2.3) in 
CD30D was acquired before a TFA solution (in CD30D) was added, to give a ca 
1:20 ratio of homohalichondrin B to TFA in the NMR tube. The reaction was 
monitored with time by 1 H NMR spectroscopy. Immediately after addition of TFA 
to homohalichondrin B, a lH NMR spectrum obtained from the mixture indicated a 
reduction in intensity of one of the multiplet resonances at ca Off 4.62 ppm, where 
the H30 and H11 proton resonances were situated in the 1 H NMR spectrum of 
homohalichondrin B. After three hours reaction, a lH NMR spectrum acquired from 
the reaction mixture showed several new resonances in the methyl and olefinic 
regions of the spectrum. The reaction was quenched after this time by the addition 
of triethylamine (TEA) and the reaction was worked-up; the product was transferred 
back to an NMR tube with CDCl3/ 0.1% pyridine-ds. A lH NMR spectrum obtained 
from this material indicated several minor changes relative to the 1 H NMR spectrum 
of homohalichondrin B (Figure 2.4.1 ). The CH3-46 methyl doublet at Off 0.90 ppm 
had decreased in intensity while the doublet at Off 0.99 ppm, where the CH3-31 
resonance was situated in the lH NMR spectrum of homohalichondrin B, had 
increased in intensity. Also visible was a new, relatively broad resonance at Off 3.82 
ppm. From this spectrum it was apparent that there was a minor amount (<10%) of 
homohalichondrin B present and one other, unidentified major component as well as 
some TFA and TEA in the reaction product. 
COSY, 2D-TOCSY (100 ms mixing time) and HMQC spectra were acquired from 
the mixture, enabling a partial assignment of the 1 H and 13c NMR spectra to be 
achieved. This acid reaction product was later recognised as being the C38 epimer 
of homohalichondrin B ( 6.3.3), and the NMR spectroscopic assignment of this 
compound is described in Section 6.3.3. 
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Silica TLC of the reaction mixture relative to homohalichondrin B (1.2.3) indicated a 
very slight decrease in polarity of the major component. C18 bench column 
chromatography was performed on the reaction mixture to separate the TFA and 
TEA from the halichondrin material. The product was dissolved in a small quantity 
of the mobile phase (55% acetonitrile/ water) and placed on the equilibrated column; 
eight fractions were then collected off the column. The column was stripped with 
100% acetonitrile and this was collected in two fractions. Fractions were combined 
on the basis of silica TLC results to give two halichondrin-containing fractions: 
fractions four to nine (major fraction) and fraction ten (minor fraction, <10% of total 
material). The final acetonitrile-stripped fraction (fraction ten) appeared to contain 
halichondrin material of a higher polarity than the earlier halichondrin-eluting 
fractions by silica TLC. A 1 H NMR spectrum was obtained from each of the 
combined fractions in CDCIJ/ 0.1% pyridine-ds. The lH NMR spectrum of the 
major fraction identified the material as pure homohalichondrin B (1.2.3). The lH 
NMR spectrum of the minor fraction had a very poor signal to noise ratio, but did not 
appear to resemble either homohalichondrin B or the major reaction product ( 6.3.3). 
From these observations, it appeared that the reaction was reversible under certain 
conditions. This aspect is described in the time-scale acid reaction studies described 
later in Section 6.4. 
6.2.3.2 TFA Reactions in Dichloromethane 
TFA in dichloromethane (a standardised solution) was added to a small quantity (0.3 
mg) of homohalichondrin B (1.2.3) dissolved in dichloromethane to give an eleven-
fold excess of TFA relative to homohalichondrin B. The resulting solution was 
stirred at room temperature for four hours. After this time the reaction was quenched 
by the addition of water and dilute sodium hydroxide to pH 7.5-8.0. The water layer 
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was removed and the dichloromethane layer was washed with water before 
extracting the halichondrin material in dichloromethane. 
A 1 H NMR spectrum obtained from the product (in CDC}J/ 0.1% pyridine-ds) 
indicated that there was a mixture of several components present. There were 
several new resonances in the Off 5.80- 6.30 ppm region of the spectrum, and an 
apparent loss or movement of the isolated H12 doublet of doublets signal at Off 4.68 
ppm. There was no evidence of the previously observed acid product (6.3.3) from 
the TFA in CD30D reaction (Section 6.2.3.1). It was apparent that the reaction had 
been taken too far, resulting in severe acid decomposition of homohalichondrin B. It 
was decided to reduce both the ratio of acid to homohalichondrin B and the duration 
of the reaction. 
The reaction was repeated on a larger quantity (2.2 mg) of homohalichondrin B 
(1.2.3) with a 1.5:1 ratio of TFA to homohalichondrin Bin dichloromethane. The 
solution was stirred at room temperature for thirty minutes before working-up the 
reaction. A 1 H NMR spectrum obtained from the product (in CDCl3/ 0.1% pyridine-
ds) indicated that a mixture of components was present. There were only two 
resonances in the Off 5.80- 6.30 ppm region of the spectrum (Figure 6.2.1)- one at 
Off 5.95 ppm (doublet) and one at Off 6.18 ppm (with the appearance of a triplet). 
Also apparent was a new, isolated, broad singlet resonance at Off 5.08 ppm. There 
was some evidence of the product from the CD30D reaction: a doublet of doublets 
(slightly obscured) at Off 3.12 ppm, and the broad singlet signal at Off 3.82 ppm. The 
methyl region of the spectrum indicated a mixture of components was present, as 
several overlapping doublets of differing relative intensities were visible. 
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Figure 6.2.1 1 H NMR Spectrum of Products From TFA Reaction of 
Homohalichondrin B 
198 
At this stage, analytical reverse phase HPLC (utilising an analytical Cl8 HPLC 
column) was investigated as a method of separating the products of the reaction. A 
series of acetonitrile/water solvent mixtures were investigated as possible mobile 
phases, with injections .of the reaction mixture, using pure homohalichondrin B 
(1.2.3) as a reference. At a solvent mix of 50% acetonitrile/ water, the standard 
method of observing the individual naturally-occurring halichondrins by analytical 
C18 HPLC, evidence of carry-over peaks from previous injections of the reaction 
mixture was observed, indicating a less polar solvent mixture was required. At 60% 
acetonitrile/ water, a peak in the chromatogram at ca 230 s corresponding to 
homohalichondrin B was observed in the reaction mixture. Also observed in the 
chromatogram of the reaction mixture was a minor peak at ca 550 s. The uv 
spectrum of this component showed absorbance maxima at A 193 nm and A 230 nm. 
Homohalichondrin B, like the other halichondrins isolated to date, exhibited end-
absorption only, at ca A 193 nm. The observance of a product with an absorbance 
maximum of A 230 nm suggested an increase in conjugation had occurred in the 
reaction. The reaction was repeated to obtain more material for HPLC separation. 
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The reaction was carried out on a similar scale (2.1 mg) and under identical 
conditions to the previous reaction. A lH NMR spectrum obtained in CDCl3/ 0.1% 
pyridine-ds was very similar to that of the previous reaction. Preparative reverse 
phase HPLC using an analytical C18 column, with 60% acetonitrile/ water as the 
mobile phase, was used to separate the peaks at ca 230 s and 550 s. A 1 H NMR 
spectrum obtained from the fraction eluting at ca 230 s was identified as 
homohalichondrin B (1.2.3). The lH NMR spectrum of the peak eluting at 550 s 
appeared to be one product. The peaks at OH 5.95 ppm and at OH 6.18 ppm were 
visible in the spectrum and the methyl region appeared much cleaner. The structural 
assignment of this component (6.3.1) was able to be made once sufficient material 
had been obtained, and this is described in Section 6.3.1. There was insufficient 
material to analyse further so the reaction was repeated on yet a larger scale ( 4.4 mg) 
under identical reaction conditions. 
HPLC separation of the product was performed using multiple injections on an 
analytical C18 column to separate the homohalichondrin B peak eluting at ca 230 s 
from the acid product ( 6.3.1) eluting at 550 s. A fraction was collected of the peak at 
230 s and another fraction containing the eluent from 550 s and the material eluting 
after this peak was collected. The solvent was removed from the two fractions, and 
they were re-injected to ascertain the quality of the separation. The chromatograms 
of the two injections showed both homohalichondrin B (230 s) and the acid product 
6.3.1 (550 s). At this stage it was realised that 0.05% TFA had been added to the 
HPLC water (as a polar modifier). TFA would have concentrated when the solvent 
was removed from the two fractions resulting in re-reaction which was detected on 
re-injection of the separated fractions. The homohalichondrin B and acid product 
fractions were recombined and subsequently re-separated using 60% acetonitrile/ 
water (with no TFA added) as the mobile phase. The solvent was removed from the 
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two fractions (eluting at 230 sand 550 s) and they were re-analysed by HPLC, which 
indicated a good separation of the two components had been achieved. 
The reaction was repeated again on a large scale ( 4.0 mg) under identical reaction 
conditions. Preparative reverse phase HPLC using 60% acetonitrile/ water as the 
mobile phase was performed on the products. The peaks at 230 s (homohalichondrin 
B) and 550 s (6.3.1) were collected separately, along with the material from between 
injections. A lH NMR spectrum was acquired on the material from between 
injections- this indicated a large amount of halichondrin material was present (half 
the total reaction material in terms of mass). This material appeared to be a mixture 
of two components; a product with resonances at OR 5.95 ppm and oR 6.18 ppm and 
another product lacking these signals. It was realised at this stage that the HPLC 
conditions were such that two additional acid reaction products were not being 
observed as they were less polar than any other halichondrins that had previously 
been analysed on a Cl8 column. The solvent mix was changed to 70% acetonitrile/ 
water and analytical-scale injections were performed on the homohalichondrin Band 
the acid product 6.3.1. The chromatogram of the homohalichondrin B (1.2.3) 
separated previously showed one peak at ca 200 s whereas the chromatogram of the 
acid product 6.3.1 showed one uv-active component (absorbance maxima at A 193 
nm and A 230 nm) eluting at ca 300 s (6.3.1). An analytical injection of the two 
additional acid products showed two components in the chromatogram, one at ca 800 
s and the other at ca 1000 s, similar in magnitude. The uv spectrum of the peak 
eluting at 800 s was similar in appearance to the component eluting at 300 s; with 
absorbance maxima at 'A 193 nm and A 230 nm. The structural characterisation of 
this component is described in Section 6.3.2 (6.3.2), performed once sufficient 
quantities had been obtained. The peak eluting at 1000 s had a uv spectrum identical 
with that of homohalichondrin B; with only end-absorption at A 193 nm. The 
structural characterisation of this component was made once sufficient material was 
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obtained, and is described in Section 6.3.3 (6.3.3). The two-component mixture 
(6.3.2 and 6.3.3) was separated preparatively by HPLC, via multiple injections on the 
analytical C18 column. Diol and silica TLC performed on the three acid products 
(6.3.1, 6.3.2 and 6.3.3) did not show any significant difference in polarity relative to 
homohalichondrin B (1.2.3). 
The interaction of the three acid products on silica and diol appeared to be quite 
different to their behaviour on C18. This may be attributed to the interaction of polar 
groups such as hydroxyl groups with silica and diol to produce the differences in 
polarity observed, whereas interactions with Cl8 are partly a function of the relative 
hydrophobicity of the components. The halichondrins possess both polar 
functionalities and hydrophobic regions which may have contributed to the effective 
"polarity" differences observed for normal and reverse stationary phases. 
Conformational differences between the products may also contribute to the differing 
interactions of the products with C18 relative to silica or diol as the stationery phase. 
There was still insufficient material to analyse the products so two final, large scale 
reactions (4.0 mg and 4.8 mg) of homohalichondrin B (1.2.3) under identical 
reaction conditions were performed. This enabled HPLC separation of enough 
material to allow structural identification and biological activity assessments to be 
performed, with the unreacted homohalichondrin B (1.2.3) from each reaction being 
fed into the next reaction. Once separated, the three acid products (viz 6.3.1, 6.3.2 
and 6.3.3) were individually re-injected on an analytical scale to ensure the 
separation and purity of the products was adequate. These reactions gave a total of 
2.0 mg of 6.3.1, 1.8 mg of 6.3.2 and 2.0 mg of 6.3.3 for further study. 
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6.3 Characterisation of TF A Reaction Products 
Each of the three acid products from the HPLC separation were individually 
characterised; primarily by NMR spectroscopy and MS. 
6.3.1 Assignment of Acid Product 6.3.1 
The uv spectrum of the component eluting at ca 300 s off the analytical C18 HPLC 
column at 70% acetonitrile/ water (6.3.1) showed absorbance maxima at A 193 nm 
and A 230 nm. High resolution FAB-MS performed on the acid product 6.3.1 gave 
the parent ion corresponding to a molecular formula of C61Hs6019. isobaric with 
that ofhomohalichondrin B (1.2.3). 
The lH NMR spectrum (CDCl3/ 0.1% pyridine-ds) of acid product 6.3.1 is displayed 
in Figure 6.3.1. The spectrum indicated several major changes relative to the lH 
NMR spectrum of homohalichondrin B (Figure 2.4.1). Notable, was the appearance 
of the two isolated doublets at DH 5.95 ppm and DH 6.18 ppm. Other new, isolated 
resonances were apparent: a broad singlet at DH 5.10 ppm; a doublet at DH 4.90 ppm; 
a doublet of doublets at DH 4.52 ppm; a broad singlet at DH 4.70 ppm and a doublet 
of doublets at DH 3.35 ppm. Movement of the methyl doublets was apparent with 
two overlying doublets at DH 1.03 ppm and two doublets overlapping at DH 0.92 ppm 
and DH 0.90 ppm. Several distinctive resonances characteristic of the lH NMR 
spectrum of homohalichondrin B were no longer apparent in the 1 H NMR spectrum 
of 6.3.1: the H32 doublet of doublets resonance at DH 3.17 ppm, the H7 resonance at 
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OH 2.94 ppm, the H2' resonance at OH 2.58 ppm, and the Hll and H12 resonances at 
OH 4.58 ppm and OH 4.68 ppm respectively. However, there were some isolated 
resonances in the spectrum of the acid product 6.3.1 that remained unshifted relative 
to the lH NMR spectrum of homohalichondrin B (Figure 2.4.1); the isolated H47 
resonance at OH 3.06 ppm and the HSS/HSS' resonance at OH 3.69 ppm. This 
indicated that the terminal region of the molecule remained intact. 
Figure 6.3.1 1 H NMR Spectrum of Acid Product 6.3.1 
A series of NMR experiments were performed on the acid product 6.3.1 viz COSY, 
2D-TOCS,Y (mixing times of 20 ms, SO ms and 100 ms), lD-TOCSY, IDyiQC, 
HMBC, NOESY and NOE experiments. From an analysis of the data generated 
from these experiments, a partial assignment of the 1 H and 13C NMR spectra of acid 
product 6.3.1 was achieved. These data are cited in Tables 6.3.1 ( 1 H NMR data) and 
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6.3.2 (13C NMR data), with the important correlations from the NMR experiments 
depicted in Figure 6.3.2. 
Table 6.3.1 lH NMR Data for Furan Acid Product (6.3.1) 
Proton8 Sppmb Proton a Sppmb Protona oppmb 
H2 2.43 H21 1.60 H37' 2.35 
H2' 2.53 H21' H39 2.18 
H3 3.95 H22 1.40 H39' 2.18 
H4 1.40 H22' 1.58 H40 3.90 
H4' 1.70 H23 3.60 H41 3.60 
H5 1.48 H24 0.94 H42 2.32 
H5' 2.08 H24' 1.85 CHJ-42 0.92 
H6 3.98 H25 2.20 H43 1.29 
H7 3.12 CH3-25 1.03 H43' 1.45 
H8 4.04 26=CH 4.78 H45 1.42 
C8-0H 3.57 26'=CH 4.81 H45' 1.42 
H9 3.90 H27 3.70 H46 2.15 
HlO 4.90 H28 1.55 CHJ·46 0.90 
H12 6.18 H28' 2.25 H47 3.06 
H13 5.95 H29 3.80 H48 3.53 
H15 2.60 H30 4.52 H49 1.79 
H15' 2.82 H31 1.88 H49' 2.15 
H16 1.75 CH3-31 1.03 H50 3.90 
H16' H32 3.35 H51 4.04 
H17 3.87 H33 3.82 H52 2.02 
H18 2.20 H34 1.90 H52' 2.02 
H18' 2.82 H34' H53 4.25 
19=CH 4.82 H35 4.12 H54 3.55 
19'=CH 5.10 H36 4.04 H55 3.69 
H20 4.70 H37 1.89 H55' 3.69 
a The symbol' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCl3 at 300 MHz with chemical shifts in ppm 
and referenced to CHC13, BH 7.25 ppm. 
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Table 6.3.2 13c NMR Data for Furan Acid Product ( 6.3.1) 
Carbon Bppma Carbon Bppma Carbon Bppma 
Cl 172.0 C21 C39 42.8 
C2 40.5 C22 30.2 C40 70.7 
C3 75.4 C23 77.1 C41 79.1 
C4 C24 43.2 C-CH3-42 25.8 
cs C-CH3-2S 36.0 C-CH3-42 17.5 
C6 68.9 C-CH3-2S C43 37.0 
C7 78.8 26C=CH2 151.0 C44 96.5 
C8 64.6 26C=CH2 105.0 C45 36.8 
C9 69.0 C27 74.6 C-CH3-46 29.0 
ClO 71.0 C28 33.8 C-CH3-46 17.2 
Cll 151.0 C29 70.8 C47 72.6 
C12 108.6 C30 75.8 C48 63.4 
C13 106.0 C-CH3-31 38.0 C49 31.2 
C14 155.0 C-CH3-31 cso 74.5 
C15 24.2 C32 76.4 CSl 76.0 
C16 C33 67.2 C52 36.8 
C17 77.0 C34 C53 79.5 
C18 39.7 C35 75.2 C54 71.8 
19C=CH2 C36 css 65.3 
· 19C=CH2 105.4 C37 44.2 
C20 78.3 C38 112.4 
a 13c NMR spectral data assigned from HMQC and HMBC experiments, recorded at 
23°C in CDCl3 at 300 MHz with chemical shifts in ppm. 
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Initial interest centred on the two lH NMR narrow doublet resonances at ~ff 5.95 
ppm and ~ff 6.18 ppm (Figure 6.3.1). An integral over each doublet signal, relative 
to the unshifted H47 resonance at Off 3.06 ppm, indicated one proton was 
contributing to each resonance. A +5.0% NOB enhancement of the ~ff 5.95 ppm 
resonance was observed from irradiation of the ~ff 6.18 resonance. Correspondingly, 
irradiation of the Off 5.95 ppm resonance gave a +3.0% NOE enhancement of the Off 
6.18 ppm resonance, indicating that the two protons were situated close in space. 
The COSY and 2D-TOCSY spectra revealed strong correlations between the two 
resonances. The chemical shifts and multiplicity of these resonances were 
characteristic of the protons at the three and four positions of either a furan or 
dihydrofuran type system.68,69 For a dihydrofuran, the 3]ffff coupling constant 
between the protons at positions three and four would typically be ca 6.0 Hz,69 
whereas the vicinal coupling between the protons at the three and four positions of a 
furan would be 3.4 Hz.68 The actual coupling constant for both doublets was 
measured at 3.0 Hz, indicating they were coupled together as furan-type protons. 
The uv spectrum of 6.3.1 was consistent with that of a furan-type compound, with 
absorption maxima at 'A 193 nm and 'A 230 nm.70 
An analysis of the NMR experiments confirmed that the terminal region (C38-C55) 
of the molecule was intact, with the 1 H and 13C NMR data consistent with those of 
homohalichondrin B (1.2.3) in this region. Chemical shift changes were apparent 
around the C1-C37 region of the molecule, with the most significant changes 
occurring around the C3-C14 region, indicating that the furan was a part of this 
system. 
It was anticipated that the furan had formed from the "B-ring" of homohalichondrin 
B, as had occurred in Salomon's synthetic fragment.31 An analysis of the COSY 
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spectrum revealed some apparent anomalies for this anticipated product. The H7 
proton had moved from OH 2.94 ppm in the lH NMR spectrum of homohalichondrin 
B to a new position at OH 3.12 ppm. COSY correlations from this resonance were 
observed to OH 3.98 ppm (H6) and OH 4.04 ppm (H8). However, the H8 resonance 
showed two additional correlations to resonances at OH 3.57 ppm and to OH 3.90 ppm 
(a weak correlation). The OH 3.90 ppm resonance was correlated to the isolated 
doublet resonance at OH 4.90 ppm in the COSY spectrum. The COSY spectrum 
revealed the doublet at OH 4.90 ppm was correlated to the furan resonance at OH 6.18 
ppm, the result of allylic coupling. The resonance at OH 4.90 ppm was therefore 
assigned as the H10 methine proton resonance, and the OH 6.18 ppm resonance as the 
H12 proton resonance, leaving the other furan signal at OH 5.95 ppm assignable as 
the H13 proton resonance. The resonance at OH 3.90 ppm was assigned as the H9 
proton resonance. However, this left the assignment of the remaining resonance at 
OH 3.57 ppm unaccounted for. The HMQC spectrum revealed that no correlation 
was apparent for a proton at OH 3.57 ppm to a directly attached carbon, indicating 
that this proton was not in fact a methine (or methylene) proton but rather a slowly 
exchanging hydroxyl proton, viz the newly created C8 substituted hydroxyl proton. 
It is likely that the hydroxyl proton was hydrogen-bonded to the newly created C9 
substituted hydroxyl oxygen resulting in its slow exchange with the surrounding 
solvent and thus its appearance in the spectrum. 
A series of selective lD-TOCSY experiments, irradiating the OH 4.90 ppm resonance 
(H10), with varied mixing times, showed the contribution of the OH 3.90 ppm signal 
(H9) with a mixing time of 10 ms, while the OH 4.04 ppm (H8) and OH 3.57 ppm 
resonances were observed only with a longer mixing time of 40 ms. Another series 
of selective lD-TOCSY experiments, irradiating the isolated H7 resonance at OH 
2.94 ppm, revealed the OH 4.04 ppm (H8) and OH 3.57 ppm resonances with a mixing 
time of 10 ms, whereas the OH 3.90 ppm resonance (H9) was only visible with a 
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relatively long mixing time of 50 ms. These experiments also supported the theory 
that the unidentified OH 3.57 ppm resonance was the C8 hydroxyl proton as its order 
in the spin system suggested it was attached at the C8 position. 
To test whether the proton at OH 3.57 ppm was exchangeable, a D20 shake test of the 
product (6.3.1) was undertaken. This involved acquiring a reference lH NMR 
spectrum and a selective 1D-TOCSY spectrum (irradiating at OH 4.90 ppm (H10), 
mixing time 80 ms) from the acid product in CDCl3/ 0.1% pyridine-ds. One drop of 
D20 was then added to the NMR tube and the resulting mixture was vigorously 
shaken. After five minutes standing at room temperature, lH NMR and 1D-TOCSY 
spectra were acquired under identical NMR experimental conditions. The spectra 
were re-acquired after another one and a half hours standing at room temperature. A 
comparison of these spectra with the spectra acquired before D20 addition revealed 
key differences. The 1 H NMR spectra showed a reduction in the size of the 
resonances at OH 3.57 ppm after D20 addition, and a slight increase in the intensity 
of the OH 4.04 ppm (H8) resonance. Similarly, the 1D-TOCSY spectra obtained after 
D20 addition showed a decrease in the intensity of the OH 3.57 ppm resonance 
relative the reference spectrum, with time. Also notable was the increase in intensity 
and decrease in complexity of the OH 4.04 ppm resonance (H8) after D20 addition, 
reflecting the loss of coupling to the OH 3.57 ppm resonance. This experiment 
confirmed that the OH 3.57 ppm resonance was the C8 hydroxyl proton resonance. 
The HMQC spectrum revealed the directly attached carbons of the OH 5.95 ppm and 
OH 6.18 ppm resonances, at oc 106.0 ppm and Cc 108.6 ppm respectively, 
(appearing as foldbacks to Oc 16.0 ppm and oc 18.6 ppm in the spectrum), similar to 
the carbon shifts ofunsubstituted C3 and C4 furan carbons (oc 109.9 ppm).71 
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The HMBC spectrum showed two important correlations from carbons at 8c 151.0 
ppm and 8c 155.0 ppm (appearing as foldback carbons at 8c 61.0 ppm and 8c 65.0 
ppm respectively) to the furan proton at bH 6.18 ppm (H12). A strong HMBC 
correlation from the carbon at 8c 151.0 ppm to the methine proton at 8H 4.90 ppm 
(HlO), and a much weaker correlation from 8c 155.0 ppm to the H10 proton 
resonance (a four-bond correlation), supported the assignment of 8c 155.0 ppm as 
the C14 carbon, and 8c 151.0 ppm as the Cll carbon. 
The NMR data was therefore consistent with 6.3.1 as the structure of the acid 
product. This compound was also isobaric with homohalichondrin B (1.2.3), as 
required by the MS result. 
1:1 1:1 
0 
55 
HO 
OH H H 
OH 0 #' 
furan acid product (6.3.1) 
A likely mechanism for the formation of 6.3.1 is depicted in Figure 6.3.3. The 
mechanism involves protonation of the C and D-ring ether protons in acid solution, 
facilitating the elimination of one of the H13 protons and the Hl2 proton to form the 
Chapter 6- Acid Stability Studies 211 
E-ring furan, and opening the C and D-rings to give the C8 and C9 hydroxyl 
derivative. This reaction probably occurs via stepwise protonations and eliminations 
rather than as the simultaneous process depicted in Figure 6.3.3. 
Figure 6.3.3 Proposed Mechanism of Furan Formation 
The NOESY spectrum of 6.3.1 showed several interesting correlations from the 
furan ring protons. A NOESY correlation was observed from the furan proton at OH 
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5.95 ppm (H13) to a methylene proton at OH 2.82 ppm (H15'). The other furan 
proton resonance at OH 6.18 ppm (Hl2) showed NOESY correlations to OH 4.90 ppm 
(HlO) and OH 3.98 ppm (H6). A cursory glance at the structure of 6.3.1 suggested 
that the stereochemistry of the H6 proton would preclude it from an NOE interaction 
with H12. Models of the Cl-C15 system were able to confirm that the NOEs 
observed were feasible, as was a subsequent computer modelling analysis. 
The C2-Cl5 subunit from the computer modelling studies of halichondrin B (Section 
2.3.2.1) was modified using the computer program Chem3D Plus to generate the C2-
C15 furan derivative 6.3.1. The ClO-Cll bond was rotated to give a conformation 
allowing both H6 and HlO to be in close proximity to H12. The energy (MM2) of 
the resulting conformation was minimised. The resulting structure is displayed in 
Figure 6.3.4, along with the interatomic distances for the H12-H6 and H12-H10 
NOESY interactions for this conformation. 
The interatomic distances for the minimised structure were within the typical limits 
for the observation of an NOE interaction. Construction of a model of the Cl-C30 
structure of the furan derivative indicated that the Hl3 to H15' NOE interaction and 
the H12-H6 and H12-H10 NOE interactions were possible within the constraints of 
the lactone ring, although the position of the furan ring H12 proton relative to H6 
and HlO could not be rotated significantly without exceeding the distance constraints 
of an NOE observation. 
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H12 
Figure 6.3.4 C2-C15 Furan Modelling Output 
The NOESY spectrum lacked the correlations across the lactone ring from the H2' 
proton to H20 and 19=CH, which were observed in the NOESY spectrum of 
homohalichondrin B (and halichondrin B). The changes in chemical shift observed 
for protons around the H ring, such as the H32 proton (from OH 3.17 ppm to OH 3.35 
ppm in 6.3.1) may have resulted from a change in the conformation of the lactone 
ring imposed by the presence of the furan ring. 
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6.3.2 Assignment of Acid Product 6.3.2 
The uv spectrum of the component eluting at ca 800 s off the analytical HPLC Cl8 
column with 70% acetonitrile/ water (6.3.2) showed absorbance maxima at A 193 nm 
and A 230 nm. High resolution FAB-MS, performed on acid product 6.3.2, gave a 
molecular formula of C61Hs6019, isobaric with that of homohalichondrin B (1.2.3). 
This indicated that no gain or loss of protons had occurred in the formation of acid 
product 6.3.2 from homohalichondrin B. 
The 1 H NMR spectrum of acid product 6.3.2 is displayed in Figure 6.3.5. This 
spectrum was obtained in CDCl3/ 0.1% pyridine-ds and shows some major changes 
relative to the 1 H NMR spectrum of homohalichondrin B (Figure 2.4.1) but 
relatively minor changes relative to the spectrum of the furan acid product 6.3.1 
(Figure 6.3.1 ). 
The resonances at OH 5.95 ppm and OH 6.19 ppm were recognisable as the previously 
assigned H12 and H13 furan signals. However, the CH3-46 and CH3-42 doublets at 
OH 0.90 ppm and OH 0.92 ppm respectively, which had the appearance of a triplet in 
the lH NMR spectrum of 6.3.1, appeared as separate doublets at OH 0.92 ppm and OH 
0.96 ppm respectively in the 1 H NMR spectrum of acid product 6.3.2. Other 
resonances appeared to have moved slightly, and a new broad resonance at OH 3.85 
ppm and the loss of the broad singlet resonance at OH 3.60 ppm were also visible. 
The distinctive H551H55' doublet at OH 3.69 ppm and the isolated H47 resonance at 
OH 3.07 ppm were still apparent, indicating that the terminal moiety was intact. 
These differences (and similarities) relative to the lH NMR spectrum of the furan 
acid product 6.3.1 indicated that the acid product 6.3.2 was a furan derivative with a 
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subtle change occurring in another part of the molecule, which was not in the 
terminal region. 
A range of NMR experiments were performed on acid product 6.3.2. COSY, lD-
TOCSY, 2D-TOCSY (mixing times of20 ms;40 ms and 100 ms), HSMQC, HMBC, 
NOESY and NOB experiments emibled a partial assignment of the 1 H and 13C NMR 
spectra of 6.3.2 to be achieved. These data, obtained from an analysis of the NMR 
experiments are listed in Tables 6.3.3 ( 1 H NMR data) and 6.3.4 ( 13C NMR data) and 
the important correlations from the NMR experiments are shown in Figure 6.3.6. 
Figure 6.3.5 1 H NMR Spectrum of Acid Product 6.3.2 
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Table 6.3.3 lH NMR Data for Epi-Furan Acid Product (6.3.2) 
Proton3 8ppmh Proton a 8ppmh Proton a 8ppmh 
H2 2.45 H21 1.55 H37' 2.19 
H2' 2.55 H21' 1.65 H39 2.02 
H3 3.95 H22 1.40 H39' 2.26 
H4 1.42 H22' 1.55 H40 3.94 
H4' 1.72 H23 3.62 H41 3.85 
H5 1.48 H24 0.94 H42 2.26 
H5' 2.09 H24' 1.87 CHJ·42 0.96 
H6 4.02 H25 2.15 H43 1.30 
H7 3.17 CH3-2S 1.03 H43' 
H8 4.00 26=CH 4.78 H45 1.28 
C8-0H 3.56 26'=CH 4.82 H45' 1.45 
H9 3.90 H27 3.68 H46 2.08 
HlO 4.90 H28 1.60 CH3-46 0.92 
H12 6.19 H28' 2.20 H47 3.07 
H13 5.95 H29 3.80 H48 3.52 
H15 2.66 H30 4.50 H49 1.79 
H15' 2.82 H31 1.95 H49' 2.15 
H16 1.80 CH3-31 1.03 H50 3.92 
H16' 1.80 H32 3.32 H51 4.04 
H17 3.90 H33 3.78 H52 2.02 
H18 2.20 H34 1.92 H52' 2.02 
H18' 2.80 H34' 2.08 H53 4.25 
19=CH 4.86 H35 4.12 H54 3.55 
19'=CH 5.08 H36 4.02 H55 3.69 
H20 4.70 H37 2.19 H55' 3.69 
a The symbol' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCl3 at 300 :MHz with chemical shifts in ppm 
and referenced to CH03, og 7.25 ppm. 
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Table 6.3.4 13C NMR Data for Epi-Furan Acid Product (6.3.2) 
Carbon oppma Carbon oppma Carbon oppma 
C1 171.0 C21 C39 44.3 
C2 40.2 C22 C40 71.4 
C3 75.2 C23 77.2 C41 78.8 
C4 C24 43.2 C-CHJ-42 25.8 
C5 C-CH3-2S 36.0 C-CHJ-42 17.5 
C6 68.9 C-CH3-2S 17.6 C43 36.8 
C7 79.0 26C=CH2 151.1 C44 96.0 
C8 64.8 26C=CHz 104.5 C45 36.8 
C9 69.0 C27 74.9 C-CHJ-46 28.9 
ClO 71.2 C28 33.8 C-CHJ-46 17.0 
Cll 151.0 C29 71.4 C47 72.7 
C12 109.1 C30 76.2 C48 63.4 
C13 105.9 C-CH3-31 36.5 C49 31.0 
C14 155.0 C-CH3-31 14.6 cso 74.6 
C15 24.0 C32 76.2 C51 76.3 
C16 34.0 C33 68.0 C52 36.7 
C17 77.2 C34 C53 79.7 
C18 39.6 C35 78.0 C54 72.1 
19C=CHz C36 C55 65.5 
19C=CH2 105.2 C37 44.2 
C20 78.6 C38 114.0 
a 13c NMR spectral data assigned from HSMQC and HMBC experiments, recorded at 
23°C in CDCl3 at 300 MHz with chemical shifts in ppm. 
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Figure 6.3.6 Epi-Furan Acid Product- Important NMR Correlations 
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An analysis of the NMR experiments showed that the connectivities in the terminal 
region were similar to homohalichondrin B (1.2.3) and acid product 6.3.1, with only 
small differences in chemical shift data. The NMR correlations and the 1 H and 13C 
NMR data in the C1-C14 region were consistent with formation of the "B-ring" furan 
derivative as observed for the furan acid product, 6.3.1. The region from the I ring to 
the L ring became the focus of attention in terms of differences relative to the furan 
acid product 6.3.1. 
The methyl group remaining unassigned after analysis of the terminal region (C44-
C55) and the A-H rings, viz the CH3-42 doublet, was situated at OH 0.96 ppm. A 
COSY correlation from this methyl resonance to a proton resonating at OH 2.26 ppm 
assigned the chemical shift of the H42 methine proton. From the CH3-42 resonance, 
a correlation to a proton resonating at OH 3.85 ppm was observed in the 2D-TOCSY 
spectra (for 20 ms, 40 ms, 80 ms and 100 ms mixing times). This resonance was 
assigned to the H41 proton. In the COSY spectrum, a correlation was observed 
between the proton at OH 3.85 ppm (H41) and a proton resonating at OH 3.94 ppm, 
assigning the chemical shift of the H40 proton. The HSMQC spectrum showed an 
unassigned correlation for a carbon at oc 78.8 ppm to the H41 proton at OH 3.85 
ppm, locating the chemical shift of the C41 carbon resonance. An HMBC 
correlation from a carbon at oc 36.8 ppm to the CH3-42 methyl protons assigned the 
chemical shift of the C43 carbon. The previously assigned C44 spiro carbon (at oc 
96.0 ppm) showed a correlation to H45' (assigned a chemical shift of OH 1.45 ppm) 
as well as to a proton at OH 1.30 ppm. The proton at OH 1.30 ppm was correlated in 
the HSMQC spectrum to the C43 carbon, so this resonance was attributed to the H43 
proton. HMBC correlations were observed from the C41 carbon to the CH3-42 
protons and to a resonance at OH 2.02 ppm. This resonance was assigned as one of 
the H39 proton resonances. An HMBC correlation from C40 to OH 2.02 ppm 
supported this assignment. 
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The HSMQe spectrum revealed three unassigned and distinct correlations: one from 
at carbon at Oc 44.2 ppm to two equivalent methylene protons at OH 2.19 ppm; the 
other correlation from a carbon at oc 44.3 ppm to two equivalent methylene protons 
at OH 2.02 ppm (H39) and OH 2.26 ppm. This implied that the methylene partner to 
the H39 proton (at OH 2.02 ppm) was situated at OH 2.26 ppm, and that the C39 
carbon chemical shift was oc 44.3 ppm. The OH 2.19 ppm proton resonance was 
assigned to the equivalent H37 and H37' protons, and the oc 44.2 ppm signal as the 
e37 resonance. The e38 spiro centre carbon at oc 114.0 ppm gave HMBe 
correlations to the H37/H37' protons (at OH 2.19 ppm) and to the H39' proton at OH 
2.26 ppm. The C38 carbon also gave HMBe correlations to the H40, H35 and H36 
protons. 
Once assigned, the NMR data for acid product 6.3.2 were compared to the 1 H and 
Be NMR data around the I to K rings relative to those of the furan acid product 
(6.3.1) and homohalichondrin B (1.2.3). In general, the changes in chemical shifts 
were most significant around the e38 centre. 
In terms of specific 13e NMR chemical shifts, the e38 spiro centre recorded a large 
change, from oc 112.4 ppm in homohalichondrin Band in furan acid product 6.3.1, 
to Oc 114.0 ppm in acid product 6.3.2. The C39 carbon located at oc 42.5 ppm in 
homohalichondrin B and oc 42.8 ppm in the furan acid product 6.3.1, moved to oc 
44.3 ppm in the Be NMR spectrum of acid product 6.3.2. 
In terms of specific changes in lH NMR chemical shifts, the H41 proton (at OH 3.85 
ppm in 6.3.2) recorded a large change, by OH 0.15 ppm, to a more deshielded 
position relative to the chemical shift of H41 in the spectra of both homohalichondrin 
B (1.2.3) and the furan acid product (6.3.1). Larger changes in chemical shift were 
observed for the H37 and H39 protons. The H37 and H37' 1 H NMR resonances 
Chapter 6- Acid Stability Studies 221 
appeared as two separate signals at OH 1.90 ppm and OH 2.35 ppm respectively in the 
spectrum of homohalichondrin B (Figure 2.4.1). In the furan acid product 6.3.1, 
these resonances were located at OH 1.89 ppm (H37) and OH 2.35 ppm (H37'). In 
acid product 6.3.2, H37 and H37' were equivalent, at OH 2.19 ppm. Conversely, the 
H39 and H39' proton signals were equivalent in homohalichondrin B (oH 2.21 ppm) 
and acid product 6.3.1 (OH 2.18 ppm), but appeared as separate resonances (OH 2.02 
ppm and OH 2.26 ppm) in the lH NMR spectrum of the acid product (6.3.2). 
This information pointed to a change around the C38 spiro centre ie epimerisation to 
give the epi-furan acid product 6.3.2. 
H 
55 
HO 
OH H 
H 
H 
H3 C 
epi-furan acid product (6.3.2) 
0 
It proved difficult to determine the stereochemistry about the C38 centre. 
Construction of a model of the H to L rings suggested that NOEs might be observed 
between the H37 /H37' and H39/H39' methylene protons for both the naturally 
occurring C38 stereochemistry and the epi-stereochemistry as these protons were 
situated close in space. Unfortunately, no NOEs were observed across the C38 spiro 
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centre in the NOESY spectra of either homohalichondrin B (1.2.3) or acid product 
6.3.2. 
It was hypothesised that an inversion in stereochemistry at the C38 centre could 
induce conformational changes in the surrounding rings. This aspect is discussed in 
Section 6.3.4. 
Like the furan acid product ( 6.3.1), the NOESY spectrum of 6.3.2 lacked the H2' to 
H20 and 19=CH correlations that were apparent in the NOESY spectra of 
homohalichondrin Band halichondrin B. Observed were the H13 to H15' and H12 
to H6 and H12 to HlO correlations seen in the NOESY spectrum of the furan acid 
product (6.3.1). The lH NMR resonances around the H-ring were also similar to 
those of 6.3.1, suggesting that the conformation of the lactone ring was similar in the 
two acid products ( 6.3.1 and 6.3.2) to give a similar electronic environment for 
protons around the H-ring, and the NOESY correlations observed for the furan 
protons. 
A possible mechanism for formation of the C38 epimer in the absence of water is 
depicted in Figure 6.3.7. This mechanism involves protonation of either the J or K 
ring ether oxygens, opening of the protonated cyclic ether and formation of the 
central oxonium ion species. From this species, attack of the hydroxyl group on 
either face of the oxonium ion to give either a retention or inversion of 
stereochemistry at the spiro centre, would result in homohalichondrin B or its C38 
epimer respectively. 
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Protonation of J-ring Ether Oxygen 
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6.3.3 Assignment of Acid Product 6.3.3 
The uv spectrum of the least polar of the three acid products (eluting off the 
analytical C18 HPLC column at ca 1000 s in 70% acetonitrile/ water), 6.3.3, 
indicated that this compound contained no uv chromophore, with end-absorption at 
ca 193 nm; a uv spectrum identical to that of homohalichondrin B (1.2.3). High 
resolution FAB-MS performed on the acid product 6.3.3 gave a parent ion 
corresponding to a molecular formula of C6tHs6019· This molecular formula was 
isobaric with homohalichondrin B (1.2.3). 
The 1 H NMR spectrum of acid product 6.3.3 is displayed in Figure 6.3.8. This 
spectrum (obtained in CDCl3/ 0.1% pyridine-ds) lacked the distinctive furan 
resonances observed in the spectra of both the furan acid product (6.3.1) and the epi-
furan acid product ( 6.3.2). There were several minor changes apparent relative to the 
lH NMR spectrum ofhomohalichondrin B (Figure 2.4.1). In the methyl region of 
the spectrum, two methyl doublet resonances at OH 0.99 ppm appeared as one 
overlapping doublet, with another doublet corresponding to one methyl group, in a 
more deshielded position at OH 1.04 ppm and another more shielded, single methyl 
group, at OH 0.94 ppm. The following distinctive resonances were still apparent in 
the 1 H NMR spectrum of acid product 6.3.3, with little or no change in chemical 
shift relative to the spectrum ofhomohalichondrin B: H47, H7, Hl8', H2', H551H55', 
H50, Hll, 19=CH2 and 26=CH2 (at OH 3.06 ppm, OH 2.94, OH 2.79, OH 2.58, OH 
3.69, OH 3.90, OH 4.58, OH 4.91, OH 4.98, OH 4.75 and OH 4.80 ppm respectively, in 
the lH NMR spectrum of homohalichondrin B). The H32 proton resonance 
appeared to have moved to a slightly more shielded position, from OH 3.17 ppm in 
the lH NMR spectrum of homohalichondrin B to OH 3.12 ppm in 6.3.3. A new, 
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broad singlet resonance was apparent at og 3.82 ppm, while the region around og 
3.60 ppm showed minor changes in the multiplicity of some of the overlapping 
resonances. The information obtained from comparison of the 1H NMR spectrum of 
6.3.3 (Figure 6.3.8) with that of homohalichondrin B. (Figure 2.4.1) indicated that 
the terminal (C44-C55) and the Cl-C30 regions were intact and unaltered. 
Figure 6.3.8 1 H NMR Spectrum of Acid Product 6.3.3 
Various NMR experiments were performed on acid product 6.3.3, viz COSY, lD-
TOCSY, 2D-TOCSY (with mixing times of 20 ms, 50 ms and 100 ms), HMQC, 
HMBC, NOB and NOESY experiments. These experiments were analysed to give a 
partial assignment of the 1 H and 13C NMR spectra of 6.3.3. The 1 H and Be NMR 
data are cited in Tables 6.3.5 and 6.3.6 respectively, and the important correlations 
from these experiments are shown in Figure 6.3.9. 
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Table 6.3.5 1 H NMR Data for Epi Acid Product ( 6.3.3) 
Proton a oppmb Proton a oppmb Protona oppmb 
H2 2.35 H21 H39 2.02 
H2' 2.62 H21' 1.85 H39' 2.28 
H3 3.86 H22 1.60 H40 3.92 
H4 1.35 H22' 1.60 H41 3.82 
H4' 1.75 H23 3.50 H42 2.26 
HS 1.38 H24 1.05 CH3-42 0.99 
HS' 2.08 H24' 1.68 H43 1.25 
H6 4.33 H25 2.20 H43' 1.40 
H7 2.94 CH3-25 1.04 H45 1.29 
H8 4.31 26=CH 4.75 H45' 1.42 
H9 4.04 26'=CH 4.81 H46 2.08 
HlO 4.18 H27 3.50 CHJ·46 0.94 
Hll 4.59 H28 1.96 H47 3.06 
H12 4.67 H28' 1.96 H48 3.50 
H13 1.93 H29 4.18 H49 1.76 
H13' 2.14 H30 4.66 H49' 2.15 
H15 1.62 H31 2.05 H50 3.90 
H15' 2.14 CH3-31 0.99 H51 4.01 
H16 H32 3.12 H52 2.00 
H16' H33 3.76 H52' 2.00 
H17 4.06 H34 H53 4.25 
H18 2.25 H34' 2.14 H54 3.55 
H18' 2.80 H35 4.08 H55 3.69 
19=CH 4.91 H36 4.04 H55' 3.69 
19'=CH 4.98 H37 2.22 
H20 4.36 H37' 2.22 
a The symbol' represents the less shielded proton of a geminal pair. 
b Data recorded at 23 °C in CDCl3 at 300 MHz with chemical shifts in ppm 
and referenced to CHC13, OH 7.25 ppm. 
Chapter 6- Acid Stability Studies 227 
Table 6.3.6 13c NMR Data for Epi Acid Product (6.3.3) 
Carbon oppma Carbon oppma Carbon oppma 
Cl 171.0 C21 C39 44.5 
C2 40.3 C22 32.0 C40 71.3 
C3 73.6 C23 74.5 C41 78.6 
C4 C24 43.2 C-CH3·42 25.3 
C5 C-CH3-2S 35.9 CCH3-42 17.9 
C6 68.0 C-.cH3-2S 18.0 C43 37.0 
C7 77.4 26C=CH2 151.8 C44 96.8 
C8 74.1 26C=CH2 104.0 C45 37.0 
C9 73.7 C27 73.2 C-CH3-46 29.0 
ClO 76.3 C28 CCH3-46 17.3 
Cll 81.8 C29 71.0 C47 72.5 
C12 80.8 C30 76.8 C48 63.4 
C13 48.2 C-CH3-31 36.2 C49 31.2 
C14 110.0 C-CH3-31 14.7 cso 
C15 34.2 C32 77.1 C51 
C16 C33 67.0 C52 
C17 C34 C53 79.4 
C18 38.6 C35 C54 71.8 
19C=CH2 C36 css 65.3 
19C=CH2 104.8 C37 43.9 
C20 75.0 C38 114.0 
a 13c NMR spectral data assigned from HMQC and HMBC experiments, recorded at 
23°C in CDCl3 at 300 MHz with chemical shifts in ppm. 
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These data confirmed that the connectivities and NMR chemical shifts around the 
Cl-C30 and C44-C55 regions were identical with those of homohalichondrin B. It 
was apparent that the changes were again most significant around the C38 centre. 
The rings around this centre appeared to be intact, and the 1 H and 13C NMR data 
compared well with those data observed for the epi-furan acid product (6.3.2). The 
H41 resonance was observed at OR 3.82 ppm, the H39 and H39' protons at OR 2.02 
ppm and OR 2.28 ppm and the H37 and H37' protons at OR 2.22 ppm. These 
resonances were at very similar chemical shifts compared to 6.3.2, but at quite 
different positions compared to homohalichondrin B. The C38 carbon resonance 
was observed at oc 114.0 ppm, identical to the C38 epi-furan acid product 6.3.2. 
The C41 ( oc 78.6 ppm), C39 ( 0c 44.5 ppm) and C37 ( oc 43.9 ppm) resonances were 
also consistent with the epi-furan acid product (6.3.2). 
These NMR data indicated that the acid product was the C38 epimer of 
homohalichondrin B, with the structure 6.3.3. 
Gt-13 
~" H H H 0 ,' J M ,, 
,' 0 
HO 
47 : H 39 H 
OH H H a;3 
epi acid product (6.3.3) 
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The lH NMR chemical shifts around the A-H rings, notably CH3-31 (DH 0.99 ppm), 
H29 (DH 4.18 ppm), H30 (DH 4.66 ppm), H31 (DH 2.05 ppm) and H32 (DH 3.12 
ppm), were close to those observed in homohalichondrin B as opposed to those 
observed in the furan acid product 6.3.1 and the epi-furan acid product 6.3.2. This 
was probably a reflection of the chemical shift changes invoked by the presence of 
the furan ring, and the conformational effects of its presence on the lactone ring and 
thus the electronic environment around the H ring. The NOESY spectrum showed a 
correlation between H2' (at DH 2.79 ppm) and 19=CH (at DH 4.91 ppm), implying a 
similar folding of the lactone ring to that observed in homohalichondrin B (and 
halichondrin B). This correlation was not observed in the NOESY spectra of the 
furan acid product (6.3.1) and the epi-furan acid product (6.3.2). 
6.3.4 Computer Modelling of C38 Epimer Acid Product 
In an effort to support the assignment of the epi stereochemistry at the C38 centre for 
the acid products 6.3.2 and 6.3.3, computer modelling of the C28-C44 fragment with 
the 11natural" C38 stereochemistry and the corresponding C38 epimer was 
undertaken. The resulting conformers were analysed to give vicinal coupling 
constants from the dihedral angles. These were compared to the vicinal coupling 
constants derived from homohalichondrin B, the epi -furan acid product 6.3.2 and the 
epi acid product 6.3.3. 
From the X -ray crystal structure of the norhalichondrin B derivative, 17 the C28-C44 
portion of the molecule was excised to give the C29-methyl, C30-hydroxyl, C44-
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hydroxyl and C44-methyl substituted derivative using the program Chem3D Plus. 
This structure was manipulated to give the epimer at C38. The energies of the X-ray 
crystallographic-derived structure and its epimer were subsequently minimised in 
Chem3D Plus. The resulting output is displayed in Figure 6.3.10 for the natural (X-
ray) and epi C38 stereochemistry. 
Dihedral angle 
(Vicinal coupling constant) 
Minimised C28-C45 X -ray Crystal Conformer 
Minimised C28-C45 C38 Epimer Conformer 
Figure 6.3.10 Chem3D Plus Minimised Structures of X-ray and Epi C38 
Stereochemistry 
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The conformation of the structure with the X-ray crystal structure stereochemistry 
was little altered from that of the original X-ray crystal structure. Conversely, the 
conformation of the C38 epimer was markedly different to that of the X-ray crystal 
structure conformation. The main conformational change was apparent in the J -ring, 
which showed a greater degree of puckering relative to the X -ray crystal structure 
conformation and X-ray crystal structure-derived minimised conformations. An 
analysis of dihedral angles and vicinal coupling constants (obtained from 
MacroModel) indicated that the conformation of the H, K and L rings was relatively 
unchanged compared to the minimised X-ray crystal structure C28-C44 values. The 
key changes were associated with the H35-H36, H36-H37 and H36-H37' dihedral 
angles and coupling constants. These values are depicted in Figure 6.3.10. The 
H35-C-C-H36 dihedral angle was observed to increase from -3° to -16° on 
minimisation. One of the H36-C-C-H37 dihedral angles moved from -14T to -8T, 
while the other moved from -24° to +3T. The calculated coupling constants 
corresponding to these dihedral angles are given in Figure 6.3.10. 
Construction of a model of this region indicated that if the C3 7 protons were pushed 
away from an interaction with the ether oxygen of the K-ring, the H35-H36 dihedral 
angle would be expected to increase and the J-ring would pucker, resulting in a 
"bent" molecule. It was discovered that the H and I rings could accommodate this 
puckering with little conformational change. 
It was anticipated that the collection of experimental coupling constants, especially 
for the H35, H36, H37 and H37' protons for homohalichondrin B (1.2.3), the epi-
furan and epi acid products (6.3.2 and 6.3.3) would provide evidence of this 
difference in the average solution conformation. Coupling constants were collected 
from the NMR experiments for these compounds for the H30-H37' region and are 
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listed in Table 6.3. 7 along with the predicted values for the minimised 
conformations from the computer modelling. 
The H36 proton was only accessible through an NOE interaction from the isolated 
H32 proton of the epi-furan acid product (6.3.2) and homohalichondrin B (1.2.3). 
Unfortunately, the complex appearance of the H36 multiplet was difficult to interpret 
in terms of coupling constants. However, the coupling constants for the H30 and 
H32 protons for the epi-furan and epi acid products (6.3.2 and 6.3.3) were consistent 
with those of homohalichondrin B (1.2.3) and the minimised computer generated 
conformers, indicating an average boat conformation existed for the epi and epi-
furan acid products. 
Table 6.3.7 Vicinal Coupling Constants: Calculated and Experimental 
Coupled Calculated 3 lHH (Hz) Experimental 3 lHH (Hz) 
protons X-ray C38 epi 1.2.3 6.3.2 6.3.3 
H30-H31 10.4 10.3 10.0 10.3 10.0 
H31-H32 10.9 11.1 7.8 9.4 8.8 
H32-H33 7.5 7.7 6.2 7.0 6.6 
H33-H34 4.7 4.5 5.7 
H33-H34' 11.2 11.2 11.2 
H34-H35 10.8 9.6 
H34'-H35 5.6 7.0 
H35-H36 6.9 5.7 
H36-H37 9.oa 5.la 
H36-H37' 7.7a 1.3a 
a Assignments may be interchanged. 
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No conclusions could be drawn on the average solution conformation of the epi or 
the epi-furan acid products from a comparison of the modelling results with the 
NMR data that would support epimerisation at the C38 centre in the acid products 
6.3.2 and 6.3.3, because the experimental coupling constants for the H35-H37 
protons could not be obtained from any of the NMR experiments performed. 
Despite the difficulties in obtaining the necessary coupling constants to assist in the 
assignment of the C38 stereochemistry of 6.3.2 and 6.3.3, there was no evidence 
from the analysis of the NMR data to suggest that the changes observed in 6.3.3 (and 
6.3.2) could have been elsewhere in the molecule. 
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6.4 Time-Scale Acid Reactions 
An investigation was undertaken to determine the inter-relationship of the three acid 
products (6.3.1, 6.3.2 and 6.3.3) and homohalichondrin B (1.2.3), under the acid 
reaction conditions. 
The time-scale reaction of CSA in dichloromethane with homohalichondrin B was 
also performed, with regard to the final step in the Kishi total synthesis of 
halichondrin B (refer to Appendix II) which involved ketalisation with CSA to form 
the final C38 spiro centre. Also of interest were the identities of the products formed 
in relation to the TFA reactions. 
These reactions were monitored closely by HPLC with time. A 1 H NMR spectrum 
was acquired on a standard mixture, comprising the three acid products (6.3.1, 6.3.2, 
6.3.3) and homohalichondrin B (1.2.3), and this standard was also injected into the 
HPLC. A calculation of the molar absorptivity (e) of the furan products (6.3.1 and 
6.3.2) relative to the non-furan products (1.2.3 and 6.3.3) was undertaken so that an 
accurate quantification of the HPLC component peaks could be calculated at each 
stage in the reaction. In the 1 H NMR spectrum, an integral over the H12 and H13 
furan resonances at OH 5.95 ppm and OH 6.18 ppm relative to the H7 resonance (OH 
2.94 ppm), common to homohalichondrin B (1.2.3) and the epi acid product (6.3.3), 
gave the true ratio of furan products relative to non-furan products. Integration of 
the four peaks in the HPLC chromatogram of the standard mixture at 'A 199 nm, gave 
the sum of the furan vs non-furan components. Comparison with the ratios from the 
1 H NMR spectrum gave the ratio of the molar absorptivities of the furan products vs 
the non-furans. This ratio was calculated at 5.9 : 1 for efurans : enon-furans· Implicit 
in this calculation· was the assumption that the molar absorptivities of the two furans 
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(6.3.1 and 6.3.2) were the same, and that the molar absorptivities of the non-furan 
compounds (1.2.3 and 6.3.3) were also the same. 
6.4.1 Time-Scale TFA Reaction of Furan Acid Product 
A small quantity of the furan acid product (6.3.1) was dissolved in dichloromethane 
and an aliquot removed for HPLC analysis, as a reference chromatogram. 
Standardised TF A in dichloromethane solution was added to the furan acid product 
to give a 2 to 1 molar ratio of 6.3.1 to TFA. The reaction was stirred at room 
temperature and analysed by HPLC (analytical Cl8 column, mobile phase 70% 
acetonitrile/ water). Samples were extracted from the reaction mixture at regular 
intervals (after 10 min, 30 min, 1 hr, 2.5 hr, 3.5 hr, 4.5 hr, 7 hr, 11 hr, 18 hr, 35.5 hr, 
49 hr and 73.5 hr of reaction) for immediate HPLC analysis. The peaks in the HPLC 
chromatograms were integrated at A. 199 nm, and each identified component was 
expressed as a relative percentage of the total amount of identified components 
present at that time. 
Figure 6.4.1 displays a graph of the relative percentage of each component with 
increasing reaction time. The proportion of furan acid product ( 6.3.1) was observed 
to decrease as its C38 epimer, the epi-furan acid product 6.3.2, formed. The decay 
was observed to level off after approximately 18 hours reaction, and after 49 hours 
reaction a slight excess of the epi-furan acid product ( 6.3.2) over the furan acid 
product (6.3.1) was observed. After this time, contributions from other, more polar 
unidentified components made an analysis of subsequent HPLC chromatograms 
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unreliable. No evidence of either homohalichondrin B (1.2.3) or the epi acid product 
(6.3.3) was observed at any time. 
100% 
80% 
20% 
I 
' 
' I 
\ 
i 
I 
I 
I 
I 
'- '"\ 
\ 
\ 
\ 
\ 
'-- ... 
...... 
,.~-·-·"""· 
I 
/ ,. 
/ 
/ 
.,..,,.../ 
... _ 
Juran acid product 
epi-furan acid product 
...._------- -_:-.... w.~:..':.:-· 
....... --~-·-·-~-·-·-·-....... -
0%~--~~--~--~-T--~--~-T--~-, 
0 10 20 30 40 50 
Time (hrs) 
Figure 6.4.1 Graph ofTFA Acid Reaction ofFuran Acid Product (6.3.1) 
These results suggested that the furan product was an end-product of the acid 
reaction of homohalichondrin B (ie it was not reversible to regenerate 
homohalichondrin B). Also apparent from these results was the relationship between 
the furan acid product (6.3.1) and the epi-furan acid product (6.3.2), suggesting an 
equilibrium existed between the two products under these reaction conditions. 
However, the equilibrium appeared to be relatively slow to establish, and 
contributions from subsequent acid decomposition mechanisms meant that the 
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analysis of the furan and epi-furan acid products became unreliable after 49 hours, 
perhaps before the equilibrium had time to fully establish. 
6.4.2 Time-Scale TFA Reaction of Epi-Furan Acid Product 
A small quantity of the e p i-furan acid product (6.3.2) was dissolved in 
dichloromethane, and a small aliquot of this solution was taken for HPLC analysis 
(using an analytical C18 column with 70% acetonitrile/ water as the mobile phase), 
for reference purposes. 
To this solution, a standard solution of TFA in dichloromethane was added, to give a 
molar ratio of 2 moles epi-furan acid product (6.3.2) to 1 mole of TFA. This solution 
was stirred at room temperature and the reaction progress was monitored at regular 
intervals (viz after 15 min, 1 hr, 2 hr, 3 hr, 4 hr, 7 hr, 22 hr, and 48 hr reaction) by 
HPLC. Each identified component peak in the chromatogram was integrated at A 
199 nm, and its contribution to the total of the identified component integrals in the 
chromatogram was expressed as a relative percentage. A plot of the percentage of 
each component at each point in time during the course of the reaction, is shown in 
Figure 6.4.2. 
From this graph, it was apparent that the epi-furan acid product (6.3.1) underwent 
decay to an equilibrium value, as the furan acid product (6.3.2) formed with time, to 
reach an equilibrium value after twenty-two hours reaction. This equilibrium 
appeared to be in favour of the epi-furan acid product (6.3.2). After forty-eight hours 
reaction, the reaction appeared to be leading off into subsequent acid decomposition 
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products. No adjustment was made to the graph for the appearance of these 
unidentified products. No evidence was observed, at any time, of the formation of 
homohalichondrin B or the epi acid product ( 6.3.3). 
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Figure 6.4.2 Graph ofTFA Acid Reaction of Epi-Furan Acid Product (6.3.2) 
These observations were consistent with the observations for the reaction of the 
furan acid product (6.3.1), and supported the belief that the reaction to produce the 
furan was not reversible. It also supported the theory that an equilibrium existed 
between the two furan acid products ( 6.3.1 and 6.3.2). 
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6.4.3 Time-Scale TFA Reaction of Epi Acid Product 
A small quantity of the epi acid product (6.3.3) was dissolved in dichloromethane, 
and an aliquot of this solution was analysed by HPLC, using the conditions 
previously described, for reference. Standard TFA solution in dichloromethane was 
added to the epi acid product ( 6.3.3) to give a 2 : 1 molar ratio of 6.3.3 to TF A. The 
reaction was stirred at room temperature and monitored by HPLC with time. The 
identified component peaks in the chromatograms were integrated (at A 199 nm), 
corrected for the appropriate £ values, and the relative percentage of each component 
was calculated. The reaction mixture was analysed by HPLC after 15 min, 45 min, 
1.17 hr, 1.75 hr, 2.5 hr, 3 hr, 3.5 hr, 4.5 hr, 7 hr, 20.5 hr and 47 hr. Figure 6.3.4 
displays the graph of the variation in the relative percentage of each component with 
time. 
A decay from 100% to 0% epi acid product (6.3.3) was observed over a reaction 
period of forty-seven hours. Initially, the build-up of homohalichondrin B (1.2.3) 
was observed, along with a build-up in both furan acid products (6.3.1 and 6.3.2). 
The build-up of the furan acid product (6.3.1) appeared to lag behind that of the epi-
furan acid product (6.3.2). As the homohalichondrin B (1.2.3) and epi acid product 
(6.3.3) decayed, the proportion of furan acid products (6.3.1 and 6.3.2) continued to 
increase. After about twenty hours reaction, the relative amounts of the furan acid 
product (6.3.1) to the epi-furan product (6.3.2) reached an equilibrium in favour of 
the latter acid product. 
From the time-scale reactions of the furan acid product (6.3.1) and the epi-furan acid 
product (6.3.2), described in Sections 6.4.1 and 6.4.2 respectively, it was apparent 
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that the formation of the furan products was not reversible under the reaction 
conditions. This implied that formation of homohalichondrin B in the time-scale 
reaction of the epi acid product ( 6.3.3) originated from epimerisation of 6.3.3. It was 
likely that furan formation from the epi acid product ( 6.3.3) and homohalichondrin B 
(1.2.3) gave the relevant furan derivative. 
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Figure 6.4.3 Graph of TFA Acid Reaction of Epi Acid Product ( 6.3.3) 
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6.4.4 Time-Scale TFA Reaction of Homohalichondrin B 
To complete the series of time-scale reactions of the components involved in the 
TF A acid reactions, a time-scale study of homohalichondrin B (1.2.3) under the same 
reaction conditions was undertaken. 
Initially, a small quantity of homohalichondrin B (1.2.3) was dissolved in 
dichloromethane and an aliquot of this solution was removed for HPLC analysis 
using the procedure described for the previous reactions. A standardised solution of 
TF A in dichloromethane was added to the homohalichondrin B solution to give a 2 : 
1 molar ratio of homohalichondrin B to TF A. The reaction was stirred at room 
temperature and the reaction progress was monitored by HPLC. Aliquots of the 
reaction mixture were removed at regular intervals (after 15 min, 1 hr, 1.5 hr, 2.5 hr, 
3 hr, 4 hr, 5 hr, 7 hr, 8 hr, 10 hr, 18 hr, 32 hr and 44 hr) and the solvent was 
immediately removed before HPLC injection in the mobile phase. For each 
injection, the resulting chromatogram was integrated at A 199 nm, over each of the 
four identified components. Correction was made for the difference in molar 
absorptivities to give a quantification of the components in the reaction mixture at 
that point in time. A graph of the results of this experiment is given in Figure 6.4.4. 
From Figure 6.4.4, it is apparent that the furan acid product (6.3.1) was the first 
product to form, after two and a half hours reaction. Subsequently, the epi acid 
product ( 6.3.3) and the epi-furan acid product (6.3.2) were observed, after four hours 
reaction. A slow build-up of furan acid products was observed as the proportion of 
homohalichondrin B slowly decreased with time. After forty-four hours reaction, no 
epi acid product (6.3.3) was observed in the reaction mixture, but some 
Chapter 6- Acid Stability Studies 243 
homohalichondrin B (1.2.3) was still present. At this time the proportion of the epi-
furan acid product (6.3.2) became dominant over the furan acid product (6.3.1). 
Unfortunately, after this time, the presence of additional and unidentified peaks in 
the chromatograms arose, making the analysis in terms of the four known 
components unreliable. 
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Figure 6.4.4 Graph of TFA Acid Reaction of Homohalichondrin B (1.2.3) 
In comparison to the epi acid product (6.3.3) time-scale reaction, it was apparent that 
homohalichondrin B (1.2.3) had a longer lifetime under the TFA reaction conditions. 
The graph of the time-scale reaction of the epi acid product (Figure 6.4.3) shows a 
relatively rapid reaction of 6.3.3 occurring with time, whereas Figure 6.4.4 shows 
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the persistence of homohalichondrin B in the reaction mixture, with a "shallower" 
curve. The reasons behind these observations were not clear. However, it was 
possible that conformational differences between the epi and "natural" C38 
stereochemistry may have resulted in the observed differences in the rates of 
reaction. 
In a qualitative sense, it was apparent that the furans ( 6.3.1 and 6.3.2) represented 
end-products of the reaction, while an equilibrium appeared to exist between the C38 
epimeric products. 
6.4.5 Time-Scale CSA Reaction of Homohalichondrin B 
As discussed in Section 6.1, it was important to consider the effect of the acid CSA 
on homohalichondrin B (1.2.3). Kishi and co-workers reported the final C38 
ketalisation step in the total synthesis of norhalichondrin B (1.2.2) and halichondrin 
B (1.2.1) with CSA in dichloromethane. 67 Their description of this reaction was 
lacking in detail as no indication as to the acid concentration or the duration of the 
reaction was given. 
Initially, a small quantity of homohalichondrin B (1.2.3) was dissolved in 
dichloromethane. An aliquot of this solution was analysed by HPLC (analytical C18 
column with 70% acetonitrile/ water as the mobile phase), for reference purposes. 
CSA in dichloromethane was then added to the homohalichondrin B ( 1.2.3) solution, 
to give a molar ratio of 10 : 1 for 1.2.3 to CSA. The reaction was stirred at room 
temperature and was monitored by HPLC after half an hour, one hour and two hours 
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and ten minutes of reaction. After this time, no reaction was apparent by HPLC so 
the CSA concentration was increased to give a 3 : 1 molar ratio of 1.2.3 to CSA. 
This reaction was stirred at room temperature and monitored with time (after 0.5 hr, 
1 hr, 1 hr 40 min, 3 hr and 22 hr at a 3 :1 molar ratio), by HPLC. Identified peaks in 
the chromatogram (at 'A 199 nm) were integrated and differences in the molar 
absorptivities were corrected, to allow quantification of the components. The data 
from this reaction is displayed in Figure 6.4.5, showing the proportion of each 
component at each point in time. After twenty-two hours reaction, contributions 
were observed from other, unidentified components, making the analysis in terms of 
the known products unreliable. 
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Figure 6.4.5 Graph of CSA Acid Reaction of Homohalichondrin B (1.2.3) 
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This reaction appeared to follow the same trends as the TFA reaction of 
homohalichondrin B (1.2.3), described in Section 6.4.4. Homohalichondrin B (1.2.3) 
appeared to react slowly as the two furan products ( 6.3.1 and 6.3.2) formed. Also 
observed was the epi acid product (6.3.3), although, as observed previously, this too 
reacted, presumably to the epi-furan acid product (6.3.2) as the reaction proceeded. 
The epi-furan product (6.3.2) appeared to be dominant over the furan product (6.3.1), 
after twenty-two hours reaction. 
The significance of these results in relation to the total synthesis of halichondrin B 
(1.2.1) and norhalichondrin B (1.2.2) is discussed in Section 6.5. 
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6.5 Biological Activity Data 
The biological activities of the three acid products (6.3.1, 6.3.2 and 6.3.3), described 
in Section 6.:3, were evaluated in the in vitro P388 assay and in the NCI primary in 
vitro antitumour screen. These data are cited in Table 6.5.1, along with those for the 
relevant parent halichondrin, homohalichondrin B (1.2.3). 
Table 6.5.1 In Vitro Cytotoxicities of Selected Halichondrins 
Compound P388 ICso 
(ng/mL) 
homohalichondrin B (1.2.3) 0.22 
furan acid product (6.3.1) 4.1 
epi-furan acid product (6.3.2) 8.4 
epi acid product (6.3.3) 15.0 
NCI Glso COMPARE 
(xlo-10 M) Correlationa 
3.16 0.95 
117 0.91 
478 
475 
0.69 
0.86 
a Correlation coefficient from the Compare pattern-recognition algorithm were 
calculated by computer using the Glso-centred mean graph profiles of differential 
cellular sensitivities to each of the compounds. The Giso-centred mean graph 
profile of halichondrin B was used as the 11Seed" for all of the comparisons. 
Analysis of the cytotoxicity data (Table 6.5.1) indicated that for all the acid 
products, a decrease in cytotoxicity was observed in both the P388 assay and the NCI 
in vitro primary screen. The results of the P388 assay indicated that the furan acid 
product (6.3.1) was the most active of the three acid products, with a ca forty-fold 
reduction in activity relative to homohalichondrin B (1.2.3). The epi-furan and epi 
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acid products (6.3.2 and 6.3.3) recorded a larger decrease in P388 cytotoxicity 
relative to the furan acid product (6.3.3). 
Similar trends were observed for the biological activities of the acid products in the 
NCI primary screen. The furan acid product (6.3.1) was the most active of the acid 
products in terms of the Glso result (averaged over all sixty cell lines), with a ca 
thirty-five-fold reduction in biological activity relative to homohalichondrin B 
(1.2.3). The biological activities of the epi-furan and epi acid products (6.3.2 and 
6.3.3) were very similar, with a ca one hundred and fifty-fold decrease in activity 
relative to homohalichondrin B (1.2.3). 
The P388 cell line appeared to be less sensitive to changes in stereochemistry at the 
C38 centre than the averaged result over the sixty cell lines comprising the NCI 
screen, as the epi-furan acid product (6.3.2) recorded only a ca forty-fold decrease in 
P388 activity, and the epi acid product (6.3.3) only a ca seventy-fold decrease in 
P388 activity, relative to homohalichondrin B (1.2.3). 
The COMPARE correlation coefficients for the furan acid product (6.3.1) and the epi 
acid product (6.3.3) were slightly reduced relative to the parent compound, 
homohalichondrin B (1.2.3), indicating that the mechanism of action for these acid 
products was still "halichondrin-like". The acid product with the C38 epi centre and 
furan ring (6.3.2) recorded a significant decrease in the COMPARE correlation 
coefficient (0.69). 
In general terms, the formation of the B-ring furan derivative did not produce as 
large a decrease in activity as would have be expected for such a major structural 
change. However, it seems that the stereochemistry at the C38 centre is of greater 
significance in determining the biological activity in the halichondrin series. 
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A further discussion of these results in relation to those of other halichondrin 
analogues is found in Chapter 9. 
These results indicate that the activity of the halichondrins (particularly the B series 
halichondrins) may be compromised if they were to be administered orally. In the 
acidic environment of the stomach (pH < 1) the halichondrins would undergo rapid 
acid reaction to the acid products (6.3.1, 6.3.2 and 6.3.3) and probably into 
subsequent decomposition products. Therefore, the administered halichondrin eg 
halichondrin B (1.2.1) would not reach the bloodstream, but rather a less potent 
derivative. 
It is worthwhile at this stage to speculate on the significance of these reactions in 
relation to the total synthesis of halichondrin B and norhalichondrin B reported by 
Kishi and co-workers.67 They indicated that the identity of the final halichondrin B 
product was confirmed "on the basis of spectroscopic (lH NMR, MS, IR, [a]o) and 
chromatographic data". These authors make no comment on how the product was 
purified. From the observations of the acid reactions of homohalichondrin B in CSA 
solutions (and in TFA and PTSA), described in this Chapter, it would seem possible 
that the final reaction step in the total synthesis of halichondrin B could have given a 
mixture of products; halichondrin Band the acid reaction products. 
Kishi's synthetic halichondrin B which was initially submitted to the NCI for 
biological testing, was less active than the naturally-derived material (a Glso of 8.40 
xlQ-10 M). Given the biological activity data results of the acid products, it would 
appear possible that the decrease in biological activity observed for the synthetic 
material may have arisen from contamination with one or more of the acid products. 
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The 1 H NMR spectra (obtained in C6D6) of the synthetic halichondrin B was 
obtained. Unfortunately, there was no way of knowing if this was the same sample 
that was submitted for biological assessment. It is likely that if either of the furan 
acid products had been produced, that this would be obvious in a 1 H NMR spectrum 
of the product mixture. However, the presence of the epi acid product (6.3.3) would 
be more difficult to detect. 
The 1 H NMR spectrum of homohalichondrin B (1.2.3) and the epi acid product 
(6.3.3) was obtained in C6D6· A comparison of these two spectra indicated that there 
would be significant differences in the appearance of some resonances in this 
solvent. Inspection of the lH NMR spectrum of the synthetic halichondrin B 
material (obtained in C6D6) did not reveal any obvious, distinctive resonances for the 
epi acid product (6.3.3). 
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7.1 Introduction 
Two aspects of the general chemistry of the halichondrins are described in this 
Chapter. 
The stability of the halichondrins under basic conditions was investigated with the 
objective of opening the twenty-two membered lactone ring. 
An investigation of the possibility of cation binding by the halichondrins was also 
initiated. As well as giving an insight into the general chemistry of the 
halichondrins, it was conceivable that the expression of biological activity in the 
halichondrins was related to an ability to chelate a metal ion under physiological 
conditions. The antibiotics valinomycin and nonactin for example, "which contain 
ether, ester, and amide bonds in 32-36-membered rings",72 are known to bind Na+ 
and K+ cations to exert their biological effects. Halichondrins exert their mechanism 
of antimitotic action via binding in the vinca domain of tubulin, inhibition of GTP 
hydrolysis, nucleotide exchange on tubulin24 (refer Section 1.2.3); it is possible that 
this mode of action may be facilitated by metal ion binding. 
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7.2 Base Stability Studies 
A dilute solution of sodium hydroxide (0.1 M) in 10% methanol/ water was added to 
a small quantity of isohomohalichondrin B (1.2.9). Methanol was added to solubilise 
the halichondrin. The solution was stirred at room temperature overnight. A lH 
NMR spectrum obtained from the worked-up material (in CDCi3/ 0.1% pyridine-ds) 
indicated that no reaction had occurred, with only isohomohalichondrin B (1.2.9) 
being identified in the spectrum. 
The stability of homohalichondrin B (1.2.3) to lithium hydroxide was tested as part 
of the Wittig reaction investigations and this is described in Section 8.4. 
Homohalichondrin B (1.2.3) was found to be stable to dilute aqueous lithium 
hydroxide. 
The base hydrolysis of isohomohalichondrin B (1.2.9), and subsequently of 
homohalichondrin B (1.2.3), was investigated using sodium methoxide. Both 
halichondrins were found to be labile in the presence of sodium methoxide in 
methanol solution. A full description of these reactions is given in Section 5.2. 
It appeared that the halichondrins were relatively stable in dilute alkaline solutions, 
but less stable in the presence of more nucleophilic, Lewis bases, such as sodium 
methoxide. 
Chapter 7- Base Stability and Chelation Studies 254 
7.3 Chelation Studies 
Pedersen estimated that a "hole" 4 A in diameter was "enough to accommodate any 
unsolvated or uncoordinated inorganic cation" in a macrocyclic polyether 
molecule.73 This author also commented that complexes in such molecules were 
"formed by ion-dipole interaction between the cation and the negative dipoles of the 
oxygens of the polyether ring" ,73 
The X-ray crystal stmcture of the norhalichondrin A derivative17 was investigated 
for possible metal chelation sites. It was apparent from an inspection of the overall 
conformation of the molecule that chelation, if it were to occur, would probably 
occur in the region of the folded lactone ring as there were several oxygens of the 
cyclic ethers in this region that could complex a single metal ion species. There 
appeared to be a large enough site to accommodate a metal ion species. However, 
the positions of the ether oxygens were not in any kind of "symmetrical" relationship 
to this site. This indicated that if metal chelation were to occur, the conformation of 
the lactone ring would be required to change significantly to achieve a symmetrical 
arrangement of the oxygens. 
Prestegard and Chan reported the investigation of cation:binding properties of the 
macrocyclic antibiotic nonactin by lH NMR spectroscopy,74 These authors reported 
the observation of conformational changes in the nonactin ring upon ion 
complexation. James et al reported significant (up to DH 0.27 ppm) changes in lH 
NMR chemical shifts of Ag+ binding to the oxazole portion of 
dihydrohalichondramide.75 It was decided to initiate ion chelation studies in the 
halichondrins by investigating the relatively small (0.98 A ionic radius), and 
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physiologically prevalent, Na + ion using 1 H NMR spectroscopy to detect the 
conformational changes and the electronic effects of metal ion binding. 
A 1 H NMR spectrum of a small quantity of isohomohalichondrin B (1.2.9) in 
CD30D with two drops of D20 was obtained as a reference spectrum. Sodium 
perchlorate in D20 was added to the NMR tube to give a 1:1 ratio of Na+: 
isohomohalichondrin B (1.2.9). A lH NMR spectrum was acquired on this solution; 
no changes were indicated relative to the reference 1 H NMR spectrum. Sodium 
perchlorate (in D20) was added to the NMR tube to give stepwise increments in the 
ratio ofNa+: isohomohalichondrin B (ie 2:1, 3:1,4: 1, 5:1 and 10:1 molar ratios). lH 
NMR spectra were acquired on the solution after each addition. No changes were 
apparent in the lH NMR spectra up to a ratio of 10:1 Na+: isohomohalichondrin B 
that indicated that Na + chelation was occurring. 
Obviously, a wide range of alternative chelating ions such asK+, Fe2+, Ca2+, Mg2+ 
and Fe2+ would need to be investigated before the possibility of metal binding in the 
halichondrins could be eliminated. Time constraints meant a fuller investigation was 
not possible. 
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8.1 Introduction 
Critical to the development of the halichondrins as anticancer drugs, will be the 
ability to study the kinetics of drug absorption, distribution, metabolism, and 
excretion (ie the pharmacokinetics) of the molecule in vivo. To facilitate the 
detection and quantification of very small quantities (sub ng) of halichondrins in a 
biological matrix such as blood serum, it is necessary to "label" the molecule. This 
labelling may involve hapten binding for enzyme-linked immunoassay (ELISA); 
isotopic labelling for radio immunoassay (RIA), NMR spectroscopic or MS 
detection; or fluorescent tagging for detection by HPLC. 
Several methods of generating selected, "labelled" halichondrins were investigated. 
Initially, a deuterium exchange reaction was attempted on isohomohalichondrin B 
(1.2.9) with the objective of producing a deuterium-labelled derivative; thus 
establishing a means for obtaining a tritium-labelled derivative. Subsequently, the 
sodium borodeuteride reduction of isohomohalichondrin B (1.2.9) was also 
undertaken using methodology previously established. This would establish a 
methodology for the inclusion of a stable tritium label. Efforts were also focused on 
the production of an isotopically-labelled halichondrin derivative produced via a 
Wittig reaction on a previously synthesised analogue. 
Additionally, derivatisations of selected halichondrins to give fluorescent-labelled 
halichondrins were undertaken. 
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8.2 Deuterium Exchange 
The deuterium exchange of isohomohalichondrin B (1.2.9) was attempted as a 
simple method of generating a deuterium-labelled derivative. It was anticipated that 
the protons adjacent to the C53 ketone (viz H52/H52' and H54/H54') of 
isohomohalichondrin B (1.2.9) would be exchangeable in basic solution. 
The deuterium exchange of isohomohalichondrin B (1.2.9) was monitored by 1H 
NMR spectroscopy. A solution of sodium deuteroxide (NaOD) in deuterium oxide 
(D20) was added to a small quantity of isohomohalichondrin B (1.2.9) in CD30D, 
and the solution was mixed thoroughly. A 1 H NMR spectrum acquired on this 
solution immediately after mixing indicated that reaction had occurred. The reaction 
mixture was worked-up and a 1H NMR spectrum was re-acquired in CDCl3/ 0.1% 
pyridine-ds solution to facilitate comparison with the 1 H NMR spectrum of 
isohomohalichondrin B (1.2.9) in this solvent. 
Although the signal to noise ratio of this spectrum was very poor, it was apparent 
that there was a decrease in the intensity of the H54 and H54' (8H 2.73 ppm), H52 
(8H 2.62 ppm) and H52' (8H 2.93 ppm) proton resonances, relative to the 1H NMR 
spectrum of isohomohalichondrin B (1.2.9). The H2' resonance, which was observed 
as a doublet of doublets in the 1 H NMR spectrum of isohomohalichondrin B (1.2.9) 
at OH 2.61 ppm, was now predominantly visible as a doublet resonance. This 
indicated the exchange of the H2 proton (obscured in the spectrum at 8H 2.36 ppm) 
was resulting in a loss of geminal coupling to the H2' resonance and the collapse of 
the doublet of doublets to give a doublet resonance. This stereospecific loss of the 
H2 proton was consistent with the conformational studies of halichondrin B and 
(vide Section 2.3) which suggested that the H2' proton was directed into the lactone 
Chapter 8- Labelling Studies 259 
ring and the H2 proton was in a relatively exposed environment. The stereospecific 
deuteration at the C2 position appeared to be exclusively on the re face of the 
enol ate. 
FAB-MS performed on the worked-up material showed the presence of an envelope 
of parent ions, corresponding to the incorporation of one, two, three, four and five 
deuterium atoms, replacing the equivalent number of hydrogen atoms of 
isohomohalichondrin B (1.2.9). The envelope was symmetrical about the most 
intense peak corresponding to the exchange of three hydrogen atoms with three 
deuterium atoms. High resolution FAB-MS performed on the central parent ion gave 
a molecular formula corresponding to C61Hs3D3019 or the incorporation of three 
deuterium atoms relative to the molecular formula of isohomohalichondrin B (1.2.9). 
It was likely that there was not 100% exchange occurring at each centre- the poor 
signal to noise ratio in the 1 H NMR spectrum made a quantitative assessment of this 
impossible. This was reflected in the appearance of the FAB-MS cluster of d1-d5 
peaks centred on d3. 
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8.3 Sodium Borodeuteride Reduction 
The sodium borodeuteride reduction of isohomohalichondrin B (1.2.9) was 
undertaken with the objective of producing the C53-deuterated derivative of the 
isohomohalichondrin B reduction isomers (3.4.1 and 3.4.2), as described in Section 
3.4. 
A small quantity of isohomohalichondrin B (1.2.9) was dissolved in dry isopropyl 
alcohol and sodium borodeuteride was added. The resulting suspension was stirred 
vigorously at room temperature for one hour, monitoring the reaction progress by 
silica TLC. After one hour, TLC performed on the reaction mixture indicated the 
appearance of two new spots of increased polarity relative to isohomohalichondrin B 
(1.2.9) and no evidence of starting material. The reaction was subsequently 
quenched and worked-up. A 1 H NMR spectrum and a COSY spectrum were 
acquired from the product (in CDCl3/ 0.1% pyridine-ds). 
The 1 H NMR spectrum of the product appeared to be identical with that performed 
on the isohomohalichondrin B sodium borohydride reduction isomers (Figure 3.4.1 ). 
The H53 resonance was located at an obscured position, at OH 4.16 ppm in the 
spectrum of the sodium borohydride reduction isomers (3.4.1 and 3.4.2), and this 
resonance would be expected to be relatively broad due to coupling to the methylene 
protons on adjacent carbons. Therefore its absence from the spectrum of the sodium 
borodeuteride reduction products would not be detectable from an inspection of the 
1 H NMR spectrum. A reduction in complexity of the H54/H54' and H52 and H52' 
resonances would be expected in the spectrum of the sodium borodeuteride reduction 
products due to a loss in coupling to the H53 proton. These methylene protons, 
H54/H54' (oH 1.74 ppm), H52 (oH 1.56 ppm) and H52' (OH 2.10 ppm) were also 
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obscured in the 1 H NMR spectrum of the isohomohalichondrin B reduction isomers 
(Figure 3.4.1 ). 
The COSY spectrum performed on the sodium borodeuteride reduction products was 
compared to the spectrum performed on the sodium borohydride reduction isomers 
(3.4.1 and 3.4.2). Apart from two notable differences, the spectra were identical 
(Figure 8.3.1). The key differences were two COSY correlations which were 
observed in the COSY spectrum of the sodium borohydride isomers (upper 
spectrum, Figure 8.3.1), but were absent in the spectrum of the sodium 
borodeuteride reduction products (lower spectrum, Figure 8.3.1). These correlations 
were the H53 and H52' correlation, at OH 4.16 pprnloH 2.10 ppm (slightly obscured); 
and the H53/H54/H54' correlation at OH 4.16 ppm/oR 1.74 ppm in the COSY 
spectrum of the sodium borohydride reduction isomers. This indicated that the H53 
proton was not present in the sodium borodeuteride reduction product, and that the 
corresponding C53 deuteride isomers 8.3.1 and 8.3.2 had been produced in the 
reaction. 
isohomohalichondrin B sodium borodeuteride reduction isomers (8.3.1 and 8.3.2) 
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High resolution F AB-MS performed on the sodium borodeuteride reduction isomers 
(8.3.1 and 8.3.2) gave the parent ion corresponding to a molecular formula of 
C61Hs7D019 (100% incorporation), the addition of one hydrogen and one deuterium 
atom relative to the molecular formula of isohomohalichondrin B (1.2.9). This 
confirmed that the C53-deuteride derivatives of 3.4.1 and 3.4.2 (8.3.1 and 8.3.2) had 
been produced in the reaction of isohomohalichondrin B (1.2.9) with sodium 
borodeuteride; 
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Figure 8.3.1 COSY Spectra of Reduction Products 
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8.4 Wittig Reaction 
It was envisaged that isotopic carbon atoms (13C or 14C) could be inserted into a 
halichondrin molecule at the 19=CH2 and 26=CH2 positions via a Wittig reaction 
with a C19 and C26 diketone halichondrin derivative using the appropriately labelled 
ylide.76 
Homohalichondrin B diacetate dike tone ( 4.3.3) was selected as the diketone 
derivative to undertake the Wittig reaction on. The synthesis of this derivative was 
described in Section 4.3.4. It was anticipated that reaction at the Cl9 and C26 
ketone centres of 4.3.3 with a labelled ylide would regenerate labelled 
homohalichondrin B (as the diacetate derivative). The isohomohalichondrin B 
diketone derivative (4.3.2), described in Section 4.3.3, was not suitable for the 
conditions of the Wittig reaction because of the potential for reaction of the ylide 
with the C53 ketone functionality. 
Initially, a series of trial Wittig reactions on cholestan-3-one were developed to give 
suitable reaction and handling conditions for applying to the diacetate diketone 
derivative of homohalichondrin B ( 4.3.3). 
The reactions were initially attempted using methyl triphenylphosphonium iodide 
(MePh3P+I-) as an "unlabelled" Wittig reagent with the objective of developing 
suitable reaction conditions for the regeneration of the olefinic functionalities. It was 
anticipated that once the reaction conditions were developed they could be applied 
using an isotopically labelled Wittig reagent to give the corresponding isotopically 
labelled halichondrin. 
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8.4.1 Trial Wittig Reaction 
A trial reaction of cholestan-3-one with the Wittig reagent MePh3+I- was undertaken, 
based on a literature method.77 The Wittig reagent, MePh3P+I-, was suspended in 
dry ether and n-butyllithium in hexane was added to the suspension to generate the 
ylide (CH2=PPh3). Cholestan-3-one, dissolved in dry ether, was added to the ylide. 
The resulting solution was stirred overnight at room temperature. 
A 1 H NMR spectrum acquired on the product (in CDCl3) showed the presence of a 
broad singlet resonance at OH 4.54 ppm which was assigned as the olefinic 3=CH2 
resonance of 3-methylene cholestane. Also apparent from the 1 H NMR spectrum 
was the movement of the CH3-l8 singlet resonance from OH 0.66 ppm to OH 0.63 
ppm, and the CH3-19 singlet resonance from OH 0.99 ppm to OH 0.83 ppm. No 
starting material was identifiable in the spectrum. 
8.4.2 Wittig Reaction of Homohalichondrin B Diacetate 
Dike tone 
The stability of homohalichondrin B (1.2.3) to lithium hydroxide (generated from 
reaction of n-butyllithium) was tested before committing the diacetate diketone of 
homohalichondrin B ( 4.3.3) to the Wittig reaction conditions. A small quantity of 
homohalichondrin B (1.2.3) was dissolved in water and an aqueous solution of 
lithium hydroxide was added. The reaction was stirred overnight at room 
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temperature. Silica TLC performed on the product indicated homohalichondrin B 
(1.2.3) was stable under these conditions. 
The Wittig reagent (MePh3P+I-) was suspended in dry ether and n-butyllithium in 
hexane was added to the suspension to generate the ylide (CHz=PPh3). 
Homohalichondrin B diacetate diketone (4.3.3) in dry ether, was added to the ylide. 
The resulting solution was stirred overnight at room temperature. After this time, the 
ether was removed and the reaction mixture was extracted with hexanes and filtered. 
A 1 H NMR spectrum of the product showed very weak halichondrin resonances. 
However, it was possible to determine that this material was unreacted 
homohalichondrin B diacetate diketone ( 4.3.3) as several resonances, characteristic 
of the 1 H NMR spectrum of 4.3.3 were still apparent in the spectrum. The 
distinctive CH3-25 doublet at SH 1.09 ppm was unshifted, indicating that the C26 
ketone was intact. The isolated quintet of the H54 resonance (at SH 5.13 ppm) was 
also visible, indicating that the diacetate remained intact. No evidence was seen in 
the olefinic region that would support formation of the 26=CHz and 19=CHz 
homohalichondrin B diacetate derivative (3.2.2). 
The filtered solid from the work-up was subsequently extracted with 20% 
dichloromethane/ hexane to remove any more polar halichondrin material present. A 
1 H NMR spectrum (in CDCl3) of this material showed very weak halichondrin 
resonances. The H54 quintet resonance at OH 5.13 ppm was a fraction of its former 
intensity in the spectrum indicating that the major component had either one or two 
acetate groups cleaved. Reactivity tables indicated that acetate functionalities would 
be unstable to alkyl lithium and stable to ylides.62 An equimolar amount of n-
butyllithium had been added to the Wittig reagent to generate the ylide to avoid this 
potential problem. However, it was possible that n-butyllithium had not fully reacted 
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with the Wittig reagent (MePh3P+I-) to form the ylide before addition of the 
halichondrin material. 
Silica TLC was performed on the two extracts. The material from the hexane extract 
showed a single spot with the same polarity as homohalichondrin B diacetate 
diketone ( 4.3.3). The 20% dichloromethane/ hexane extract showed two spots by 
silica TLC; one minor spot with the same polarity as 4.3.3, and the other, major spot 
of increased polarity relative to 4.3.3. This supported the NMR observations that the 
hexane extract was unreacted 4.3.3, whereas the dichloromethane/ hexane extract 
contained predominantly a diacetate-cleaved derivative (from the Rf of the spot). 
The two extracts were combined and the reaction was reattempted under identical 
conditions. 
The reaction was worked-up as previously, with the hexane and dichloromethane/ 
hexane extracts combined. A 1 H NMR spectrum acquired on the combined material 
(in CDCl3) appeared to be similar to the previous reaction, indicating a mixture of 
acetylated and non-acetylated homohalichondrin B diketone material was present. 
No evidence of 26=CH2 or 19=CH2 olefinic resonances were observed in this 
spectrum. There was insufficient material to progress further with. 
Two explanations for the non-reaction observed were postulated. It was possible that 
the conformation of the diketone may have precluded a close approach by the ylide 
to the C19 and C26 ketone centres. Also possible was the low solubility observed 
for the starting material, homohalichondrin B diacetate diketone (4.3.2) in ether, 
resulting in non-reaction with the ylide. 
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8.5 Fluorescent Labelling 
The majority of fluorescent labels have been developed for the labelling of primary 
and secondary amino acids. 78 A few reagents, such as anthracene-isocyanate 
(AIC) 79, 4-dimethylamino-1-naphthoylnitrile (DMA-NN)80 and naphthyl-isocyanate 
(NIC), 81 have been developed for the labelling of hydroxyl functional groups. 
Other, traditional and readily available fluorescent labels such as the acid chloride 5-
dimethylaminonaphthalene-1-sulfonylchloride (dansyl chloride, 8.5.1) are reported 
to reactslowly82 with hydroxyl groups. 
OQ 
N(CHah 
dansyl chloride (8.5.1) 
Detection of halichondrins in blood serum using a fluorescent label would, in theory, 
involve derivatisation in blood serum and possible purification, or alternatively, 
extraction of the halichondrin material prior to derivatisation, followed by HPLC 
quantification, using a fluorescence detector to give increased analytical sensitivity. 
For a fluorescent label to be of analytical use, the derivatisation reaction should 
ideally give a 100% yield. However, a derivatisation that gives a reproducible yield 
of less than 100% may still be of analytical use, although in this situation the 
detection limit of the analytical method would be compromised. 
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Dansyl chloride (8.5.1) was selected as a fluorescent label for the terminal hydroxyl 
group of selected halichondrins. Initially, a series of trial reactions were performed 
on n-hexanol before applying the reaction conditions to selected halichondrins. 
8.5.1 Trial Reactions of Dansyl Chloride 
To a solution of n-hexanol dissolved in pyridine, dansyl chloride in pyridine was 
added at 0°C while stirring to give a 1: 1 molar ratio of dansyl chloride to n-hexanol. 
The solution was then stirred at room temperature for four and a half hours. The 
reaction was worked-up after this time and a 1 H NMR spectrum acquired on the 
product in CDCI3/ 0.1% pyridine-ds. The lH NMR spectrum showed the shift of the 
terminal hydroxyl methylene protons from OH 3.64 ppm in n-hexanol to OH 3.98 
ppm, indicating dansylation had occurred at the hydroxyl group. Changes in the 
chemical shift of the aromatic dansyl proton resonances and in the other n-hexanol 
resonances were also apparent. No evidence of either unreacted starting material or 
reagent was apparent in the spectrum. 
The NMR solution fluoresced green under a visible wavelength (A. 380-400 nm) 
lamp. The fluorescence excitation wavelength for dansyl derivatives is typically A. 
375 nm to give fluorescence at A, 540 nm (green). 83 
Reactions were also attempted using carbonate as the base with either ethyl acetate 
or acetone as the solvents. 
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To a solution of n-hexanol in ethyl acetate, dansyl chloride and sodium carbonate 
were added to give a molar ratio of 1:2:6 n-hexanol: dansyl chloride : sodium 
carbonate. The reaction was stirred overnight at 35°C. A 1 H NMR spectrum 
acquired from the product (in CDCl3/ 0.1% pyridine-ds) indicated a 70% conversion 
to dansylated n-hexanol, by integration over the terminal hydroxyl methylene 
triplets. 
The reaction of n-hexanol in ethyl acetate was subsequently repeated on the 
incompletely dansylated material from the previous reaction, under identical reaction 
conditions. A lH NMR spectrum of the product obtained in CDCl3/ 0.1% pyridine-
ds showed a 100% conversion of n-hexanol to its dansylated derivative. 
A trial reaction using an alternative aqueous solvent (acetone) was subsequently 
undertaken. To a solution of n-hexanol in acetone, dansyl chloride and sodium 
carbonate were added to give a molar ratio of 1:1:3 n-hexanol: dansyl chloride: 
sodium carbonate. The resulting mixture was stirred overnight at room temperature. 
The reaction was worked-up and a 1 H NMR spectrum acquired from this material (in 
CDCl3/ 0.1% pyridine-ds) indicated a 78% conversion to dansylated n-hexanol, by 
integration. 
8.5.2 Dansyl Chloride Reactions With Homohalichondrin B 
A series of reactions of homohalichondrin B (1.2.3) with dansyl chloride were 
performed with the objective of producing dansyl homohalichondrin B (8.5.2) in 
quantitative yield. 
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H H 
H H 
55 
0 
H H 
dansyl homohalichondrin B (8.5.2) 
Homohalichondrin B (1.2.3) was dissolved in pyridine and dansyl chloride (1 mole 
equivalent) in pyridine was added, at 0°C. The solution was stirred at room 
temperature for four hours. Silica TLC and a 1 H NMR spectrum obtained from the 
product (in CDCl3/ 0.1% pyridine-ds) indicated only unreacted homohalichondrin B 
(1.2.3) was present. This material was committed for the next reaction. 
Homohalichondrin B (1.2.3) was dissolved in pyridine, and dansyl chloride in 
pyridine was added at 0°C to give a 5:1 molar ratio of dansyl chloride: 1.2.3. The 
solution was stirred at room temperature for four hours. A 1 H NMR spectrum 
acquired on the reaction product (in CDCl3/ 0.1% pyridine-ds) indicated that no 
reaction had occurred, as only homohalichondrin B (1.2.3) was present. This 
material was again used in the next reaction. 
The reaction was performed as described previously except fifteen mole equivalents 
of dansyl chloride were added to homohalichondrin B (1.2.3). No reaction was 
apparent by silica TLC or 1 H NMR spectroscopy on the product. The material from 
this reaction was subsequently submitted for the next reaction. 
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At this stage it was decided to increase the reaction temperature. Homohalichondrin 
B (1.2.3) was dissolved in pyridine and ten mole equivalents of dansyl chloride (in 
pyridine) were added at room temperature. The resulting solution was stirred at 
35°C. After four hours reaction at 35°C, silica TLC performed on the reaction 
mixture indicated the presence of two components. One component had an Rr 
identical to that of homohalichondrin B (1.2.3); the other component, possessing a 
greater Rt, was observed as a fluorescent yellow spot under a visible wavelength (A.. 
380-400 nm) lamp. Both components were stained blue by phosphomolybdic acid 
spray and heat (the standard TLC detection method used for the halichondrins). 
After nine hours reaction, silica TLC performed on the reaction mixture indicated no 
change in the relative intensities of the two components, so the reaction was worked-
up. 
A lH NMR spectrum obtained from the product (in CDCI3/ 0.1% pyridine-ds) 
indicated the presence of two components. The spectrum showed the presence of 
two H47 resonances, one unshifted homohalichondrin B (1.2.3) H47 resonance at SH 
3.06 ppm, the other at SH 3.02 ppm. Also apparent in the spectrum was the decrease 
in the intensity of the SH 3.69 ppm (H55/H55') doublet resonance. The CH3-42 and 
CH3-46 doublet resonances appeared to be split into new resonances overlapping in 
the region where the homohalichondrin B CH3-46 (SH 0.90 ppm) and CH3-42 (SH 
0.93 ppm) doublets resonated. This spectrum also showed several resonances in the 
aromatic region, and a singlet at SH 2.88 ppm, which were attributed to the dansyl 
N(CH3)2 methyl groups. Comparison of these "dansyl" resonances with a lH NMR 
spectrum of dansyl chloride (in CDCl3/ 0.1% pyridine-ds) indicated several 
differences. The doublet at SH 8.68 ppm (in the lH NMR spectrum of dansyl 
chloride) was apparent at SH 8.60 ppm in the lH NMR spectrum of the product. A 
doublet (integral corresponding to two protons) present at SH 8.26 ppm in the lH 
NMR spectrum of the product appeared to have arisen from overlap of the SH 8.42 
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ppm (doublet) and OH 8.35 ppm (doublet of doublets) resonances observed in the lH 
NMR spectrum of dansyl chloride. Two doublet of doublets (appearing as two 
triplets) at OH 7.69 ppm and OH 7.56 ppm in the lH NMR spectrum of dansyl 
chloride, were visible as a "quintet" (ie two overlapping "triplets") resonance at OH 
7.58 ppm and OH 7.52 ppm in the lH NMR spectrum of the product. This 
information indicated that dansyl homohalichondrin B (8.5.2) was formed in the 
reaction. An integral over the two H47 resonances indicated that there was 51% 
homohalichondrin B (1.2.3) and 49% dansyl homohalichondrin B (8.5.2) present in 
the reaction product. 
This material was re-reacted with the objective of increasing the amount of product 
formed. 
Thirteen mole equivalents of dansyl chloride (in pyridine) were added to the material 
from the previous reaction dissolved in pyridine. The resulting solution was stirred 
at 35°C for seventeen hours. Silica TLC performed on the reaction mixture did not 
indicate any change in the relative amounts of homohalichondrin B (1.2.3) or dansyl 
homohalichondrin B (8.5.2). A 1 H NMR spectrum obtained from the reaction 
product indicated that a mixture of 56% dansyl homohalichondrin B (8.5.2) and 44% 
homohalichondrin B (1.2.3) was present. This was little improvement in terms of 
reaction yield, relative to the initial reaction. 
An analysis of several TLC stationary phases and solvent systems indicated that 
either C18 or diol stationary phases would provide a good basis for chromatographic 
separation of the two components in the product. 
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Analytical reverse phase HPLC (using a C18 column), performed on the product, 
indicated homohalichondrin B (1.2.3) was eluting slightly before a uv-active 
component. The uv spectrum of this component showed absorbance maxima at A, 
195 nm, 215 nm, 245 nm and 330 nm. A standard injection of dansyl chloride gave 
a uv spectrum with absorbance maxima at A, 208 nm, 264 nm and 369 nm for the 
only peak in the chromatogram. However, a base-line separation of the two 
components was not able to be achieved on the analytical C18 HPLC column which 
would provide a good basis for a preparative separation. 
A diol cartridge column was investigated as a potential separation method. The 
product was placed onto a cartridge diol column, eluting with acetonitrile and 
increasing isopropyl alcohol/ acetonitrile mixtures. Silica TLC of the resulting 
fractions indicated that the presence of halichondrin material was predominantly in 
the first three fractions. The first fraction appeared to be pure dansyl 
homohalichondrin B (8.5.2), the second fraction appeared to be a mixture of dansyl 
homohalichondrin B and homohalichondrin B (1.2.3) while the third fraction 
appeared to be pure homohalichondrin B. It was decided that the column should be 
started with a less polar solvent to retain the halichondrins on the column longer to 
provide a better separation. The three fractions were recombined and placed on a 
cartridge diol column equilibrated to dichloromethane. Fractions eluting with 
dichloromethane and increasing acetonitrile/ dichloromethane mixtures were 
collected before stripping the column with acetonitrile. The progress of the 
fluorescent material through the column was able to be followed by shining the 
visible lamp on the column and observing the movement of the yellow fluorescence. 
Silica TLC indicated that the halichondrins were spread over the first eight fractions. 
The first fraction appeared to contain only dansyl homohalichondrin B (8.5.2), while 
fractions three through to eight contained homohalichondrin B (1.2.3). Fractions 
were combined on the basis of the TLC results. 
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A lH NMR spectrum (in CDCl3/ 0.1% pyridine-ds) acquired on the combined 
fractions three through to eight from the diol column, showed very weak signals. 
However, it was possible to detect the distinct H55/H55' doublet (at OH 3.69 ppm) 
and the isolated H47 resonance (at OH 3.06 ppm), characteristic of homohalichondrin 
B (1.2.3). No evidence of the aromatic or N(CH3)2 resonances of dansyl 
homohalichondrin B ( 8.5.2) were observed in the spectrum. 
A 1 H NMR spectrum of the least polar component from the diol column (in CDCl3/ 
0.1% pyridine-ds) showed the presence of very weak signals. The H47 resonance 
was apparent at OH 3.02 ppm, and the N(CH3h methyl singlet was also apparent at 
OH 2.88 ppm. No H47 resonance was apparent at OH 3.06 ppm, as would be the case 
if homohalichondrin B (1.2.3) was present. The NMR tube was observed to 
fluoresce strongly yellow under the visible lamp. These observations supported the 
TLC evidence that the sample was pure dansyl homohalichondrin B (8.5.2). There 
were insufficient quantities of this sample to progress further with. 
A modified method for generating dansyl homohalichondrin B (8.5.2) was attempted 
with the objectives of increasing the yield of the reaction and providing sufficient 
material to allow a NMR spectroscopic assignment of the product. 
Homohalichondrin B (1.2.3) was dissolved in dichloromethane and dansyl chloride 
and pyridine (a slight excess relative to dansyl chloride) were added to the solution 
to give five mole equivalents of dansyl chloride. The solution was stirred at room 
temperature. After three hours reaction, silica TLC indicated some evidence of the 
dansyl derivative forming. The reaction was continued with stirring overnight at 
room temperature. TLC performed on the reaction mixture after this time indicated 
no change, relative to the TLC performed after three hours reaction. The molar ratio 
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of dansyl chloride ratio was increased to 10:1 and additional pyridine was added. 
The reaction was stirred at 35°C for a further three hours. TLC performed after this 
time indicated an increase in the relative amount of dansyl homohalichondrin B 
(8.5.2), although homohalichondrin B (1.2.3) appeared to be the major component of 
the reaction mixture. After six hours at 35°C, TLC indicated the major component 
of the reaction was dansyl homohalichondrin B (8.5.2). After ten hours at 35°C, no 
change in the appearance of the TLC of the reaction mixture was evident. The molar 
ratio of dansyl chloride was increased again to give fifteen mole equivalents and 
more pyridine was added. The resulting solution was stirred overnight at 35°C. No 
change in the appearance of the TLC of the reaction mixture was apparent, so the 
reaction was worked-up. 
This material was combined with the dansyl homohalichondrin B (8.5.2) separated 
previously from the diol column and a diol cartridge separation of the combined 
mixture was undertaken. Fractions of 10% hexane/ dichloromethane elutions were 
collected and analysed by silica TLC. When TLC indicated the two components had 
been successfully separated, the remaining homohalichondrin B (1.2.3) was stripped 
off the column with methanol. Fractions were combined on the basis of the TLC 
results. 
A lH NMR spectrum acquired from the more polar, non-fluorescent component (in 
CDCl3/ 0.1% pyridine-ds), was identified as being homohalichondrin B (1.2.3) with 
very minor dansyl-related impurities (as evidenced by the presence of the N(CH3)z 
singlet at OH 2.88 ppm). 
A lH NMR spectrum acquired from the less polar, fluorescent yellow component 
was identical with the previously described spectrum of dansyl homohalichondrin B 
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(8.5.2). This spectrum was obtained in CDCl3/ 0.1% pyridine-d5 and is displayed in 
Figure 8.5.1. 
Figure 8.5.1 lH NMR Spectrum ofDansyl Homohalichondrin B (8.5.2) 
COSY, 2D-TOCSY (100 ms mixing time) and HMQC experiments, acquired from 
the product, enabled the partial assignment of the 1 H and 13C NMR spectra to be 
achieved. The HMQC spectrum acquired gave a low signal to noise ratio, a 
reflection of the small sample size (0.4 mg). This meant only a few correlations 
were observed and consequently only a few 13C resonances were able to be assigned. 
The important correlations from these experiments are depicted in Figure 8.5.2 and 
the 1H and 13C NMR data are listed in Tables 8.5.1 and 8.5.2 respectively. 
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Table 8.5.1 1 H NMR Data for Dansyl Homohalichondrin B (8.5.2) 
Proton a oppmb Proton a oppmb Proton a oppmb 
H2 2.34 H23 3.52 CH3-42 0.89 
H2' 2.58 H24 1.05 H43 1.26 
H3 3.89 H24' 1.70 H43' 1.42 
H4 1.35 H25 2.20 H45 
H4' CH3-25 1.06 H45' 1.36 
H5 1.37 26=CH 4.75 H46 2.10 
H5' 2.07 26'=CH 4.80 CH3-46 0.89 
H6 4.33 H27 3.50 H47 3.02 
H7 2.94 H28 H48 3.47 
H8 4.32 H28' H49 1.70 
H9 4.04 H29 4.19 H49' 2.07 
HlO 4.18 H30 4.65 H50 3.79 
Hll 4.58 H31 2.04 H51 3.96 
H12 4.68 CH3-31 0.99 H52 1.88 
Hl3 1.94 H32 3.17 H52' 1.88 
Hl3' 2.16 H33 3.78 H53 4.12 
H15 H34 H54 3.67 
H15' H34' 2.14 H55 4.02 
H16 H35 4.10 H55' 4.02 
H16' H36 H2' 8.60 
H17 4.09 H37 1.90 H3' 7.52 
H18 2.25 H37' 2.33 H4' 8.26 
H18' 2.79 H39 2.17 N(CH3)2 2.88 
19=CH 4.90 H39' 2.17 H6' 7.25 
19'=CH 4.98 H40 3.87 H7' 7.58 
H20 4.37 H41 3.54 H8' 8.26 
H22' H42 2.28 
a The symbol' represents the less shielded proton of a geminal pair. 
h Data recorded at 23 °C in CDCI3 at 300 MHz with chemical shifts in ppm 
and referenced to CH03, SH 7.25 ppm. 
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Table 8.5.2 13C NMR Data for Dansyl Homohalichondrin B ( 8.5.2) 
Carbon oppma Carbon oppma Carbon oppma 
C1 C24 C44 
C2 C-CH3-25 C45 
C3 C-CH3-2S 17.8 C-CH3-46 
C4 26C=CH2 C-CHJ-46 17.0 
C5 26C=CH2 C47 72.6 
C6 C27 C48 63.6 
C7 77.5 C28 C49 
C8 C29 C50 74.7 
C9 73.8 C30 76.9 C51 
C10 76.5 C-CH3-31 C52 
Cll 82.1 C-CH3-31 14.7 C53 
C12 81.2 C32 77.3 C54 70.5 
C13 48.2 C33 66.3 C55 71.6 
C14 C34 Cl' 
C15 C35 C2' 
C16 C36 C3' 
C17 C37 C4' 
C18 C38 C5' 
19C=CH2 C39 42.2 N(CH3h 45.3 
19C=CH2 C40 70.6 C6' 
C20 75.3 C41 79.3 C7' 
C21 C-CH3-42 C8' 
C22 C-CHJ-42 17.0 C9' 
C23 73.3 C43 C10' 
a Be NMR spectral data assigned from an HMQC experiment, recorded at 23 oc in 
CDCl3 at 300 MHz with chemical shifts in ppm. 
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NMR spectroscopic assignments of the 1 H and 13C NMR spectra for resonances in 
the C1-C37 region were consistent with those of homohalichondrin B (1.2.3). As 
expected, interest was focused on changes in the terminal region of the molecule. 
From the H47 proton resonance (at SH 3.02 ppm) correlations in the 2D-TOCSY 
spectrum were observed to a proton resonating at bH 3.47 ppm (H48), the CH3-46 
methyl protons at SH 0.89 ppm, a resonance at bH 2.10 ppm and another at bH 1.36 
ppm. The CH3-46 resonance was correlated to the OH 2.10ppm resonance in the 
COSY spectrum, identifying it as the H46 resonance. The bH 1.36 ppm resonance 
was therefore assigned as an H45 resonance. A COSY correlation observed between 
OH 2.10 ppm (H46) and SH 1.36 ppm (H45) supported this assignment. The H50 and 
H51 proton resonances were located from a COSY correlation between a resonance 
at SH 3.79 ppm (H50) and another at OH 3.96 ppm (H51). The H50 resonance was 
correlated to a signal at bH 1. 70 ppm (H49'). The H49 resonance was located from a 
COSY correlation between the H49' resonance and its geminal partner at OH 2.07 
ppm. The H51 resonance was correlated to a proton at OH 1.88 ppm which was 
attributed to the H52/H52' signal. Two COSY correlations were observed from a 
resonance at OH 3.67 ppm, to bH 4.02 ppm and to OH 4.12 ppm. The central proton 
resonance (bH 3.67 ppm) was assigned as H54. An HMQC correlation was observed 
for a carbon at Be 71.5 ppm to the proton resonance at OH 4.02 ppm. The carbon 
resonance was too shielded to be attributed to the C53 carbon resonance so was 
assigned as the C55 resonance. The OH 4.04 ppm proton signal was assigned as the 
H55/H55' resonance. The H55/H55' resonance in the 1 H NMR spectrum of 
homohalichondrin B (1.2.3) was observed at OH 3.69 ppm; a shift of OH 0.33 ppm to 
a more deshielded chemical shift for the corresponding protons in 8.5.2. In the trial 
reaction to form the dansyl n-hexanol derivative (Section 8.5.1), a shift of OH 0.34 
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ppm, to a more deshielded position, was noted for the terminal hydroxy 1 H NMR 
resonances in the product. 
Two spin systems were evident for the aromatic proton resonances from the COSY 
spectrum. One spin system was assigned from the COSY spectrum, from a central 
proton at OH 7.58 ppm resonance to protons correlated at OH 8.26 ppm and OH 7.25 
ppm. The other spin system showed COSY correlation from a central resonance at 
OH 7.52 ppm to aromatic protons on either side at OH 8.60 ppm and OH 8.26 ppm. 
These represented the H2'-H3'-H4' and H6'-H7'-H8' spin systems. The most upfield 
resonance(~ 7.25 ppm) was assigned as the proton adjacent to the N(CH3)2 group 
ie the H6' resonance, thereby assigning the H7' (OH 7.58 ppm) and H8' (OH 8.26 ppm) 
resonances. The H2' resonance, adjacent to the sulfonyl functionality, was assigned 
as the most downfield proton resonance, OH 8.60 ppm, thereby assigning the 
chemical shifts of the H3' (OH 7.52 ppm) and H4' (OH 8.26 ppm) resonances. 
These NMR data supported the formation of the dansyl derivative of 
homohalichondrin B (8.5.2). 
Subsequent dansylation reactions were attempted on homohalichondrin B (1.2.3) in 
an attempt to increase the reaction yield. Reaction was attempted in a dry nitrogen 
atmosphere using the dichloromethane solvent method described previously. 
Reaction was then attempted using carbonate as the base in an aqueous acetone 
solvent system. 
Homohalichondrin B (1.2.3) was dissolved in dichloromethane and dansyl chloride 
(15 mole equivalents), and pyridine were added to the solution. The resulting 
solution was stirred at 35°C for six and a half hours under an atmosphere of dry 
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nitrogen. Silica TLC performed on the reaction mixture indicated a minor amount of 
dansyl homohalichondrin B (8.5.2) had formed. More pyridine was added to the 
solution to ensure the pH remained high, and the solution was continued stirring 
overnight at 35°C. Silica TLC performed after this time indicated the major 
component was the dansyl homohalichondrin B derivative (8.5.2). A lH NMR 
spectrum performed on the product (in CDCl3/ 0.1% pyridine-ds) indicated the 
mixture was ca 65% dansyl homohalichondrin B (8.5.2) and 35% homohalichondrin 
B (1.2.3). This material was committed for the next reaction. 
Dansyl chloride and sodium carbonate were added to the product from the previous 
reaction. Acetone and water were added and the resulting solution was stirred at 
35°C for twenty-four hours. A lH NMR spectrum of the worked-up material, 
performed in CDCl3/ 0.1% pyridine-ds, indicated that the reaction had not gone to 
completion, with the H47 resonance of homohalichondrin B still visible at OH 3.06 
ppm. 
The dansylation reaction was attempted on isohomohalichondrin B (1.2.9) which has 
a primary hydroxyl group, rather than a terminal diol as in homohalichondrin B 
(1.2.3), to ascertain if the reaction would to completion in the absence of a terminal 
diol. The reaction was also attempted on halichondrin B (1.2.1). 
Chapter 8- Labelling Studies 283 
8.5.3 Dansyl Chloride Reactions of lsomohalichondrin B 
Isohomohalichondrin B (1.2.9) was dissolved in dichloromethane and dansyl 
chloride and pyridine were added to give a 15:1 ratio of dansyl chloride to 1.2.9. 
The solution was stirred at 35°C for twenty-four hours. The reaction was carried out 
under an atmosphere of dry nitrogen and the reaction progress was monitored by 
silica TLC. TLC performed after twenty-four hours indicated the appearance of two 
components; a fluorescent yellow spot (under a visible lamp) at a higher Rr relative 
to isohomohalichondrin B (1.2.9) and a component with the same Rr as 1.2.9. There 
appeared to be similar amounts of the two components in the reaction mixture. 
Additional pyridine was added to the reaction mixture to ensure the pH remained 
high and the reaction was continued for another six hours at 35°C. A 1 H NMR 
spectrum obtained from the product (in CDCI3/ 0.1% pyridine-ds) indicated the 
presence of a new H47 resonance at OH 3.08 ppm. An integration over this 
resonance indicated 59% of the dansylated isohomohalichondrin B product (8.5.3) 
was formed. Also apparent from this spectrum was the appearance of a new methyl 
doublet at OH 0.58 ppm, at a relatively shielded position. Several aromatic 
resonances were also apparent in the spectrum. 
A COSY experiment was performed on the mixture. An analysis of this spectrum 
revealed the CH3-46 resonance at OH 0.58 ppm was correlated to a proton resonance 
at OH 2.03 ppm. The OH 2.03 ppm resonance was correlated to the H47 resonance at 
OH 3.08 ppm. A COSY correlation was observed between the H47 resonance and the 
H48 resonance at OH 3.53 ppm. The H52 and H52' resonances were located from a 
COSY correlation observed between them at OH 2.40 ppm and OH 2.92 ppm. The 
H55/H55' and H54/H54' resonances were unable to be located in the COSY 
spectrum. The COSY spectrum revealed the two spin systems (H2'-H3'-H4' and H6'-
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H7'-H8') for the aromatic protons of the dansyl derivative. COSY correlations were 
observed from a central triplet at OH 7.40 ppm to a resonance at OH 8.24 ppm and a 
resonance at OH 8.34 ppm. Another triplet at OH 7.44 ppm showed correlation to 
protons resonating at OH 8.70 ppm and OH 7.10 ppm. 
These NMR data supported the TLC evidence that dansyl isohomohalichondrin B 
(8.5.3) had been formed in the reaction. 
dansyl isohomohalichondrin B (8.5.3) 
The product was re-reacted in pyridine with a ninety-fold excess of dansyl chloride. 
The reaction was stirred at 35°C, monitoring the reaction by silica TLC. After thirty 
hours reaction, silica TLC indicated the presence of a component with the same Rr as 
isohomohalichondrin B (1.2.9) and a less polar fluorescent yellow component. A lH 
NMR spectrum of the product (CDCb/ 0.1% pyridine-ds) showed an increase in the 
complexity of the spectrum. The H47 resonance of isohomohalichondrin B (at OH 
3.23 ppm) appeared to have reduced in intensity. The methyl region showed several 
new doublet resonances at ca OH 0.90 ppm and two new doublets at OH 0.69 ppm and 
OH 0.74 ppm. Also apparent from the spectrum was a decrease on the intensity of the 
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OH 0.58 ppm (CH3-46) resonance of 8.5.3. The distinctive H55/H55' triplet of 
isohomohalichondrin B (1.2.9) was no longer apparent at OH 3.69 ppm. Several 
aromatic resonances and the N(CH3)2 resonance were apparent in the spectrum. 
There appeared to be changes in the chemical shifts of other isohomohalichondrin B 
resonances, such as the H32 resonance (8H 3.20 ppm) and the CH3-31 resonance (8H 
1.00 ppm). This spectrum indicated that there were several components present in 
the product mixture, including minor amounts of isohomohalichondrin B (1.2.9) and 
dansyl isohomohalichondrin B (8.5.3). There also appeared to be at least one other, 
unidentified product present. 
8.5.4 Dansyl Chloride Reaction of Halichondrin B 
Halichondrin B (1.2.1) was dissolved in dichloromethane and dansyl chloride in 
dichloromethane, and pyridine, were added to give a 1: 1 molar ratio of dansyl 
chloride to halichondrin B. The reaction was stirred at 35°C. Silica TLC performed 
on the reaction mixture after twenty minutes showed the formation of a less polar, 
fluorescent component relative to homohalichondrin B. The dansyl chloride: 
halichondrin B ratio was increased to 5:1 and the reaction mixture was stirred at 
35°C. After a total of one hour reaction, silica TLC indicated an increased 
proportion of the less polar component. After a total of three hours reaction, silica 
TLC indicated no further change so the dansyl chloride to halichondrin B ratio was 
increased to 10:1. The reaction was continued stirring at 35°C for a further two and 
a half hours and the ratio was increased to 15:1 and the reaction was stirred overnight 
at 35°C. After this time the reaction was worked-up and a 1 H NMR spectrum was 
obtained from the product (in CDCl3/ 0.1% pyridine-ds) which indicated a mixture 
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of components was present. In the 1 H NMR spectrum of halichondrin B (Figure 
2.2.1), the H47 resonance was obscured by other resonances at OH 3.61 ppm. This 
meant a quantification of the relative amounts of dansyl halichondrin B and 
halichondrin B was not possible directly from the 1 H NMR spectrum. Several 
proton resonances were apparent in the aromatic region and the N(CH3)2 singlet was 
also visible at ca DH 2.90 ppm, indicating that dansylation had occurred. TLC 
performed on the worked-up material indicated there were similar amounts of 
dansylated halichondrin B and halichondrin B present. 
8.5.5 Conclusion 
It was apparent, from the series of dansylation reactions that were performed on 
selected halichondrins, that a quantitative yield was not able to be achieved using the 
described methods. It was not possible to achieve greater than 60-65% dansylation, 
despite the variety of conditions attempted. The trial reactions with n-hexanol 
(Section 8.5.1) indicated that the reagent and methodology were suitable for the 
derivatisation of a simple alcohol. Failure to produce a quantitative yield for the 
dansylation reactions of the halichondrins appeared to be associated with the 
halichondrins themselves. If this problem was indeed a halichondrin-based problem 
it would not be a suitable analytical method. 
Possible alternative fluorogenic reagents that may be more amenable to quantitative 
reaction at the primary alcohol of a halichondrin include AIC,79 DMA-NN80 or 
NJC.81 
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8.6 Biological Activity Data 
The P388 cytotoxicity of the dansyl homohalichondrin B derivative (8.5.2) was 
tested to give additional structure-activity information. The activity of this 
derivative is cited in Table 8.6.1 along with the P388 activity of the parent 
halichondrin, homohalichondrin B (1.2.3). 
Table 8.6.1 In Vitro Cytotoxicities of Selected Halichondrins 
Compound P388 ICso 
(ng/mL) 
homohalichondrin B (1.2.3) 0.22 
dansyl homohalichondrin B (8.5.2) 2. 7 
The P388 activity of the dansyl homohalichondrin B derivative (8.5.2) was ca twelve 
times less active than the parent halichondrin, homohalichondrin B (1.2.3). It is 
interesting to note that the addition of a relatively large substituent to the terminal 
hydroxyl group of homohalichondrin B did not result in a particularly large decrease 
in the P388 activity. 
The biological activity of the dansyl homohalichondrin B derivative (8.5.2) is further 
discussed in relation to other halichondrin derivatives in Chapter 9. 
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9.1 Introduction 
The biological activities of the individual hemi-synthetic halichondrin derivatives 
were described in the previous Chapters. The activities of these derivatives are 
reviewed in this Chapter, in relation to each other and in relation to the biological 
activities of specific naturally-occurring halichondrins, to give an overall picture of 
structure-activity relationships in the halichondrin series. 
The primary constraint placed upon the production of the hemi-synthetic 
halichondrin derivatives required to facilitate an investigation of the relationship 
between structure and activity in the halichondrin series, was the limited supply of 
halichondrin material available. The total amount of halichondrin material used for 
this project was less than 80 mg. 
A second constraint placed on this aspect of the project was attributable to the 
complexity of the halichondrin molecule, placing relatively long time frames on the 
spectroscopic characterisation of the derivatives produced. 
Another, less significant, limitation was the small number of functionalities that 
could be targeted for modification in the halichondrin molecule. Generally, this 
restricted the modifications to the terminal moiety, the lactone ring (Cl-C30), the 
exocyclic methylenes (19=CH2 and 26=CH2) and the tricyclo system (C-B rings) of 
the halichondrin molecule. 
Consequently, the derivatives produced were, for the most part, carefully selected to 
provide maximal structure-activity information. As such, these derivatives by no 
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means represented the complete range of "useful" semi-synthetic derivatives, in 
terms of structure-activity information. 
9.1.1 Physical Properties and the Biological Assays 
The antitumour activity observed for a compound is a function of several factors. In 
the case of mitotic inhibitors, the compound must first gain entry to the cell across 
the plasma membrane. There are several mechanisms by which compounds can 
cross the cell membrane: via simple diffusion, facilitated diffusion, active transport, 
through "pores" in the membrane or via pinocytosis or phagocytosis. 84 The process 
by which a molecule is transported across a membrane depends on the membrane 
type and the nature of the molecule. Generally, simple diffusion is governed by the 
partition coefficient; the higher the lipid/water ratio of the substance, the greater the 
proportion is found inside the cell after equilibration. 84 This relationship appears to 
fall off with increasing molecular weight (> 150 g/mol) and increasing 
hydrophilicity. 84 This would tend to suggest that the physical size of the 
halichondrins reduces the likelihood of simple diffusion acting as the primary 
transport mechanism to enter the cell. There is evidence to suggest the entry to 
tumour cell types in the halichondrin series, and other antimitotic compounds, is 
receptor-mediated as tumour-specific activity is observed in the NCI primary screen 
(discussed in Section 1.1.3). Once inside the cell, the halichondrins arrest mitosis at 
metaphase by preventing tubulin polymerisation and other associated processes 
(discussed in Section 1.2.3).24 The antitumour activity observed is therefore a 
complex interaction of several important factors. 
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The "structure" of the compound includes physical considerations such as the shape 
of the molecule (ie its conformation); its hydrophobicity and/or hydrophilicity and 
electronic effects. Any alteration to the nature of functional groups, chirality etc is 
likely to alter one, if not all of the above "structure" considerations and, as such, 
exert an influence on any one of the factors which determines antitumour activity in 
the halichondrin series. 
It is important, in order to assess the significance of the biological activities 
observed, to have an appreciation of the kind of (statistical) errors and their relative 
importance in the generated results. These errors can be broadly classified into two 
groups: those arising from the submitted sample and those arising from the assay 
itself. 
In terms of the sample, significant errors arise from the mass measurement of small 
samples and their corresponding dilutions for submission in the assay. Errors in 
volume measurements in the preparation of assay samples are also relatively 
significant. Another important consideration is the purity of the derivatives. 
Contamination arising from active compounds, such as the presence of small 
quantities of starting materials in the reaction product, would give misrepresentations 
in the activity observed and the possibility of synergistic or antagonistic effects in the 
assay. 
In terms of the P388 assay, possible sources of error include the measurement of 
volumes for dilution series, the extrapolation of the logiCso value from the dose-
response curve and the inherent 11biological nature" of the assay. To minimise the 
errors arising from these aspects of the biological activity measurements, samples 
were generally submitted at least twice, at two or more solution concentrations. Also 
included with each assay performed on a hemi-synthetic halichondrin derivative, was 
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a 11Control" halichondrin- either isohomohalichondrin B (1.2.9) or homohalichondrin 
B (1.2.3). Any control assay performed that gave an activity of greater than 0.4 
ng/mL or less than 0.1 ng/mL was treated with suspicion and was subsequently re-
assayed, along with the hemi-synthetic derivatives. Overall, examining the 
variability of the "control" halichondrins, the standard error averaged less than ca 
20% of the mean, including the ICso results >0.4 mg/mL and <0.1 ng/mL. This also 
accounts for errors in volume measurements in preparing samples for assay, but does 
not account for any possible errors in mass measurement. 
The results for compounds submitted for assay in the NCI's primary in vitro 
antitumour screen were generally more reliable from a statistical sense. Each 
compound was tested in quadruplicate at three concentration ranges over sixty 
different cell lines. The standard errors for the Glso results averaged less than 15% 
of the respective means. 
Statistical errors arising from inaccuracies in mass measurement contributed up to 
±20% to the actual activity results observed. Errors arising from sample impurities 
are addressed in the respective Chapters for the individual hemi-synthetic 
derivatives. 
More emphasis is placed on the biological data results from the NCI primary screen, 
as these results represent an average activity over sixty different cell lines, and 
therefore represent the "average" cytotoxicity of the compound. However, it is likely 
that the most useful derivatives from a therapeutic sense will display a strong 
differential inter-panel (ie tumour-specific) activity. The following analysis does not 
take this aspect into account. 
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9.2 Summary of Biological Activity Data 
9.2.1 P388 and NCI GI5o Data 
Figures 9.2.1 to 9.2.6 summarise the P388 assay and NCI primary screen data, in 
graphical form. Included in these figures are the activities of selected derivatives 
produced in this work (discussed in Chapters 3-8), and the activities of selected, 
naturally-occurring halichondrins. 
Figure 9.2.1 displays the absolute P388 in vitro assay results for selected 
halichondrins. Included in Figure 9.2.1 are the naturally occurring halichondrins 
1.2.1, 1.2.3, 1.2.9, 1.2.10, 1.2.11, 1.2.12 and 1.2.13. Also included are the terminal 
moiety-modified derivatives viz 3.2.1, 3.4.1, 3.4.2 and 8.5.2; the olefinic moiety-
modified derivatives, viz 4.3.1, 4.3.2 and 4.5.1; the lactone-modified derivatives, viz 
5.2.1, 5.2.2 and 5.3.1; and the three acid products, viz 6.3.1, 6.3.2 and 6.3.3. Not 
included in Figure 9.2.1 was the P388 activity of the oxidation product of 
isohomohalichondrin B monoacetate (3.2.1), as the structure was not able to be 
characterised with any degree of certainty (see Section 3.3). 
It can be concluded that most of the derivatives produced were less active than the 
naturally occurring compounds (Figure 9.2.1). One exception to this generalisation 
was the naturally-occurring Me-isohomohalichondrin B-b (1.2.12), the C55 methyl 
derivative of isohomohalichondrin B (1.2.9), which recorded a reduced P388 activity 
relative to the other naturally-occurring halichondrins. The significance of this 
observation is discussed later. 
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In general terms, Figure 9.2.1 indicates that changes in the terminal moiety resulted 
in less significant reductions in biological activity than alterations to other parts of 
the molecule. Large reductions in P388 activity were apparent when modifications 
involved the olefins and the lactone functionalities and the C38 stereochemistry. The 
isohomohalichondrin B di-osmate ester ( 4.3.1), was essentially inactive relative to 
the activities of the naturally occurring halichondrins. 
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Figure 9.2.1 Graph of P388 Activities of Selected Halichondrins 
In similar fashion, Figure 9.2.2 displays the NCI in vitro primary screen assay Glso 
results (over all sixty cell lines comprising the screen) for selected halichondrin 
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derivatives and naturally-occurring halichondrins. The hemi-synthetic derivatives 
3.2.2 and 8.5.2 were not assessed in the NCI screen. 
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Figure 9.2.2 Graph of In Vitro Biological Activities of Selected Halichondrins in 
the NCI Primary Screen 
Included with the naturally occurring compounds are norhalichondrin B (1.2.2) and 
the halistatins 1 and 2 (1.2.7 and 1.2.8 respectively). Pettit et a[,20 reported the Gl5os 
of these halistatins in the NCI screen at 7.1 x 1 Q-lOM (1.2. 7) and 6.8 x 10-1 OM 
(1.2.8) respectively. These compounds are lOa-hydroxy substituted halichondrin B 
(1.2.7) and lOa-hydroxy substituted homohalichondrin B (1.2.8) derivatives. The 
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activity observed for these lOa-hydroxy compounds is significantly reduced relative 
to the parent halichondrins, halichondrin B (1.2.1) at 1.38 x 10-lOM and 
homohalichondrin B (1.2.3) at 3.16 x I0-10M. The presence of hydroxyl groups at 
C 10 (in the tricyclo system) appears to reduce the cytotoxicity observed. 
It is relevant to note that Hirata and Uemural8 reported the B-16 (melanoma) in vitro 
activities of the "A-series" halichondrins norhalichondrin A and homohalichondrin A 
which have hydroxyl groups at the C12 and C13 positions of the molecule. These 
authors also included the B-16 activity of halichondrin C, the Cl2 hydroxyl 
derivative of halichondrin B. These naturally-occurring halichondrins were slightly 
less active than the corresponding "B series" halichondrins (vide Table 1.2.1). This 
result is consistent with the reduction in activity observed for the halistatin 
compounds. 
Norhalichondrin B (1.2.2) and isonorhalichondrin B (1.2.13) with observed Gisos of 
29.5 x lO-lOM and 12.30 x lO-lOM also display significant reductions in cytotoxicity 
relative to the other naturally occurring halichondrins. This implies the presence of a 
carboxylate at the terminus of norhalichondrin B results in a reduction in cytotoxicity 
as do the unusual M and N rings of isonorhalichondrin B. 
The activity of Me-isohomohalichondrin B-b (1.2.12) (2.00 x IQ-lDM) appears to be 
comparable to halichondrin B (1.2.3) (1.38 x lO-lDM), homohalichondrin B (1.2.3) 
(3.16 x IQ-lOM) and isohomohalichondrin B (1.2.9) (1.15x 10-10M). This was not 
the case in the P388 assay, suggesting that the P388 cell line is relatively more 
sensitive than the "average cell line" represented by the NCI overall Giso result to 
the presence of a terminal methoxyl group. 
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In general terms, it was apparent that the hemi-synthetic derivatives produced which 
involved alteration to the terminal moiety (viz 3.2.1, 3.4.1 and 3.4.2) were of 
comparable activity to the naturally-occurring halichondrins. All of the other 
derivatives presented significantly reduced activities, with the di-osmate ester of 
isohomohalichondrin B ( 4.3.1) and the lactone-opened isohomohalichondrin B 
derivative ( 5.2.1) appearing inactive relative to the naturally-occurring halichondrins. 
Next, the relative biological activities of the derivatives were examined. Figure 
9.2.3 shows the biological activities of the hemi-synthetic derivatives produced, 
relative to their parent halichondrins. The relative activity of the lactone-opened 
isohomohalichondrin B derivative (5.2.1) was ,expressed relative to Me-
isohomohalichondrin B-b (1.2.12) to ascertain the effect of opening the lactone ring 
without the complication of the terminal methoxyl group. Implicit in this, was the 
assumption that the reduction in activity due to the presence of a terminal methoxyl 
group and an opened lactone ring in the same molecule produced effects that were 
mutually exclusive ( ie there were no synergistic or antagonistic effects). 
Generally, Figure 9.2.3 shows that for the P388 assay results, the largest relative 
decreases in biological activity appeared to be associated with alterations to the 
olefins ( 4.3.1, 4.3.2 and 4.5.1), the lactone ring ( 5.2.1, 5.2.2 and 5.3.1) and the C38 
stereochemistry (6.3.2 and 6.3.3). The furan acid product (6.3.1) appeared to show a 
significant, but lesser relative decrease in biological activity. The derivatives 
involving alteration of the terminal moiety (viz 3.2.1, 3.2.2, 3.4.1, 3.4.2 and 8.5.2) 
showed little change in the activity relative to the relative parent halichondrins. 
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Figure 9.2.3 Graph of In Vitro Biological Activities of Derivative Halichondrins in 
the P388 Assay, Relative to the Relevant Parent Halichondrins 
Figure 9.2.4 shows the NCI in vitro antitumour primary screen results (the Giso 
averaged over all sixty cell lines) for the hemi-synthetic derivatives relative to the 
relevant parent halichondrins. From this graph, similar trends to Figure 9.2.3 are 
observed; little change in activity of the derivatives involving terminal modifications, 
and large relative changes for alterations to the olefins ( 4.3.1, 4.3.2 and 4.5.1), the 
lactone ring (5.2.1, 5.2.2 and 5.3.1) and the C38 stereochemistry (6.3.2 and 6.3.3). 
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The furan acid product (6.3.1) also showed a significant, but lesser, relative decrease 
in biological activity. 
It is interesting to note that the relative changes in activity overall were larger for the 
NCI primary screen results than the P388 assay results. This suggested that the 
murine leukemia cell line (P388) was less sensitive to changes in halichondrin 
structure than the NCI average over all of the sixty cell lines in the screen. 
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Figure 9.2.4 Graph of In Vitro Biological Activities of Derivative Halichondrins in 
the NCI Primary Screen, Relative to Relevant Parent Halichondrins 
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To ascertain if there was a relationship between the P388 assay results and the results 
obtained from testing in the NCI in vitro primary screen the results from the two 
assays were directly compared. Following discussions with Dr. David Newman of 
the NCI, 86 a comparison of one specific cell line from the NCI screen was 
undertaken, viz the CCRF CEM cell line (a human leukemia cell line) which was 
suggested to be the most comparable to the murine leukemia cell line (P388). 
Initially, the Glso over all sixty cell lines was compared with the Glsos extracted for 
the CEM cell line (Figure 9.2.5). From this graph, it is apparent that the Glsos from 
the CEM cell line correlated well with the average Glso over all sixty cell lines. One 
exception was the lactone-opened homohalichondrin B derivative (5.2.2) which 
appeared to be more sensitive to the CEM cell line than the "average" cell line. 
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Chapter 9- Summary of Structure-Activity Results 301 
The CEM cell line therefore appeared to give a good representation of the "average" 
cell line in the NCI primary screen. 
To facilitate the comparison of the P388 assay ICsos to the Gisos of the CEM cell 
line for the halichondrins tested in the NCI screen, the P388 assay results were 
converted to molar units. Figure 9.2.6 displays the P388 assay results against the 
CEM cell line Glso data for all of the halichondrins which underwent testing in the 
NCI screen. 
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Figure 9.2.6 Graph of In Vitro Biological Activities of Selected Halichondrins 
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From Figure 9.2.6, it is apparent that a correlation existed between the cytotoxicities 
observed in the P388 cell line and those observed in the NCI in vitro primary screen 
from one selected cell line from the screen (ie the CEM cell line). In general terms, 
those data appearing to the right of the bisecting line in the graph in Figure 9.2.6 
represent halichondrins which were more cytotoxic against the CEM cell line in the 
NCI screen, in terms of the Giso results. Conversely, those data situated to the left of 
the bisecting line represent halichondrins which displayed greater cytotoxicities 
against the murine leukemia cell line (P388) than to the CEM cell line in the NCI 
screen. There appears to be a good correlation between the two sets of data. 
However, two halichondrins showed significant deviations from this trend; the 
lactone-opened isohomohalichondrin B derivative (5.2.1) and the naturally-occurring 
Me-isohomohalichondrin B-b (1.2.12). Interestingly, these two halichondrins 
showed a similar trend for the average Giso (ie over all NCI cell lines) versus the 
P388 ICso results and both halichondrins possess terminal methoxyl groups. This 
suggests that the P388 cell line is relatively insensitive to the presence of terminal 
methoxyl groups in the halichondrin series. The lactone-opened homohalichondrin 
B derivative (5.2.2) appeared to show a similar level of activity against the CEM cell 
line. This indicated that this derivative was significantly more cytotoxic against the 
two leukemia cell lines (CEM and P388) than the NCI "average" cell line. 
9.2.2 NCI COMPARE Data 
The COMPARE correlation coefficient, extracted from the NCI primary screen mean 
graph profiles, gives useful information as to the mechanism of action of a class of 
inhibitors (Section 1.1.3).24,85 
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Essentially, calculations of the COMPARE correlation coefficient involve 
comparison of a selected mean-graph profile, for example, a compound with a 
defined mechanism of action (denoted the "seed"), to the mean-graph profile of 
another compound. In practical terms, the delta values (the deviation relative to the 
average selected response ie Giso, TGI or LCso) are calculated for each of the sixty 
cell lines in the mean-graph of a selected compound. Default or otherwise unreliable 
delta values from individual cell lines are discarded and a comparison of the 
individual "seed" deltas to those of the corresponding partner cell lines of the 
selected compound is subsequently quantified using the SAS statistical program to 
generate a Pearson product correlation coefficient for the pairs of delta values. 85 The 
resulting COMPARE correlation coefficient value ranges from 0 (mean-graph 
profiles displaying no similarity) to 1 for compounds with identical mean-graph 
profiles relative to the "seed". 
Figure 9.2.7 shows a comparison of the COMPARE correlation coefficients to the 
CEM cell line cytotoxicities (Gisos) from the NCI primary screen. Compounds 
included in Figure 9.2.7 are the hemi-synthetic derivatives and the naturally-
occurring halichondrins tested in the NCI in vitro primary screen. The "seed" 
compound, against which comparisons of the Glso-centred profiles were made, was 
halichondrin B (at the I0-7 M (upper limit) concentration) which was assigned a 
value of 1.00. Halichondrin B (1.2.1) and homohalichondrin B (1.2.3) are known to 
act as mitotic inhibitors, and as such display characteristic Glso-centred profiles. 24 It 
was interesting to determine whether there was a correlation between the biological 
activity observed and the ability to display the characteristic mitotic inhibition 
features of the Glso-centred profile. 
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Figure 9.2.7 has been arbitrarily divided into four quadrants to facilitate analysis of 
the data. The vertical line, placed at a Gls o of 10 x 10-10 M, divides those 
compounds which were relatively cytotoxic (appearing to the left of the line) from 
those displaying significantly reduced cytotoxicity relative to the parent 
halichondrins (appearing to the right of the line). 
Some interesting points arise from an examination of Figure 9.2.7, such as those 
compounds lying in QUADRANT 2 which correspond to compounds with high 
COMPARE correlation coefficients relative to the naturally-occurring halichondrins 
but were relatively inactive; the furan acid product (6.3.1), the tetrahydro 
homohalichondrin B derivative (4.5.1) and the epi acid product (6.3.3). This 
indicates that these compounds were still mechanistically acting as mitotic inhibitors, 
but with significantly reduced potency. These derivatives may provide important 
lead compounds which are less cytotoxic, but which still display the characteristic 
mechanistic profiles of the more cytotoxic halichondrins such as halichondrin B 
(1.2.1). These derivatives may also provide important leads in the development of 
antibody-linked halichondrins for therapeutic use. 
Also of interest are the six compounds in QUADRANT 4 which displayed reduced 
COMPARE correlation coefficients relative to the naturally-occurring halichondrins 
and correspondingly reduced cytotoxicities viz isohomohalichondrin B diketone 
(4.3.2), lactone-opened isohomohalichondrin B (5.2.1), lactone-reduced 
homohalichondrin B (5.3.1), the epi-furan acid product (6.3.2), the di-osmate ester 
(4.3.1) and the lactone-opened homohalichondrin B (5.2.2) derivative. The 
isohomohalichondrin B di-osmate ester ( 4.3.1) COMPARE correlation coefficient 
was calculated as <0.71, and as discussed previously, was essentially inactive in 
terms of cytotoxicity. This indicated that 4.3.1 had lost the ability to act as a mitotic 
inhibitor, resulting in the inactivity observed. These four compounds appeared to 
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follow the trend of displaying a loss in the characteristic halichondrin B antimitotic 
Glso-centred profile with a concomitant loss in cytotoxicity. This is probably a 
reflection of the reduced ability of the compound to inhibit tubulin polymerisation 
and/or microtubule assembly giving rise to an observed decrease in cytotoxicity. 
Four compounds situated in QUADRANT 3 displayed reduced COMPARE 
correlation coefficients with high cytotoxicities. These compounds appear to retain 
significantly high levels of cytotoxicity with a reduced ability to display the 
characteristic antimitotic mean-graph profile of halichondrin B (1.2.1). 
QUADRANT 1 contains the "seed" halichondrin, halichondrin B (1.2.1) and five 
other halichondrins: three naturally-occurring halichondrins; Me-
isohomohalichondrin B-a (1.2.10), neohomohalichondrin B (1.2.11) and 
homohalichondrin B (1.2.3), and two derivatives; reduction isomer (3.4.2) and 
isohomohalichondrin B monoacetate (3.2.1). These compounds presented high 
levels of cytotoxicity while displaying the characteristic mean-graph profile of 
halichondrin B (1.2.1). 
For the less active derivatives displaying relatively low cytotoxicities 
(QUADRANTS 2 and 4), the compounds 5.2.1, 5.2.2, 5.3.1, 6.3.2, 6.3.1 and 6.3.3 
appeared to display CDC!) conformations (as determined by NMR spectroscopy) 
which were unlike those of the active compounds halichondrin B (1.2.1) and 
homohalichondrin B (1.2.3). This implies that the reduction in biological activity 
observed, in a quantitative (Giso) and qualitative sense (COMPARE),85 was 
probably a function of the overall conformation of the molecule. In terms of the 
CDCh conformations for the derivatives producing relatively high cytotoxicities 
(QUADRANTS 1 and 3), generally they appear to display CDCb conformations 
similar to halichondrin B (1.2.1) such as homohalichondrin B (1.2.3) and 
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isohomohalichondrin B (1.2.9). This appeared to correlate with the Giso results; 
those with CDC}) solution conformations corresponding more closely to those of the 
naturally-occurring halichondrins (eg halichondrin B and homohalichondrin B) 
presented correspondingly high cytotoxicities and vice versa. 
Chapter 9- Summary of Structure-Activity Results 308 
9.3 Structure-Activity Conclusions 
It is essential for the expression of potent antitumour activity (ie compounds in 
QUADRANTS 1 and 3 in Figure 9.2.7) that the halichondrin molecule retains the 
integrity of the lactone ring (Cl-C30), the exocyclic methylenes (Cl9 and C26) and 
the natural stereochemistry of the C38 spiro centre. Of lesser importance is the 
nature of the tricyclo system; the presence of polar groups in this region resulted in a 
decrease in activity, although the presence of the B-ring furan reduced the activity 
significantly more. The nature of the terminal region of the molecule is less critical 
to the activity observed; this area was less sensitive to changes in structure, although 
the presence of an ionic terminal group (carboxylate) resulted in a significant 
decrease in activity. It would appear that the display of a high level cytotoxicity 
(QUADRANTS 1 and 3 in Figure 9.2.7) in the halichondrin series requires a CDCl3 
solution conformation similar to that of halichondrin B (1.2.1) and homohalichondrin 
B (1.2.3). 
In a qualitative sense, it appears that some halichondrin derivatives may still act as 
inhibitors oftubulin polymerisation and microtubule assembly (as determined by the 
COMPARE correlation coefficient) while exhibiting a reduction in cytotoxicity. 
These halichondrins (ie those in QUADRANT 2 in Figure 9.2.7) appeared to exhibit 
different CDCl3 solution conformations to those of halichondrin B (1.2.1) and 
homohalichondrin B (1.2.3). 
It would be purely speculative, without knowing more about the detailed 
mechanisms by which the halichondrins enter cells eg interaction with a cell-specific 
receptor or simple diffusion, and the nature of the interactions of the active 
halichondrins with tubulin to inhibit its polymerisation and microtubule assembly, to 
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ascertain the essential conformational features of halichondrins under physiological 
conditions. However, it does appear that any change in the chemical structure of 
halichondrins which results in a conformational change (as observed by NMR 
spectroscopy in CDCl3 solution) results in a large decrease in the cytotoxicity 
observed. As previously indicated, this conformational change does not necessarily 
ret1ect the ability of the compound to display the characteristic differential 
cytotoxicity patterns observed for more cytotoxic halichondrins. 
It is important to note that the CDCb solution conformation observed in the 
halichondrin series may not in fact represent the average solution conformation 
under physiological conditions or indeed the "active" conformation(s) which 
determine the high levels of cytotoxicity observed for selected members of the 
halichondrin series. However, it does appear that there is a correlation between the 
CDCl3 solution conformation and the biological activities observed. 
In terms of energetic considerations, the halichondrins, being relatively large 
molecules, have a high energetic cost associated with their synthesis relative to 
essential primary metabolites of similar size. The high energetic cost to the 
organism in producing such a large and apparently non-essential molecule indicates 
that it is producing a compound which has essential features for the display of 
cytotoxicity, with little or no structural redundancy, and this is reflected in the 
interpretation of the structure-activity results. 
It is also likely that, in such a large structure, the overall folding conformation of the 
molecule is an important determinant of cytotoxicity rather than any one specific 
functional feature. 
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My interpretation of these results suggests that the synthesis of a model compound 
with only the essential features present which are required for the expression of 
antitumour activity would not be an efficient process from a total synthesis approach 
because such a large portion of the molecule appears to be essential for the display of 
cytotoxicity. 
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CHAPTERlO 
Concluding Comment 
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The halichondrins, at the time of writing, represent exciting leads as anticancer 
compounds. Hopefully, the aspects of the chemistry and the biological activity of 
the compounds in the halichondrin series described in this thesis will improve the 
understanding of these compounds and will aid in the development of their future 
r6le as anticancer drugs. 
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General Methods 
All NMR spectra were recorded on a Varian Unity 300 spectrometer at 23·c, 
operating at 300 MHz for 1 H nuclei and at 75 MHz for 13C nuclei. Other NMR 
experiments described in this thesis viz lD and 2D-TOCSY, NOB, COSY, NOESY 
and the reverse-detected HMQC and HMBC experiments were recorded at 300 
MHz. This instrument was fitted with a Nalorac Z.spec 5 mm Indirect Detection 
Probe, except that for work described in Chapters 6 and 8 the data were obtained 
from the Varian Unity 300 spectrometer fitted with a Nalorac Z.spec MID300 3 mm 
Indirect Detection Probe. Chemical shifts in this thesis were described in parts per 
million (ppm), on the o scale, and were referenced to the appropriate solvent peaks: 
CDC13 referenced to CHCb at OH 7.25 ppm (lH) and CHCb at oc 77.0 ppm (13C); 
CD30D referenced to CHD20D at OH 3.30 ppm (lH) and CD30D at oc 49.3 ppm 
(13C). lH NMR spectra were recorded using an acquisition time (AT) of 2 s; 13C 
NMR spectra were recorded using an AT= 0.5 s. All difference NOB experiments 
were recorded on undegassed solutions, with AT= 1 s and an irradiation time (D2) of 
2 s and the decoupler offset 10,000 Hz for the control experiment. Percentage 
enhancements reported in this thesis represent the observed increase in the intensity 
of a specific resonance relative to the corresponding signal in the control spectrum. 
COSY experiments, including Phase-Sensitive and Double Quantum Filtered 
variants were recorded using an AT= 0.7 s, and a relaxation delay (D1) of 0.7 s. 1D 
and 2D-TOCSY spectra were recorded using an AT= 0. 7 s, and D1= 1 s, with mixing 
times indicated in the discussion. An AT= 0.5 sand D1= 0.33 s with a mixing time 
of 0.3 s were used for the NOESY experiments discussed in this thesis. All HMQC 
spectra (including HSMQC) were recorded with an AT= 0.24 s, D1= 0.3 s, J (X-H 
spin coupling constant)= 130Hz and null= 0.2 Hz. The acquisition parameters for 
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the HMBC experiments described in this thesis included: AT= 0.24 s, D1= 0.3 s, J = 
130Hz and JNXH = 6.0-8.0 Hz (average 2-3 bond coupling constant). 
Mass Spectrometry was performed on a Kratos MS80 RFA Mass Spectrometer 
operated at 4000 V. FAB was performed with an Ion Tech ZNIIFN ion gun using 
Xe as the reagent gas, operating at 8 kV and 2 rnA current with a m-nitrobenzyl 
alcohol (NOBA) matrix. Some samples (stated) were sent to Lewis Pannell 
(NIDDK, NIH) in the USA for HR F AB-MS analysis. 
Infrared (IR) Spectra were recorded using a Perklin Elmer 1600 Series FTIR 
spectrometer equipped with a Hewlett Packard Color Pro plotter. Samples were 
recorded as films on a potassium bromide plate. 
The HPLC work described in this thesis was performed on either one of two 
instruments. A Philips PU4100 Liquid Chromatograph equipped with a Philips 
PU 4120 Diode Array Detector interfaced to a PC General 486 computer running 
Philips PU6003 Diode Array Detector System Software (V3.0), and a Philips PPG 
3160/10 colour plotter was used for analytical and small-scale preparative HPLC. 
This instrument was equipped with a reverse-phase Brownlee Labs analytical C18 
column (dimensions 220 mm (L) x 4.6 mm (ID), 5 f.!ID particle size). Stated pre-
mixed solvent mixtures of acetonitrile (filtered, HPLC grade) and water (deionised 
and filtered, with 0.05% trifluoroacetic acid (TFA) added as stated) were used with a 
solvent flow rate of 1 mL/ min. A Shimadzu LC-4A instrument equipped with a 
Shimadzu UV Spectrophotometric Detector SPD-2AS (wavelength A= 199 nm) and 
a Hewlett Packard 3390A integrator was used for preparative reverse phase work 
using a Rainin Dynamax-60A C18 column (dimensions 250 mm (L) x 21.4 mm (ID), 
8 f.!m average particle size (APD)), the stated acetonitrile (ACN)/ water (no TFA 
added) mixture with a flow rate of 5 mLI min. 
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Diol column chromatography was performed using either ca 500 mg Bakerbond diol 
(40 ~m APD) in a Pasteur pipette or using a 500 mg disposable diol Bakerbond spe 
extraction cartridge, typically eluting with increasing ACN/ dichloromethane (DCM) 
mixtures. Octadecyl (C18) column chromatography was performed using a Cl8 500 
mg disposable Bakerbond spe ·cartridge, either gravity feed or vacuum-eluted using 
an Analytical International Vac-elut system, with stated solvent mixtures. 
Alternatively ca 500 mg C18 in a Pasteur pipette was used to perform gravity-feed 
C18 colu~n chromatography using the stated solvent mixtures. "Florisil" column 
chromatography was performed using 100-200 US mesh "Florisil" in a Pasteur 
pipette, eluting with the stated solvents. 
The analytical silica TLC described in this thesis was performed using Merck silica 
gel 60 F254 plastic-coated sheets, the silica 0.2 mm in thickness. Diol analytical 
TLC was performed using Merck F254 glass-backed plates of 0.2 mm thickness. 
Silica and diol plates were eluted with the stated methanol (MeOH)/ DCM mixtures, 
100% ethyl acetate (EtOAc), or isopropyl alcohol (IPA)/ ACN mixtures. Whatman 
MKC1s F TLC plates of 0.2 mm thickness were used for the analytical Cl8 TLC 
performed in this thesis. Typically, the C18 TLC plates were eluted with the stated 
ACN/ HzO mixtures. TLC plates containing halichondrins were visualised using a 
phosphomolybdic acid (PMA) in ethanol (EtOH) spray (1 0 % PMA in EtOH wlv ), 
followed by heating at ca 8o·c for 5 min to yield characteristic blue-brown spots. 
Some TLC plates (as stated) were initially visualised with iodine vapour or under 
short-wave (A 254 nm) and/or visible lamps (A 380-400 nm) before application of 
PMA spray. TLC results are described, where relevant, in Chapters 3-8. 
Computer modelling described in this thesis was performed on an IBM RISC System 
/6000 computer using the program MacroModel V 4.0 (in 2D graphics mode) and the 
associated computational program BatchMin V 4.0. CSC ChemDraw 3D Plus V3.1.1 
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was used for manipulation, structure editing, structure display purposes and 
performing simple energy minimisations. 
Micro scale reactions were primarily performed in 1 mL, 3 mL or 5 mL reacti-vials, 
apparatus from an Ace microscale glassware kit and specially constructed glassware 
that was required for specific reactions, as described. The vials were silylated prior 
to use by filling with a 10% solution of dichlorodimethylsilane in toluene for 20 min. 
The vials were then washed with MeOH, and rinsed with water before use. 
Technical grade solvents were distilled, dried and stored, where applicable, using 
standard procedures. Acetic anhydride was distilled immediately prior to use. Other 
reagents were either CP or AR grade, or were synthesised from CP or AR grade 
reagents and were used without further purification. "Ether" refers to specifically to 
diethylether. Methyltriphenylphosphonium iodide was obtained from Dr. Alan 
Rapper in this Department. Hexane was prepared from petroleum ether (10 L, b.pt. 
60-70°C), nitrating with a mixture of c. HN03 (1 L) and c. H2S04 (1 L) for two 
days. After this time, the nitrating mixture was removed and the petroleum ether 
was washed with water (20 L), and dried over CaCh overnight. The resulting 
solution was filtered through alumina and distilled. 
The pure halichondrins used to undertake the investigations described in this thesis 
were obtained from a Lissodendoryx sp. extraction performed by Dr. Marc Litaudon; 
this extraction procedure is described in the paper in Appendix IV. 
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Work Described in Chapter Two 
2.2 NMR Spectroscopic Assignment of Halichondrin B 
Halichondrin B (1.2.1): 
A pale yellow oil. 
1H and l3C NMR data cited in Tables 2.2.1 and 2.2.2 respectively. 
2.4 NMR Spectroscopic Assignment of Homohalichondrin B 
Homohalichondrin B (1.2.3): 
A clear, colourless oil. 
1H and 13C NMR data cited in Tables 2.4.1 and 2.4.2 respectively. 
2.5 Conformational and Stereochemical Studies on 
Isohomohalichondrin B 
Optical rotation of isohomohalichondrin B (1.2.3, ([a]n -21.6°)) determined in 
methanol solution at a concentration of 1.02 ng/mL using a Jasco J-20 recording 
spectropolarimeter. 
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Work Described in Chapter Three 
3.2 Acetylations 
Isohomohalichondrin B (1.2.9, 1.4 mg) was dissolved in dry pyridine (100 flL) and 
acetic anhydride (100 flL) was added. The reaction was stirred overnight at room 
temperature. The reaction was quenched by the addition of 0.5 mL water and the 
mixture was extracted with EtOAc (4 x 0.5 mL) and the solvent removed to give the 
products (1.4 mg). Silica TLC of the products was developed in 100% EtOAc and 
visualised. 
Isohomohalichondrin B acetylation: 
A pale yellow oil. 
FAB-MS: mlz monoacetate: 1164 (MH+), 1187 (MNa+), 1129 (MNa+-
AcO•) and diacetate: 1206 (MH+). 
Isohomohalichondrin B (1.2.9, 2.3 mg) was dissolved in dry pyridine (100 flL) and 
placed in an ice-bath at -YC, before acetic anhydride was added (100 flL). The 
reaction was stirred for 3 hrs at -5"C. The reaction was quenched with water (0.5 
mL) after this time, and the mixture was extracted with EtOAc (5 x 0.5 mL). The 
solvent from the EtOAc extract was removed to give the product (3.2.1, 2.4 mg). 
Silica TLC of the product (3.2.1) was developed in 100% EtOAc and visualised. 
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Isohomohalichondrin B monoacetate (3.2.1): 
A pale yellow oil. 
PartiallH NMR data (H45/H45'- H55/H55') cited in Table 3.2.1. 
To a solution of homohalichondrin B (1.2.3, 0.5 mg) in dry pyridine (75 j..tL), acetic 
anhydride (75 j..tL) was added, and the reaction was stirred at room temperature for 
45 min. Silica TLC performed on a small aliquot (ca 2 j..tL) removed from the 
reaction mixture was developed in 100% EtOAc and visualised. After 5 hrs reaction, 
silica TLC was performed on a small aliquot removed from the reaction mixture, 
developed (in 100% EtOAc) and visualised. The reaction was quenched at this time 
with 0.5 mL water and extracted with EtOAc (5 x 1 mL). The solvent (EtOAc) was 
removed, to give 0.6 mg of the product (3.2.1). 
Homohalichondrin B (1.2.3, 2.0 mg) was dissolved in dry pyridine (100 j..tL) and 
acetic anhydride (100 j..tL) was added to the solution. The reaction was stirred 
overnight at room temperature. Silica TLC was performed on a small aliquot 
removed from the reaction mixture, developed in 100% EtOAc, and then visualised. 
At this time the reaction was quenched (with 0.5 mL water), and the resulting 
solution was extracted with EtOAc (5 x 1 mL) and the solvent was removed to give 
2.1 mg of the product ( 3.2.2). 
Homohalichondrin B diacetate (3.2.2): 
A pale yellow oil. 
PartiallH NMR data cited in Chapter 3 (Section 3.2.1). 
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Homohalichondrin B (1.2.3, 1.5 mg) was dissolved in dry pyridine (75 IlL) before 
acetic anhydride (75 !J.L) was added to the solution. The reaction was stirred 
overnight at room temperature. Silica TLC was performed on a small aliquot 
removed from the reaction mixture, developed in 100% EtOAc and visualised. At 
this time the reaction was quenched (with 0.2 mL water), and the resulting solution 
was extracted with EtOAc (10 x 0.2 mL) and the solvent was removed to give 1.5 
mg of the product ( 3.2.2). 
3.3 Oxidation 
Isohomohalichondrin B monoacetate (3.2.1, 0.6 mg), dissolved in DCM ( ca 100 IlL), 
was added to freshly prepared pyridinium chlorochromate48 (2.2 mg) and sodium 
acetate (0.4 mg) in DCM (50 !J.L). The resulting solution was stirred at room 
temperature. Silica TLC was performed on a small aliquot ( ca 2 !J.L) removed from 
the reaction mixture after 60 hrs reaction, developed in 1% MeOH/ DCM and 
visualised initially with iodine vapour then PMA spray /heat. The reaction mixture 
was passed through a Florisil column equilibrated to 100% ether, and eluted with 
ether (6 mL) then 1% MeOH/ DCM (6 mL). These elutions were combined on the 
basis of silica TLC (developed and visualised as previously) and the solvent was 
removed to give 0.5 mg of material. 
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3.4 Sodium Borohydride Reduction 
Sodium borohydride (2.2 mg) was added to isohomohalichondrin B (1.2.9, 0.9 mg) 
dissolved in 200 J.!L dry IP A. The resulting suspension was vigorously stirred at 
room temperature for 0.5 hr. At this time, silica TLC was performed on an aliquot 
(ca 2 J.!L) taken from the reaction mixture, developed in 5% MeOH/ DCM and 
visualised. After a further 0.5 hr the reaction was quenched by the addition of 2 mL 
aqueous ammonium chloride solution (NH4Cl(aq), pH 3). This material was placed 
on a C18 cartridge (equilibrated with 100% H20) and washed with 6 mL 10% 
MeOH/ H20 (2 column volumes) under vacuum. The column was eluted with 100% 
MeOH (2 x 6 mL, 4 column volumes) under vacuum and the solvent removed from 
the eluent to yield 0.9 mg of products (3.4.1 and 3.4.2). 
To a solution of isohomohalichondrin B (1.2.9, 1.1 mg) in dry IPA (200 J.!L), sodium 
borohydride (2.5 mg) was added and the reaction was stirred vigorously at room 
temperature for 15 min. Silica TLC was performed at this time with a small aliquot 
of the reaction mixture, developed with 5% MeOHI DCM and visualised. The 
reaction was quenched after a further 15 min by the addition of 2 mL NH4Cl(aq) 
solution (pH 3) and placed on a C18 cartridge (equilibrated to 100% H20) under 
vacuum. The column was washed with 6 mL 10% MeOHI H20 and the products 
eluted with 100% MeOH (2 x 6 mL), under vacuum. The solvent was removed from 
the MeOH fractions to give 1.1 mg products (3.4.1 and 3.4.2). 
The products from both sodium borohydride reactions were combined and 
preparative HPLC was performed on the combined material. The Shimadzu HPLC 
was equipped with the preparative C18 column and the column was equilibrated to 
55% ACN/ H20 prior to a single injection of the product mixture dissolved in a 
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mixture of 100 JlL MeOH and 100 JlL of the mobile phase. The two peaks 
containing the products were collected separately and the solvent was removed to 
give 0.6 mg of reduction isomer 3.4.1 and 0.4 mg of reduction isomer 3.4.2. 
To a solution of isohomohalichondrin B (1.2.9, 5.0 mg) in 1 mL dry IPA, 14.4 mg of 
sodium borohydride was added, and the reaction was stirred vigorously at room 
temperature for 0.5 hr. Silica TLC was performed at this time, on a small aliquot of 
the reaction mixture, with the TLC plate being developed in 5% MeOHI HzO and 
visualised. After a further 0.5 hr reaction, the reaction was quenched with 2 mL 
NH4Cl(aq) solution (pH 3), and placed onto a cartridge Cl8 column equilibrated to 
100% HzO under vacuum. The cartridge was washed with 10% MeOH/ HzO (14 
mL) and the products were eluted off the column with 100% MeOH (2 x 6 mL). The 
solvent was removed from the MeOH fractions to give the products (3.4.1 and 3.4.2, 
4.8 mg). Preparative HPLC using the Shimadzu HPLC equipped with the 
preparative C18 column and equilibrated to 55% ACN/ HzO was performed in one 
injection of the products dissolved in 100 JlL and 100 JlL 55% ACN/ HzO. 
Collection of the two respective product peaks, followed by solvent removal, yielded 
1.6 mg of reduction isomer 3.4.1 and 1.2 mg of reduction isomer 3.4.2. The 
respective reduction isomers were combined from both preparative HPLC 
separations and reweighed to yield a total 2.4 mg of reduction isomer 3.4.1 and 1.8 
mg of reduction isomer 3.4.2. 
Reduction isomer (3.4.1): 
A white powder. 
lH and 13C NMR data cited in Tables 3.4.1 and 3.4.2 respectively. 
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High Resolution FAB-MS mlz 1125.6016 (MH+, +1.6 ppm for 
C6tHsgOtg). Performed at NIDDK, NIH (Lewis Pannell). 
Reduction isomer (3.4.2): 
A white powder. 
lH and 13C NMR data cited in Tables 3.4.3 and 3.4.4 respectively. 
High Resolution FAB-MS mlz 1125.5952 (MH+, -4.1 ppm for 
~lHsgOtg). Performed at NIDDK, NIH (Lewis Pannell). 
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Work Described in Chapter Four 
4.2 Trial Ozonolysis 
~-Pinene (9.4 mg) dissolved in 1 mL DCM was placed in a reacti-vial which was 
then sealed with a teflon septum. The sharpened end of a 3 em needlestock was 
inserted through the septum above the solvent level, with the other end inserted into 
a teflon tube which was placed into a solution of 10% potassium iodide and starch in 
5% aqueous sulfuric acid. The ozoniser needle was inserted through the septum and 
lowered into the ~-pinene solution with oxygen gas flowing through the needle. An 
energised Tesla coil vacuum tester was touched to the ozoniser needle stock above 
the reacti-vial to generate ozone, until the iodide/ starch solution turned blue/ black 
indicating complete 03 absorption had occurred in the reacti-vial and the reaction 
was complete. Nitrogen gas was flushed through the system. A suspension of ca 20 
mg zinc dust in a 50% aqueous acetic acid solution (200 ~-tL) was added to the reacti-
vial and the mixture was stirred overnight at room temperature. The mixture was 
extracted with ether ( 4 x 0.5 mL) and the solvent was removed. 
4.3 Osmylation Reactions 
An ether solution of osmium tetroxide ( 400 IlL at 50 mg/ mL) was added to 10 mg of 
~-pinene in 500 j..tL ether and 280 IlL pyridine and the reaction was stirred at room 
temperature. After 2 hrs, a solution of 18 mg sodium metabisulfite (NazSzOs) in 260 
IlL water and 175 j..tL pyridine was added to the reaction mixture and stirred at room 
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temperature for a further 15 min. The reaction was extracted with DCM (4 x 2 mL) 
and the solvent removed to give an oily product. 
Benzoin (10 mg) was dissolved in an aqueous solution of freshly prepared 40 mM 
sodium periodate (Nai04, 600 J,tL) and two drops of MeOH. The reaction was 
stirred at room temperature, in the dark overnight. The reaction solution was 
extracted with DCM (3 x 1 mL) and the solvent was removed to give the products. 
Isohomohalichondrin B (1.2.3, 0.4 mg) was dissolved in 20 J,tL Nai04 (aq) solution 
( 40 mM) and two drops of MeOH. The resulting solution was stirred at room 
temperature in the dark overnight. After this time, the solution was extracted with 
DCM (3 x 1 mL). The solvent was removed to give 0.5 mg isohomohalichondrin B. 
Silica TLC was developed in 5% MeOH/ DCM and visualised. 
A 100 mg/ mL solution of osmium tetroxide in ether (20 J.tL, 2.6 mol. equiv.) was 
added to isohomohalichondrin B (1.2.9, 3.3 mg) dissolved in pyridine (75 J,tL). After 
stirring the solution at room temperature for 4.5 hrs, a solution of Na2S 20s ( 6.0 mg) 
in water (90 J.LL) and pyridine (60 J.LL) was added to the reaction and stirred for a 
further 20 min at room temperature. The reaction mixture was extracted with DCM 
(4 x 2 mL) and the solvent removed to give 6.5 mg of material ( 4.3.1). 
Isohomohalichondrin B di-osmate ester ( 4.3.1): 
A black oil. 
lH and 13C NMR data cited in Tables 4.3.1 and 4.3.2 respectively. 
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A Pasteur pipette C18 column was equilibrated to 55% ACN/ HzO and the 
isohomohalichondrin B di-osmate ester ( 4.3.1, 1.1 mg) dissolved in 100 ~L MeOH 
and 100 ~L 55% ACN/HzO was placed on the column bed, eluting with 55% ACN/ 
HzO. Six fractions of ca 1 mL were collected before the column was stripped with 
100% ACN (2 x 5 mL fractions). Fractions two through to five were combined on 
the basis of silica TLC results (developed in 10% MeOH/ DCM), and the solvent 
was removed to give 0.7 mg of 4.3.1 for bioassay analysis. 
An aqueous 40 mM Nai04 solution (150 ~L) was added to 5.4 mg of 4.3.1 with two 
drops of MeOH to solubilise the halichondrin material. The reaction was stirred in 
the dark at room temperature for 4 days. Silica TLCs of small aliquots from the 
reaction mixture (ca 2 ~L) were developed in 10% MeOH/ DCM and visualised. 
The reaction mixture was extracted with DCM (8 x 1 mL) and the solvent removed 
to give 3.1 mg of the product ( 4.3.2). 
After acquisition of the NMR data, this material was subjected to preparative HPLC 
using the Shimadzu instrument with the preparative Cl8 column equilibrated to 55% 
ACN/ HzO. Fractions were collected from a single injection of the periodate 
cleavage product dissolved in a mixture of 100 ~L MeOH and 100 ~L mobile phase. 
The C18 column was subsequently stripped with 100% ACN. Silica TLC of the 
resulting fractions, developed in 10% MeOH/ DCM indicated that the halichondrin 
material was present in the 100% ACN column strip (2.8 mg). This material was 
placed on a C18 Pasteur pipette column equilibrated to 55% ACN/ HzO. Fractions 
of 500 to 750 ~L elutions of 55% ACN/ HzO were analysed by silica TLC 
(developed in 10% MeOH/ DCM and visualised). Fractions nine through to fifteen 
which contained isohomohalichondrin B diketone ( 4.3.2), as determined by 
comparison to a reference TLC spot, were combined to give 0.8 mg of 4.3.2 forMS 
and bioassay analysis. 
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Isohomohalichondrin B diketone ( 4.3.2): 
A yellow oil. 
1 H and 13C NMR data cited in Tables 4.3.3 and 4.3.4 respectively. 
High Resolution FAB-MS mlz 1165.49610 (MK+, -2.1 ppm for 
Cs9Hs2021K). Average of 7 acquisitions. 
A 40 mM aqueous Nai04 solution (20 ~L) was added to homohalichondrin B 
diacetate (3.2.2, 0.6 mg) with two drops of MeOH. The resulting solution was 
stirred at room temperature for 55 hrs in the dark. Silica TLC of the reaction mixture 
was developed in 100% EtOAc and visualised. The solution was extracted with 
DCM (5 · x 0.5 mL) and the solvent· removed to give 0.5 mg unreacted 
homohalichondrin B diacetate (3.2.2). 
Homohalichondrin B diacetate (3.2.2, 2.5 mg) was dissolved in pyridine (60 ~L), 30 
~L of osmium tetroxide solution in dry ether (50 mg/ mL, 2.8 mol. equiv.) was 
added, and the reaction was stirred at room temperature for 4.5 hrs. After this time a 
solution ofNa2S20s (4.8 mg) in water (75 ~L) and pyridine (50 ~L) was added and 
stirred for a further 20 min at room temperature. The reaction mixture was extracted 
with DCM (4 x 1 mL) and the solvent removed to give 2.8 mg of product. Silica 
TLC of the product was performed in 100% EtOAc and visualised. 
A freshly prepared aqueous 40 mM Nai04 solution (110 ~L) was added to the 
homohalichondrin B diacetate osmylation product with two drops of MeOH. The 
reaction was stirred in the dark at room temperature. Silica TLC was developed in 
10% MeOH/ DCM and visualised. After 45 hrs reaction the reaction mixture was 
extracted with DCM (5 x 1 mL) and the solvent removed to give 2.5 mg of 4.3.3. 
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Homohalichondrin B diacetate diketone (4.3.3): 
A yellow oil. 
lH and l3C NMR data cited in Tables 4.3.5 and 4.3.6 respectively. 
Homohalichondrin B diacetate (3.2.2, 1.5 mg) was dissolved in 30 ~L pyridine, then 
15 ~L (nominally) of osmium tetroxide in ether (50 mg/ mL, 2.4 mol. equiv.) was 
added and the resulting solution was stirred at room temperature for 4.5 hrs. After 
this time a solution ofNa2S20s (2.7 mg) in water (45 ~L) and pyridine (30 ~L) was 
added to the reaction mixture and stirred at room temperature for a further 20 min. 
The mixture was extracted with DCM (10 x 0.5 mL) and the solvent removed to give 
1.9 mg of products. After reaction was determined to be incomplete by lH NMR 
spectroscopy, the mixture of starting material and products were re-reacted under 
identical conditions to yield 1.7 mg of products. This material was subsequently 
dissolved in two drops of MeOH and 70 ~L of freshly prepared 40 mM aqueous 
Nai04 solution was added. The reaction was stirred at room temperature for 47 hrs 
in the dark. Silica TLC was developed in 10% MeOH/ DCM prior to visualisation. 
The reaction mixture was extracted with DCM (5 x 0.5 mL) and the solvent was 
removed to give 1.0 mg of product ( 4.3.3). 
4.4 Homohalichondrin B Diacetate Diketone Reduction 
Homohalichondrin B diacetate diketone ( 4.3.3, 1.0 mg) was dissolved in 60 ~.L of 
20% DCM/ IPA and a suspension of 2.1 mg NaBH4 in 150 ~L dry IPA was added. 
The reaction was stirred at room temperature and the reaction was monitored by 
silica TLC. Silica TLC was developed in 10% MeOHI DCM and visualised. The 
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reaction was quenched after 18 hrs by the addition of 2 mL NH4Cl(aq) solution (pH 
3). This material was placed on a C18 cartridge equilibrated to 100% H20 and 
washed with 6 mL 10% MeOHI H20 under vacuum. The column was eluted with 
100% MeOH under vacuum and the solvent removed from the eluent to yield 0.7 mg 
of products. Silica TLC performed on the products was developed with 10% MeOH/ 
DCM and visualised. Diol TLC was developed in 1% IPA/ ACN and visualised. 
The reduction products were dissolved in DCM and placed on a cartridge diol 
column equilibrated to 100% DCM. Nineteen fractions of 0.5 mL 100% DCM 
elutions (fractions 1-19) were collected. A further five fractions (fractions 20-24) 
were eluted with 10% ACN/ DCM. One 2 mL fraction eluting with 50% ACN/ 
DCM (fraction 25) was followed by a 2 mL elution of 100% ACN (fraction 26). The 
column was stripped with 100% MeOH (fraction 27). All fractions were analysed by 
silica TLC (developed in 10% MeOH/ DCM and visualised). Fractions 11 to 20, 
containing the less polar component(s) of the reaction mixture were combined on the 
basis of silica TLC to give 0.2 mg of material. Fractions 22 to 25 were combined to 
give 0.2 mg of the more polar component(s). 
4.5 Hydrogenation 
A suspension of 5% Pd/C catalyst in 200 ~L EtOH was added to homohalichondrin 
B (1.2.3, 2.3 mg) in a silylated 3 mL reacti-vial. The reacti-vial was attached to a 3-
way tap and a hydrogen-filled balloon and a vacuum supply. The reacti-vial was 
evacuated then hydrogen was admitted; this procedure was repeated. The reaction 
was stirred vigorously under hydrogen overnight at room temperature before the vial 
was evacuated. The vial contents were filtered through celite in a Pasteur pipette 
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with EtOH and the solvent was removed to give 2.1 mg of unreacted 
hornohalichondrin B (1.2.3). 
A suspension of 2.0 rng Pt02 (Adams' catalyst) in 200 J!L EtOAc was placed in a 10 
mL round bottom two-neck flask. On one neck, a three-way tap with a hydrogen-
filled balloon was attached together with a vacuum supply. On the other neck of the 
flask a rubber seal was attached. The flask was evacuated and then filled with 
hydrogen three times and the catalyst was stirred at room temperature under 
hydrogen for 30 min. Homohalichondrin B (1.2.3, 2.1 rng) dissolved in 200 JlL 
EtOAc was then injected through the septum into the flask. The reaction was stirred 
at room temperature for 4 hrs before the flask was evacuated. The flask contents 
were filtered through celite in a Pasteur pipette with EtOAc and the solvent was 
removed to give 2.1 mg of tetrahydro homohalichondrin B (4.5.1). 
Tetrahydro homohalichondrin B (4.5.1): 
A yellow oil. 
lH and 13C NMR data cited in Tables 4.5.1 and 4.5.2 respectively. 
High Resolution FAB-MS m/z 1149.59430 (MNa+, -2.7 ppm for 
C6tH9o019Na). 
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Work Described in Chapter Five 
5.2 Methanolysis 
Sodium methoxide (NaOMe) solution was freshly prepared by dropping sodium (Na) 
wire into dry methanol. A solution of NaOMe (10 mM, 200 JlL) in dry methanol 
was added to isohomohalichondrin B (1.2.9, 1.1 mg). The resulting solution was 
stirred overnight at room temperature. After this time, Na wire was added to the 
reaction whilst cooling the reaction vessel to give a sodium methoxide concentration 
of ca 0.5 M. The resulting solution was stirred at room temperature overnight. 
Silica TLCs were developed in 5% MeOH/ DCM and visualised. The reaction was 
quenched by the addition of 2 mL acidified water (aqueous ammonium chloride 
(NH4Cl)aq, pH 3) and placed on a cartridge C18 column. The column was washed 
with 10% MeOH/ H20 (2 x 5 mL) before eluting the halichondrin material off the 
column with 100% MeOH (2 x 5 mL). The MeOH fractions were combined and the 
solvent removed to give 1.3 mg of material (5.2.1). Some of this material (0.4 mg) 
was submitted forMS analysis and P388 assay. 
Isohomohalichondrin B (1.2.9, 2.2 mg) was stirred in a solution of sodium 
methoxide in dry MeOH ( ca 0.5 M, 200 JlL) at room temperature overnight. After 
this time, Na wire was added to the reaction mixture to give a NaOMe concentration 
of ca 1 M, and the reaction was stirred overnight. Silica TLCs were developed in 
5% MeOH/ DCM and visualised. The reaction was quenched with 2 mL acidified 
water ((NH4Cl)aq, pH 3) and placed on a cartridge C18 column. The column was 
washed with 10% MeOH/ H20 (2 x 8 mL) and the halichondrin material was eluted 
in 100% MeOH (2 x 8 mL). The MeOH fractions were combined and the solvent 
Experimental 333 
removed to give 2.2 mg of material (5.2.1). After comparison of their lH NMR 
spectra, the products from both reactions were combined to give 2.8 mg of 5.2.1. 
Lactone-opened isohomohalichondrin B (5.2.1): 
A clear, pale yellow oil. 
lH and 13C NMR data cited in Tables 5.2.1 and 5.2.2 respectively. 
IR (film) Umax 3444, 1574 cm-1. 
High Resolution FAB-MS mlz 1193.56600 (MK+, -0.2 ppm for 
C62H9oOzoK). 
Homohalichondrin B (1.2.3, 2.1 mg) was reacted with NaOMe in dry MeOH ( ca 0.5 
mM, 200 !lL) stirring the reaction overnight at room temperature. Silica TLCs were 
developed in 10% MeOHI DCM and visualised. The reaction was quenched with ca 
2 mL acidified water ((NH4Cl)aq, pH 3) and placed onto a cartridge C18 column. 
The column was washed with 10% MeOHI HzO (2 x 8 mL), eluting the halichondrin 
material in 100% MeOH (2 x 8 mL). The MeOH fractions were combined and dried 
down to give 2.1 mg of a 50:50 mixture of starting material and product. The 
mixture was committed for re-reaction with NaOMe in dry MeOH ( ca 0.5 mM, 200 
IlL), stirring the reaction at room temperature overnight. The reaction was quenched 
after this time and worked-up as previously described to give 1.9 mg of 5.2.2. 
Lactone-opened homohalichondrin B (5.2.2): 
A white powder. 
lH and 13C NMR data cited in Tables 5.2.3 and 5.2.4 respectively. 
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High Resolution FAB-MS m/z 1179.55005 (MK+, -0.4 ppm for 
C6tHssOzoK). 
5.3 Lithium Aluminium Hydride Reduction 
Homohalichondrin B (1.2.3, 1.1 mg) was dissolved in 2 mL dry tetrahydrofuran 
(THF) before the addition of fresh lithium aluminium hydride (2.5 mg). The 
resulting suspension was stirred vigorously for 4 hrs at room temperature. After this 
time, the reaction was quenched with 2 mL acidified water ((NH4Cl)aq, pH 3), and 
placed on a C18 cartridge column. The column was washed with 10% MeOH/ HzO 
(2 x 5 mL) and eluted with 100% MeOH (2 x 5 mL) to obtain 1.4 mg of 5.3.1. Silica 
TLC was developed in 10% MeOH/ DCM and visualised. 
Lactone-reduced homohalichondrin B (5.3.1): 
A white powder. 
lH and 13C NMR data cited in Tables 5.3.1 and 5.3.2 respectively. 
High Resolution FAB-MS mlz 1165.56800 (MK+, -2.8 ppm for 
C6tH9o019K). 
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Work Described in Chapter Six 
6.2 Acid Stability Studies 
CDCb was stored over K2C03 overnight to remove residual HCI from the solvent. 
Homohalichondrin B (1.2.3, 0.3 mg) was dissolved in ca 600 J!L of the supernatant 
CDCb and the solution was transferred to an NMR tube. After a reference lH NMR 
spectrum was acquired, then 9 J!L of a solution of pyridinium p-toluene sulfonate 
(PPTS) in the carbonate-treated CDCb solvent (2.5 mg/mL, 0.33 mole equivalent) 
was added to the NMR tube. The solution in the NMR tube was thoroughly mixed 
and lH NMR spectra were acquired on the resulting solution after 0.5 and 0.75 hr. 
After this time, another 18 J!L of the PPTS solution was added to the NMR tube to 
give a 1:1 molar ratio of PPTS: 1.2.3. lH NMR spectra were acquired on this 
solution immediately after addition of PPTS (to give a 1:1 ratio), and at the following 
times subsequently: 2.5 hrs, 3.5 hrs , 4.5 hrs , 24.5 hrs , 50 hrs , 77 hrs, 4 days, 6 
days, 7 days, 8 days, 9 days, 10 days, 12 days, 15 days, 19 days and 22 days. After 
this time, the solvent was removed and 1 rnL of H20 was added and 0.1 M sodium 
hydroxide (NaOH) was added to give a pH 7.5-8.0. The resulting solution was 
extracted with DCM (5 x 0.5 mL) and the solvent was removed to give 0.3 mg of 
worked-up material. Silica TLC performed was developed in 5% MeOHI DCM and 
visualised. Analytical HPLC was performed using an analytical Cl8 column with 
50% ACNI H20 as the mobile phase. Four injections (20 J!L) were made of the 
worked-up material dissolved in the mobile phase (at 3.75 mg/ mL), and the peaks 
eluting before 400 s, the peak eluting at ca 400 s and the peak eluting at ca 550 s 
were collected as separate fractions. 
Experimental 336 
Homohalichondrin B (1.2.3, 0.5 mg) was dissolved in 100 JlL DCM. An aliquot (ca 
2 J.1L) of this solution was taken and the solvent was removed. A solution of 50% 
ACN/ H20 (10 J.1L) was added to the aliquot and an analytical HPLC injection (using 
an analytical C18 column equilibrated to 50% ACN/ H20) of the resulting solution 
was made. An aqueous solution (25 JlM, 50 J.1L) of p-toluene sulfonic acid (PTSA) 
was added to the homohalichondrin B (1.2.3) in DCM solution to give a 360: 1 molar 
ratio ofPTSA to 1.2.3. The resulting mixture was stirred at room temperature, and 2 
IlL aliquots were removed from the DCM layer at regular intervals (viz after 1 hr, 3 
hrs, 6 hrs, 23 hrs and 47 hrs reaction) for analytical HPLC analysis as described 
previously. After 47 hrs stirring at room temperature, 100 JlL water was added to the 
reaction mixture. The pH of the aqueous layer was adjusted to pH 7.5-8.0 with 0.1 
M NaOH solution before extracting with DCM (5 x 0.5 mL). The solvent (DCM) 
was removed to give homohalichondrin B (1.2.3, 0.3 mg). 
Homohalichondrin B (1.2.3, 0.3 mg) was dissolved in DCM (50 flL) and 50 J.1L of an 
aqueous PTSA solution (5 roM) was added to give a 1:1 molar ratio of PTSA to 
1.2.3. The resulting mixture was stirred vigorously at room temperature. Aliquots 
(ca 2 flL) from the DCM layer were removed after 1.5 hrs and 27 hrs for analytical 
HPLC analysis. The solvent was removed from the aliquots and 10 IlL of 50% 
ACN/ H20 was added for HPLC injection (performed using an analytical C18 
column with 50% ACN/ H20 as the mobile phase). After 48 hrs stirring at room 
temperature, 100 flL water was added to the reaction mixture and the pH of the 
aqueous layer was adjusted to pH 7.0-7.5. The resulting mixture was extracted with 
DCM (5 x 0.5 mL). The solvent was removed to give unreacted homohalichondrin 
B (1.2.3, 0.3 mg). 
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Homohalichondrin B (1.2.3, 0.3 mg) was dissolved in a PTSA in DCM solution (1.1 
mg/ mL, 100 ~L) to give a molar ratio of ca 220: 1 PTSA to 1.2.3. The resulting 
solution was stirred at room temperature for 48 hrs. After this time, 100 ~L water 
was added and the pH of the aqueous layer was adjusted to pH 7.0-7.5 (with 0.1 M 
NaOH). The resulting mixture was extracted with DCM (5 x 0.5 mL) and the 
solvent was removed from this extract to give unreacted homohalichondrin B (1.2.3, 
0.3 mg). 
Homohalichondrin B (1.2.3, 0.8 mg) was dissolved inca 500 IlL CD30D and the 
resulting solution was transferred to an NMR tube. After the acquisition of a lH 
NMR spectrum from this solution, 25 IlL of a solution of 1FA in CD30D (5% vlv 
1FA in CD30D) was added to the NMR tube to give a ca 1:20 molar ratio of TFA: 
homohalichondrin B (1.2.3). The solution was thoroughly mixed and lH NMR 
spectra were acquired from the resulting solution immediately after 1F A addition 
and after 3 hrs. After this time one drop of triethylamine (TEA) was added to give a 
pH of 8.0. The solvent was removed and 1 mL water was added and the resulting 
solution was extracted with DCM (5 x 1 mL). The solvent was removed from the 
DCM extract and the material was transferred to an NMR tube with CDC13/ 0.1% 
pyridine-d5 and a lH NMR spectrum was re-acquired. Silica TLC performed was 
developed in 10% MeOH/ DCM and visualised. Cl8 in a Pasteur pipette was 
equilibrated to 55% ACN/ H20 and the worked-up material was dissolved in the 
mobile phase and placed onto the column bed. Eight fractions of 1 mL were 
collected, followed by two fractions (1 mL) eluting with 100% ACN. Silica TLCs 
performed on the fractions were developed in 10% MeOH/ DCM and visualised. 
Fractions four through to nine were combined to give 0.6 mg of homohalichondrin B 
(1.2.3). Fraction ten contained 0.1 mg of materiaL 
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A ca 250 !-LL volume of TFA was made up to 100 mL with DCM in a volumetric 
:flask. Two aliquots of this solution (10 mL) were titrated against standard aqueous 
NaOH solution (24.625 mM), using phenolphthalein indicator. The TF A 
concentration calculated from these titrations was 30.04 mM. 
Homohalichondrin B (1.2.3, 0.3 mg) was dissolved in 100 !-LL of the standardised 
TF A solution to give an 11: 1 molar ratio of TFA: 1.2.3. The resulting solution was 
stirred at room temperature for 4 hrs. After this time, 200 !-LL water was added to the 
reaction mixture and the pH of the aqueous layer was adjusted to pH 7.5-8.0 with 0.1 
M NaOH(aq)· The water layer was removed and another 200 !-LL water was added to 
the reaction mixture. The resulting mixture was extracted with DCM ( 4 x 0.2 mL) 
and the solvent was removed to give 0.3 mg of worked-up material. 
Homohalichondrin B (1.2.3, 2.2 mg) was dissolved in 100 !-LL of the standardised 
TF A in DCM solution to give a 1.5: 1 molar ratio of TF A to 1.2.3. The reaction was 
stirred at room temperature for 30 min. After this time, 1 mL water was added to the 
reaction mixture and the pH of the aqueous layer was adjusted to pH 7.5-8.0 with 0.1 
M NaOH. The water layer was removed and the reaction mixture was washed with 
water (5 x 1 mL). Water was added to the reaction mixture (1 mL) and the resulting 
mixture was extracted with DCM (5 x 0.5 mL). The solvent was removed from the 
DCM extract to give 2.0 mg of worked-up material. Analytical HPLC was 
performed on the worked up material using an analytical C18 column with 50% 
ACN/ HzO, 52.5% ACN/ HzO and 60% ACN/ HzO as the mobile phases. 
Analytical injections of 10 !-LL were made of the worked-up material dissolved in the 
mobile phase (2 mg/ mL). 
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Homohalichondrin B (1.2.3, 2.1 mg) was dissolved in 100 ~L of the titrated TFA 
solution. The resulting solution was stirred at room temperature for 30 min. After 
this time, 1 mL water was added to the reaction mixture and the pH of the aqueous 
layer was adjusted to pH 7.5-8.0 with 0.1 M NaOH(aq)· The water layer was 
removed and the reaction mixture was washed with water (5 x 1 mL). Water was 
added to the reaction mixture (1 mL) and the resulting mixture was extracted with 
DCM (5 x 0.5 mL). The solvent was removed from the DCM extract to give 2.1 mg 
of worked-up material. Preparative analytical HPLC was performed on the worked-
up material using an analytical Cl8 column equilibrated to 60% ACN/ H20. The 
worked-up material was dissolved in 200 ~L of mobile phase and injections of ca 20 
~L were made, and the peaks eluting at 230 s (1.2.3) and 550 s (6.3.1) were 
collected. The solvent was removed from the 230 s eluting fraction to give 0.6 mg 
homohalichondrin B (1.2.3). The solvent was removed from the 550 s eluting 
fraction to give 0.5 mg of the furan acid product (6.3.1). 
Homohalichondrin B (1.2.3, 4.4 mg) was dissolved in 200 ~L of the titrated TFA in 
DCM solution. The resulting solution was stirred at room temperature for 30 min. 
After this time, 1 mL water was added to the reaction mixture and the pH of the 
aqueous layer was adjusted to pH 7.5-8.0 with 0.1 M NaOH(aq)· The water layer was 
removed and the reaction mixture was washed with water (4 x 1 mL). Water was 
added to the reaction mixture (1 mL) and the resulting mixture was extracted with 
DCM (5 x 1 mL). The solvent was removed from the DCM extract to give 4.2 mg of 
worked-up material. Preparative analytical HPLC was performed on the worked-up 
material using an analytical Cl8 column with 60% ACN/ H20 (0.05% TFA) as the 
mobile phase. Mobile phase (210 ~L to give 20 mg/ mL) was added to the worked-
up material and preparative injections of ca 20 ~L were performed and the peaks 
eluting at ca 230 s (1.2.3) and ca 550 s (6.3.1) were collected. The solvent was 
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removed from the 230 s eluting fraction to give 2.4 mg of material. The solvent was 
removed from the 550 s eluting fraction to give 1.1 mg of material. These fractions 
were re-injected into theHPLC on an analytical scale (10 ~L of2 mg/ mL). The two 
fractions were re-combined and preparative HPLC using an analytical C18 column 
with 60% ACN/ H20 (no TFA) was repeated, and the fractions were re-injected on 
an analytical scale indicating a good separation had been achieved. 
Homohalichondrin B (1.2.3, 4.0 mg) was dissolved in 200 ~L of the standardised 
TF A in DCM solution. The reaction was stirred at room temperature for 30 min. 
After this time, 1 mL water was added to the reaction mixture and the pH of the 
aqueous layer was adjusted to pH 7.5-8.0 with 0.1 M NaOH(aq)· The water layer was 
removed and the reaction mixture was washed with water (4 x 1 mL). Water was 
added to the reaction mixture (1 mL) and the resulting mixture was extracted with 
DCM (5 x 1 mL). The solvent was removed from the DCM extract to give 4.4 mg of 
worked-up material. Preparative HPLC was performed on the worked-up material 
using an analytical C18 column with 60% ACN/ H20 as the mobile phase. The 
worked-up material was dissolved in 220 ~L and injections of 20 ~L were 
performed, collecting the peaks eluting at ca 230 s (1.2.3) and ca 550 s ( 6.3.1) 
separately and the material eluting between injections. The solvent was removed 
from the three respective fractions to give 1.5 mg (1.2.3), 0.8 mg (6.3.1) and 1.6 mg 
(6.3.2 and 6.3.3). Each of the three respective fractions was re-analysed by HPLC on 
an analytical-scale using an analytical C18 column with 70% ACN/ H20 as the 
mobile phase. The mixture of components (6.3.2 and 6.3.3) was subsequently 
separated on a preparative scale under the same HPLC conditions. The mixtnre was 
dissolved in 80 ~L of the mobile phase and 20 ~L injections were performed, 
collecting the peaks eluting at ca 800 s and ca 1000 s separately. These fractions 
were re-injected on an analytical scale to assess the quality of the separation. Diol 
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TLC performed on the four separated components (1.2.3, 6.3.1, 6.3.2 and 6.3.3) from 
the HPLC separation were developed in 1% MeOHI DCM and visualised. 
Homohalichondrin B (1.2.3, 4.0 mg) was dissolved in 200 IlL of the titrated TFA in 
DCM solution. The reaction was stirred at room temperature for 30 min. After this 
time, 1 mL water was added to the reaction mixture and the pH of the aqueous layer 
was adjusted to pH 7.5-8.0 with 0.1 M NaOH(aq)· The water layer was removed and 
the reaction mixture was washed with water (4 x 1 mL). Water was added to the 
reaction mixture (1 mL) and the resulting mixture was extracted with DCM (5 x 1 
mL). The solvent was removed from the DCM extract to give 4.0 mg of worked-up 
material. Preparative HPLC was performed on the worked-up material using an 
analytical C18 column and 70% ACN/ HzO as the mobile phase. The worked-up 
material was dissolved in 200 IlL of the mobile phase and 40 IlL HPLC injections 
were performed. The peaks eluting at ca 230 s, 300 s, 800 s and 1000 s were 
collected separately and the solvent was removed to give 0.9 mg (1.2.3), 0.8 mg 
(6.3.1), 1.0 mg (6.3.2) and 1.1 mg ( 6.3.3) of material respectively. 
Homohalichondrin B (1.2.3, 4.8 mg) was dissolved in 200 IlL of the standardised 
TF A in DCM solution. The reaction was stirred at room temperature for 30 min. 
After this time, 1 mL water was added to the reaction mixture and the pH of the 
aqueous layer was adjusted to pH 7.5-8.0 with 0.1 M NaOH. The water layer was 
removed and the reaction mixture was washed with water (4 x 1 mL). Water was 
added to the reaction mixture (1 mL) and the resulting mixture was extracted with 
DCM (5 x 1 mL). The solvent was removed from the DCM extract to give 4.6 mg of 
worked-up material. Preparative HPLC was performed on the worked-up material 
using an analytical C18 column and 70% ACN/ HzO as the mobile phase. The 
worked-up material was dissolved in 200 IlL of the mobile phase and 40 IlL HPLC 
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injections were performed. The peaks eluting at ca 230 s, 300 s, 800 sand 1000 s 
were collected separately and the solvent was removed to give 0.9 mg (1.2.3), 0.8 mg 
( 6.3.1 ), 0.9 mg ( 6.3.2) and 1.1 mg ( 6.3.3) of material respectively. This material was 
combined with the respective acid products from the previous reactions. This gave a 
total of 2.0 mg of the furan acid product ( 6.3.1), 1.8 mg of the epi-furan acid product 
(6.3.2) and 2.0 mg of the epi acid product (6.3.3) for subsequent structural 
identification. 
6.3 Characterisation of TF A Reaction Products 
A D20 exchange experiment was performed on the furan acid product (6.3.1). A lH 
NMR spectrum and a selective lD-TOCSY spectrum (irradiating at OH 4.90 ppm 
with an 80 ms mixing time) were acquired on the furan acid product (6.3.1) in 
CDC!}/ 0.1% pyridine-d5 solution. A single drop of D20 was added to the NMR 
tube and the resulting mixture was vigorously mixed (vortexed). The mixture was 
left standing at room temperature for 5 min. After this time, a 1 H NMR spectrum 
and a selective lD-TOCSY spectrum were acquired under identical NMR 
experimental conditions. The mixture was left standing at room temperature for 
another 1.5 hrs and the two NMR experiments were again repeated under identical 
NMR experimental conditions. 
Furan acid product ( 6.3.1): 
A clear, colourless oil. 
lH and 13C NMR data cited in Tables 6.3.1 and 6.3.2 respectively. 
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High Resolution FAB-MS mlz 1123.58689 (MH+, +2.43 ppm for 
CtitHs7019). 
Epi-furan acid product (6.3.2): 
A clear, colourless oil. 
lH and 13C NMR data cited in Tables 6.3.3 and 6.3.4 respectively. 
High Resolution FAB-MS mlz 1145.56413 (MNa+, -1.75 ppm for 
C6tHs60t9Na). 
Epi acid product (6.3.3): 
A clear, colourless oil. 
lH and 13C NMR data cited in Tables 6.3.5 and 6.3.6 respectively. 
High Resolution FAB-MS mlz 1123.58589 (MH+, +1.54 ppm for 
C6tHs7019). 
6.4 Time-Scale Acid Reactions 
A mixture of the three acid products (6.3.1, 6.3.2 and 6.3.3) and homohalichondrin B 
(1.2.3) was prepared with nominally equal amounts ( ca 0.04 mg) of each compound. 
A lH NMR spectrum was obtained on this sample in CDCl3/ 0.1% pyridine-ds. 
Integrals over the two furan resonances at OH 5.95 ppm and OH 6.18 ppm, and the H7 
resonance at OH 3.06 ppm (common to the epi acid product (6.3.3) and 
homohalichondrin B (1.2.3)) were obtained. The actual amount of furans in the 
standard mixture was calculated as 24% and the non-furan components therefore 
contributed 76% to the 1H NMR spectrum. The standard mixture was dissolved in 
40 ~L of 70% ACN/ HzO and 10 ~L of this solution was analysed by HPLC 
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(analytical C18 column with 70% ACN/ H20 as the mobile phase). The four 
component peaks in the chromatogram were integrated at 'A 199 nm. The sum of the 
furan components ( 6.3.1 and 6.3.2) contributed 65% to the total integral and the non-
furan components (1.2.3 and 6.3.3) contributed 35% to the total integral. The ratio 
of the molar absorptivities of the furan products vs the non-furan components was 
calculated. This ratio was calculated as 5.9: 1 for tfurans: Enon-furans· 
The furan acid product (6.3.1, 0.5 mg) was dissolved in 85 ~-tL DCM. An aliquot (ca 
2 ~-tL) of this solution was taken and the solvent removed. This aliquot was dissolved 
in 70% ACN/ H20 (10 ~-tL) and this sample was analysed by HPLC (using an 
analytical C18 column and 70% ACN/ HzO as the mobile phase). A 14.8 ~-tL volume 
of diluted standardised TFA in DCM solution (a 1 + 1 DCM dilution of standardised 
TFA in DCM (30.04 mM)) was added to 6.3.1 in DCM to give a 1:2 molar ratio of 
TFA: 6.3.1. The reaction was stirred at room temperature and monitored by 
analytical HPLC, with time. Aliquots ( ca 2 ~-tL) were removed after 10 min, 30 min, 
1 hr, 2.5 hrs, 3.5 hrs, 4.5 hrs, 7 hrs, 11 hrs, 18 hrs, 35.5 hrs, 49 hrs and 73.3 hrs of 
reaction. The solvent was removed from each aliquot, immediately after removal 
from the reaction mixture, and 10 ~-tL of the HPLC mobile phase (70% ACN/ HzO) 
was added to each. Each 10 J.!L aliquot was immediately analysed by analytical 
HPLC using the same conditions as the first analysis. The identified component 
peaks (viz 6.3.1 and 6.3.2) in the chromatogram (at 'A 199 nm) were integrated. Each 
product was expressed as a relative percentage of the total identified components 
present at that point in time. Graph of results displayed in Figure 6.4.1. 
The epi-furan acid product ( 6.3.2, 0.5 mg) was dissolved in 85 ~-tL DCM. An aliquot 
(ca 2 ~-tL) of this solution was taken and the solvent removed. This aliquot was 
dissolved in 70% ACN/ H20 (10 ~-tL) and this sample was analysed by HPLC (using 
an analytical C18 column and 70% ACN/ H20 as the mobile phase). A 14.8 ~-tL 
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volume of diluted standardised TF A in DCM solution (a 1 + 1 dilution of standardised 
TFA in DCM (30.04 mM) with DCM) was added to 6.3.2 in DCM to give a 1:2 
molar ratio of TFA: 6.3.2. The reaction was stirred at room temperature and 
monitored by analytical HPLC, with time. Aliquots ( ca 2 ~L) were removed after 15 
min, 1 hr, 2 hrs, 3 hrs, 4 hrs, 7 hrs, 22 hrs, 48 hrs of reaction. The solvent was 
removed from each aliquot, immediately after removal from the reaction mixture, 
and 10 ~L of the HPLC mobile phase (70% ACN/ H zO) was added to each. Each 10 
~L aliquot was immediately analysed by analytical HPLC using the same conditions 
as the first analysis. The identified component peaks (viz 6.3.1 and 6.3.2) in the 
chromatogram (at A, 199 nm) were integrated. Each product was expressed as a 
relative percentage of the total identified components present at that point in time. 
Graph of results displayed in Figure 6.4.2. 
The epi acid product (6.3.3, 0.5 mg) was dissolved in 85 ~L DCM. An aliquot (ca 2 
~L) of this solution was taken and the solvent removed. This aliquot was dissolved 
in 70% ACN/ HzO (10 ~L) and this sample was analysed by HPLC (using an 
analytical C18 column and 70% ACN/ HzO as the mobile phase). A 14.8 ~L volume 
of diluted standardised TF A in DCM solution (a 1 + 1 dilution of standardised TF A in 
DCM (30.04 mM) with DCM) was added to 6.3.3 in DCM to give a 1:2 molar ratio 
of TFA: 6.3.3. The reaction was stirred at room temperature and monitored by 
analytical HPLC, with time. Aliquots ( ca 2 ~L) were removed after 15 min, 45 min, 
1.17 hrs, 3 hrs, 3.5 hrs, 4.5 hrs, 7 hrs, 20.5 hrs, 47 hrs of reaction. The solvent was 
removed from each aliquot, immediately after removal from the reaction mixture, 
and 10 ~L of the HPLC mobile phase (70% ACN/ HzO) was added to each. Each 10 
~L aliquot was immediately analysed by analytical HPLC using the same conditions 
as the first analysis. The identified components in the chromatogram (viz 1.2.3, 
6.3.1, 6.3.2 and 6.3.3) were integrated at A, 199 nm. The integrals were corrected to 
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account for the differences in the molar absorptivities (E) of the furans (6.3.1 and 
6.3.2) and the non-furan components (1.2.3 and 6.3.3). Each integrated component 
was expressed as relative percentage of the total of the integrated components. 
Results displayed in Figure 6.4.3. 
Homohalichondrin B (1.2.3, 0.5 mg) was dissolved in 85!-lL DCM. An aliquot (ca 2 
IlL) of this solution was taken and the solvent removed. This aliquot was dissolved 
in 70% ACN/ H20 (10 )lL) and this sample was analysed by HPLC (using an 
analytical C18 column and 70% ACN/ H20 as the mobile phase). A 14.8 )lL volume 
of diluted standardised TFA in DCM solution (a 1 + 1 dilution of standardised TFA in 
DCM (30.04 mM) with DCM) was added to 1.2.3 in DCM to give a 1 :2 molar ratio 
of TFA: 1.2.3. The reaction was stirred at room temperature and monitored by 
analytical HPLC, with time. Aliquots (ca 2!-lL) were removed after 15 min, 1 hr, 1.5 
hrs, 2.5 hrs, 3 hrs, 4 hrs, 5 hrs, 7 hrs, 8 hrs, 10 hrs, 18 hrs, 32 hrs and 44 hrs of 
reaction. The solvent was removed from each aliquot, immediately after removal 
from the reaction mixture, and 10 )lL of the HPLC mobile phase (70% ACN/ H20) 
was added to each. Each 10 )lL aliquot was immediately analysed by analytical 
HPLC using the same conditions as the first analysis. The identified components in 
the chromatogram (viz 1.2.3, 6.3.1, 6.3.2 and 6.3.3) were integrated at 'A 199 nm. 
The integrals were corrected to account for the differences in the molar absorptivities 
(E) of the furans (6.3.1 and 6.3.2) and the non-furan components (1.2.3 and 6.3.3). 
Each integrated component was expressed as relative percentage of the total of the 
integrated components. Results displayed in Figure 6.4.4. 
Homohalichondrin B (1.2.3, 0.5 mg) was dissolved in 48 IlL DCM. A volume (2 
)lL) of camphor sulfonic acid (CSA, 30 mM) in DCM was added to the resulting 
solution to give a 10:1 molar ratio of 1.2.3: CSA. An aliquot of this solution (ca 2 
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JlL) was taken an the solvent was removed. This aliquot was dissolved in 70% 
ACN/ HzO (10 JlL) and this sample was analysed by HPLC (using an analytical C 18 
column and 70% ACN/ HzO as the mobile phase). The reaction was stirred at room 
temperature and monitored by analytical HPLC, with time. Aliquots ( ca 2 JlL) were 
removed from the resulting solution after 30 min, 1 hr and 2.17 hrs. The solvent was 
removed from each aliquot, immediately after removal from the reaction mixture, 
and 10 JlLoftheHPLC mobile phase (70% ACN/HzO) was added to each. Each 10 
JlL aliquot was immediately analysed by analytical HPLC using the same conditions 
as the first analysis. After 2.17 hrs, an additional 3 JlL of CSA in DCM solution (30 
mM) was added to the reaction mixture to give a 3:1 molar ratio of 1.2.3: CSA. The 
reaction was continued stirring at room temperature Aliquots (ca 2 JlL) were 
removed from the resulting solution after 0.5 hr, 1 hr, 1.67 hrs, 3 hrs and 22 hrs at a 
molar ratio of 3:1. The solvent was removed from each aliquot, immediately after 
removal from the reaction mixture, and 10 JlL of the HPLC mobile phase (70% 
ACN/ H20) was added to each. Each 10 JlL aliquot was immediately analysed by 
analytical HPLC using the same conditions as the first analysis. The identified 
components in the chromatogram (viz 1.2.3, 6.3.1, 6.3.2 and 6.3.3) were integrated at 
'A 199 nm. The integrals were corrected to account for the differences in the molar 
absorptivities (£)of the furans (6.3.1 and 6.3.2) and the non-furan components (1.2.3 
and 6.3.3). Each integrated component was expressed as relative percentage of the 
total of the integrated components. Results displayed in Figure 6.4.5. 
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Work Described in Chapter Seven 
7.2 Base Stability Studies 
A 0.1 M solution of sodium hydroxide (NaOH) in 10% MeOHI H20 (1 mL) was 
added to isohomohalichondrin B (1.2.9, 1.0 mg). Additional MeOH (600 IlL) was 
added and the resulting solution was stirred overnight at room temperature. The 
reaction was quenched with 1 mL acidified water ((NH4Cl)aq, pH 3) and placed on a 
cartridge C18 column. The cartridge was eluted with the acidified water (1 x 3 mL), 
then 10% MeOHI H20 (1 x 3 mL). The halichondrin material was eluted in 100% 
MeOH (2 x 3 mL) and the solvent was removed from the MeOH fractions to give 1.4 
mg isohomohalichondrin B (1.2.9). 
7.3 Chelation Studies 
Isohomohalichondrin B (1.2.9, 3.5 mg) was dissolved in 600 IlL CD30D and two 
drops of D20, and the resulting solution was transferred to an NMR tube. A lH 
NMR spectrum was performed on this sample. An aqueous 0.16 M sodium 
perchlorate (NaCl04) solution was added to the NMR tube (20 IlL) to give a 1:1 
molar ratio of isohomohalichondrin B to NaCl04. The solution was mixed in the 
NMR tube and a lH NMR spectrum was acquired. Another 1 mole equivalent of the 
0.16 M NaCl04 solution was added (20 IlL), mixed, and a lH NMR spectrum was 
acquired. Successive 20 IlL additions of 0.16 M NaCl04 solution were added to the 
NMR tube give a 3:1, 4:1 and 5:1 molar ratio ofNaCl04 to isohomohalichondrin B 
(1.2.9). After each addition of NaCl04 the NMR tube was mixed carefully and a lH 
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NMR spectrum was acquired. Finally 100 !JL of 0.16 M NaCl04 was added to the 
NMR tube to give a 10:1 molar ratio of NaCl04 to isohomohalichondrin B (1.2.9). 
The solution was mixed and a 1 H NMR spectrum was acquired from the resulting 
solution. 
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Work Described in Chapter Eight 
8.2 Deuterium Exchange 
A 2 M solution of NaOD was prepared by dropping Na wire (24 mg) into 520 ~L 
D20. Isohomohalichondrin B (1.2.9, 0.4 mg) was dissolved inca 600 ~L CD30D 
and transferred to an NMR tube. Three drops of the NaOD solution was added to the 
NMR tube and mixed thoroughly. A lH NMR spectrum was acquired from this 
solution. The solvent was removed and a 1H NMR spectrum was re-acquired in 
CDCl3/ 0.1% pyridine-ds. 
Deuterated isohomohalichondrin B: 
A pale yellow oil. 
lH NMR data (selected) described in Section 8.2. 
FAB-MS mlz 1124, 1125, 1126, 1127 and 1128 (MH+). 
High Resolution FAB-MS mlz 1126.60358 (MH+, +0.53 ppm for 
C6tHs4D3019). 
8.3 Sodium Borodeuteride Reduction 
Isohomohalichondrin B (1.2.9, 0.5 mg) was dissolved in dry IPA (50 ~L) and 1.0 mg 
sodium borodeuteride (NaBD4 (98 atom% D)) in 150 ~L dry ether was added. The 
resulting suspension was stirred vigorously at room temperature for 1 hr. Silica 
TLCs were developed in 10% MeOH/ DCM and visualised. After this time, 1 mL 
NH4Cl (aq) (pH 3) solution was added to the reaction mixture and the resulting 
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solution was placed onto a 500 mg C18 cartridge. The column was washed with 
10% MeOH/ HzO (2 x 5 mL) and the halichondrin material was eluted with 100% 
MeOH (2 x 5 mL). The solvent was removed from the MeOH fractions to give 0.6 
mg of 8.3.1 and 8.3.2. 
Isohomohalichondrin B sodium borodeuteride reduction isomers (8.3.1 and 8.3.2): 
A white powder. 
lH NMR data (selected) described in Section 8.3. 
High Resolution FAB-MS mlz 1126.60722 (MH+, +1.01 ppm for 
C61HssDOt9). 
8.4 Wittig Reaction 
All Wittig reactions described in this Section were performed in a dry-box under an 
atmosphere of dry nitrogen. 
Cholestane-3-one (2.0 mg) was dissolved in dry ether (50 ~L) and added to a 
suspension containing the ylide (CHz=PPh3). The ylide was generated by addition 
of 1.6 M n-butyllithium solution (n-BuLi in hexane, 15 ~L) to a stirred suspension of 
methyl triphenylphosphonium iodide (MePh3P+r-, 7.4 mg) in 50 ~L dry ether. The 
ylide suspension was stirred vigorously for ca 30 s before addition of cholestan-3-
one in solution. The reaction was stirred overnight at room temperature. After this 
time, the ether was removed from the reaction mixture and the remaining material 
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was placed on a filter and washed with hexane. The solvent was removed to give 1.6 
mg of 3-methylene cholestane. 
Homohalichondrin B (1.2.3, 0.2 mg) was dissolved in water (170 JlL) and 30 JlL of 
an aqueous 1.6 M lithium hydroxide solution was added. The resulting solution was 
stirred overnight at room temperature. After this time, 1 mL acidified water 
((NH4Cl)aq, pH 3) was added and the solution was extracted with DCM (4 x 2 mL). 
The solvent (DCM) was removed to give unreacted homohalichondrin B (1.2.3, 0.2 
mg). Silica TLC was developed in 10% MeOHI DCM and visualised. 
Dry ether (100 JlL) was added to homohalichondrin B diacetate diketone (4.3.3, 1.9 
mg). The ylide was generated by the addition of n-BuLi in hexane (1.6 M, 8 JlL) to 
MePh3P+r- (7.4 mg) in 100 JlL dry ether while vigorously stirring. The 4.3.3 
solution was added to the ylide, while stirring, and the resulting suspension was 
stirred overnight at room temperature. After this time, the ether was removed and 
the remaining material was placed on a filter and was washed with hexane. The 
hexane was removed to give 0.5 mg of material. The filter was washed with 20% 
DCM/ hexane and the solvent was removed from this extract to give 0.6 mg of 
material. Silica TLCs performed on both extracts were developed in 10% MeOH/ 
DCM prior to visualisation. The two extracts were recombined and re-reacted as 
described previously. The reaction was similarly worked-up except the hexane and 
20% DCM/ hexane extracts were combined. The solvent was removed to give ca 0.5 
mg of material. 
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8.5 Fluorescent Labelling 
To a solution of n.-hexanol ( ca 2 mg) in pyridine (100 JlL) at 0°C, a solution of 
dansyl chloride (5.8 mg, 1 mole equivalent) dissolved in 100 JlL pyridine was added. 
The solution was stirred at room temperature for 4.5 hrs. After this time, 1 mL H20 
was added to the reaction mixture and the solution was extracted with DCM ( 4 x 1 
mL). The solvent was removed to give pure dansyl n-hexanol. 
To a solution of n-hexanol (2.2 mg) in EtOAc (100 JlL), 11.8 mg (2 mole 
equivalents) dansyl chloride, and 13.6 mg Na2C03 (6 mole equivalents) in EtOAc 
(100 JlL) were added. The reaction was stirred overnight at 35°C. After this time, 
the solvent was removed and 100 JlL H20 was added and the resulting solution was 
extracted with DCM (4 x 1 mL). The solvent was removed from the DCM extract to 
give 70% dansyl n-hexanol. The worked-up material was re-reacted under identical 
reaction conditions to give 100% dansyl n-hexanol. 
To a solution of n-hexanol (1.9 mg) in acetone (100 JlL), 5.8 mg (1 mole equivalent) 
of dansyl chloride and 7.3 mg (3 mole equivalents) sodium carbonate (Na2C03) and 
100 JlL H20 were added. The reaction was stirred overnight at room temperature. 
After this time, the reaction mixture was extracted with DCM ( 4 x 1 mL) and the 
solvent was removed to give 78% dansyl n-hexanol. 
Homohalichondrin B (1.2.3, 0.5 mg) was dissolved in 30 JlL pyridine, and 20 JlL (1 
mole equivalent) of a solution of dansyl chloride (1.3 mg) in 200 IlL pyridine was 
added at 0°C. The solution was stirred at room temperature for 4 hrs. Silica TLC 
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was developed in 5% MeOH/ DCM and visualised under a visible lamp before 
application of PMA spray. Water (50 ~L) was added to the reaction mixture and the 
solution was extracted with DCM (4 x 0.5 mL) and then the solution was extracted 
with MeOH ( 4 x 1 mL) The solvent (DCM) was removed to give 0.5 mg of 
unreacted homohalichondrin B (1.2.3). The solvent was removed from the MeOH 
extract and this material was extracted with DCM (4 x 0.5 mL) and combined with 
the first DCM extract to give 0.6 mg of 1.2.3. 
Homohalichondrin B (1.2.3, 0.6 mg) was dissolved in 30 JlL pyridine, and 20 JlL (1 
mole equivalent) of a solution of dansyl chloride (1.3 mg) in 200 IlL pyridine was 
added at 0°C. The reaction was stirred at room temperature for 10 min and another 4 
mole equivalents of dansyl chloride in pyridine were added to the reaction mixture. 
The resulting solution was stirred for 4 hrs at room temperature. Water (50 JlL) was 
added to the reaction mixture and the solution was extracted with DCM (4 x 1 mL) 
and MeOH (4 x 1 mL). The solvent was removed from the DCM extract to give 1.0 
mg unreacted homohalichondrin B (1.2.3). 
Homohalichondrin B (1.2.3, 1.0 mg) was dissolved in 30 ~L pyridine and 56.5 JlL 
(15 mole equivalents) of a 58 mg/ mL dansyl chloride solution in pyridine, at 0°C, 
were added. The reaction was stirred at room temperature for 4 hrs. After this time 
water (50 JlL) was added to the reaction mixture and the solution was extracted with 
DCM (4 x 1 mL) and MeOH (4 x 1 mL). The solvent was removed from the DCM 
extract to give 1.0 mg of unreacted homohalichondrin B (1.2.3). The silica TLC 
performed was developed in 10% MeOH/ DCM, visualised under a visible lamp 
before application of PMA spray. 
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Homohalichondrin B (1.2.3, 1.0 mg) was dissolved in 50 JlL pyridine and a solution 
of dansyl chloride (2.6 mg, 10 mole equivalents) in pyridine (50 JlL) was added at 
room temperature. The reaction was stirred at 35°C for 4 hrs. The silica TLCs 
performed were developed in 10% MeOH/ DCM, visualised under a visible lamp 
before application ofPMA spray. Water (100 IlL) was added to the reaction mixture 
and the solution was extracted with DCM (4 x 1 mL), then withMeOH (4 x 1 mL). 
The solvent was removed from the DCM extract to give 0.8 mg of product which 
was a mixture of 49% dansyl homohalichondrin B (8.5.2) and 51% 
homohalichondrin B (1.2.3). 
The product was dissolved in 50 IlL pyridine and a solution of dansyl chloride (2.6 
mg, 13 mole equivalents) in pyridine (50 IlL) was added at room temperature. The 
reaction was stirred at 35°C for 17 hrs. The silica TLC performed was developed in 
10% MeOH/ DCM, visualised under a visible lamp before the application of PMA 
spray. Water (100 IlL) was added to the reaction mixture and the solution was 
extracted with DCM (4 x 1 mL), then with MeOH (4 x 1 mL). The solvent was 
removed from the DCM extract to give 1.1 mg of product which was a mixture of 
56% dansyl homohalichondrin B (8.5.2) and 44% homohalichondrin B (1.2.3). 
HPLC was performed using an analytical C18 column with 50% ACN/ HzO as the 
mobile phase. Analytical injections of 10 IlL of 2 mg/ mL solutions were made, the 
samples were dissolved in the mobile phase. 
A diol cartridge was equilibrated to 100% ACN. The mixture of 1.2.3 and 8.5.2 (1.1 
mg) was dissolved in ACN and was placed onto the column bed. Three ACN 
fractions of 1 mL were collected. Three lmL fractions of 0.5% IPA/ ACN were 
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collected followed by three 1 mL fractions eluting with 1% IPA/ ACN. Silica TLCs 
performed were developed in 10% MeOHI DCM, visualised under a visible lamp 
before application of PMA spray. 
The first three fractions were combined and placed onto a diol cartridge equilibrated 
to 100% DCM. Five 1 mL DCM fractions were collected before eluting with 10% 
ACN/ DCM (2 x 1 mL fractions). The column was eluted with 20% ACN/ DCM (2 
x 2 mL fractions) and stripped with 100% ACN (2 x 2 mL fractions). The 
movement of the fluorescent material through the column was observed by shining a 
visible lamp on the column. The silica TLCs performed were developed in 10% 
MeOH/ DCM, visualised under a visible lamp before application of PMA spray. The 
solvent was removed from fraction one to give 0.1 mg of dansyl homohalichondrin 
(8.5.2). The solvent was removed from fraction two (containing a mixture of dansyl 
homohalichondrin B (8.5.2) and homohalichondrin B (1.2.3)) to give 0.4 mg of 
material. Fractions three through to eight were combined to give ca 0.1 mg 
homohalichondrin B (1.2.3). 
Homohalichondrin B (1.2.3, 0.4 mg) was dissolved in 100 flL DCM, and 0.5 mg 
dansyl chloride (5 mole equivalents) and 5 flL pyridine (15 mole equivalents) were 
added to the solution. The solution was stirred overnight at room temperature. The 
silica TLCs performed were developed in 10% MeOH/ DCM, visualised under a 
visible lamp before application of PMA spray. After this time, 0.5 mg dansyl 
chloride (to give a total of 10 mole equivalents) in 50 JlL DCM and 5 flL pyridine 
were added to the reaction mixture. The resulting solution was stirred at 35°C for 10 
hrs before another 0.5 mg dansyl chloride (to give a total of 15 mole equivalents) in 
50 flL DCM, and 5 JlL pyridine were added to the reaction mixture. The resulting 
solution was stirred overnight at 35°C. The reaction was worked-up after this time. 
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Water (100 IlL) was added to the reaction mixture and the solution was extracted 
with DCM (4 x 1 mL), then with MeOH (4 x 1 mL). The solvent was removed from 
the DCM extract to give 0.9 mg of worked-up material. This material was combined 
with fraction two from the previous diol column separation and the combined 
material was subjected to diol chromatography. 
A diol cartridge was equilibrated to 10% hexane/ DCM and the combined material 
(1.3 mg) was dissolved in the mobile phase and placed onto the column. Fifteen 
0.25 mL fractions were collected before eluting with 100% DCM (2 x 3 mL 
fractions). The column was stripped with 100% MeOH (2 x 3 mL fractions). The 
silica TLCs performed on the column fractions were developed in 10% MeOH/ 
DCM, visualised under a visible lamp before application of PMA spray. Fractions 
eleven through to twelve were combined to give 0.4 mg homohalichondrin B (1.2.3). 
Fractions three through to nine were combined to give 0.4 mg of dansyl 
homohalichondrin B (8.5.2). 
Dansyl homohalichondrin B (8.5.2): 
A yellow oil. 
lH and 13C NMR data cited in Tables 8.5.1 and 8.5.2 respectively. 
The following reaction was performed in a dry-box under an atmosphere of dry 
nitrogen. Homohalichondrin B (1.2.3, 0.4 mg) was dissolved in dry DCM (100 IlL) 
and 1.5 mg dansyl chloride (15 mole equivalents) in 100 IlL DCM, and 5 IlL dry 
pyridine were added. The resulting solution was stirred at 35°C for 6.5 hrs. The 
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silica TLCs performed were developed in 10% MeOH/ DCM, visualised under a 
visible lamp before the application of PMA spray. Additional pyridine was added 
(20 ~L) and the reaction was stirred at 35°C overnight. After this time, water (1 00 
!!L) was added to the reaction mixture and the solution was extracted with DCM ( 4 x 
1 mL), then with MeOH (4 x 1 mL). The solvent was removed from the DCM 
extract to give 0.6 mg of product which was a mixture of 65% dansyl 
homohalichondrin B (8.5.2) and 35% homohalichondrin B (1.2.3). This material 
was used in the next reaction. 
Dansyl chloride (1.8 mg, 15 mole equivalents) and Na2C03 (2.0 mg) were added to 
the product (0.6 mg) from the previous reaction. Acetone (25 ~L) and water (25 ~L) 
were added and the reaction was stirred at 35°C for 24 hrs. After this time, the 
solvent was removed and 100 ~L H20 was added and the resulting solution was 
extracted with DCM (4 x 1 mL). The solvent (DCM) was removed to give 0.6 mg of 
product. 
The following reaction was performed in a dry-box under an atmosphere of dry 
nitrogen. Isohomohalichondrin B (1.2.9, 0.5 mg) was dissolved in 50 ~L dry DCM. 
To this solution 1.5 mg dansyl chloride (15 mole equivalents) and dry pyridine (20 
~L) were added. The reaction was stirred at 35°C for 24 hrs. The silica TLCs 
performed were developed in 10% MeOH/ DCM, visualised under the visible lamp 
before application of PMA spray. Additional dry pyridine (20 !!L) was added to the 
reaction mixture. The solution was stirred for another 6 hrs at 35°C. After this time, 
water (100 ~L) was added to the reaction mixture and the solution was extracted 
with DCM ( 4 x 1 mL), then with MeOH ( 4 x 1 mL). The solvent was removed from 
the DCM extract to give 0.8 mg of product which was a mixture of 59% dansyl 
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isohomohalichondrin B (8.5.3) and 31% isohomohalichondrin B (1.2.9). This 
material was used in the next reaction. 
The product from the previous reaction (0.8 mg) was dissolved in dry pyridine and 
11.5 mg of dansyl chloride (90 mole equivalents) in 150 ~L dry pyridine were added. 
The reaction was performed in a dry-box under a dry-nitrogen atmosphere. The 
reaction was stirred for 30 hrs at 35°C. The silica TLC performed was developed in 
10% MeOH/ DCM, visualised under a visible lamp before application of PMA 
spray. Water (200 ~L) was added to the reaction mixture after this time and the 
solution was extracted with DCM (4 x 1 mL), then with MeOH (4 X l mL). The 
solvent was removed from the DCM extract to give the product which was a mixture 
of several components. 
The following reaction was performed in a dry-box under a dry nitrogen atmosphere. 
Halichondrin B (1.2.1, 0.5 mg) was dissolved in 100 ~L DCM. To this solution, 37 
J.lL of a 3.5 mg/mL dansyl chloride in DCM solution (1 mole equivalent), and 5 ~L 
dry pyridine were added. The resulting solution was stirred at room temperature for 
20 min then an additional 148 ~L (4 mole equivalents) dansyl chloride in DCM 
solution (3.5 mg/mL) was added. The reaction was stirred at 35°C for 3 hrs. After 
this time 0.5 mg dansyl chloride in 50 ~L DCM (to give 10 mole equivalents total) 
was added and the reaction was stirred at 35°C for another 2.5 hrs. After this time a 
further 0.5 mg dansyl chloride and 5 ~L pyridine were added to the reaction mixture, 
and the reaction was stirred at 35°C overnight. Water (100 ~L) was added to the 
reaction mixture and the solution was extracted with DCM ( 4 x 1 mL), then with 
MeOH ( 4 x 1 mL). The solvent was removed from the DCM extract to give 0.6 mg 
of product. 
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APPENDIX I 
Antimicrobial and Antiviral Assays 
The antimicrobial assay currently screens against six bacterial and fungal organisms 
of interest: Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa, Candida 
albicans, Trichophyton mentagrophytes and Cladosporium resinae. The bacteria or 
fungi are grown over agar in a petri dish and the extract or compound of interest is 
impregnated on a paper disk and placed on the agar surface. The plate is then 
incubated with the appropriate positive controls. Samples exhibiting antimicrobial 
activity display a zone of inhibition outside the disk. 
The antiviral in vitro assay uses the BSC-1 cell line (African Green Monkey kidney 
cells) infected with either Herpes simplex type 1 virus (a DVA virus) or Polio virus 
type 1 (an RNA virus). These cells are grown on the surface of plastic cells, infected 
with a test virus and the sample-impregnated paper disk is placed into the well. 
After incubation the well is examined for the size of the antiviral and/or cytotoxicity 
zones and the type of cytotoxicity present. An interpretation of the cytotoxicity 
observed by morphological evaluation of the cells relative to control cells can 
provide valuable information as to the specific mode of action of the test compound. 
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APPENDIX III 
Total Synthesis of the Halichondrins 
A summary of the synthetic strategy undertaken in the total synthesis of halichondrin 
B, achieved by Kishi and co-workersl-5 in 1992, is illustrated in Scheme 1. A brief 
summary and discussion of this synthesis follows. Particular reference is given to 
the chemistry involved, the emphasis being in the final stages of the synthesis where 
the fragments resemble large fragments of the halichondrins. It was envisaged that a 
knowledge of the chemistry involved in these syntheses would provide further 
insight into the general chemistry of the halichondrins. 
Synthetic work towards the halichondrins has also been undertaken in other 
laboratories.6-15 A paper by Cooper et al6 is given special reference as the authors 
comment on possible acid decomposition pathways for the tricyclo fragment Cl-
C 14. Their observations have important implications in this project. 
The total synthesis of halichondrin B (1) centred around the synthesis of the "leftu 
(C39-C54) and !fright halfu (Cl-C38) fragments of the structure and the coupling of 
the two "halves" to form the spiro centre at C38. The "leftu hand side of the 
molecule from C39 furnished the desired halichondrin family fragment viz 
norhalichondrin, homohalichondrin or halichondrin (2). The uright" half of the 
molecule from Cl to C38 was synthesised (3) to furnish the B series fragment of the 
halichondrins. 
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Generally, the starting points for the synthesis of the fragments began with 
inexpensive, commercially available compounds of known absolute stereochemistry 
such as simple sugars. 
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Scheme 1 Kishi Synthesis: Strategic Summary 
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Cl-C13 Subunit and C14-C38 Coupling 
The Cl-C14 subunit was originally synthesised from 1,6-anhydro-D-galactose 3,4-
acetonide and converted to 1,6-anhydro-D-talose 3,4-acetonide with antipodal 
stereochemistry around the B ring)6 The C1-C14 subunit synthesised was therefore 
the antipode of the B series of halichondrins. 
In the total synthesis, the construction of the Cl-Cl3 subunit 6 involved starting with 
the diacetonide of D-glucose and conversion to the L-talofuranoside derivative17 
with the correct absolute stereochemistry. 
The closure of the C, D and E rings of the tricyclo system was not carried out until 
coupling of the C1-C13 and Cl4-C38 fragments had been completed. Initially, the 
C14 aldehyde of 5 was coupled with 6 to form the new Cl3-C14 bond mediated by 
Ni(II)/Cr(II).18 This reaction was carried out in THF (tetrahydrofuran) with DMF 
(N,N-dimethylformamide) as the base. This was then oxidised to the ketone at C14 
to give the desired trans-enone in 77% overall yield. The Dess Martin reagent 
(periodinane) was used at room temperature as the oxidising agent. The C30 MPM 
((p-methoxyphenyl) methyl) group was cleaved with DDQ (2,3-dichloro-5,6-
dicyano-1,4-benzoquinone) at pH 7.0 in tBuOH. After the C1 methyl ester was 
hydrolysed with LiOH/H20 in THF, a Yamaguchi lactonisation 19 furnished the 
lactone 4. A Yamaguchi lactonisation involves initial formation of a mixed 
anhydride at the Cl carboxylic acid with 2,4,6-trichlorobenzoyl chloride with 
triethylamine in THF. Alcoholysis of the anhydride by the C30 alcohol in the 
presence of the acylation catalyst DMAP (dimethylamino pyridine) in toluene then 
forms the lactone ring. After cleavage of the TBS (tert-butyldimethylsilyl) 
protecting groups with TBAF ((n-Bu)4NF) the trans-enone (4) underwent a Michael 
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addition to form the desired 5-membered C ring with a stereoselectivity of 5-6:1 at 
C12. Acid treatment with PPTS (pyridinium p-toluene sulfonate) in 
dichloromethane (DCM) resulted in intramolecular ketalisation and completion of 
the D and E rings to give 3. 
Formation of C14-C38 
This subunit ( 5) was coupled to the C1-C13 subunit 6 to form the new 11 Cl-C30" and 
C13-C14 bonds. The synthesis began with the pivaloyl (Pv; trimethylacetyl) ester 10 
derived from 2-deoxy-L-arabinose diethyl thioacetal 4,5-acetonide in 13 steps (47% 
overall yield). The primary alcohol at C21 (halichondrin numbering) was then 
oxidised to give the aldehyde and coupling to 9 via a Horner-Emmons reaction 
resulted in formation of the new C21-C22 bond, and was followed by the conjugate 
reduction of the enone produced. Hydride reduction of the resulting saturated ketone 
produced a 1:1 ratio of the possible diastereoisomeric alcohols at C23. Kishi states 
that the two diastereoisomers were readily interconvertible via the Mitsunobu 
reaction20 to form 8. The next step was to add the C27-C38 subunit 7. 
The C27-C38 fragment was synthesised from D-galactose glycal using the C34 
stereochemistry (halichondrin numbering) to dictate the C32 and C31 
stereochemistry. This was achieved by way of an Ireland-Claisen rearrangement21 
of the C35 protected dipropionate of D-galactose glycal to give 11 initially, trapped 
as the silyl enol ether. This was carried out under HMP A 
(hexamethylphosphoramide)-THF solvent conditions with a stereoselectivity of 8:1 
in favour of the desired stereoisomer. 
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The mixture was iodolactonised, and the iodine reductively removed to give the y-
lactone 12. 
OH 
34 H 
12 
0 
This was then converted to the aldehyde at C30 and coupled to acrylate to form the 
C29-C30 bond as a 2:1 diastereoisomeric mixture of the alcohol favouring the 
desired stereoisomer. A Michael reaction from the C33 deprotected alcohol gave the 
cyclised product with a 20:1 stereoselectivity at the new chiral centre formed at C29. 
The alcohol produced was then oxidised to form the aldehyde 7. 
Coupling of the two fragments 7 and 8 mediated by Ni(II)/Cr(II) with DMF in THF 
gave a 6:1 ratio of the two ally lie alcohols at C27 which was then cyclised under 
basic conditions (KH/DME (1 ,2-dimethoxyethane)) to produce the desired 
tetrahydropyran ring "G" (5) in 50-60% overall yield. 
That completed the synthesis of the C14-C38 subunit (5) which was subsequently 
coupled to Cl-C13 (6) by the formation of the C13-Cl4 and 11C1-C30" bonds and 
cyclisation of the tricyclo system as described previously. 
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C39-C54 halichondrin B 
Coupling of this fragment (2) to the right hand side of halichondrin B (Cl-C38). 
Kishi synthesised the "left hand" portions corresponding to norhalichondrin (derived 
from the C27-C38 synthesis; Ireland-Claisen rearrangement of the D-galactose 
glycal dipropionate in the absence of HMPA), and homohalichondrin and 
halichondrin families.3,4 
The synthesis of the halichondrin subclass started from L-ascorbic acid. Protection 
of the diol as an acetonide followed by conversion of the a,~-unsaturated y-lactone 
to 13 by methylcuprate (Me2CuLi). This was converted to the epoxide 14 by routine 
functional group interconversions and coupled to the acetylene 15 derived from D-
malic acid. Lindlar reduction of the product gave the expected cis-olefin 16 (86% 
yield from the epoxide). 
16 OMPM 
OMPM 
14 15 
OPv 
The epoxide was formed across the olefin by the Sharpless method, 22 and acid 
treatment gave the desired tetrahydofuran 17 with a 7-8:1 stereoselectivity. 
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The free hydroxyl groups were protected and the pivaloyl ester group removed and 
oxidised to the aldehyde before coupling to 18. 
gHa 
Br OMPM ,, ,, 
,, 
,, 
18 II 
TMS 
Fragment 18 was synthesised from S-(+)-methy13-hydroxy-2-methylpropionatein 8 
steps (40% overall yield). After coupling of 18 to the oxidised 17 fragment the 
selective reduction of the acetylene to the trans-olefin, iodination and Dess-Martin 
oxidation23 of the alcohol at C42 gave 2. 
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Coupling of the left and right hand fragments 
Deprotection and oxidation of the Cl-C38 primary alcohol 3 at C38 under Dess-
Martin conditions and coupling was achieved with the left "half' C39-C54 subunit 2 
by a Ni(II)/Cr(II)/DMF mediated reaction. Dess-Martin oxidation of the C38 alcohol 
formed furnished the trans-enone. Three steps transformed this into halichondrin B 
with a high degree of stereoselectivity. Removal of the C48 TBS group with TBAF 
in DMF resulted in hemiketal formation at C44 gave the "M" ring. Michael addition 
from the hemiketal hydroxyl group furnished the "L" ring and the 6,6 spiro centre. 
Deprotection of the C41 MPM ((p-methoxyphenyl)methyl) group by DDQ (2,3-
dichloro-5,6-dicyano-1,4-benzoquinone) at pH 7.0 followed by CSA (camphor 
sulfonic acid) treatment in DCM resulted in ketalisation and completion of the final 
5,5 spiro centre at C38. Kishi comments that the stereoselectivity of the three steps 
was "very high". 
Kishi reports that the product formed was assigned as halichondrin B on the basis of 
lH NMR spectroscopy, MS, IR, [a]n and chromatography, relative to a sample of 
natural halichondrin B. 
The Cooper Paper6 
As part of an overview of the work in the synthetic area, an interesting observation 
was noted in a paper by Cooper et al6. They observed the formation of a furan 
derivative (20) after the synthetic fragment 19 was placed in CDCb for 8 hours at 
room temperature, "presumably due to traces ofHCl in the solvent". They comment 
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that a specific mode of acid decomposition for the halichondrins has not previously 
been reported and that this reactivity may have biological "significance". 
MeO 1 
0 
19 
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lsohomohalichondrin B, a New Antitumour Polyether Macrolide from the 
New Zealand Deep-Water Sponge Lissodendoryx sp. 
Marc Litaudon, Joanne B Hart, John W Blunt,* Robin J Lake & Murray II G Munro.* 
Department of Chemistry, University of Canterbury, Christchurch, NBW ZEALAND. 
Abstract: Jsohomohalichondrin B, a new structural type in the halichomlrin group, has been isolated from the deep-water New 
Zealand sponge Lissodet1doryx sp. Like some other members of the halichondrin family isohomohalichondrin B exhibited remarkable 
cytotoxicity against the P388 (murine leukaemia) cell line and selective cytotoxicity in the NCI's primary screen. 
During our investigation of the biological potential of the New Zealand marine biota, I attention was drawn 
to a bright yellow sponge Lissodendoryx sp. (family Myxillidae, order Poecilosclerida) collected by dredging 
from deep water (100m) off the Kaikoura Peninsula. Trial extracts from this sponge were strongly inhibitory 
against the murine leukemia cell line P388, a DNA virus (Herpes simplex Type I) and an RNA virus (Polio 
vaccine virus). Initial studies on the sponge established that the active components were stable, and furthermore, 
cmde extracts of this sponge offered significant extensions of life-span in an in vil'o murine P388 model (TIC 
-250% ). Extraction of the sponge (5 kg) with CH30H/CH2C12 (3: l) was followed by partitioning of the crude 
extract between CHzCh and water. Further partitioning of the organic soluble portion between aqueous CH30H 
(80%) and hexane yielded a crude organic extract (3.8 g). This was subjected to bioassay-directed C-18 reverse 
phase flash chromatography, LH-20 gel permeation chromatography (2x) using CH30H/CH2Ci2 (6:4) as eluent, 
and preparative C-18 reverse phase high pressure liquid chromatography with CH3CN!HzO (1: 1) as eluent to 
yield three biologically active components I (2 mg; 4x I0-5% ), 2 (3.5 mg; 7x w-5%) and 3 ( 4.5 mg; 9x to-5%) 
and several (>6) minor components. Based on HRFAB mass spectroscopy and extensive 1-D and 2-D nmr 
analysis 1 and 2 were identified as halichondrin B and homohalichondrin B respectively, while 3 was 
recognised as a new class of halichondrin. 2 
2. Homohalichondrin B 3. lsohomnhalichondrin B 
The halichondrins are a series of poly ether macro! ides originally isolated from the sponge Haliclwndria 
okadai Kadota.3 Some of these, in particular halichondrin B, have shown potent in vitro and in vivo antitumor 
activity.J-5 Subsequently, halichondrin B 1 and homohalichondrin B 2 have been isolated from two other 
Southern Hemisphere sponges,4,5 along with halistatin 1 4, (lOa-hydroxyhalichondrin B).5 Halichondrin B 1 
and halistatin 1 4 have been determined to be noncompetitive inhibitors of the binding of vincristine to tubulin 
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and to inhibit nucleotide exchange on tubulin.5,6 In 1992 halichondrin B 1 was selected by the NCI Decision 
Network Decision Committee for development as an anticancer dntg,7 indicating the importance of this family of 
compounds as potential anticancer agents. The finding of a new halichondrin therefore is of significance for 
stntcture-activity relationships. 
HRFABMS on 3 (as MK+) corresponded to C6tHs60 19, isobaric with homohalichondrin B. 
Consequently, the new halichondrin was named isohomohalichondrin B. The structure of 3 was established 
using IH-IH COSY (two different solvents, CD30D and CDCI3/pyridine-ds (1 drop)), lD and 2D TOCSY, 
HMQC and HMBC experiments. Proton connectivities from Cl to C48 were identical with those already 
defined for halichondrin B 1 and homohalichondrin B 2.2.3-5 This region constitutes the unchanged section of 
the halichondrin system found through the norhalichondrin,3 halichondrin 1 and homohalichondrin 2 series of 
compounds and their associated A, Band C families.3,8 This unifying aspect of the halichondrin structure has 
been annunciated as the ha/ipyran system by Pettit et a/.5 For isohomohalichondrin B 3 the "unique" region 
encompassing H48 to H55 was identified as three additional proton spin systems.2 In the Be NMR spectntm at 
125 MHz all 61 carbons were observed, but the ketone resonance for C53 was absent from a spectrum obtained 
at 75 MHz. The HMQC experiment confirmed the presence of 4 methines and 4 methylenes in the unique "left 
hand" end (from C47 to C55), while HMBC supported the unique sequence C51 to C55 by the observation of 
long-range correlations between the protons at positions 51, 52, 54 and 55 and the carbon at 209.5 ppm as 
shown in Figure I. The sequence from H46 through to H51 was established by COSY and TOCSY 
correlations. 
HO....._ 
.. ~: 
(?t-O '""" 1 HMBC oo""'"'"""' $tOH Figure 2 NOESY Connectivities 
Figure 3 
H 
H 
55 
OH 
The relative stereochemistry of isohomohalichondrin 3 
was established by NOESY experiments (see Figure 2). This 
conl1rmed the cis fusion of the M/N ring junction (H47 and 
H48 cis) as in all other halichondrins isolated to date. A 
strong correlation between H50 and H51, which was also 
correlated with H47, established the cis relationship of all 3 
hydrogens. These NOESY results, supported by the derived 
coupling constants for the spin systems, are best interpreted 
in terms of a chair/chair conformation for this I ,5-
bisoxadecalin system (Figure 3). 
The absolute stereochemistry of isohomohalichondrin B, as depicted in 3 and Figure 3, is based on the 
defined stereochemistry of a norhalichondrin derivative by X-ray crystallography3a and the similarity in sign and 
magnitude of the optical rotation of 32 with that of homohalichondrin B 2, and other members of the 
halichondrin family of compounds. 3b 
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The side-chain (C52-C55) of 3 has more degrees of motional freedom than the central core. This is shown 
by the low intensity resonance for C53 (oc 209.5 ppm), which can be attributed to a longer relaxation time in 
comparison to the other carbons present and supported by the measurement of the relaxation times for the C54 
and C55 protons which were 2x the average ofthe Tt values of the other methylene protons. 
Testing of the halichondrins from Lissodendoryx sp. in our in-house murine leukaemia (P388 cell line) 
assay confirmed the exceedingly potent nature of this group of compounds. [lsohomohalichondrin B 3, 
halichondrin B l and homohalichondrin B 2 (ICso 0.18, 0.78 and 0.22 ng/mL respectively)]. These results 
were confirmed when the New Zealand samples of the halichondrins (1, 2 and 3) were tested against the >60 
cell lines in the US NCI's human tumour cell line in vitro screen.9 The pattern of inhibition demonstrated by the 
isohomohalichondrin B 3 was highly characteristic and use of the COMPARE algorithm!O showed that it was 
highly correlated with the other known halichondrins (see Table below). As noted previously for halichondrin B 
1 and homohalichondrin B 2,11 isohomohalichondrin B 3 was also highly correlated with tubulin-binding agents 
such as vincristine, maytansine and taxol. When tested in a tubulin binding assay 11 isohomohalichondrin B 3 
was found to be an effective inhibitor of tubulin polymerisation. 
ll 
b 
Compound8 
Halichondrin B I 
Homohalichondrin B 2 
Isohomohalichondrin B 3 
Mean Panel Glso (xto·lOMJb 
1.38 
1.58 
1.15 
COMPARE Correlation Coeff.c 
1.00 
0.91 
0.80 
Compounds 1, 2, 3 were tested in quadruplicate at each ofJ different concentration ranges. 
Standard errors averaged < 15% of tl1e respective means. 
Coefficients were calculated using the TGI-centered mean graph profiles from the highest test concentration. The 
TGI mean graph profile ofhalichondrin B 1 was used as the "seed" for all comparisons. 
The halichondrins have now been isolated from three quite diverse sponge sources and detected in a fourth. 
The first reported isolation was from a Halichondrid sponge, Halichondria okadai Kadota, found on the Pacific 
coast of Japan.3 The next reported findings were from the Axinellid sponges, Axinet/a sp and Phake/lia carteri, 
found in the Western Pacific Island of Palau4 and in the Republic of Comoros in the Eastern Indian Ocean,5 
respectively. This most recent finding has been from the New Zealand Poecilosclerid sponge Lissodendoryx sp. 
We have also detected the halichondrins in yet another New Zealand sponge, the black shallow-water Axinellid, 
Raspalia agminata.12 The finding of the same compounds in such geographically and biologically diverse series 
strongly suggests that these compounds are less likely to be biosynthesised de novo by the sponge cells and 
more likely to originate from a sponge symbiont. Considerable attention has been focused recently on sponge 
symbionts and the role they play in the production of many of the so-called sponge metabolites.l3 We are 
currently examining samples of the Ussodendoryx sp. for symbionts and have undertaken a series of cellul~tr 
dissoci~ttion experiments in an attempt to determine the possible origin of the halichondrins.14 
One notable difference between the other halichondrin-containing sponges and the Lissodend01yx sp. is the 
relative yield of the halichondrins. The yield from the New Zealand sponge is >I Ox more than that noted for the 
other sponges. Notwithstanding, the halichondrins are another example of a rare resource with potential as an 
anticancer agent. Despite the successful synthesisl5 and partial synthesesl6 of the halichondrin skeleton the 
most obvious source of the compound in the near future is from natural sources. Lissodendory.x sp. is found in 
a challenging environment at only one site in New Zealand. To protect this resource and establish an altemative 
source of supply, intensive studies on the aquaculture of this sponge have been initiated.l7 
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APPENDIXV 
Two views of X -ray crystal structure of p-bromophenacyl ester of norhalichondrin A 
(p-bromophenacyl ester and C12 and Cl3 hydroxyls removed for simplicity).17 
